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Abstract 
The gonadal steroid l7 -ß oestradiol (E2) influences a variety of neural 
activities, not only those involved in aspects of reproductive physiology but also in 
other functions, including autonomic regulation and cognitive processes. The effects 
of sex steroid hormones are principally, although not exclusively, mediated by 
binding to their cognate intracellular receptors to regulate functions of their target 
cells. The expression of these receptors is an important determinant of the actions of 
steroid hormones. There are two principal oestrogen receptors (ER) characterised to 
date, ER -a and ER -ß, the products of two distinct genes. 
Using quantitative in situ hybridisation histochemistry we first described the 
distribution of neurones expressing the messenger ribonucleic acid (mRNA) moieties 
for both types of ER in rat brain. We then investigated whether changes in the 
expression of these transcripts occur in response to hormonal manipulations as well 
as physiological stimulation in two discrete regions: the hippocampus, involved in 
memory, behaviour and regulation of the hypothalamo- pituitary- adrenal (HPA) axis 
and the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei, producing 
oxytocin and vasopressin, and autonomic regulation. Both ER -a and -ß mRNAs 
were found to be expressed in the hippocampus, while only ER -ß mRNA was 
localised in the PVN and SON. 
In the hippocampus, changes in the expression of both mRNA transcripts 
following gonadectomy were found in a region- and time -specific manner and 
displayed a sexual dimorphic pattern. However, replacement of E2 in ovariectomised 
rats did not restore the basal level of expression indicating that factors other than the 
ligand itself are involved in mediating effects of gonadectomy. Hippocampal 
neurones also express GR and MR, receptors by which adrenal steroid hormones act 
through. Because glucocorticoids might act by heterologous regulation of ER mRNA 
expression, the effects of decreasing or increasing corticosteroid secretion were 
studied. 
None of the adrenal manipulations changed ER -a expression, but 
adrenalectomy decreased ER -p mRNA expression, only in CA1, and this was 
prevented by corticosterone replacement. Repeated stress for 72 h had no effect on 
either ER -a or -ß mRNA expression in the hippocampus. 
The expression of ER -ß mRNA was found in regions containing oxytocin and 
vasopressin magnocellular neurones; expression in the PVN was low in the medial 
parvocellular neurones, projecting to the median eminence, but high in the ventral 
group of parvocellular neurones which project to brainstem and spinal cord. 
In the SON the greater ER-I3 mRNA signal found in female than in male rats 
was abolished by gonadectomy, but not restored or altered in intact male rats by E2 
treatment. In the ventral parvocellular neurones, we found no sex difference in the 
expression of ER-E3 mRNA. Here, ovariectomy significantly increased the expression 
of ER -ß mRNA. The expression of ER-E3 mRNA in both the magno- and parvo- 
cellular neurones was not changed at the end of pregnancy, when oestrogen secretion 
is maximal. In contrast, marked changes in ER -ß mRNA expression were found in 
SON and PVN neurones, but not in the hippocampus, following manipulation of 
adrenal- corticoid secretion. First, bilateral adrenalectomy, removing gluco- and 
mineralo- corticoids, significantly increased ER -ß mRNA expression in the SON but 
not in the ventral parvocellular neurones. The effect of adrenalectomy was partially 
reversed by replacement with corticosterone. Stimulation of the HPA axis by 
repeated stress did not alter expression of ER -ß mRNA, except in the ventral 
parvocellular neurones where expression was significantly increased. Stimulating the 
magnocellular neurones by salt -loading markedly attenuated the expression of ER -p 
mRNA selectively in these neurones, and also in the ventral parvocellular PVN 
neurones. 
The results indicate actions of E2 via ER -a / -ß in hippocampus, but only via 
ER-I3 in the PVN /SON; there is a weak, regionally- specific regulation of ER-a/-13 by 
sex steroids. In contrast, ER -ß in magnocellular neurones may be up- regulated by 
gluco- and mineralo- corticoid deficiency, and down- regulated by physiological 
stimulation of the neurones. This would alter any ER- mediated effects of E2 on the 
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1.1. Sex steroid hormones 
The principal female sex steroids consist of three different oestrogenic 
compounds, oestradiol -l7ß (E2), oestrone (E1), and oestriol (E3) as well as naturally 
occurring progestogens, principally progesterone (P4). Of the three oestrogens, E2 is 
the most potent and most abundant molecule, and is responsible for mediating most 
of the oestrogenic effects in the body. 
In women, the circulating concentrations of these hormones fluctuate during 
the reproductive cycle. Before pregnancy, the main source of oestrogens is the E2 
produced by the granulosa cells (and to a lesser extent thecal cells) of the follicles in 
the adult ovaries (Hilf & Wittliff, 1975). Other sites of oestrogen production include 
cells in the corpus luteum where E2 is produced during the luteal phase as well as the 
adrenal glands, although they do not produce E2 in any significant amount. During 
pregnancy, however, the foeto -placental unit takes over as the primary synthesis site 
for oestrogens and produces E3 in large amount from precursors derived from 
maternal and foetal adrenal glands. On the other hand, the role of E2 becomes less 
significant in postmenopausal women when the ovary has ceased to produce 
oestrogens. Instead the major source of circulating oestrogens is E1 which is formed 
from the peripheral conversion of androstenedione under the control of the enzyme 
aromatase. Formation of E1 occurs in many peripheral organs but chiefly in the 
adipose tissue from where the majority of Ei is derived. Indeed, obese menopausal 
women can have normal or even raised oestrogen levels compared to the 
premenopausal non -obese women (Laycock & Wise, 1996). 
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As for P4, it is secreted primarily by the corpus luteum during the luteal phase 
of the reproductive cycle and by the foeto -placental unit during pregnancy. P4 is not 
only important for its own endocrine actions but also for its role as a precursor 
molecule in the synthesis of steroids in tissues that produce them. 
The chief male sex hormones, the androgens, are primarily synthesised by the 
interstitial (Leydig) cells in the testes with the remainder being produced by the 
adrenal glands. Androgens are presented in two molecular forms; testosterone (T) 
and 5 -a dihydrotestosterone (DHT). The conversion of T into DHT is controlled by 
the 5a- reductase enzyme (Normington & Russell, 1992; Russell & Wilson, 1994; 
Selmanoff et al., 1977), where DHT exerts its physiological role in peripheral 
androgen- dependent structures such as the development and function of prostate 
gland (Poletti et al., 1998). Moreover, in the CNS, the cytochrome P450 aromatase 
(oestrogen synthase) enzyme converts T into E2 (Lephart & Ojeda, 1990; Naftolin et 
al., 1975) where it elicits most of its effects in this tissue (MacLusky & Naftolin, 
1981; Roselli, Horton, & Resko, 1987; Roselli & Klosterman, 1998). 
The biosynthesis of oestrogens begins with the formation of androgens from 
the common precursor cholesterol, which can be synthesised by endocrine cells from 
acetate or it can reach the cell following its transport in the blood associated with 
lipoproteins. In fact, all steroid hormones are derived from cholesterol and therefore 
consist of the cyclopentanoperhydrophenanthrene nucleus with varying side chains 


























Figure 1.1. A schematic representation of steroid 
principle steroidogenic enzymes involved in the 
are indicated. Most of these enzymes, however, 
cytochromes that have multiple activities (Miller, 
(Reproduced from Bolander, 1994) 
orrymaroraoao 
biosynthetic pathways. Some of the 
interconvertion of various steroids 
belong to a large family of P450 
1988). 
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Classically, the steroid hormones were believed to derive exclusively from 
the peripheral endocrine glands. However, recent studies have suggested that the 
CNS of rodent brain is also capable of synthesising various steroid hormones, such 
as pregnenolone (05P) and dehydroepiandrosterone (DHEA). These neurosteroids, 
which are synthesised de novo from cholesterol or other precursors in the CNS, are 
present in higher concentrations in tissue from the nervous system than in the 
plasma. Moreover, they are maintained in substantial amounts in the CNS even after 
the removal of the peripheral endocrine sources (Robel & Baulieu, 1994). These 
molecules have been implicated in the control of metabolic, behavioural and 
psychical processes including cognition, stress, anxiety and sleep (Baulieu & Robel, 
1996; Majewska, 1992) (for a recent review on Neurosteroids see Compagnone & 
Mellon, 2000) 
Effects of gonadal steroids are exerted both in adult life and during 
development, when many tissues including the brain are fundamentally organised as 
a result of an early life exposure to the gonadal hormones. These `organisational' 
effects of sex steroids are believed to occur during the critical time -frame from late 
foetal development and continue through to the first few days of post natal life. The 
effects are mostly permanent and provide the neurological basis for adult behaviour. 
Later in life, however, sex steroid hormone exposure can also exert an `activational' 
effect upon responsive neurones by a number of mechanisms e.g., by changing 
neurotransmitter function (Biegon & McEwen, 1982; Di Paolo, 1994) or affecting 
neuronal plasticity (Frankfurt, 1994). Often this results in an induction of a 
temporary alteration in the animal's behaviour. A prime example of these dual 
effects of sex steroids is evident in mammalian brain structures which are highly 
susceptible to circulating sex steroid hormone level. For instance, Phoenix et al. 1959 
has shown that exposure of female rodents to androgens in utero permanently 
reduced their sexual receptivity which was persistent through to adulthood (Phoenix 
et al., 1959). The permanence of such effects seems likely to occur as a result of an 
organisation effect on the nervous tissue rather than a mere temporary activation of 
the system. In contrast the induction in the short term of many well -established 
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behaviours such as maternal and sexual behaviours, can be induced experimentally 
by exposure of adult female rats to E2 and P4, the effects which are reversed upon 
removal of the hormone exposure (Bridges, 1984; Moltz et al., 1970; Siegel & 
Rosenblatt, 1975). 
Although generally regarded as sex hormones, gonadal steroids, in particular 
E2, affects a wide range of physiological processes. This is reflected by the 
prominent expression of oestrogen receptor (ER), the mediator of E2 action, found in 
many organs. 
1.2. Pathways mediating actions of oestrogens 
Actions of steroid hormones are largely dependent on the receptors in cells in 
target organs. Although other cellular proteins are involved, it is the receptor that 
largely dictates the magnitude of steroid response. Pathways mediating actions of 
steroids are generally classified into two modes, although some other concepts have 
emerged in attempts to explain actions that deviate from both pathways (see below). 
1.2.1. Genomic pathway 
The major mode of steroid action is considered to be via the classical 
genomic pathway. Principally, the mechanism involves binding of the ligands to their 
cognate intracellular receptors, which function as ligand- dependent transcription 
factors. Steroid molecules are lipophilic in nature and so they diffuse readily across 
cell membranes and are retained in target cells by binding to their receptors. In the 
absence of hormone, each receptor monomer is sequestered with an inhibitory 
complex of heat -shock protein90 (hsp90) as well as other molecules (Smith, 1993; 
Smith & Toft, 1993). This receptor complex resides either in the cytoplasm or is 
loosely bound in the nucleus (this is the case for ER) (Parker, 1995). Once bound by 
ligand the receptor translocates into the nucleus and undergoes conformational 
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changes leading to dissociation of hsp90. The hormone- receptor complex then forms 
(homo -/hetero -) dimers and interacts sequence -specifically with a specific hormone 
response element (HRE) in the promoter region of target DNA to modulate the 
transcription process. The consensus oestrogen response element (ERE) is 
characterised by the inverted repeat of two half -sites palindromes 5'- 
GGTCAnnnTGACC-3' separated by 3 bp (Klein -Hitpass et al., 1988; Klein -Hitpass 
et al., 1986; Seiler -Tuyns et al., 1986). 
Such genomic events involve de novo protein synthesis and are characterised 
by a long latency and duration of action which usually takes up to hours or days to 
occur (Lee & Gorski, 1996). The process can be blocked by mRNA or protein 
synthesis inhibitors such as actinomycin D, purinomycin or cyclohexamide. 
Oestrogen receptor (ER) together with the receptors for various other sex and adrenal 
hormones constitute a large steroid -hormone receptor superfamily, which includes 
glucocorticoid (GR), mineralocorticoid (MR), thyroid hormone (TR), vitamin D 
metabolites (VD), retinoic acid (RAR), androgen (AR) as well as progesterone (PR) 
receptors (Keightley, 1998). Hormone receptor molecules are found in substantial 
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Figure 1.2. Proposed model for the oestrogen -signalling pathway suggests various 
alternative dimerisation states of the oestrogen receptors. Steroid hormone receptors 
are known to form predominantly homodimers and bind to the hormone response 
element to modulate the transcription of target genes (Beato, 1989; Kumar & 
Chambon, 1988). However, several in vitro as well as in vivo studies have shown that 
ER -a and ER -ß can heterodimerise and that the activity of this complex is different 
from, and intermediate between that of the homodimers of either receptor subtype (in 
mouse (Pettersson et al., 1997) and in human (Pace et al., 1997)). Consequently this 
combinational approach could enhance the repertoire of possible target genes 
modulation by E2. Indeed a study by Giguère et al. 1998 suggests that 
heterodimerisation is in fact the preferred state in the presence of both ER subtypes 
(Giguère, Tremblay, & Tremblay, 1998). Ultimately the response of genes to 
oestrogens would depend on the overall proportion of the ER -a or -13 homodimers as 
well as the heterodimers in tissues that express both receptor subtypes. Alternative to 
the classic ERE, both ERs have recently been reported to be able to stimulate gene 
expression from promoters that contain the activating protein (AP) -1 site, the cognate 
binding site for the transcription factors Jun and Fos (Gaub et al., 1990). Intriguingly 
the response of transcription via this AP -1 site appears to mediate an opposite effect 
between ER -a and -13 in the presence of E2. While ER -a exhibits dose -dependent 
transcriptional activation, ER -13, on the other hand, shows no effect or inhibits the 
stimulation in an antiestrogen- dependent fashion (Paech et al., 1997). This suggests a 
novel route by which E2 could modulate gene transcription in addition to the ER- 
ERE pathway. 
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1.2.2. Non -genomic pathway 
In contrast to the genomic pathway, a non -genomic mechanism does not 
require the presence of the intracellular receptors. Instead, the mechanism involves 
putative membrane -bound receptor molecules which interact with 2nd messenger 
coupling systems. The rapid time course of these effects, typically within the range 
of seconds, and its insensitivity to transcriptional and translational inhibitors, 
suggests that the genomic pathway is unlikely to be involved. The underlying 
mechanism for the non -genomic pathway is not completely understood and the 
receptor(s) involved is not fully characterised, as yet, although membrane ERs have 
been reported in a cell line (Pappas et al., 1994), brain (Ramirez, Zheng, & Siddiquc, 
1996), liver (Moats & Ramirez, 1998; Pietras & Szego, 1979a; Pietras & Szego, 
1979b; Pietras & Szego, 1980), uterus (Monje & Boland, 1999), as well as on 
neuronal cell membranes (Clarke et al., 2000). The study by Razandi et al. 1999 
suggests that, perhaps, both the cell membrane and nuclear ER (both -a and -p) 
might originate from the same transcript, although the number of those membrane - 
bound ERs are markedly less than that found in the nuclear compartment ( Razandi et 
al., 1999). 
In recent years the non -genomic action of steroids has gained a better 
appreciation. In particular, effects on neuronal excitability (Moss & Gu, 1999) have 
been intensely explored in the past couple of years. A detailed description of the 
mechanism for non -transcriptional pathway of oestrogen signalling is not intended as 
a primary aim in this thesis, thus only relevant points will be commented upon. 
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1.3. Nuclear oestrogen receptors 
There are two oestrogen receptors (ER) identified and characterised to date. 
The first of the two ERs, named ER -a, was among the very first of the steroid 
receptors to be characterised and was cloned from many species during the late 
1980s (for human (Green et al., 1986; Greene et al., 1986; Walter et al., 1985), for 
rat (Koike, Sakai, & Muramatsu, 1987), for mouse (White et al., 1987) and for 
chicken (Maxwell et al., 1987). The physiological role of ER -a is well documented 
in many areas, particularly those related to reproductive function, and served as the 
basis for understanding the actions of oestrogens for a number of years. In contrast, 
the novel ER-13 has only been recently cloned (Kuiper et al., 1996; Mosselman, 
Polman, & Dijkema, 1996) and so relatively less is known about its role compared to 
that of the classic ER -a. The two receptors represent examples of steroid receptor 
molecules existing as two isoforms but encoded by two separate genes (Kuiper et al., 
1996). In the human, ER-13 is located on chromosome 14 while the -a isoform is on 
chromosome 6 (Enmark et al., 1997). Both ER -a and -ß are able to stimulate the 
transcription of an ERE -transfected reporter gene in a dose -dependent manner 
(Cowley et al., 1997; Kuiper et al., 1997; Mosselman, Polman, & Dijkema, 1996; 
Watanabe et al., 1997). 
Although both receptors have been shown to be co- localised in a number of 
tissues including the central nervous system, the cellular distribution of the two 
forms of ER is rather distinct suggesting significant differences of each receptor 
subtype in conferring specific biological processes in a tissue- and /or cell type - 
specific manner (Brandenberger, Tee, & Jaffe, 1998; Byers et al., 1997; Couse et al., 
1997; Kuiper et al., 1997; Kuiper et al., 1998b; Shughrue, Komm, & Merchenthaler, 
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Figure 1.3. Schematic representation of the structures of rat ER -a (1) and ER -ß (2) 
showing percentage (numbers in italics) of amino -acid identity between the two 
cDNAs. Unique to the nuclear receptor superfamily, their primary structure is 
characterised by amino acid sequence encoding four or five functional domains, A -F. 
The amino -terminal A/B domain is the most variable portion of the steroid receptor, 
both in length and sequence, and demonstrates only 16.5% homology between ER -a 
and -13. This domain contributes to the transactivation function of the receptor which 
activates target genes via the core transcription machinery (Horwitz et al., 1996). The 
C region, denoted DNA -binding domain (DBD), is most conserved between different 
nuclear receptors including that of ER -a vs -ß, with 97% homology between the two. 
Not surprisingly, both ERs interact with similar binding to a consensus DNA 
response elements (namely, ERE) located in the regulatory regions of the target 
genes. Apart from its role in the binding of the receptor to the DNA hormone 
response element, this region also contains a weak dimerisation activity. The ligand- 
binding domain (LBD), E region, is relatively conserved and possesses multiple 
activities but most importantly it is responsible for the receptor -specific ligand 
binding process. Although the amino acid encoding this domain of the two ERs 
shares ca. 60% sequence identity, each ER subtype binds to E2 with nearly equal 
affinity and show a very similar ligand binding characteristics for a number of 
oestrogenic compounds (Kuiper et al., 1997). The D region, also known as the hinge 
domain, is located between the DBD and the LBD. Its major function lies in its 
specific sequence for the nuclear localisation signal. The carboxy- terminal F domain 
is not present in all nuclear receptors and its sequence in ERs is unique. It is involved 
in modulating the expression of target genes. (Detail based on ER -a (Koike et al., 
1987) and ER -13 (Kuiper et al., 1996)). 
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1.3.1. Oestrogen receptor -a 
An intense search for a gene encoding a protein with the ability to concentrate 
tritiated -E2 resulted in the cloning of the ER -a gene during the late 1980s. In We 
human the ER -a gene encodes a protein of 595 amino acids and is transcribed from 8 
exons (Green et al., 1986). The transcription of the mouse ER -a gene is slightly 
longer with 599 amino acids from a single transcript of 6.3 kb, and is transcribed 
from 9 exons (White et al., 1987). The rat ER -a clone with a complete open reading 
frame encodes 600 amino acid residues and shares 97% overall homology with the 
mouse ER -a protein sequence (Koike et al., 1987). 
The tissue distribution of ER -a indicates a relatively high degree of 
expression in the uterus, mammary gland, testis, pituitary, kidney and skeletal muscle 
and moderate to low expression in the epididymis, ovary and brain, although this 
depends on species, sex and techniques employed. (Byers et al., 1997; Couse et al., 
1997; Cuhna et al., 1991; Greco, Duello, & Gorski, 1993; Kuiper et al., 1997; 
Pasquálini & Sumida, 1986; Shughrue et al., 1996). Subsequent to the identification 
of the first ER -a many other splicing isoforms have been discovered. A recent 
investigation of the single human ER -a gene suggests a multiple promoter usage 
mechanism which gives rise to a total of 6 ER -a splicing transcripts, all of which 
encode a common receptor protein but containing a unique 5'- untranslated region 
(UTR) of their own. Furthermore each of these alternative splicing isoforms has been 
shown to exhibit a tissue -specific distribution and is subject to differential regulation 
by a number of transcription factors including their endogenous ligand, E2 (Flouriot 
et al., 1998). In rats, an isoform of the ER -a lacking exon four, which encodes part 
of the LBD, is expressed in the brain (Skipper et al., 1993). Another report extended 
the finding and suggested possibly at least four other subtypes of rat ER -a mRNA. 
Again the expression of these alternative splicing isoforms is quantitatively different 
from one tissue to another, and they are present at different developmental stages 
(Kato et al., 1998). 
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Although some of these splicing variants might not be translated into 
functional receptor protein or may be unable to bind ligand, they might function as 
important modulators of the tissue- and promoter- specific effects of E2 behaving in 
either a dominant -negative or dominant -positive manner (Dotzlaw, Alkhalaf, & 
Murphy, 1992; Lehrer et al., 1990; Murphy & Dotzlaw, 1989). 
The role of ER -a is further highlighted by the generation of oestrogen 
receptor `knock -out' (aERKO) mice in the early 1990s (Couse et al., 1 995 ; Lubahn 
et al., 1993). This molecular technique in which the gene encoding a particular 
protein has been disrupted, resulting in a non -functional receptor molecule, has 
partially enabled the identification of function of those genes of interest (or rather the 
function of the missing genes). This approach is useful particularly ill assessing 
altered behaviours as a result of the disrupted genes. Oestrogen receptor was 
traditionally thought to be critical for the survival of embryonal organisms, since no 
mutation in the ER gene that results in insensitivity to E2 had been reported in human 
or laboratory animals, while critical roles of E2 during embryonic development were 
demonstrated. However, this idea was challenged by the discovery of a man lacking 
functional ER in 1994 (Smith et al., 1994). Analysis of the ER gene of this patient 
showed a point mutation of codon 157 resulting in a non -functional ER lacking both 
the DBD and LBD. This homozygous mutation of the gene results in a range of 
impaired functions in many systems, especially within peripheral tissues, leading for 
example to osteoporosis. Equally, the aERKO mice, although they are viable and 
show normal gross development compared to their wild -type litter mates, exhibit 
several abnormalities in adulthood. Of note, these mice are infertile and display 
various alterations in their sexual behaviours both in males and females, confirming 
the essential role of ER -a in reproductive physiology (Ogawa et al., 1998a; Ogawa 
et al., 1997; Ogawa et al., 1998c). However, in the brains of aERKO mice, neurones 
in some structures including the preoptic, arcuate, bed nucleus of the stria terminalis 
and amygdala nuclei can still concentrate 
125I- oestrogen, the effect being 
competitively eliminated by E2 but not by an ER -a selective agonist, 16aIE2 
(Shughrue, Lane, & Merchenthaler, 1999). Functionally, E2 has been shown to up- 
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regulate the expression of the progesterone receptor (PR) mRNA in the medial 
preoptic area of aERKO mice (Shughrue et al., 1997b). 
Collectively these findings highlight the critical roles of the oestrogen - 
signalling pathway in many tissues although the disruption in the ER -a gene did 
prove to be non -lethal. Indeed the rescue mechanism and the remaining oestrogenic 
activity seen in the knock -out mice might be due to compensation mechanisms by 
other molecules, with ER- 3 being one very likely candidate. 
1.3.2. Oestrogen receptor -f3 
The recent discovery of ER-13 has provided an alternative nuclear receptor 
pathway by which oestrogenic compounds could mediate their effects upon certain 
tissues. The initial characterisation of the first reported ER-13 cDNA, cloned from rat 
prostate, indicated that it is composed of 485 amino acids with a molecular weight of 
54 kDa ( Kuiper et al., 1996) and shows a high degree of sequence homology to that 
of ER -a, particularly in the DBD (see Figure 1.3.). The genomic clone for ER -ß was 
subsequently cloned from many other mammalian species including human 
(Mosselman et al., 1996), mouse (Tremblay et al., 1997), gold fish (Tchoudakova, 
Pathak, & Callard, 1999), catfish (Xia et al., 1999), and cow (Rosenfeld et al., 1999). 
These homologs all have a similar relationship to ER -a. A number of miii;l 
investigations indicated high degree of expression of ER-3 in the ovary and prostate, 
moderate expression in the oviduct, testis, bladder, uterus, brain and lung and little or 
no expression in the mammary gland (Couse et al., 1997; Kuiper et al., 1997; Kuiper 
et al., 1996; Shughrue et al., 1998). 
In terms of ligand binding activity, ER -13 was found to bind E2 with a near - 
equal affinity to ER -a (Kd of 0.4 nM for -13 and 0.1 nM for -a), with low affinity for 
testosterone, progesterone and corticosterone (Kuiper et al., 1997; Kuiper et al., 
1996). Other potent ligands for ER -13 are the phyto -oestrogens, such as coumestrol, 
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genistein and kaempferol, which compete more strongly with E2 for binding to ER -13 
than to ER -a. These phyto- oestrogens possess the ability to stimulate transcriptional 
activity of both types of ER in the low nM range, at least in vitro (Kuiper et al., 
1997; Kuiper et al., 1998a). 
Following the identification of the first ER -ß clone, many isoforms of ER -ß 
have subsequently been cloned, with at least 9 or 10 reported in the current literature 
(Warner, Nilsson, & Gustafsson, 1999). They appear to be alternative splicing 
isoforms of the first ER-I3 (ER -(31), some of which have extended N- termini and 
others with truncations or insertions in the LBD. ER -ß2 mRNA contains an 
additional 54 nucleotides in the ligand binding domain of the first ER -ß (for human 
(Hanstein et al., 1999; Moore et al., 1998), for rat (Maruyama et al., 1998), and for 
mouse (Lu et al., 1998). The insertion of extra amino acids in this splicing isoform 
leads to decreased binding to E2. Hence ER -132 has an 8 -fold lower affinity for E2 
and requires a 100- to 1000- greater concentration of E2 for transcription activation 
compared to ER -131 or ER -a. ER -(32 coexists with both ER -a and ER -13l in varying 
proportions in a variety of tissues. In the brain, ER -(32 is located in the cortex, 
hypothalamus and hippocampus, although it is 2 to 6 -fold less abundant than ER -131 
(Petersen et al., 1998). Despite its reduced ligand binding activity, however, ER -(32 
can heterodimerise with both -a and -131 and bind to an ERE. It appears to function 
as a negative modulator of oestrogens since it suppresses ER -a and ER -ß I mediated 
transcription in a dose -dependent manner (Maruyama et al., 1998). Other ER -ß 
isoforms include the isoform 1 -5 from a human clone as well as ER -(3cx (for mouse 
(Pettersson et al., 1997), for human (Moore et al., 1998; Ogawa et al., 1998b). 
Whether all of the ER splicing isoforms identified thus far are translated into 
functional proteins and have any significant biological role is currently unknown. 
In contrast to aERKO, homozygous mutant mice bearing non -functional ER- 
(3 ( PERKO) develop normal sexual behaviour and are reproductively competent, 
although female ( aERKO have a reduced fertility capacity, i.e., fewer and smaller 
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litter sizes, presumably as a result of reduced ovarian efficiency. They have normal 
mammary development and lactate normally (Krege et al., 1998). 
1.4. Regulation of oestrogen receptor expression 
The concentration of hormone (ligand) and the number of their cognate 
receptor molecules determine the formation of active hormone- receptor complexes, 
which are related to the magnitude of the hormone response. Many physiological 
processes induced by E2 result from changes in the expression of those oestrogen - 
responsive genes which are in large part mediated by the ER. As a reflection of the 
variety of processes controlled by E2, ERs are found in many tissues. Their 
expression varies considerably among these tissues as well as within a single tissue. 
Clearly the expression of such important genes is subject to multiple control 
mechanisms to ensure that the appropriate amount of receptor is available in the 
correct cells at the specific time frame, both during early development as well as at 
later stages in life. 
The regulation of ER has been intensively studied, both in vivo and in vitro 
and in many different models. The effects of a number of oestrogenic compounds on 
target tissues can be very different and a single compound can mediate agonist- or 
antagonist -like responses depending on the tissue. Aside from the difference in the 
distribution pattern of the two ERs, these complex mechanisms are governed by a 
number of other factors and occur at several levels (Keightley, 1998). These include; 
1) nature of the ER, i.e., whether it is wild type or mutant, 2) differential receptor 
expression 3) the promoter organisation of the ER gene, 4) interaction of ER with co- 
activators and co- repressors 5) dimerisation status of the receptor (homo -/hetero -), 6) 
species/ developmental stage/ sex and tissue- /cell- context, and 7) differential ligand 
binding specificity. 
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The changes in ER mRNA expression might arise as a consequence of altered 
stability of the mRNA (Martin et al., 1995) or changes at the level of transcription 
(Koritnik, Koshy, & Hoversland, 1995; Shupnik, Gordon, & Chin, 1989). In a 
number of cases, the primary regulator of expression of the receptor is the ligand 
itself. Previous studies by Flouriot et al. 1996 have shown that E2 treatment in vitro 
induced rainbow trout (rt) ER mRNA accumulation in a hepatocyte culture system 
(which contains high level of ER) by inducing a 5 -fold increase in the ER gene 
transcription rate as well as a 3 -fold increase in the mRNA half life, indicating both 
transcriptional and post -transcriptional regulation of ER (Flouriot, Pakdel, & 
Valotaire, 1996). In another model study using a cancer cell line, Read et al. 1989 
(Read, Greene, & Katzenellenbogen, 1989) demonstrated that treatment of T47D 
cells (which contain a low level of ER) with E2 induced a 2.5 -fold increase in ER 
mRNA levels after 48 h, while progestin exposure resulted in an 80% decrease in ER 
mRNA and protein. On the other hand, the response of ER in MCF -7 cells (which 
possess a high level of ER) following E2 exposure depended upon the prior growth 
history of the cells. In cells previously exposed to a low oestrogen medium, treatment 
with E2 caused little change in either ER mRNA or protein. In contrast, cells that had 
been maintained in medium with a high level of oestrogen responded robustly, with a 
40% and 50% decrease in the mRNA and protein respectively, following E2 
treatment. This indicates that ER can be regulated by its own ligand (auto- regulation) 
and /or by another ligand (heterologous regulation). The response was evident both at 
the level of the mRNA and protein and dependent on the cell type context. 
1.4.1 Regulation of ER in the brain 
The regulation of ER has also been studied extensively in vivo, particularly in 
the CNS. A study by Shughrue et al. 1992 showed that the expression of ER mRNA 
increased at 72 h after ovariectomy in the mPOA, ARC, VMH and the magnitude of 
responses was quantitatively different among the three regions. This effect was not 
observed in castrated male rats (Shughrue, Bushnell, & Dorsa, 1992). On the other 
hand, a recent report on the expression of ER -(3 mRNA showed that gonadectomy 
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markedly attenuated the expression of ER -(3 mRNA in peripheral tissues, with the 
level of ER -(3 mRNA in the prostate reduced to non -detectable levels (Shughrue et 
al., 1998). By using Western blot analysis, Zhou et al. 1995 reported the detection of 
ER -a protein in the mPOA of normal cycling female and male rat brain. Quantitative 
analysis showed an alteration in ER protein content over the oestrous cycle, with the 
highest level detected during met -oestrus, attenuated on di- oestrus, and lowest during 
oestrus and pro -oestrus thus reflecting the response of ER to the available circulating 
E2 (Zhou, Shughrue, & Dorsa, 1995). A heterologous regulation of ER was also 
observed in vivo where P4 has been shown to decrease the concentration of ER in the 
hypothalamus of ovariectomised rats (Blaustein & Brown, 1984). Some recent 
studies have compared the expression of ER -a and ER -f3. Osterlund et al. 1998 have 
reported a differential regulation of both receptor transcripts in rat brain. In the 
hypothalamus treatment with a high dose of E2 in OVX rats (total of 170 µg over 14 
days) decreased ER -a mRNA in the ARC, VMH and posterolateral cortical 
amygdala nuclei, but increased ER-13 mRNA in the ARC nucleus. In the medial 
amygdala nuclei, only ER -13 mRNA level was altered by E2 treatment. The effect was 
largely not seen with a low dose of E2 (17µg) (Osterlund et al., 1998). Similar to in 
vitro experiments, the responses of both ER transcripts in vivo are largely dependent 
on cell -type and exhibit region- and dose -dependent manner. 
As previously mentioned, alternative pathways have been proposed to explain 
how ER action and expression is regulated. One mechanism is perhaps by interaction 
of ER with other transcription factors including its own splice variants. For instance, 
Wang et al. 1999 has found that human ER splice isoforms, ERAS and ERA7, 
substantially decreased the response of wide -type ER (wtER) activity in a yeast 
system, perhaps by competition with wtER to bind to the ERE (Wang, Zeng, & 
Khan, 1999). Another pathway is suggested by a recent study by Alarid et al. 1999 
which showed an autologous down -regulation of ER protein via a proteosome- 
mediated pathway that involved nuclear ER but apparently in the absence of protein 
synthesis and transcription (Alarid, Bakopoulos, & Solodin, 1999). Another study 
has suggested that long term activation of the protein kinase C signal transduction 
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pathway could inhibit ER function through activation of other cofactors which 
interact with ER (Martin et al., 1995). 
Thus the expression and action of ER is multi -level and subject to a complex 
hormonal regulation both by homologous (controlled by its own ligand, oestrogenic 
compounds) and heterologous (controlled by other hormone signals) mechanisms. 
Both types of regulation appear largely to follow the tissue- and cell -specific as well 
as dose -dependent manner in both the direction and the extent of modulation. The 
regulation of ER can occur at many levels including transcriptional, post - 
transcriptional, translational and post -translational mechanisms as well as via other 
mechanisms such as protein -protein interaction. The precise molecular mechanism of 
how these regulations might come about, however, remain largely undetermined. 
1.5. Hypothalamic paraventricular and supraoptic nuclei 
The production and secretion of oxytocin (OXT) and vasopressin (VP) by the 
hypothalamic neurones in the paraventricular (PVN) and supraoptic (SON) nuclei are 
modulated by sex steroid hormones. Recent studies have demonstrated the presence 
of ER-f3 in these two nuclei, suggesting the potential direct regulation of the 
neurosecretory system by E2. A full account of the relevant introductory material on 
this regulation of gonadal steroids in the PVN and SON will be discussed in the 
experimental chapter 5. 
1.5.1. The hypothalamo- pituitary connection 
Many of the endocrine glands in the body are controlled by the pituitary, or 
hypophysis. The pituitary is, in turn, under the influence of the hypothalamus, which 
in effect means that most of the endocrine system is brought under the control of the 
central nervous system. The pituitary gland comprises two major lobes, one neural 
tissue and the other glandular. The posterior lobe, or neurohypophysis, develops as 
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an outgrowth from the hypothalamus. It serves as the storage site for two 
neuropeptides, OXT and VP, synthesised in the magnocellular neurones in the SON 
and PVN of the hypothalamus. OXT and VP are transported from the hypothalamus 
to the posterior pituitary in the axons of the magnocellular neurones that project 
through the pituitary stalk and terminate on capillaries in the neurohypophysis where 
the stored peptide is contained within these axon terminals. This pathway forms the 
hypothalamo -neurohypophysial tract. In response to certain stimuli exciting the 
magnocellular neurones, the two peptides, separately or together are released into the 
general circulation (Figure 1.4.). 
The anterior lobe, or adenohypophysis, on the other hand, is composed of 
glandular tissue, and arises as an ectodermal invagination from the stomodeum. A 
number of trophic factors are produced from cells within the adenohypophysis 
including, among other molecules, corticotrophin (also known as 
adrenocorticotrophic hormone, ACTH) which controls the synthesis and release of 
glucocorticoids from the adrenal glands. The release of anterior pituitary hormones is 
regulated by the releasing hormones synthesised in neuroendocrine neurones located 
primarily in the periventricular zone of the hypothalamus, one of which is 
corticotrophin -releasing factor (CRF) from the PVN which, together with VP in 
these neurones, regulates the release of ACTH. 
As opposed to the hypothalamo -neurohypophysial tract, there is no direct 
neural connection between the hypothalamus and the anterior pituitary. Instead these 
hypothalamic factors are released into a primary capillary network in the external 
layer of the median eminence, and thus enter the hypothalamo -hypophysial portal 
system whence they influence the release of adenohypophysial hormones (Figure 
1.4.). 
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Magnocellular neurosecretory neurones 
Parvocellular in the hypothalamus 
Superior hypophysial 
artery 







artery Anterior Pituitary 
Intermediate pituitary 
Figure 1.4. Schematic representation of the hypothalamus and pituitary. A schematic 
of a section through the hypothalamus and the pituitary showing several of the main 
anatomical components. The pituitary gland is connected to the hypothalamus 
through the hypophysial stalk. The posterior pituitary is connected to the 
hypothalamus via the infundibulum of the stalk, and it receives its blood supply from 
the inferior hypophysial artery. The anterior pituitary is connected to the 
hypothalamus by the pars tuberalis which contains, amongst other things, the veins 
of the hypophysial portal system. The portal system is supplied by the superior 
hypophysial artery in the hypothalamus, and the portal system provides the blood 
supply to the anterior pituitary gland (Adapted from Brown, 1994). 
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1.5.2. The SON and PVN: Morphology and functional anatomy 
The supraoptic (SON) and paraventricular (PVN) nuclei can be easily 
identified in standard Nissl preparations as two pairs of relatively discrete nuclei 
around the base of the third ventricle in the hypothalamus. Two types of neurones are 
present within the PVN, the magnocellular and parvocellular neurones, while only 
magnocellular neurones are found within the SON. 
a) Supraoptic nucleus (SON) 
The SON, situated immediately lateral to the optic chiasm, contain essentially 
only magnocellular neurones. There are ca. 4400 -7000 neurones in each rat SON 
(Bodian & Maren, 1951; Léránth et al., 1975). Each cell body in the SON 
synthesises either VP or OXT. The oxytocinergic neurones are predominantly 
located posterodorsolaterally while the vasopressinergic neurones occupy the more 
anteroventromedial portion of the nucleus (Swaab, Nijveldt, & Pool, 1975a; 
Vandesande & Dierickx, 1975). Although the two peptides are produced by separate 
neurones their relative abundance can change in response to certain stimuli, and 
under certain physiological conditions involving prolonged stimulation a few cells 
express both peptides (Kiyama & Emson, 1990). Although these magnocellular 
neurones may project collaterals to various central sites, the major axon outputs from 
the SON terminate in the neurohypophysis (Hatton, 1990; Sherlock, Field, & 
Raisman, 1975) where OXT and VP are secreted from the nerve terminals (Scharrer 
& Scharrer, 1954) into the peripheral circulation following specific stimulation (see 
Hatton & Li, 1998; Leng, Brown, & Russell, 1999). 
Although these neurones synthesise OXT or VP, they can also produce and 
store some other neuropeptides, the amount of which can vary with the functional 
state. OXT- containing neurones have been shown to co- produce numerous other 
peptides, such as cholecystokinin (CCK), enkephalin as well as CRF, while VP 
neurones contain immunoreactivity for galanin, dynorphin, and a small amount of 
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CCK (Meister et al., 1990). Following osmotic stress, in particular, a massive up- 
regulation of CRF mRNA and peptide expression occurs in the magnocellular OXT 
neurones (Dohanics, Kovacs, & Makara, 1990; Jessop et al., 1989; Young, 1986). 
b) Paraventricular nucleus (PVN) 
The PVN is an important integrating site for behavioural, neuroendocrine and 
autonomic responses to various stimuli (Swanson & Sawchenko, 1983). These 
physiological responses are mediated by distinct subsets of intricately organised 
neurones found in this nucleus. 
In contrast to the SON, the PVN represents a much more heterogeneous 
population of neurones in terms of the cytoarchitecture, chemical signatures and 
functional properties (Armstrong et al., 1980; Swanson & Kuypers, 1980). 
Anatomically, the PVN can be divided into 8 distinct subdivisions, 3 of which are of 
magnocellular type while the rest Each subdivision carries distinct 
neuroendocrine functions and is regulated differentially (Swanson & Kuypers, 1980). 
Functionally, neurones within the PVN can be classified into 3 groups: those that 
project to the posterior pituitary, those that project to the median eminence and those 
associated with the autonomic nervous system (the visceromotor cell group). 
The posterior magnocellular PVN (MPVN) forms the largest group of 
neurones at the lateral edge of the nucleus. Like those in the SON, almost all of these 
large cells synthesise either OXT or VP and project their axons to the neural lobe of 
the pituitary (Fisher et al., 1979; Sawchenko & Swanson, 1983; Swanson & 
Sawchenko, 1983). The anterior and medial MPVN largely consists of OXT 
neurones, ca. 400 -600 in number (Sawchenko & Swanson, 1982). 
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On the contrary neurosecretory cells of the parvocellular (pPVN) origin send 
their axons to loci other than the neurohypophysis. The pPVN can be divided into 5 
distinct subdivisions; periventricular, anterior, medial, dorsal and lateral parts 
(Swanson & Kuypers, 1980). The periventricular, medial and dorsal pPVN project to 
the median eminence (Swanson et al., 1980; Wiegand & Price, 1980). Axons from 
dorsal, lateral and medial pPVN neurones also project to the dorsal vagal complex 
(Swanson & Kuypers, 1980), to the lateral medulla (Swanson et al., 1980) as well as 
to the preganglionic sympathetic neurones in the spinal cord (Swanson & Kuypers, 
1980) (Figure 1.5.). 
Neurones in the parvocellular subdivisions of the PVN generally participate 
in functions other than those related to the neurohypophysis, although some of these 
cells have been identified to contain OXT or VP (Sawchenko & Swanson, 1982). 
Some of these small cells have been shown to express immunoreactivity and mRNA 
for CCK, neurotensin, dopamine, enkephalin, substance P, as well as CRF (Swanson 
& Sawchenko, 1983 for review). Likewise, the abundance of these peptide molecules 
varies among, the separate subdivisions and their relative amount can change in 
response to various stimulations (Angulo, Ledoux, & McEwen, 1991; Sawchenko, 










































































































































































































































































































































































































































































































































































































































































































































































1.6. Functions of the magnocellular neurosecretory neurones: Oxytocin and 
Vasopressin 
Oxytocin (OXT) and vasopressin (VP) are the two principal secretory 
products of the magnocellular neurosecretory neurones (MCN) in the SON and PVN. 
The peptides are similar to each other with respect to their chemical structures 
(Acher, 1980; Du Vigneaud, 1956; Gainer & Wray, 1994). Each comprises 9 amino 
acids (nonapeptides) with a carboxy- terminal amide and a disulphide loop between 
residues 1 and 6. OXT differs from VP by having the amino leucine instead of 
arginine or lysine (depending on species) and isoleucine instead of phenylalanine, 
otherwise they are identical (Figure 1.6.). The genes encoding the peptides show a 
remarkable similarity in both organisation and nucleotide sequence (Ivel1 & Richter, 
1984; Schmale, Heinsohn, & Richter, 1983). 
Position: 1 2 3 4 5 6 7 8 9 
VP Cys Tyr Plie Gln Asn Cys Pro Ar.' Gly -NH2 
OXT Cys Tyr Ile Gln Asn Cys Pro Leu Gly -NH2 
Figure 1.6. Sequences of vasopressin and oxytocin peptides. The two nonapeptides 
are highly related. They differ from one another by 2 residues only and both possess 
a disulphide -linked ring structure between residues 1 and 6. 
Abbreviations: 
Asn = Asparagine Ile = Isoleucine 
Arg = Arginine Leu = Leucine 
Cys = Cysteine Phe = Phenylalanine 
Gln = Glutamine Pro = Proline 
Gly = Glycine Tyr = Tyrosine 
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The two peptides are initially synthesised as larger prohormone molecules 
which also contain neurophysin and, in the case of VP, a glycopeptide of unknown 
function. These complex molecules are incorporated into granules, which are stored 
in the neurohypophysis following axoplasmic transport from the cell bodies of the 
neurones of origin. The release of OXT and VP is elicited upon the arrival of action 
potentials at the nerve endings which depolarise the terminal membranes. As a result 
of depolarisation there is a prolonged opening of the voltage- dependent calcium 
channels which results in an influx of calcium and this subsequently triggers the 
exocytosis of the granule contents into the extracellular space, and diffusion into the 
bloodstream (Armstrong, 1995; Hatton, 1990). 
Cellular effects of VP and OXT are mediated via G- protein coupled 
receptors. Various studies have, to date, identified the existence of three different VP 
receptors (Via, V 1 b and V2) and one single OXT receptor (OTR), each coupled to a 
characteristic second messenger system (Barberis, Mouillac, & Durroux, 1998; 
Zingg, 1996). Whereas the V1 receptor is present in liver, vascular smooth muscle, 
adrenal cortex, uterus and the CNS (see Zingg, 1996), the V 1 b receptor is localised 
in the pituitary corticotrophs (Du Pasquier et al., 1991) where VP potentiates CRF- 
stimulated ACTH release (Antoni, 1986a; Gillies & Lowry, 1979). On the other 
hand, V2 receptors are chiefly present in the distal tubules and collecting ducts of the 
kidney where they mediate the renal resorption of water (Barberis & Tribollet, 1996; 
Burnatowska -Hledin & Spielman, 1989; Jard et al., 1988; Ostrowski et al., 1993; 
Tribollet et al., 1988a). On the other hand OTR are expressed within many peripheral 
tissues including the mammary gland (Soloff, Fernström, & Fernström, 1989), 
kidney (Schmidt et al., 1990), thymus (Elands, Resink, & De Kloet, 1990), the uterus 
and ovary (Fuchs et al., 1990) and testis (Bathgate & Sernia, 1994) as well as in the 
brain (Tribollet et al., 1988b) and anterior pituitary (probably on lactotroph cells) 
(Antoni, 1986a; Antoni, 1986b; Breton et al., 1995; Chadio & Antoni, 1993). 
Although the two peptides are closely related, they have distinct functions. 
The primary role of VP in the periphery is to control osmotic balance by promoting 
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renal tubule reabsorption of water (hence VP is otherwise known as antidiuretic 
hormone) as well as to conserve blood pressure through vasoconstriction in certain 
vascular beds (Hatton & Li, 1998). 
Peripheral OXT, on the other hand, is generally involved in reproduction - 
related events such as mediating the contraction of uterine smooth muscle at term 
and sustaining milk- ejection during lactation (Fuchs & Dawood, 1980; Higuchi et 
al., 1985; Higuchi et al., 1986; Jenkins & Nussey, 1991; Russell & Leng, 1998; 
Wakerley & Lincoln, 1973). Although it has been recently shown that parturition can 
continue without OXT, successful lactation, however, is critically dependent upon 
the presence of OXT. Without it contraction of the mammary myoepithelium can not 
occur resulting in an unrewarded suckling event even in the presence of a copious 
amount of milk in the mammary gland. This is evidently seen in the failure of 
transfer of milk in the oxytocin gene- knockout mice, an effect that is reversed by 
oxytocin injection (Nishimori et al., 1996; Young et al., 1996). 
Although OXT is synthesised in both sexes its principal biological effects are 
in females. Nonetheless, similar amounts of OXT (and VP) mRNA have been 
reported in the SON and PVN of male and female rats (Swaab, Pool, & Nijveldt, 
1975b) suggesting that OXT might have additional roles beyond those confined to 
female reproduction. In rats, OXT stimulates in vitro the release of ACTH from the 
pituitary cells (apparently via VP receptor of V 1 b type) (Schlosser et al., 1994). It 
also potentiates the ACTH response to CRF, both in vivo (Rivier & Vale, 1985b) and 
in vitro (Antoni, Holmes, & Jones, 1983; Gibbs et al., 1984). OXT has been shown 
to be released from the median eminence into the portal blood system (Antoni, Fink, 
& Sheward, 1990; Tannahill et al., 1991) and the concentration found here is 
substantially higher than that in the periphery (Gibbs, 1984), parallel to that of VP 
(Koenig et al., 1986). This evidence supports the notion that perhaps OXT, in 
addition to its role in the periphery, can act as a releasing factor influencing ACTH 
secretion from the anterior pituitary. 
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Moreover, neurohypophysial OXT also appears to play a complementary role 
in the neuroendocrine stress -response. In the rat, an increase in plasma OXT 
concentration has been observed after stress exposures such as immobilisation and 
shaker stress, while plasma VP remained unchanged (Callahan et al., 1992; Iványi, 
Wiegant, & de Wied, 1991; Lang et al., 1983b). Interestingly, a study by Jezova et 
al. 1993 has shown that surgical denervation of the PVN by anterolateral knife cuts, 
leaving the SON -neurohypophysial connections intact, reduced the peripheral OXT 
increase following 30 min of immobilisation stress (Jezová et al., 1993). This 
indicates that, at least in relation to immobilisation stress, the PVN is crucial for 
stress -induced OXT secretion and without the PVN the SON cannot preserve OXT 
release during stress. More recently Nishioka et al. 1998 also found that, in addition 
to an increase in plasma OXT concentration, central release of OXT in the PVN, 
measured by microdialysis (MD), is also increased in response to shaker stress. 
Similarly this central OXT increase also demonstrated site -specificity as such an 
increase in OXT release was not observed when MD probes were located outside the 
vicinity of the PVN (Nishioka et al., 1998). This supports the notion that OXT is also 
a stress responsive hormone, specifically released from the PVN neurones (Callahan 
et al., 1992; Iványi et al., 1991; Lang et al., 1983b; Onaka & Yagi, 1993). 
Additionally, centrally released OXT can also act as a neurotransmitter where 
it mediates sexual, social and maternal behaviours (Argiolas & Gessa, 1991; de 
Wied, Diamant, & Fodor, 1993; Insel, 1992; Pedersen & Prange, 1979; Richard, 
Moos, & Freund -Mercier, 1991; Schumacher et al., 1989) and exerts anxiolytic 
effects, as well as inhibiting food and salt appetite (Blackburn et al., 1992; Stricker & 
Verbalis, 1987; Stricker & Verbalis, 1996; Verbalis et al., 1995). Overall, OXT may 
serve multiple functions, in addition to its hormonal actions in the periphery, it acts 
in the CNS to modulate behaviour, peptide release as well as autonomic responses. 
An additional role of VP is in the potentiation of CRF effects, acting as a co- 
secretagogue to stimulate the release of ACTH from the pituitary corticotrophs 
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(Rivier & Vale, 1985a). This is particularly applicable to its role under stressful 
stimuli. This is discussed more below. 
1.7. The magnocellular neurosecretory system and specific stimuli 
Activation of the magnocellular neurosecretory neurones (MCN) occurs in 
response to various physiological stimuli including induced hyperosmolarity, cellular 
dehydration, a decrease in blood pressure, depletion of extracellular fluid volume as 
well as in response to suckling, causing milk let -down, and in parturition. It is the 
reversal of these conditions, e.g. rehydration, normalisation of blood pressure, which 
resets the system to the basal condition, suggesting the plasticity of the MCN 
(Hatton, 1997). 
The response of the MCN to various physiological stimuli is a result of 
interactions of the intrinsic properties of the neurones with synaptic inputs from 
various afferent pathways, some of which are excitatory while others are inhibitory. 
These inputs contribute to the regulation and dictate the magnitude of the responses 
of the MCN. Numerous inputs of both peripheral and central origins, have been 
identified as projecting to the magnocellular neurosecretory system. Among the well - 
defined inputs are the ascending noradrenergic projections from the A2 neurones of 
nucleus tractus solitarii (NTS) which preferentially innervate the OXT neurones 
(Sawchenko, Arias, & Bittencourt, 1990; Sawchenko et al., 1988) as well as from the 
Al cell group of the caudal ventrolateral medulla (VLM) which projects more 
extensively to VP neurones (Beroukas, Willoughby, & Blessing, 1989; Cunningham 
& Sawchenko, 1988; Day, Ferguson, & Renaud, 1984; Iwai, Ochiai, & Nakai, 1989). 
These two nuclei are noradrenergic in nature and generally associated with 
somatosensory and haemodynamic influences upon the release of neurohypophysial 




A descending pathway influencing both types of magnocellular neurones 
arises from forebrain structures around the third ventricle collectively known as the 
`osmoreceptor complex' which comprises the organum vasculosum of the lamina 
terminalis (OVLT), the subfornical organ (SF0), and the MnPO (median preoptic 
nucleus) (McKinley, Pennington, & Oldfield, 1996). The OVLT and SFO project 
directly to the SON and PVN and also indirectly via the MnPO (McKinley, Hards, & 
Oldfield, 1994; Oldfield et al., 1994). This complex, as the name suggests, 
contributes essentially to the mechanisms regulating osmoresponsiveness of the OXT 
and VP neurones, as lesions in these brain sites result in a disrupted response of the 
magnocellular neurones to increased osmolarity (Hamamura et al., 1992; Leng et al., 
1989). 
1.7.1. Osmotic stimulation 
As mentioned earlier, one of the well -established roles of VP is in controlling 
plasma osmolarity by acting via the V2 receptor to stimulate the reabsorption of 
water from the tubular fluid in the cortical and medullary collecting ducts in the 
kidneys. The plasma concentration of VP thus determines water balance in the body. 
This indirectly regulates the concentration of the osmotically actives solutes in the 
extracellular fluid, the most important molecule being sodium. The synthesis and 
secretion of VP is in turn linearly controlled by plasma osmolarity and, to a lesser 
extent, by blood volume and pressure. This effect is achieved through activation of 
central pathways with input to the hypothalamus (Chowdrey & Lightman, 1993). In 
rats, OXT is also natriuretic acting upon the kidney in conjunction with VP (Dicker 
& Heller, 1946; Verbalis, Mangione, & Stricker, 1991), although this is not its prime 
function. 
Osmotic stimulation associated with salt loading provides a useful model to 
study the activity of the MCN. Both VP and OXT cells are osmoreceptors 
themselves, displaying the ability to sense and respond to changes in the osmotic 
pressure of their extracellular environment (Mason, 1980; Oliet & Bourque, 1993). 
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Increased osmolarity, induced by chronic salt loading by replacing drinking water 
with 2% NaCI for 14 d, induced a massive reduction in OXT and VP content in the 
neural lobe, while this increased both plasma OXT and VP concentrations and 
expression of their mRNAs in the SON and PVN (Burbach et al., 1984; Van Tol, 
Voorhuis, & Burbach, 1987). Hyperosmolarity induced by water deprivation for 7 d 
also resulted in OXT depletion from the neural lobe (Young & Van Dyke, 1968). 
Conversely, hypoosmolarity, as found in hyponatraemia, suppresses the activity of 
the MCN and hence the secretion of VP /OXT (Hatton, 1997; Robinson et al., 1990). 
Although an increase in osmotic pressure directly induces a depolarisation of 
the magnocellular neurones, this effect is relatively small and is not sufficient to 
trigger an increase in spike activity. However, these magnocellular neurones 
constantly receive synaptic inputs from other neurones, some of which are excitatory 
while others are inhibitory, resulting in a constantly fluctuating membrane potentials 
(Leng & Brown, 1997). Only when the depolarisation exceeds this resting membrane 
potential do spikes occur. Thus, as previously described, the osmoresponsiveness of 
the magnocellular neurones depends on brain areas which provide synaptic inputs, as 
lesions in these areas can abolish the responses of magnocellular neurones to changes 
in plasma osmolarity. 
Intriguingly, chronic hyperosmolarity induced by salt loading also modulates 
the expression and secretion of CRF in the PVN and SON. In particular the 
expression of CRF is predominantly reduced in the parvocellular system while the 
opposite effect is observed in the OXT- containing magnocellular neurones with a 
corresponding increase in neural lobe peptide content (Dohanics et al., 1990; Imaki 
et al., 1991; Imaki, Vale, & Sawchenko, 1992; Jessop et al., 1989; Young, 1986). 
Both of these effects might contribute to the natriuresis and antidiuresis that are 
clearly needed upon salt loading; the diminished output of the HPA axis could serve 
to dampen a posited weak glucocorticoid inhibition of VP secretion (Raff, 1987), 
while increase in CRF content in the neural lobe could exert a paracrine effect upon 
stimulation of VP release (Alzein et al., 1984). 
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Thus the response of CRF in salt- loading provides an opportunity to examine 
co- ordinate and differential effects on two closely -linked neuroendocrine cell types 
simultaneously. 
1.7.2. Oxytocin system in pregnancy and parturition 
Oxytocin has a prominent role in the progression of parturition, being 
released in large amount during delivery in all placental mammals studies thus far 
(Russell & Leng, 1998). Parturition is a time of high demand for OXT such that 
almost 30% of the neurohypophysial OXT store would be depleted during the 60 -90 
min of parturition (see Leng et al., 1999). Thus an accumulation of OXT prior to 
term is important in the progression of parturition. Stores of OXT in the 
neurohypophysis increase substantially during pregnancy, particularly shortly before 
term. This increase in the pituitary store of OXT is a result of both a restraining of 
OXT secretion from the neural lobe as well as a stimulation of OXT synthesis in the 
magnocellular neurones. During mid -pregnancy a reduction in OXT release is due to 
a restraint effect of an opioid peptide, dynorphin which acts via x- receptors (Rusin et 
al., 1997) by blocking voltage -gated calcium influx into the neurosecretory terminals 
(Rusin et al., 1997) thus inhibiting the release of OXT from the pituitary. In late 
pregnancy this reduction in OXT secretion is mediated by an inhibitory effect of 
histamine on the electrical activity of the OXT neurones (Yang & Hatton, 1994) 
provided by cells in the dorsomedial tuberomammillary nucleus (Weiss, Yang, & 
Hatton, 1989). Apart from its role in inhibiting the release of OXT secretion, 
histamine also induces an increase in OXT synthesis during pregnancy as central 
administration of histamine has been shown to increase the expression of OXT 
mRNA in the SON and stimulate the expression of Fos in magnocellular neurones 
indicating that OXT gene is activated (Kjaer et al., 1994a; Kjaer et al., 1994b). 
On the other hand, the increase in OXT production might be related to 
changes in the steroid environment especially with a rise in circulating E2 during 
pregnancy as well as a precipitous decline in P4 level immediately before term. 
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The importance of steroid hormones upon the magnocellular system in pregnancy 
and parturition was part of our current study and is discussed in detail in Chapter 5. 
There are multiple hormonal changes associated with pregnancy, in particular 
those associated with osmotic balance and plasma volume homeostasis. In rats, from 
about day 12 of pregnancy until term, relaxin is secreted in a large amount from the 
ovary to prepare the birth canal for parturition (Sherwood et al., 1980). In addition 
relaxin also acts upon the circumventricular organs such as the subfornical organ 
(SFO) and the organum vasculosum of the lamina terminalis (OVLT); neurones in 
these loci project their axons directly to the OXT and VP cells in the hypothalamus. 
Systemic administration of relaxin has been shown to excite both OXT and VP cells 
as well as increase OXT and VP secretion (Way & Leng, 1992). Thus an increase in 
VP cell activity under the influence of relaxin results in antidiuresis and plasma 
volume expansion. This process allows an essential adaptation to cope with an 
increase in vascular needs of the developing placenta and foetus during pregnancy. 
However, the consequent increase in blood volume then exerts a negative feedback 
and inhibits the VP cells. Overall there is no gross chronic activation of VP cells in 
pregnancy, even in the presence of large relaxin content. The OXT cell activity, on 
the other hand, is maintained throughout late pregnancy, presumably to sustain OXT 
synthesis required for the ensuing parturition (Leng & Brown, 1997). 
When parturition begins the OXT cells are activated and demonstrate 
synchronised bursts of very high frequency action potentials, intervened by a brief 
period of silence (Summerlee, 1981), similar to those occurring during the milk - 
ejection reflex (Wakerley & Lincoln, 1973). Such a burst induces a release of ca. 1 
mU of OXT as a bolus into the general circulation, resulting in the progression of 
parturition. This pattern of OXT cell electrical activity is only seen during parturition 
and suckling. Following other stimuli, including increased osmolarity, OXT is 
released continuously as a result of a maintained increase in the background non - 
burst activity of OXT neurones. Thus continuous OXT release provides an effective 
means for the natriuretic role of OXT while pulsatile OXT release is efficient only 
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for functions in suckling and parturition. These dual modes of release enable OXT 
cells to perform two physiological functions independently yet simultaneously. 
1.8. Functions of the parvocellular PVN: autonomic responses and regulation 
of the HPA axis 
The PVN comprises both magnocellular and parvocellular neurones, each 
with a characteristic topographical distribution. These neurones express different 
peptides, and have different functions, and respond differently to a range of inputs. 
The magnocellular PVN contains OXT and VP neurones as in the SON. The 
parvocellular PVN comprises two principal groups of neurones: those projecting to 
the median eminence and concerned with neuroendocrine stress mechanisms, and 
those projecting to the brainstem and spinal cord influencing autonomic responses. 
1.8.1. Role of oxytocin neurones in cardiovascular regulation 
The notion that the PVN is one of the co- ordinating centres controlling 
autonomic responses stems from retrograde labelling studies in which injection of 
fluorescent dye, true blue, into the spinal cord or the dorsal vagal complex labels 
cells primarily in the parvocellular subdivision of the PVN, in particular those 
concentrated in the lateral and medial zone (Sawchenko & Swanson, 1982; Swanson 
& Kuypers, 1980). The chemical signature here is chiefly OXT localised mainly in 
the ventral parvocellular PVN neurones (Swanson, 1987). Lesions of the PVN 
resulted in a large decrease of OXT content in the spinal cord (Hawthorn, Ang, & 
Jenkins, 1985; Lang et al., 1983a). These neurones project directly to sympathetic 
preganglionic neurones (SPN) in the dorsal vagal complex and spinal cord (Conrad 
& Pfaff, 1976; Saper et al., 1976), and are involved in autonomic regulation by the 
PVN, particularly in cardiovascular responses such as defence against plasma 
volume expansion (Coote et al., 1998; Gilbey et al., 1982). Previous studies have 
indicated a critical role of the PVN in cardiovascular homeostasis. Lesion of the 
PVN attenuates the development of hypertension in Dahl salt- sensitive rats (Goto et 
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al., 1981) as well as in spontaneously hypertensive rats (Ciriello et al., 1984) and 
reduces the renal vascular response to volume load (Gilbey et al., 1982; Lovick, 
Malpas, & Mahony, 1993). Previous studies have shown that the OXT 
paraventriculospinal pathways also mediate the tachycardic response to stress 
(Callahan et al., 1989; Morris et al., 1995). Collectively these findings suggest a role 
of parvocellular OXT PVN neurones in mediating the cardiovascular responses. 
1.8.2. PVN and the regulation of the HPA axis 
The PVN has a pivotal role in mediating stress reactivity via the regulation of 
the hypothalamo- pituitary -adrenal (HPA) stress axis. This HPA axis is primarily 
responsible for the control of secretion of glucocorticoid (GC) hormones which, 
upon release into the systemic circulation, mediate a wide range of adaptive 
responses in many organ systems (Antoni, 1986a). The major GC in human and non- 
human primates is cortisol and corticosterone in rodents, with the majority being 
produced by the adrenal cortex (Mason, 1950; Nelson et al., 1951; Reich, Nelson, & 
Zaffaroni, 1950). These are 21- carbon steroid compounds synthesised from 
cholesterol. The hydroxy group at carbon -11 is required for their therapeutic efficacy 
(Kendall, 1941; Olson, Thayer, & Kopp, 1944). 
GC actions are devised for preserving homeostasis under stressful conditions. 
GC initiates arrays of physiological actions essential for immediate survival while 
suppressing non -vital processes. Nonetheless these effects are largely catabolic 
serving to consume resources. They are particularly deleterious and can lead to 
severe damage, especially when the secretion of GC is prolonged and exaggerated. 
GC excess has been shown to be associated with many neurological conditions, in 
particular depression and memory disorders (Davis et al., 1986; Lupien et al., 1999). 
These effects are likely to occur at the level of the hippocampus, however, and will 
be discussed in details in the following section (see below). 
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The HPA responses to stress are initiated primarily by neurones located in the 
medial parvocellular division of the PVN which synthesise chiefly, among other 
neuropeptides, CRF and VP (Antoni, 1986a; Whitnall, 1993). Upon release 
following stress the two peptides act in concert to stimulate the secretion of ACTH 
from the anterior pituitary corticotrophs which in turn initiate, the production of 
glucocorticoids from the adrenal cortex (Antoni, 1986a). 
The CRF- containing neurones in the PVN receive numerous afferent 
projections from various sources (Sawchenko & Swanson, 1985). The 
catecholaminergic neurones of the brainstem located principally in the A2 and C 1, 
C2, and C3 cell groups in the caudal medulla have been shown to innervate the 
parvocellular PVN (Cunningham, Bohn, & Sawchenko, 1990; Cunningham & 
Sawchenko, 1988). The CRF neurones also share, in common with the magnocellu lar 
neurones, afferents arising from the lamina terminalis (Miselis, Shapiro, & Hand, 
1979; Saper & Levisohn, 1983; Sawchenko & Swanson, 1983) as well as from the 
NTS and the ventrolateral medulla (VLM), although in the latter case at least, the 
particular aspects of the NTS and the VLM that project to those two groups of 
neurones are partially distinct (Cunningham et al., 1990; Cunningham & Sawchenko, 
1988). These pathways provide the mediators of the potent reflex control of the 
stress -related neuroendocrine neurone output by visceral sensory stimuli. Other 
afferent inputs to the PVN comprises the several components of the limbic area 
including the amygdala, the septal nuclei and the hippocampus which are involved in 
conveying the emotional and cognitive stimuli upon the CRF -rich zone of the PVN. 
This is, however, mediated indirectly via the bed nucleus of the stria terminalis 
(BNST), the key integrative centre for the limbic region, which receives substantial 
direct inputs from the amygdala, septum and hippocampus (Swanson, Kohler, & 
Bjorklund, 1987) and reciprocally provides a direct projection to the PVN 
(Sawchenko & Swanson, 1983). 
The sensitivity of CRF expression towards stress exposure appears to be 
dependent upon the type of stress used in the study. Previous studies have 
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demonstrated that chronic stress increases CRF mRNA expression (Kiss & Aguilera, 
1993; Makino, Smith, & Gold, 1995; Mamalaki et al., 1992) in the parvocellular 
PVN. However, other studies have failed to find any up- regulation of CRF mRNA 
(Harbuz et al., 1992). In addition to CRF, neurones in the medial parvocellular 
portion of the PVN are also capable of synthesising VP which is released into the 
median eminence via the portal blood to regulate the secretion of ACTH from the 
anterior pituitary (Antoni, 1986a; Gillies & Lowry, 1979; Yates et al., 1971) via V 1 b 
receptors (Antoni, 1984; Baertschi & Friedli, 1985; Du Pasquier et al., 1991). The 
expression of VP is low under basal conditions, but is manifest following either 
adrenal steroid withdrawal (Kiss, Mezey, & Skirboll, 1984; Young, Mezey, & Siegel, 
1986a) or chronic stress (Herman et al., 1989a; Lightman & Young, 1988). 
Following ADX in rats ca. 70 % -90% of the parvocellular CRF immunoreactive 
neurones exhibit immunoreactivity for VP (Kiss et al., 1984; Sawchenko, Swanson, 
& Vale, 1984) and contain the mRNA for VP prohormone (Wolfson et al., 1985). At 
the level of the median eminence 95% of CRF- containing axons and nerve terminals 
contain VP following ADX (Whitnall, Smyth, & Gainer, 1987). Indeed there is 
evidence suggesting that during repeated or chronic stress there is a shift in the 
modulation of pituitary adrenal activity from CRF to VP (Hashimoto et al., 1988; 
Scaccianoce et al., 1991). In a recent study, exposure to repeated immobilisation for 
14 d in rats resulted in an increase in VP mRNA content which was greater than that 
seen for CRF mRNA (Makino et al., 1995). 
Similar to CRF, there appears to be a stress -specificity in the response of VP 
to various stimuli. The responses appear to vary from no activation or a small 
increase (Darlington, Barraclough, & Gann, 1992; Harbuz et al., 1994; Lightman & 
Young, 1988) to a more substantial increase (Bartanusz et al., 1994; Herman, 1995), 
indicating that this may reflect differences in the stress paradigm used. 
A distinction between the regulation of VP gene expression in neurones in the 
parvocellular PVN and that of the magnocellular PVN is their differential sensitivity 
to glucocorticoids. VP and VP mRNA expression in the parvocellular subdivision is 
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under the negative control of glucocorticoids (Davis et al., 1986b: Sawchenko, 
1987b; Sawchenko et al., 1984; Wolfson et al., 1985). On the other hand. VP mRNA 
in the magnocellular neurones is generally insensitive to changes in circulating 
glucocorticoids (Young, Mezey, & Siegel, 1986b) even though corticosteroid 
treatment inhibits, while its withdrawal increases basal and stimulates VP secretion 
from the neural lobe (Healy et al., 1985; Papanek & Raff, 1994). 
2.1. Hippocampus 
Recent epidemiological studies have demonstrated an association between 
increased risk in cognitive impairment and the loss of ovarian hormones after 
menopause. Moreover, in non -demented women E2 has been shown to enhance 
cognitive performance, while E2 replacement therapy in postmenopausal women is 
associated with a reduced incidence of neurodegenerative disorder, especially 
Alzheimer's disease. Collectively, the evidence suggests a neuroprotective role of E2. 
Learning and memory are essentially governed by structures within the 
limbic system, one of which is the hippocampus. Its role in maintaining cognitive 
functions, particularly those aspects related to spatial memory (Eichenbaum, Otto, & 
Cohen, 1992), as well as its involvement in a number of neurological disorders, such 
as senile dementia of Alzheimer's type, has led to extensive studies on the regulation 
of this structure. The synaptic organisation and functional characteristic of its 
neurones are also among one of the most extensively studied areas in neurobiology 
(Skrede & Westgaard, 1971; Yamamoto & Mcllwain, 1966). 
2.1.1. Anatomical organisation of the hippocampus 
The hippocampus proper can be divided into four regions, designated CA 1- 
CA4 which derived from the Latin `cornu Ammonis' or Ammon's horn. The more 
general term describing the hippocampal formation includes the dentate gyrus, the 
subiculum, and the entorhinal cortex, in addition to the CA regions. Cells in CA I and 
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CA3 are large pyramidal neurones which occupy most of the hippocampal proper. 
The CA2 area, a morphological transitional zone, is perhaps a trivial distinction and, 
in some species, is indistinguishable from CAI and CA3 that it is often ignored. In 
rats the approximate number of CAI pyramidal neurones is around 250,000 while 
that in the CA3 is 160,000 and the dentate gyrus contains ca. 1,000,000 granule cells 
(Squire, Shimamura, & Amaral, 1989). Both the hippocampus and the dentate gyrus 
are three -layered cortices. In the hippocampus, these comprise the polymorphic layer 
(stratum oriens), the pyramidal layer (stratum pyramidale) and the molecular layer 
(stratum radiatum and stratum lacunosum- moleculare). The dentate gyrus consists of 
a polymorphic layer (hilus), a granular layer (stratus granulosum), and a molecular 
layer (stratum moleculare). The molecular layer of the dentate is a continuation of 
that of the hippocampal molecular layer (see Brown & Zador, 1990). 
The principal organisation of the hippocampal neuronal connectivity is 
generally known as the tri- synaptic circuit. Fibers of the perforant path from the 
entorhinal cortex synapse onto granule cells of the dentate gyrus. Granule cells in the 
dentate gyrus send their mossy- fibers and synapse onto CA3 pyramidal neurones. 
The pyramidal cells in the CA3 region then project their axons to and innervate the 
CA1 pyramidal cells via the Schaffer collaterals. These three synapses display the 
unique unidirectional progression of excitatory pathways and define the tri -synaptic 
circuit. However, the current understanding of such connectivity is considerably 
more complex than this simple closed loop (see Brown & Zador, 1990). 
2.1.2. The involvement of the hippocampus in HPA axis negative feedback: 
correlation with cognitive function 
In the preceding section we have mentioned the role of glucocorticoids in 
mediating the stress response to pervasive stimuli. As mentioned previously, 
prolonged exposure to glucocorticoids is particularly detrimental, thus organisms are 
equipped with a system to limit the extent of glucocorticoid secretion. This is 
achieved via a co- ordinated negative feedback loop mediated by glucocorticoids 
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themselves. The effects of glucocorticoids are mediated by two types of 
corticosteroid receptors; 1) type I, also known as the mineralocorticoid receptor 
(MR) (Arriza et al., 1987; Patel et al., 1989) and 2) type II, or glucocorticoid 
receptor (GR) (Hollenberg et al., 1985; Miesfeld et al., 1984). While aldosterone, 
corticosterone and synthetic mineralocorticoids bind to MR with very high affinity 
(Kd - 0.5 nM), corticosterone bind to GR with a 10 -fold lower affinity (Kd - 2 -5 
nM). Thus MR are largely occupied under basal nadir corticosterone levels while GR 
become increasingly occupied at the peak of the diurnal rhythm and during stress 
(Reul, van den Bosch, & de Kloet, 1987; Spencer et al., 1990). 
This negative feedback mechanism occurs at several levels but is principally 
mediated by the brain, with the major sites of such feedback mechanism being the 
hypothalamus and the pituitary. Additionally higher central loci such as the 
hippocampus (see more below), the amygdala and the bed nucleus of the stria 
terminalis (Casada & Dafny, 1991; Cullinan et al., 1995; Gray et al., 1993), the 
septum (Dobrakovová et al., 1982; Seggie, Uhlir, & Brown, 1974) as well as the 
medial prefrontal cortex (Diorio, Viau, & Meaney, 1993) also play the prominent 
roles in regulating this negative feedback. Other sources include the brainstem, 
predominantly although not exclusively, the noradrenergic, adrenergic (Plotsky, 
Cunningham, & Widmaier, 1989) as well as serotonergic projection pathways 
(Feldman, Conforti, & Melamed, 1987; Saphier & Feldman, 1989; Sawchenko et al., 
1983). Local hypothalamic integrative systems involving the medial preoptic area as 
well as other hypothalamic nuclei known to provide afferent inputs to the 
parvocellular PVN also contribute to the regulation of the HPA axis activity 
(Herman, Prewitt, & Cullinan, 1996). The end point of the negative feedback is to 
facilitate the termination of stress response by inhibiting the secretion of CRF (and 
VP) from the hypothalamic neurones and ACTH from pituitary corticotrophs, 
ultimately preventing excess glucocoticoids being released into the peripheral 
circulation. 
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Considerable evidence shows the importance of hippocampus as one of the 
crucial sites for the HPA axis feedback regulation (Dallman et al., 1987; Keller - 
Wood & Dallman, 1984; McEwen, De Kloet, & Rostene, 1986; Plotsky, 1987). 
Lesions in the hippocampus are associated with increased glucocorticoid levels under 
basal and stress conditions (Feldman & Conforti, 1976; Sapolsky, Krey, & McEwen, 
1984; Wilson et al., 1980), reduced suppression of ACTH following glucocorticoid 
administration (Feldman & Conforti, 1976) and elevated hypothalamic CRF and VP 
mRNA expression (Herman et al., 1989b). Application of corticosteroid to the 
hippocampus suppresses the stress response, whereas receptor antagonists elevate 
basal glucocorticoid levels and block negative feedback. Indeed the hippocampus 
contains the largest accumulation of both GR and MR mRNA as well as protein in 
the brain (Herman, 1993; Jacobson & Sapolsky, 1991; Reul & de Kloet, 1985). 
However, the apparent lack of significant direct projections of the hippocampus to 
the hypophysiotrophic neurones of the PVN (Cullinan, Herman, & Watson, 1993; 
Sawchenko & Swanson, 1983) suggests that any interactions with neurones 
responsible for ACTH release are likely to be indirect, requiring at least one 
intermediary synapse. 
The hippocampus plays a pivotal role in learning and memory processes. It is 
also particularly vulnerable to disruptive events such as seizures (Sloviter, 1983), 
head trauma (Lowenstein et al., 1992), and ischemia (Hsu & Buzsáki, 1993) as well 
as degenerative changes accompanying ageing and neurodegenerative disorder such 
as Alzheimer's disease and depression (de Leon et al., 1988; Pasquier et al., 1994). In 
fact, both conditions are associated with impaired memory and hypercortisolism 
(Davis et al., 1986a; Dinan, 1994) indicating a link between elevated levels of 
glucocorticoids and hippocampal damage. 
There is an 'inverted U- shaped' relationship between glucocorticoids and the 
hippocampal spatial memory (Diamond et al., 1992; Kerr, Huggett, & Abraham, 
1994). Thus low glucocorticoid levels or MR agonists facilitate memory processes 
by increasing long -term potentiation (LTP) (an electrophysiological correlate of 
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memory) while reducing after -hyperpolarisation (AHP) (which negatively correlates 
with spatial learning). On the other hand high level of glucocorticoids or GR agonists 
reduce LTP and increase AHP leading to hippocampal damage and memory 
impairment (Diamond, Fleshner, & Rose, 1994; Joëls & de Kloet, 1992). 
Extensive studies have shown that chronically elevated glucocorticoid levels, 
such as those occur following stress, are detrimental to hippocampal neurones, 
increasing their vulnerability to a variety of insults (Landfield, Waymire, & Lynch, 
1978; Sapolsky, 1985; Sapolsky, Krey, & McEwen, 1985). On the other hand 
Landfield et al. 1981 have shown that adrenalectomy with low dose of corticosterone 
replacement from middle -age prevented hippocampal neurodegeneration and 
cognitive impairment at later stage in life. Thus hippocampal atrophy and impaired 
cognitive function can be prevented by keeping glucocorticoid levels low (Landfield 
et al., 1978). 
The cellular mechanism underlying the effect of glucocorticoids might 
involve the plasticity of the hippocampal neurones. High levels of glucocorticoids 
produced by daily injection of corticosterone induce atrophy in the apical dendritic 
tree of CA3 pyramidal subfield leading to neurone loss (Woolley, Gould, & 
McEwen, 1990). Moreover, this atrophy is prevented by phenytoin, given prior to 
corticosterone treatment, thus implicating the involvement of the excitatory amino 
acids (EAA) in causing these dendritic atrophy (Watanabe et al., 1992a). Similarly, 
application of restraint stress to the rats also produces the same pattern of CA3 
dendritic atrophy (Watanabe, Gould, & McEwen, 1992b) and the effect is also 
blocked by phenytoin administration, confirming the involvement of EAA 
(Watanabe et al., 1992a). 
Interestingly, glucocorticoid depletion also adversely attenuates the 
hippocampus, although this predominantly affects granule neurones in the dentate 
gyrus (Gould, Woolley, & McEwen, 1991; Sloviter et al., 1989) rather than the CA 
pyramidal neurones of Ammon's horn (McEwen et al., 1992). 
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Conversely, the gonadal steroid E2 has been shown to maintain the dendritic 
tree of neurones in the hippocampus. Thus removal of endogenous ovarian hormones 
leads to a decrease in the number and density of dendritic spines and axospinous 
synapses, specifically, in the apical dendrites of the CA1 pyramidal neurones (Gould 
et al., 1990). This decrease can be prevented or reversed by E2 treatment (Woolley & 
McEwen, 1992; Woolley et al., 1997). Thus the hippocampus is subject to regulation 
of both the adrenal and gonadal steroid hormones. 
3.1. Aim of the thesis 
Oestrogens have effects on neuronal phenotype and function. Apart from the 
classically described effects of oestrogens on brain resulting in changes in 
reproductive behaviour and physiology, they also affect regions that are important in 
memory and cognition as well as in homeostasis. The majority of oestrogen effects 
are mediated by the ER -a and -ß, both of which are expressed in the brain. In order 
to understand how oestrogens could affect the brain, it is thus crucial to understand 
what governs the tissue -specific expression of those receptors and how they are 
regulated, particularly under varying physiological situations. In particular, the recent 
discovery of ER -f3, in addition to ER -a, suggests additional pathways by which E2 
could exert its actions in the CNS. 
Using in situ hybridisation histochemistry (ISH), we first determined the 
cellular distribution of the two types of ER mRNA in the laboratory rat brain, thus 
revealing the possible loci where E2 could mediate its, probably, genomic actions in 
the brain. 
We further investigated in detail the regulation of the ER mRNAs in two 
brain areas; the hippocampus and the PVN and SON, using quantitative ISH. A 
decline in cognitive functions is associated with the loss of ovarian steroids in 
postmenopausal women. Moreover, several epidemiological studies suggest that 
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oestrogen replacement therapy in postmenopausal women could potentially protect 
against Alzheimer's disease (AD) (for review see Henderson, 1997). 
Since the hippocampus is involved in learning and memory and this area is 
also severely affected by AD, the known beneficial effects of E2 on cognition might 
be effected in this brain structure. The underlying mechanism of E2 action in the 
hippocampus, however, is not fully understood but might involve direct genomic 
action of E2 via ER expressed here. Using a variety of hormonal (both sex- and 
adrenal- steroid) manipulations we examined the regulation of both types of ER 
mRNA expression within the hippocampus. 
The hypothalamic PVN and SON have prominent roles in regulating fluid 
homeostasis and blood pressure via VP, and in the events of parturition and lactation 
by OXT, both being synthesised in magnocellular neurones in these nuclei. This 
neurosecretory system is also known to be modulated by sex steroid hormones. The 
discovery of ER -(3 and its high level of expression in these two nuclei suggests a 
possible direct genomic influence of E2 upon the OXT /VP neurones. The expression 
of ER -(3 mRNA here was examined under the influence of changes in sex- and 
adrenal- steroid environments. In addition the regulation of the ER -13 transcript was 
also determined under physiological manipulations associated with stimulation of 
neuronal activity. 
This thesis is about investigating the regulation of the ER mRNAs within the 
CNS. Changes in the expression of such receptor transcripts, if translated into 
functional protein, will alter the sensitivity of the neurones to E2, thus ultimately 
contributing to the impact E2 has on the CNS. 
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BDH (Merck Ltd.), UK 
Difco Ltd., UK 
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35S -UTP Amersham Pharmacia Biotech UK 
3H- Corticosterone Amersham Pharmacia Biotech UK 
2.1.3. Miscellaneous 
Amfix fixative H.A. West Ltd., UK 
Coverslips BDH (Merck Ltd.), UK 
Cryostat Bright Instruments Ltd., UK 
DPX mountant BDH (Merck Ltd.), UK 
Hyperfilm 13 -max Amersham Pharmacia Biotech UK 
Lens tissue Whatman Labsales Ltd., UK 
Microscope slides (frosted) BDH (Merck Ltd.), UK 
Microtome blades BDH (Merck Ltd.), UK 
NICK column, Sephadex G50 Amersham Pharmacia Biotech UK 
Photographic nuclear emulsion, NTB2 Anachem Ltd., UK 
Spectrophotometre (UV -160A) Shimadzu UK 
Whatman paper 3 M Whatman International Ltd., UK 
49 
Materials & Methods 
2.2. Methods 
2.2.1. In situ hybridisation histochemistry 
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In situ hybridisation histochemistry (ISH) involves a reaction whereby a 
nucleic acid probe that has been labelled with a radioisotope, or otherwise detectable 
molecules, hybridises to target nucleic acid residing in a tissue section by means of 
hydrogen bonding of complementary base pairs. This technique allows the precise 
anatomical localisation and identification of individual cells that contain a specific 
nucleic acid sequence. Under appropriate conditions the specificity of the technique 
can be high, such that little or no detectable non -specific binding occurs. 
ISH is particularly useful for the study of gene expression in the nervous 
system. Heterogeneous tissues such as the brain contain a myriad of different cell 
types, each of which produce a variety of proteins subserving different functions, and 
so they contain many mRNA species. An estimated 145,000 mRNA species can be 
found in mouse brain (Hahn, Van Ness, & Chaudhari, 1982) and the amount of each 
specific species varies vastly from neurone to neurone. Some of the rare mRNA 
molecules are specific to one cell type and contribute to only a small fraction of the 
cellular mRNA content. Detection of such a rare mRNA in situ is achievable due to 
the specificity of complementary base pairing between a nucleic acid probe and its 
mRNA target. The ISH technique generally involves 5 main steps including tissue 
preparation, probe labelling, hybridisation of probe to tissue, posthybridisation 
stringent wash and visualisation. The ultimate goal of ISH is to retain the target 
nucleic acids in situ, ensuring that they are not degraded by nucleases, to make 
probes that can effectively penetrate tissue and hybridise specifically and to preserve 
tissue morphology to enable subsequent identification of the mRNA of interest and 
its cellular localisation. 
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There are many alternatives available regarding types of probe, methods of 
labelling the probes and visualisation of the signal for ISH. Three main classes of 
probe are in current use: 
1) Complementary DNA (cDNA) probes; These probes are double- stranded, 
relatively easy to use and label, have high specific activity and thus give good 
amplification of the signal. However, because of the duplex nature of these probes 
they are not readily free to hybridise and so have to be denatured prior to use. The 
other disadvantage of using this type of probes is the reannealling of the two strands 
of the probes in a hybridisation solution, resulting in the reduction of the 
concentration of probe available for hybridisation (Cox et al., 1984). 
2) Oligonucleotide probes; These probes are short (typically 15 -50 bp in length) 
single- stranded DNA oligonucleotides which are quick and simple to use. The short 
length of the probes ensures a better access to target tissue sections. However, this 
also means that fewer labelled nucleotides are incorporated into each molecule of 
probe leading to a lesser sensitivity compared to that of nucleic acid probes. The 
relative ease of synthesising without involving the cloning procedures offers another 
attractiveness for these oligonucleotide probes. 
3) Single -stranded RNA probes (riboprobes); These are single- stranded RNA 
molecules generated by in vitro transcription from a cloned cDNA that is introduced 
into a specifically designed plasmid transcription system (vector) which contains 
RNA polymerase promoters. This enables the transcription of either antisense (non- 
identical but complementary which will hybridise to the cellular mRNA thus used for 
detection of the mRNA of interest) or sense (identical and will not hybridise to 
cellular mRNA, therefore employed as a control) probes (Melton et al., 1984). We 
chose to use riboprobes in our ISH studies because of the high stability of RNA - 
RNA hybrids compared to DNA -RNA hybrids. The longer length of RNA probes 
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relative to oligonucleotide probes allows the use of more stringent hybridisation 
conditions, leading to the highest sensitivity when detection of a single- stranded 
target like cellular mRNA is required. However, riboprobes have a tendency to 
hybridise to non -specific sites in the tissue sections therefore pre - and post - 
hybridisation treatments including the use of RNase are employed to reduce the 
background. The specificity of the hybridisation signal of an antisense probe is 
routinely determined by the use of a sense probe, which is conducted under an 
identical condition as that employed for an antisense probe. The lack of the 
hybridisation signal from the sense probe verifies that probe binding is a result of its 
base sequence and not its physical properties. 
The stability of the hybrids formed, whether they are DNA -DNA, RNA - 
RNA, or DNA -RNA duplexes, is influenced by many factors, such as temperature, 
ionic strength, percentage of guanosine /cytosine (G /C) base pair and probe length 
(Wilkinson, 1992). 
2.2.2. In situ hybridisation protocol 
a) Slide preparation 
During handling of microscope slides gloves were worn at all times to 
prevent RNase contamination. Prior to use, slides were washed in 0.2 M HCI, DEPC - 
treated water (0.1% DEPC in ultrapure water) and acetone for 3 min each. Slides 
were subsequently treated with subbing solution containing 0.03% Sodium azide and 
15% gelatine and left to dry at 50 °C. On the following day, slides were subbed in 
poly -L- lysine solution (100 mg in 500 ml DEPC- treated water) for 20 sec, washed in 
DEPC -water twice for 10 min and left to dry at 50 °C. Slides were wrapped in 
aluminium foil and stored until use. 
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b) Tissue collection 
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At the end of the experiments the rats were killed by decapitation, their brains 
were removed, snap -frozen with powered dry ice and stored at -80 °C. Coronal brain 
sections (10 µM thick) at various levels were cut using a cryostat (Bright) at -20 °C. 
The sections were thaw -mounted onto gelatin and poly -L- lysine coated slides and 
stored at -80 °C until processed for ISH. 3 -4 brain sections were collected onto each 
slide. To identify the area of interest marker slides were stained with either 1% w/v 
Pyronin Y (Sigma) or 1% w/v Toluidine- Blue -O (Sigma). During tissue processing 
for ISH, gloves were worn at all times, including while handling the cryostat -cut 
sections on microscope slides to prevent contamination with RNase, a common 
concern for all types of ISH. 
c) Tissue preparation and fixation 
To achieve the best compromise between preserving tissue morphology, 
retaining the nucleic acid, and allowing easy penetration of probe to the target RNA, 
sections were fixed in cold freshly prepared 4% (w /v) paraformaldehyde in 0.1 M 
phosphate buffered saline (PBS, 20 mM NaH2PO4, 80 mM Na2HPO4, pH 7.4). 
Paraformaldehyde is an alkylating agent which cross -links nucleic acid and protein to 
form a network within the cells. As such, it provides good RNA retention as well as 
maintaining tissue morphology. Fixation was carried out at 0 -4 °C to inhibit 
endogenous ribonucleases. The fixation was immediately followed by 2 washes in 1 
x PBS (diluted from 10 x stock solution (80 g NaCI, 29 g Na2HPO42H20, 2 g 
KH2HPO4, and 2 g KC1 in 1 1 DEPC- treated water) for 5 min each. To reduce the 
background activity the sections were then subjected to acetylation treatment which 
prevents the non -specific binding that normally occurs from binding of the probe to 
positively charged amino groups in the tissue. Slides were incubated for 10 inin with 
0.75 ml acetic anhydride (added prior to transfer of slides) in 300 ml of 0.1 M 
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Triethanolamine pH 8.0 (13.3 ml triethanolamine in 1 L DEPC- treated water), 
followed by another 5 min wash with 1 x PBS. The sections were then dehydrated 
through a series of alcohols (70 %, 80 %, and 95% ethanol made up with DEPC- 
treated water, 2 min each). The slides were then air -dried. 
d) Prehvbridisation treatment 
To reduce the non -specific background binding which might occur during the 
subsequent hybridisation all tissue sections were incubated with the prehybridisation 
buffer (2 x stock containing 0.6 M NaCI, 10 mM Tris -HC1 pH 7.5, 1mM EDTA pI-1 
7.5, 1 x Denhardt's solution, 0.5 mg /ml denatured salmon sperm DNA and 0.1 
mg /ml yeast tRNA). The purpose was to saturate sites in the tissue sections that 
might otherwise bind nucleic acids nonspecifically. The buffer was initially made up 
as a 2 x stock but was diluted 1:1 with deionised formamide (deionised using 10% 
amberlite resin) to provide sufficient to apply 200 µl of the hybridisation mix to each 
slide. The slides were placed flat in the humidified hybridisation boxes on 3 M 
Whatman paper soaked in box buffer (50% deionised formamide, 20% 20 x SSC and 
30% DEPC- treated water) and incubated at 50 °C for 2 h. 
e) Hybridisation 
Similarly, sufficient hybridisation buffer was made up to provide 200 µ1 per 
slide. The hybridisation mix is composed of 50% deionised formamide, 10 x 106 
cpm/ml of the probe made up to the final volume of 200 µl with 2 x hybridisation 
buffer (10% dextran sulphate, 0.6 M NaC1, 10 mM Tris -HC1 pH 7.5, 1mM EDTA pH 
7.5, 1 x Denhardt's solution, 0.1 mg /ml denatured salmon sperm DNA and 0.1 
mg /ml yeast tRNA). The mix was denatured at 70 °C for 10 min, briefly cooled on 
ice and 1 M DTT (10 µ1/m1 of probe) added. The tissue sections were drained and 
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dried around the edges prior to the hybridisation mix being applied. 200 tl of the 
hybridisation mix was applied per slide. The slides were then placed in humidified 
hybridisation boxes, sealed and hybridised for 16 h (or overnight) at 50 °C, after 
which the slides were subjected to posthybridisation washes. 
fl Posthybridisation stringent wash 
Following the hybridisation the slides were drained and washed 3 times in 2 x 
SSC (diluted from 20 x stock (3 M NaCl and 0.3 M Na3Citrate pH 7.0) for 5 min 
each. They were then subjected to posthybridisation washing which was designed to 
reduce the background through a series of wash steps plus the use of nucleases that 
specifically degrade single- stranded nucleic acid, leaving only double -stranded 
hybrid intact. In particular, RNA probes tend to exhibit a degree of non -specific 
binding, which are most effectively reduced by the use of RNase (John, Birnstiel, & 
Jones, 1969). 200 µl of RNase buffer containing 30 mg /ml RNase A (RNase buffer 
composed of 10 mM Tris -HC1 pH 7.5, 1mM EDTA pH 7.5 and 0.5 M NaC1 in 
ultrapure water) was applied to each slide. The incubation lasted for 60 min at 37 °C. 
Afterwards the slides were progressively washed with more stringency to remove 
non -specific adherence to tissue components, beginning with a 30 min wash in 2 x 
SSC at room temperature. Subsequently slides were washed in 0.1 x SSC at 60 °C for 
90 min followed by another wash in 0.1 x SSC starting at 60 °C and allowed to cool 
to room temperature. The slides were then dehydrated in 50 %, 70% and 90% ethanol 
in 0.3 M ammonium acetate for 2 min each. They were allowed to air dry then 
apposed against Hyperfilm-f3 max for 2 weeks. 
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g) Visualisation of hybridisation signal 
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Following film development, slides were dipped in photographic nuclear 
emulsion (NTB -2) diluted 1:1 with ultrapure H2O, allowed to dry then stored in 
lightproof boxes at 4 °C for 4 -5 weeks before being developed. Slides were 
developed with D -19 diluted 1:1 with ultrapure H2O for 5 min, briefly rinsed with 
H2O then fixed in a 1:5 dilution of Amfix fixative for 5 min. Slides were then washed 
in H2O for a further 5 min. All development steps were carried out at 15 °C under 
safe light conditions. Following development, sections were counterstained with 1% 
w/v pyronin Y and coverslipped using DPX as mountant. 
h) Quantification of autoradiographs 
Anatomical identification of brain structures was based on Paxinos and 
Watson stereotaxic rat brain atlases (Paxinos & Watson, 1986; Paxinos & Watson, 
1996). Autoradiographs were evaluated by measuring optical density of film images 
of regions of interest via a digital camera, or by counting silver grains over the 
profiles of individual neurones (x 40 objective), using a computer -aided image 
analyser (MCID -M4 (Version 3.0 Rev. 1.5), Imaging Research, Inc., Canada). For 
film measurements, optical density (units were given arbitrarily) was measured for 6- 
8 images of region of interest per animal. Silver grain counts were made over 8 
neurones per section, and in 3 -4 sections per region per rat. Background 
measurements were made over appropriate adjacent tissue with no evident 
expressing neurones and subtracted to obtain the net value of silver grain counts. The 
slides were coded so that the experimenter was unaware of the treatment of the rats at 
the time of evaluation. Animal means were calculated for each variable, and these 
values were used to calculate group means. 
Materials & Methods 
i) Statistical Analysis 
57 
Student's t -test or one -way Analysis of Variance (ANOVA or Kruskal- Wallis 
analysis on ranks), and post -hoc tests (Student -Newman-Keuls or Duncan's) were 
used (SigmaStat software) as appropriate to determine the statistical significance 
between groups. The alpha value was set at P < 0.05. Results are expressed as the 
group means ±sem. 
2.2.3. Restriction Endonuclease Digestion and Electrophoresis of DNA 
DNA was normally digested using 5 unit (U) of restriction enzyme per 1 µg 
of DNA in 1 x restriction buffer (from a 10 x stock solution) and distilled H2O 
(dH2O) to the required volume. Digestion of plasmid DNA was routinely carried out 
at 37 °C for 1 -2 h. Digested DNA was visualised after electrophoresis through 
agarose gels. Typically a 1% w/v agarose gel was used to separate DNA fragments 
between 400 bp - 7 kb in size and was prepared by dissolving agarose in 1 x TBE 
(diluted from 10 x stock solution containing 108 g Tris base, 55 g Boric acid and 0.5 
M EDTA pH 8.0 in DEPC- treated water) in a microwave oven. The melted agarose 
was allowed to cool down before adding 1 -2.5 p.1 of ethidium bromide (10 mg /ml) 
and pouring the solution into a gel mould with a comb in place (the tooth size of the 
comb was dependent on the size of the DNA sample), and allowed to set. 2 µl of 
agarose loading buffer (0.25% (w /v) bromophenol blue, 0.25% (w /v) xylene cyanol 
and 30% glycerol, Gibco BRL) was added to DNA samples before loading onto the 
gel. Gels were usually run with 1 x TBE at 50 -80 mA with a 1 kb DNA ladder (Gibco 
BRL) containing DNA fragments of 75 bp - 12 kb as a size marker, for as long as 
required to see sufficient separation of DNA fragments. 
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2.2.4. Preparation of oestrogen receptor riboprobes 
2.2.4.1. Oestrogen receptor -a (ER -a) 
a) Subcloning of 367 bp PstI -EcoRI fragment of mouse oestrogen receptor -a cDNA 
into vector pGEM3 
A plasmid encoding the full- length mouse ER -a cDNA, pMOR100 (White et 
al., 1987), was generously provided by Dr K E Chapman, Molecular Endocrinology, 
MMC, Western General Hospital, Edinburgh, UK. In order to generate the riboprobe 
for ER -a, we first subcloned our required fragment into vector pGEM3 ( Promega 
UK Ltd., UK) which carries RNA polymerase promoters, SP6 and T7, thus enabling 
the production of both `sense' and `antisense' riboprobes. The 367 bp PstI -EcoRI 
fragment from the pMOR100 cDNA was subcloned by ligation between the PstI site 
and EcoRI sites of pGEM3. This 367 bp fragment encodes part of the ligand- binding 
domain of the mouse oestrogen receptor -a. We chose this fragment of the cDNA 
because 1) it is highly conserved between rat and mouse (it shares 92% sequence 
identity with the rat ER -a cDNA) 2) it shows very limited similarity to other steroid 
receptors so that cross hybridisation between steroid receptors would not occur. The 
purified plasmid DNA was obtained and designated as pJS 1. 
Digests were set up as follows: - 
1) 3 of pMOR100 was restricted with l0U of PstI and l0U of EcoRI in a 
total volume of 30 µl of 1 x restriction buffer (Buffer H (Promega) which contains 90 
mM Tris -HCI, 10 mM MgC12, and 50 mM NaC1) to obtain the 367 bp fragment of 
interest. 
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2) 3µg of vector pGEM3 was restricted with 10U of Pstl and l0U of EcoRI in a 
total volume of 30 µl of 1 x restriction buffer (Buffer H) to give compatible ends to 
the obtained 367 bp fragment. 
Digests were carried out at 37 °C for 1 h and an aliquot of I tl of each digest 
in loading buffer was used to verify digestion on a 1% low melting point agarose gel 
with 0.5 x TBE and visualised under UV light at 365 nM wavelength in the presence 
of ethidium bromide. PstI -EcoRI digestion of pMOR100 yielded 4 fragments:- 1) 
1400 bp PstI- EcoRI, 2) 170 bp PstI -PstI, 3) 367 bp PstI -EcoRI, 4) 3000 bp EcoRI- 
EcoRI while PstI -EcoRI digestion of pGEM3 yielded 2 fragments, a large fragment 
of 2832 bp with EcoRl/PstI ends and a 35 bp fragment. 
The 367 bp fragment from pMOR100 was excised from the gel using a sterile 
scalpel as was the larger fragment from pGEM3, then DNA was extracted from the 
gel using a Hybaid DNA purification kit II (Hybaid RecoveryTM), according to the 
manufacturer's instructions. DNA fragments were purified as follows. Before use 
400 pi of resuspended silica gel matrix in binding buffer was added to a spin filter 
and mixed with the gel slice, then heated at 55 °C for 5 min. After mixing, the tube 
was spun for 15 -30 sec and the eluent discarded. The filter was washed with 500 µl 
of wash solution and DNA eluted using 12 pi of elution solution. Recovery was 
estimated by electrophoresis of 1 41 of recovered fragment. Equimolar amounts of 
vector and insert DNA were visually assessed and used for ligation. 
The 367 bp restriction fragment from pMOR100 was ligated into pGEM3 in a 
10 pi ligation reaction containing 1 µl of 10 x ligation buffer (50 mM Tris -HCI pH 
7.5, 10 mM MgC12, 1 mM DTT and 1 mM ATP pH 7.0), 3U of T4 DNA ligase and 
0.5 µl of linearised pGEM3 and 7.5 pi of pMOR100 fragment. The ligation was 
carried out at 12 °C overnight. 
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Escherichia coli strain HB101 cells were made competent based on the CaC12 
method (described in Molecular Cloning, a laboratory manual, T. Maniatis 1982, p 
250 -251). 200 µl of competent cells were then mixed with 4 µl of ligation mix and 
stored on ice for 30 min. Cells were then heat shocked at 42 °C for 1 min, then 
returned to ice for a further 2 min. The whole transformation mixture was plated onto 
an LB agar plate containing 100 .tg /ml ampicillin and incubated at 37 °C overnight. 
The positive control contained 1 µl of uncut pGEM3 (10 ng /µl), and the negative 
control contained only HB 101 alone. 
b) Plasmid DNA Minipreparation (Miniprep) 
Single transformed bacterial colonies were transferred into tubes containing 2 
ml LB broth (10 g Tryptone peptone, 5 g Yeast extract and 5 g NaCI in 1 1 H2O) and 
100 µg /m1 of ampicillin and incubated with shaking at 37 °C overnight. Cells were 
pelleted, resuspended in 100 µl of GTE (0.05 M Glucose, 0.025 M Tris -HCI pH 7.5 
and 0.01 M EDTA) then gently mixed with 200 µl of fresh 0.2 M NaOH /1% SDS 
and stored on ice for 15 min. Afterwards, 150 pl of 5 M K.Ac (147.2 g K.Ac and 
57.5 ml Glacial acetic acid in 500 ml DEPC- treated water) pH 4.8 was added, mixed 
by vortexing before storing on ice for a further 15 min. Denatured chromosomal 
DNA and cellular proteins were removed by centrifugation at 13000 rpm for 5 min. 
The supernatant was tranferred into another tube then mixed with an equal volume of 
phenol /chloroform to remove residual protein. The mixture was vortexed then spun 
for 2 min. The top layer, containing the plasmid DNA was transferred to another tube 
and the DNA precipitated with 2 volumes of ethanol at room temperature for 5 min. 
After centrifugation for 5 min, the supernatant was removed and the pellet air dried 
then resuspended in 50 pl TE (10mM Tris -HC1 pH 8.0 and 1mM EDTA pl-I 8.0) 
containing 1 pl of DNase -free RNase A and stored at -20 °C. 
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To verify whether plasmid preparations contained the correct insert 10 1.11 of 
miniprep DNA was restricted with 5U of PstI and 5U of EcoRl in a total volume of 
15 µl of lx restriction buffer H. The digests were carried out as in section 2.2.3.1. 
Out of 16 miniprep DNAs 15 contained the correct DNA insert (> 93 %). One of 
these was designated as pJS 1. 
c) Large Scale Plasmid DNA Preparation (Maxiprep) 
A single bacterial colony was transferred into a tube containing 2 nil LB plus 
100 µg /ml ampicillin and incubated overnight at 37 °C. The overnight culture was 
diluted into 500 ml LB containing 100 pg /ml ampicillin, and grown at 37 °C 
overnight. Cells were harvested by centrifugation at 6000 rpm for 5 min at 4 °C in a 
JA14 rotor in a Beckman J2 -MC centrifuge. The obtained pellet was resuspended in 
12 ml of GTE solution and mixed with 24 ml of freshly prepared alkaline /SDS (1 ml 
0.2 M NaOH and 5 ml 1% SDS) then stored on ice for 5 min. 16 ml of cold 5 M 
K.Ac was added, mixed by flick and left on ice for a further 10 min before 
centrifuging at 6000 rpm for 10 min at 4 °C in a JA14 rotor. The supernatant was 
strained through several layers of gauze into a clean 250 ml centrifuge pot, and 
precipitated with 32 ml of isopropanol at room temperature for 30 min. The plasmid 
DNA was recovered by centrifugation at 10000 rpm for 3 min at 4 °C. The 
supernatant was decanted and the pellet was left to air dry at room temperature 
before being resuspended in 2.2 ml TE. Afterwards, 2.8 g of CsCI as well as 100 µl 
of ethidium bromide was added to the suspension. The resulting DNA /CsCI solution 
was then transferred into a 3 ml Beckman Quick Seal ultracentrifuge tube topped up 
with CsCI solution (100 g CsCI plus 100 ml TE). The tube was centrifuged at 70000 
rpm for 17h at 20 °C. Plasmid DNA bands were collected through the tube wall using 
a syringe and a 21 gauge needle. Ethidium bromide was removed from the plasmid 
DNA by repeated extractions with equal volumes of isopropanol until the pink colour 
disappeared. The DNA was dialysed overnight against 3 changes of TE. 
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The concentration of the plasmid was determined spectrophotometrically by 
measuring absorbance at 260 nm wavelength (1 OD260 = 50 µg /ml DNA). 
2.2.4.2. Oestrogen receptor-13 (ER-f3) 
A cDNA clone (EcoRI -AccI fragment) encoding approximately 400 bp of the 
5' untranslated region (UTR) of rat oestrogen receptor -ß (ER -ß) subcloned into 
pBluescript KS (Stratagene) was kindly provided by Dr George G.J.M. Kuiper, 
Karolinska Institute, Sweden (Kuiper et al., 1996). The clone was transformed into 
E. coli, and plasmid DNA prepared as described in section 2.2.4.1. The plasmid was 
designated as pBETA24. 
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Plasmids were linearised with appropriate restriction enzymes (as described 
in Table 2.1) to generate the antisense (non- identical but complementary which will 
hybridise to the cellular mRNA) or sense (identical and will not hybridise to the 
cellular mRNA) templates. The linearisation was carried out at 37 °C for 1 h and 
confirmed by electrophoresis. 
Antisense Sense 
pJS1 (ER-a) HindIIl + T7 EcoRl + SP6 
pBETA24 (ER-E3) EcoRI + T3 Accl + T7 
Table 2.1. Diagram showing the restriction enzymes used to linearise plasmids and 
specific RNA polymerases used to generate antisense and sense riboprobes from 
pJS1 and pBETA24 accordingly. 
2.2.4.4. Phenol /chloroform Extraction of the Plasmid 
Protein was removed from templates using an equal volume of 
phenol /chloroform, the mix vortexed then spun at 13000 rpm for 3 -5 min and the 
upper aqueous layer, containing the DNA, was carefully removed and collected into 
a fresh RNAse -free eppendorf. An equal volume of chloroform:isoamyl alcohol 
(24:1) was added to the eppendorf, vortexed and spun as above. The top layer was 
Materials & Methods 64 
removed into another fresh RNAse -free eppendorf and ethanol- precipitated with 0.1 
volumes of 3 M Na acetate (or 5 M NaC1) and 2.5 volumes of absolute ethanol. The 
mix was gently vortexed, placed on dry ice for no longer than 10 min then 
centrifuged for 15 min and the supernatant removed. The pellet was air dried at room 
temperature and resuspended in 20 µl of DEPC- treated H2O. 1 IA aliquot of the DNA 
solution was electrophoresed on a 1% agarose gel to check for any contamination. 
The remaining template was aliquoted into fresh eppendorfs at a concentration of 1 
mg /ml and stored at -20 °C. 
2.2.4.5. In vitro transcription of 35S -UTP- labelled cRNA probes 
We chose to use riboprobes for our ISH studies because of the higher stability 
of RNA -RNA hybrids compared to DNA -RNA hybrids. Since these probes are 
single- stranded and as such are not prone to the problem of reannealing, this leads to 
a greater amount of probe available for hybridisation. The longer length of RNA 
probes relative to oligonucleotide probes also allow the use of more stringent 
hybridisation conditions, leading to the highest sensitivity when it comes to detection 
of a single -stranded target like cellular mRNA. 
1 pg of each of the linearised templates was incubated with 1.5 µl of mixed 
cold nucleotides (10 mM of ATP, CTP & GTP), 0.5 pi of 200 mM freshly -made 
DTT, 0.5 µl of RNase inhibitor, 4 µ1 of 35S -UTP (specific activity 40 mCi/ 1 ml), I 
pi of the specific RNA polymerases (as described in Table 2.1.) in the presence of 5 
x transcription buffer in a volume of -10 pl. The reaction was carried out in an 
RNase -free eppendorf The incubation was carried out at 37 °C for T7 and T3, and 
40 °C for SP6 polymerases for approximately 1 h. 
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After the incubation 1µl of RNase -free DNase was added to the reaction 
mixture and incubated for a further 15 min at 37 °C. The reaction was stopped by 
placing the tube on ice. The newly synthesised probe was then purified through a 
Nick column, Sephadex G50. The column was first washed with 3 ml of TE, pH 8.0 
in order to equilibrate the gel bed. The reaction mix was applied to the column 
followed by 400 µl of TE. The eluant, which contained little radioactivity, was 
discarded. A further 400 µl of TE buffer was applied to the column and the eluant 
collected, as this contained the labelled cRNA probe. Probes were stored up to 4 
weeks at -20 °C. 
Incorporation of 35S -UTP was measured in 1µl of the probe in 1 ml of Pico- 
fluor in a n- counter. Probes generally gave between 2 to 5 x 105 cpm/ml. To assess 
quality of the probe 1 gl of the probe was added to 4 µl of loading buffer and 
electrophoresed on a 6 M Urea:5% Polyacrylamide gel at 10 mA until the first dye 
front reached the gel end. The gel was then apposed against the Hyperfilm -ß max 
overnight and developed the following morning. An intact probe should yield only 
one discrete band on the film. A smearing of the band suggests a possibility of a 
degraded probe. These probes were discarded. 
2.2.5. Preparation of corticotrophin- releasing factor riboprobe 
A cDNA clone (BamHI -PvuII fragment; base 1525 -2043) encoding 
approximately 518 bp spanning the intron/exon II boundary of rat corticotrophin - 
releasing factor (CRF) was subcloned into pBluscript KS (the cDNA clone was 
provided by Dr M C Holmes, Molecular Endocrinology, MMC, Western General 
Hospital, Edinburgh, UK) (Thompson, Seasholtz, & Herbert, 1987). The plasmid 
was linearised with either XbaI or HindIll at 37 °C for 1 h to generate the antisense or 
sense templates, respectively. 
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Antisense riboprobe was generated by in vitro transcription in the presence of 35S- 
UTP with T3 RNA polymerase at 37 °C for 1 h. (described in detail in section 
2.2.4.5.) 
2.3. Ill vivo studies 
2.3.1. Animal maintenance 
Male and female Hooded -Lister rats (obtained from Harlan-Olac UK limited) 
were employed in all of our studies except in the pregnancy experiment where 
Sprague -Dawley rats (Bantin and Kingman, Hull, UK) were used instead. The rats 
were caged in groups of 3 unless otherwise stated. They were maintained under 
controlled light:dark cycles with light on at 0700 h and off at 1900 h, ambient 
temperature at 18 -20 °C with rat chow and water available ad libitum. They were 
allowed a period of at least 2 weeks to acclimatise to their new surroundings prior to 
experimentation. 
2.3.2. Surgery and experiments 
2.3.2.1. Sex steroid manipulation studies (Gonadectomy and Sex steroid 
replacement) 
Groups of male and female Hooded -Lister rats (180 -220 g; n =5 -6 /group) 
were either gonadectomised (GDX) or sham -operated under 5% halothane 
anaesthesia. Male rats were bilaterally gonadectomised (castrated, CX) by a ventral 
incision through the scrotum followed by tying off the vas deferens. The testes were 
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then removed by cutting below the sutures. Female rats were ovariectomised (OVX) 
by bilateral dorsal incisions and removal of both ovaries. 
While still anaesthetised, some gonadectomised rats were subcutaneously 
implanted with silastic capsules containing 17 -3 oestradiol (E2). Sham -operated 
controls received vehicle -containing capsules. Silastic capsules were modified and 
prepared after Bridges (Bridges, 1984) by first sealing one end of the silastic tubing 
(Altesil High Strength Tubing, internal diameter 2 mm, external diameter 3 mm, and 
1.5 cm in length) with silicone sealant, the capsules were autoclaved and 
subsequently filled with steroid. E2 was dissolved in 100% ethanol and mixed (1:10) 
in oil vehicle (89.7% arachis oil, 10% benzylalcohol, and 0.3% cresol) to form a 15 
mg /ml suspension which was used to fill the 1.5 cm capsule. All capsules were 
sealed with silicone sealant at the open end and, when the capsules were set, washed 
in 100% ethanol for 2 h and incubated in 0.1 M phosphate buffer saline (pH 7.4) at 
room temperature for 24 h prior to implantation. 
2.3.2.2. Adrenal steroid manipulation studies 
a) Adrenalectomy and Adrenal steroid replacement 
Groups of male Hooded -Lister rats (180 -220 g; n =5 -6 /group) were 
anaesthetised with 5% halothane and bilaterally adrenalectomised (ADX) through 
dorsal incisions and were given 0.9% NaC1 to drink after the surgery. Control 
animals included rats that were sham- operated by making bilateral dorsal 
subcutaneous incisions under halothane anaesthesia. Sham- operated controls were 
injected with vehicle (corn oil) as were the ADX rats. Another group of rats was 
ADX and injected subcutaneously with 10 mg /kg of corticosterone (CORT) at 4 p.m. 
daily for 72 h. Concentration of CORT was 20 mg /ml dissolved in vehicle. 
Concentration of CORT replacement at around 4 -10 mg/kg /day has been shown to 
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restore the physiological level of CORT. This was based on two sources of 
information; (1) studies of metabolic clearance in intact rats which suggests CORT 
production rates of 2.5 mg /rat/d (e.g. Waddell & Atkinson, 1994); (2) studies with 
steroid implants in ADX rats where the weight of implant at the end of the 
experiment is used to estimate release rate (Akana et al., 1985; Meyer et al., 1979). 
b) Stress 
The chronic stress model involved exposing rats to a cycle of various stress 
paradigms. A group of male Hooded -Lister rats (180 -220 g; n =5 -6) was subjected 
each day to forced water swim for 15 min at 4 °C, 5% halothane exposure for 1 min 
in an air -tight box and immobilised in a restraint tube (a Perspex cylinder) for 60 min 
at different times for 3 days. The sequence of these stress paradigms was changed 
each day to prevent the adaptation of rats to the treatment as follows; 
Day 1: Immobilisation in restraint tube for 60 min (1000 -1100 h) 
Forced water swim at 4 °C for 15 min (1200 -1215 h) 
5% Halothane exposure for 1 min (1600 h) 
Day 2 5% Halothane exposure for 1 min (1000 h) 
Forced water swim at 4 °C for 15 min (1200 -1215 h) 
Immobilisation in restraint tube for 60 min (1600 -1700 h) 
Day 3 Forced water swim at 4 °C for 15 min (1000 -1015 h) 
Immobilisation in restraint tube for 60 min (1200 -1300 h) 
5% Halothane exposure for 1 min (1600 h) 
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2.3.3. Bioassay of sex steroid replacement 
Bioassay was used to verify the effectiveness of E2 replacement in OVX rats 
by determining the weight of the uteri between the treatment and the vehicle groups. 
The uteri were removed post mortem. Data are expressed as uterus/body weight ratio 
and shown in Figure 2.1. 
Uterus weight relative to body weight compared between ovariectomised females 










Figure 2.1. The uterus/body weight ratio from the ovariectomised rats treated with E2 
was significantly higher than those from rats treated with vehicle. The increase in 
uterine weight following chronic oestrogen treatment is expected to be a result of 
hypertrophy and hyperplasia of the myometrium and endometrium, and the 
stimulation of fluid secretion in the uterine horns. Asterisk indicates statistical 
significance between groups (P < 0.0001, Student's I- test). 
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2.4. In vitro Assay 
2.4.1. Corticosterone Radioimmunoassay 
Total plasma corticosterone concentrations were measured using an in -house 
radioimmunoassay. Blood plasma was diluted 1:10 in borate buffer (163 mM boric 
acid, 81 mM sodium acetate, and 0.5% BSA, pH 7.4) and heated at 75 °C for 30 min 
to dissociate steroid from protein in the samples. An aliquot of 20 µl of each of the 
corticosterone standards (0.625 -320 mmol /1, Sigma) or the diluted sample were 
incubated with a mix of 3H- corticosterone (total counts of around 1.0000 cpm) and 
rabbit anti -corticosterone antibody (1:100 dilution) for 60 min at room temperature in 
a flexible 96 well plate (in duplicate). Afterwards, 50 µl of anti -rabbit scintillation 
proximity assay (SPA) reagent was added and samples incubated overnight. The 
SPA reagent acts by binding to the first antibody -corticosterone complex, bringing it 
in close contact with the scintillant, allowing detection of the emission signal. In 
contrast, the radioactivity of the unbound ligand goes undetected because it is not 
brought into close proximity with the scintillant. The samples were quantified in a (3- 
counter using the Microsoft MultiCal programme, and sample contents (expressed as 
nmol /1) estimated from the standard curve (Figure 2.2.). The sensitivity of the assay 
was 1.25 nmol /1 and the intra- and inter -assay coefficients of variation were below 
7% and 10 %, respectively. 
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Comparative distribution of two types of oestrogen receptor mRNAs 
( -a vs -(3) in rat brain 
3.1. Introduction 
It is generally accepted that most of the biological responses to steroid 
hormones are mediated via the genomic pathway, although over the past few years 
there has been a considerable number of studies providing convincing evidence for 
the alternative non -genomic pathway in some of the actions of steroids (Schmidt et 
al., 2000; Wehling, 1997). The genomic mechanism of steroid action involves 
binding of the ligands to their cognate intracellular receptors, which function as 
ligand- regulated transcription factors (see Chapter 1). The steroid -thyroid receptor 
superfamily comprises a large collection of the transcription factors including 
glucocorticoid (GR), mineralocorticoid (MR), thyroid hormone (TR), retinoic acid 
(RAR), androgen (AR), progesterone (PR) as well as oestrogen (ER) receptors 
(Mangelsdorf et al., 1995). These nuclear receptors are modular in construction, 
having four or five distinct domains, depending on the type of the receptor. 
Oestrogens regulate a wide variety of neural processes ranging from 
organising sexual differentiation of the brain (Arnold & Breedlove, 1985), mediating 
various reproductive physiologies (Couse & Korach, 1999), controlling 
hypothalamic GnRH neuroendocrine function (Kalra & Kalra, 1983), modulation of 
mood and behaviour (Fink et al., 1996) as well as its newly discovered role as a 
neuroprotective molecule in certain neurodegenerative diseases (Xu et al., 1998). 
Such diversity of effects indicates that several areas of the brain are involved. 
Following the cloning of the first ER (ER -a) in the late 1980s (see Chapter 1) there 
was a general belief that only one ER existed, despite the commonality that many 
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receptors are expressed as multiple isoforms selective for a particular steroid (Tsai & 
O'Malley, 1994). In 1996, however, a second ER, designated ER -ß, was cloned from 
a rat prostate cDNA library (Kuiper et al., 1996). The two oestrogen receptor 
subtypes are products of two distinct genes, located in two different chromosomes, at 
least in the human (Enmark et al., 1997). 
Because of the essential role of the receptors for a hormone in mediating its 
action the distribution of the receptor is of key importance. Formerly, the 
identification of the sites of hormone action (e.g. oestrogens) relied on the use of 
systemically administered radiolabelled -ligand, which is concentrated by oestrogen - 
responsive cells, thus reflecting the cellular location of the hormone receptor binding 
site. This approach, however, relies on ligand- binding conformation and would not 
differentiate among many other receptor isoforms, some of which might not be able 
to bind ligand, but nonetheless possess the ability to modulate the transcription 
process and vice versa (see Maruyama et al., 1998; Warner, Nilsson, & Gustafsson, 
1999). The advent of elaborate molecular biology techniques over the past few 
decades has enabled the detection of a particular receptor, both at the level of 
transcription and translation by identifying the receptor mRNA or the protein, 
respectively. The biological role of the receptor is then assessed by various 
functional studies including at the behavioural level, plus the use of `receptor knock- 
out' models whereby the receptor gene has been rendered functionally impaired. 
Since the initial cloning of ER -a over a decade ago a great deal of information 
regarding its localisation, functional properties and physiological relevance has been 
obtained. Despite the fact that ER -a mRNA or protein has been identified in most 
areas where oestrogens are known to exert their effects, there are some instances 
whereby oestrogens could evidently exert physiological actions in the absence of the 
classic ER -a mRNA or protein. One such system comprises the magnocellular 
neurosecretory neurones where the oxytocin gene is undoubtedly, although not 
necessarily directly, regulated by oestrogens (Van Tol et al., 1988) (see more in 
Chapter 5). Moreover the retention of systemically administered 
125I- oestrogen in 
certain areas of brain, such as the medial preoptic area or the amygdala in oestrogen 
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receptor -a knockout mice (a -ERKO) (Shughrue et al., 1997b) suggests that the 
effects of oestrogens might be accounted for by the newly discovered ER -ß. 
Therefore this experiment was designed to investigate the comparative distribution of 
both types of oestrogen receptor in the rat brain. 
Various techniques are available to approach this problem such as radio - 
ligand binding and autoradiography and immunocytochemistry. However, we chose 
in situ hybridisation histochemistry (ISH) because this technique allows a precise 
anatomical identification of cells that express the particular mRNA. This is 
particularly useful when dealing with tissue of such high anatomical heterogeneity 
such as the brain. This method can also be combined with some other techniques 
such as immunocytochemistry thus enabling the detection two or more moieties in 
the same tissue /cell simultaneously, although not used here. This technique is also 
quantifiable which enables 1) evaluation of relative expression of receptor gene 
between different types of neurones, or other cell types 2) determination of changes 
in receptor gene expression, reflecting the process regulating expression of the gene 
in different physiological states. 
3.2. Aims 
By using semi -quantitative ISH, we designed and carried out a detailed 
comparison of the cellular distribution of two types of ER mRNAs ( -a vs -ß) in adult 
male and female Hooded -Lister rat brains. The distribution was confirmed in 
subsequent studies where the focus was on investigating the regulation of expression 
of the mRNA transcripts in selected brain regions (see Chapter 4 & 5). 
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3.3. Methods 
3.3.1. Animals 
Adult male and female Hooded -Lister rats (weighing between 180 -220 g.) 
were obtained from a local supplier (Harlan-Olac UK limited) and allowed to 
acclimatise for at least 2 weeks prior to use. Rat chow and water were available ad 
libitum. Two rats of each sex were used in this study. The stage of the oestrous cycle 
in the female rats was not determined in this experiment. The rats were killed by 
decapitation, their brains removed, snap -frozen with powdered dry ice and stored at - 
80°C until used. Details of the preparation of ER -a and -ß riboprobes as well as the 
in situ hybridisation protocols are described in detail in Chapter 2 (section 2.2.2.- 
2.2.4.) 
3.3.2. Data analysis 
Anatomical identification and nomenclature of brain structures was based on 
the stereotaxic rat brain atlases (Paxinos & Watson, 1986; Paxinos & Watson, 1996). 
The hybridisation signal was evaluated using a computer -aided image analyser 
(MCID -M4 (Version 3.0 Rev. 1.5), Imaging Research, Inc., Canada). Film 
autoradiographs and emulsion- coated sections were used. Film autoradiographs 
showed regional distribution of hybridisation, and in emulsion- coated sections 
hybridisation signal was visualised in dark -field as silver grains over neurones. The 
relative intensity of the hybridisation signal was measured as silver grain numbers 
overlying individuals neurones. Each mRNA transcript was hybridised in an adjacent 
series of anatomically comparable sections to compare the expression of both ER 
mRNAs, from rostral to caudal. 
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Abbreviations 
3V third ventricle 
AhiAL amygdalohippocampal area, anterolateral 
ARC arcuate nucleus 
AVPV anterior ventral periventricular nucleus 
BNST bed nucleus of the stria terminalis 
CA 1 -CA4 Ammon's horn of the hippocampus 
CP choroid plexus 
CVOs circumventricular organs 
DG dentate gyrus 
HIP hippocampus 
LC locus coeruleus 
LV lateral ventricle 
MeAD medial anterodorsal amygdaloid nucleus 
MePD medial posterodorsal amygdaloid nucleus 
MPN median preoptic nucleus 
mPOA medial preoptic area 
Opt optic tract 
OX optic chiasm 
Pe periventricular hypothalamic nuclei 
PVN, dp paraventricular nucleus, dorsal cap 
PVN, mpd paraventricular nucleus, medial parvocellular dorsal zone 
PVN, mpv paraventricular nucleus, medial parvocellular ventral zone 
PVN, pml paraventricular nucleus, posterior magnocellular lateral zone 
SFO subfornical organ 
SON supraoptic nucleus 
VMH ventromedial hypothalamic nucleus 
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3.4. Results 
3.4.1. Specificity of the probes 
Sense probes were included in the experiments for both ER -a and -ß 
mRNAs. A sense probe has an identical sequence to the cellular mRNA of interest, 
and will not hybridise so serving as a negative control. All ISHs with sense probes 
were conducted under identical conditions to those for antisense probes. ER -a sense 
labelling was undetectable in all sections we examined (Figure 3.1.). For most 
regions showing ER-I3 hybridisation with antisense probe, there was no detectable 
labelling with the comparable sense probe. The exception was a degree of labelling 
of ER-I3 sense probe within the hippocampal formation, including the DG, although 
the intensity of the signal was less than that from ER -ß antisense probe (Figure 3.2.). 
Certain CNS structures which contain high cellular and ribosomal RNA content tend 
to show such non -specific probe binding. These include the dentate gyrus (DG) and 
CA pyramidal subfields of the hippocampus, granule cell layer of the cerebellum, 
piriform cortex and some other regions that stain intensely with Nissl substance. This 
is especially true when using RNA probes since they appear to contain short 
sequences which hybridise to ribosomal RNA, even though corresponding DNA 
probe sequences do not recognise the RNA. 
Additionally we also included tissue sections that were pretreated with RNase 
to eliminate mRNA from the tissue prior to hybridisation with antisense riboprobes 
for ER -a mRNA. No hybridisation signal was detected in any of the sections 
examined. 




Figure 3.1. Representative film autoradiographs from in situ hybridisation 
histochemistry of 10 p.M thick coronal rat brain sections hybridised with A) 35S- 
labelled antisense riboprobe for ER -a mRNA and B) 35S- labelled sense riboprobe for 
ER -a mRNA. The hybridisation signal from the ER -a mRNA antisense probe was 
detected in all subfields of the hippocampus (HIP) and in the arcuate (ARC) as well 
as the ventromedial hypothalamic (VMH) nuclei. The signal from the ER -a sense 
probe was undetectable in all regions examined. 
A B 
HIP 71,41464*" 
Figure 3.2. Representative film autoradiographs from in situ hybridisation 
histochemistry of 10 µM thick coronal rat brain sections hybridised with A) 35S- 
labelled antisense riboprobe for ER -(3 mRNA and B) 35S- labelled sense riboprobe for 
ER -(3 mRNA. The hybridisation signal from the ER-I3 mRNA antisense probe was 
detected in all subfields of the hippocampus (HIP) and in the paraventricular nucleus 
(PVN). The expression was also detectable in the choroid plexus (CP). The 
hybridisation from the comparable sense probe was undetectable in most regions 
except in the hippocampus although the intensity of the signal was less than that 
from the antisense riboprobe. 
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In general there was no marked difference in terms of the distribution and the 
intensity of expression for either ER -a or -13 mRNAs between intact male and female 
rats. 
3.4.2. Distribution of ER -a mRNA 
ISH with antisense riboprobe revealed an extensive distribution of ER -a 
mRNA throughout the rat brain although the majority of the labelled cells were 
localised within the diencephalon, in particular the hypothalamus as well as regions 
of the telencephalon that provide inputs to the hypothalamus. 
In the telencephalon, the ER -a mRNA signal was detected as rostra) as the 
piriform cortex (Pir) (Figure 3.3A). Labelling for ER -a mRNA was also seen in the 
bed nucleus of the stria terminalis (BNST) while the expression in individual cells 
was found to be weakly labelled (Figure 3.3C & 3.4A). Among the circumventricular 
organs (CVOs) the subfornical organ (SFO) expressed ER -a mRNA (Figure 3.3C). 
Analysis of the distribution revealed a considerable degree of expression of ER -a 
mRNA in the amygdaloid nuclei, although the expression was not uniformly 
distributed throughout the nuclei with heavily labelled cells found in the 
amygdalohippocampal, anterolateral portion of the nucleus (AhiAL) (Figure 3.6). 
Within the hippocampal formation, a moderate level of hybridisation signal was seen 
throughout the extent of Ammon's horn (CA1 -CA4) and DG, with the most intense 
signal found within the CA1 and CA3 subfields (Figure 3.3I). 
In the diencephalon, robust expression of ER -a mRNA was found within 
several structures of the periventricular zone of the hypothalamus, including the 
anterior ventral periventricular (AVPV) and the periventricular hypothalamic nuclei 
(Pe) (Figure 3.3E). Neurones intensely labelled for ER -a mRNA were also observed 
in the medial preoptic area (mPOA) (Figure 3.5A). In the caudal hypothalamus, a 
dense accumulation of the hybridisation signal was found within the arcuate nucleus 
(ARC), particularly in the lateral subdivision of the nucleus (Figure 3.8). 
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The ventromedial nucleus of the hypothalamus (VMH) also exhibited a 
marked ER -a mRNA hybridisation signal although the most heavily labelled 
neurones were found in the ventrolateral aspect of the nucleus (Figure 3.8 & 3.9). 
Within the metencephalon, only a few weakly ER -a labelled cells were found 
in the locus coeruleus (Figure 3.10). There was no discrete labelling of ER -a of cells 
in the cerebellar cell layers. 
3.4.3. Distribution of ER-I3 mRNA 
The present ISH study for ER-13 mRNA revealed a different pattern of 
distribution from that of ER -a mRNA although both transcripts share a considerable 
degree of overlap within certain structures in the rat brain. 
In the telencephalon a weak signal for ER -ß mRNA was seen in the piriform 
cortex (Pir) (Figure 3.3B). Strong ER -ß mRNA signal was evident over several cells 
in the bed nucleus of the stria terminalis (BNST) (Figure 3.3D & 3.4B). In the 
amygdaloid nuclei ER -(3 mRNA was widely distributed throughout the structure. A 
moderate level of ER -ß mRNA expression was found in the medial anterodorsal 
(MeAD) nucleus with a gradual increase in the intensity of the signal towards the 
medial posterodorsal nucleus (MePD) (Figure 3.7). A low level of ER -ß mRNA 
expression was found throughout the whole hippocampal formation including CA I - 
CA4 and DG, similar to the expression pattern found for ER -a mRNA (Figure 3.3J). 
In the diencephalon ER -ß mRNA containing cells were mainly localised in 
the hypothalamus, and particularly neurones in the periventricular zone were the 
most heavily labelled. Perhaps the most striking differences in the distribution of ER- 
a and -13 mRNAs were found in the hypothalamic paraventricular (PVN) and 
supraoptic (SON) nuclei (Figure 3.3H & J). Neurones within the PVN and SON, 
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completely devoid of the classic ER -a, expressed a high level of ER-I3 mRNA. In 
fact, the highest intensity of ERP mRNA signal was seen in the PVN. At high 
resolution, ER -P mRNA was found to be differentially expressed among the discrete 
subnuclei of the PVN. The majority of heavily labelled cells were localised mostly in 
the parvocellular part of the nuclei, especially in the medial parvocellular part, 
ventral zone (mpvPVN) with little expression found in the dorsal zone (mpdPVN), 
while some heavily labelled cells were also found in the dorsal parvocellular part 
(dpPVN) (Figure 3.11). Within the magnocellular neurones, both in the PVN 
(pm1PVN) as well as the SON, the expression of ERP mRNA was obviously less 
intense but nevertheless present throughout the rostro- caudal extent of the SON, and 
in both the dorsal (predominantly oxytocin- containing) and ventral (predominantly 
vasopressin- containing) portions of the nucleus. (Figure 3.12) Small accessory cell 
groups of magnocellular origin including the nucleus circularis (oxytocin neurones) 
also expressed ER-I3 mRNA (Figure 3.13). 
Moderate expression of ER -P mRNA was found in the periventricular 
nucleus (Pe) (Figure 3.3F & 3.5B). Weak ER -P labelling was found in the medial 
preoptic area (mPOA) (Figure 3.5B). Similarly, in the arcuate nucleus (ARC) ER-I3 
mRNA expression was weak whereas the ventromedial nucleus of the hypothalamus 
(VMH) showed no ER-I3 mRNA signal. 
In the metencephalon, the largest concentration of ER-I3 mRNA containing 
cells was seen in the cerebellum, with the majority of the Purkinje cell layers being 
labelled (Figure 3.14). 
One of the interesting findings in this present study was the exclusive 
expression of ER-(3 mRNA in the choroid plexus. We detected the signal in the 
choroid in the lateral ventricle, while the ER -a mRNA signal was completely absent 
from this structure as was sense control (Figure 3.3H & 3.2B). 
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Figure 3.3. Representative film autoradiographs from in situ hybridisation 
histochemistry of 10 µM thick coronal rat brain sections at various rostro- caudal 
levels. Pairs of autoradiograms of anatomically comparable sections hybridised with 
35S- labelled antisense riboprobes for ER -a mRNA (left hand column) and ER -ß 
mRNA (right hand column). Abbreviations indicated for different brain structures are 
defined on p5. 
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Figure 3.4. Dark -field photomicrographs showing silver grains over neurones 
hybridised with A) ER -a mRNA and B) ER-I3 mRNA in the bed nucleus of the stria 
terminalis (BNST). Asterisks indicate the medial septal nucleus. Scale bar = 100 µM. 
Figure 3.5. Dark -field photomicrographs showing neurones in the anterior 
hypothalamus hybridised with A) ER -a mRNA and B) ER -ß mRNA. Intense 
hybridisation signal from ER -a mRNA was seen throughout the anterior ventral 
periventricular nucleus whereas signal from ER -ß mRNA was restricted to a 
confined dorsal periventricular area (Pe). The medial preoptic area (mPOA) also 
contained a substantial number of neurones hybridised with the ER -a mRNA probe 
while a low density of ER -ß mRNA signal was found in this region. OX denotes 
optic chiasm. Scale bar = 200 µM. 
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Figure 3.6. Dark -field photomicrographs showing neurones in the amygdala 
hybridised with ER -a mRNA. Strong hybridisation signal was localised in neurones 
in the anterolateral portion of the nucleus (AhiAL). Opt denotes optic tract and LV 
denotes lateral ventricle. Scale bar = 200 RM. 
Figure 3.7. Dark -field photomicrographs showing neurones in the anterior amygdala 
hybridised with ER-0 mRNA. The neurones strongest labelling for ER -13 mRNA was 
found in the medial posterodorsal part of the nucleus (MePD). Opt denotes optic 
tract. Scale bar = 20011M. 
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Figure 3.8. Dark -field photomicrograph exhibiting silver grains over neurones 
hybridised with an antisense riboprobe for ER -a mRNA in the arcuate (ARC) and 
ventromedial hypothalamic (VMH) nuclei. Asterisks indicate the third ventricle. 
Scale bar = 200 µM. 
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Figure 3.9. Bright -field photomicrograph exhibiting silver grains from in situ 
hybridisation signal for ER -a mRNA over neurones in the ventromedial 
hypothalamic nucleus. Scale bar = 50 µM. 
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Figure 3.10. Autoradiograph from in situ hybridisation for ER -a mRNA antisense 
riboprobe on 10 µM thick coronal rat brain section. Hybridisation signal was 
detected in the locus coeruleus (LC) in the metencephalon. 
Figure 3.11. Dark -field photomicrograph showing silver grains over neurones 
hybridised with an antisense riboprobe for ER-f3 mRNA in the paraventricular 
nucleus (PVN). The hybridisation signal was expressed differentially in the different 
discrete subpopulations of the nucleus, with the majority of heavily labelled cells 
localised mostly in the parvocellular part of the nuclei, especially in the medial 
parvocellular part, ventral zone (mpvPVN). The posterior magnocellular part 
(pm1PVN) and the dorsal parvocellular part (dpPVN) also contained ER -13 mRNA 
expressing neurones. Asterisks indicate the third ventricle. Scale bar = 
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Figure 3.12. Dark -field photomicrograph showing silver grains over neurones 
hybridised with an antisense riboprobe for ER -ß mRNA in the supraoptic nucleus 
(SON). The hybridisation signal was present in both the dorsal (predominantly 
oxytocin -containing) and ventral (predominantly vasopressin- containing) portions of 
the nucleus. OX denotes optic chiasm. Scale bar = 100 µM. 
4 
Figure 3.13. Bright -field photomicrograph showing silver grains over neurones in the 
nucleus circularis (accessory magnocellular neurones) hybridised with an antisense 
probe for ER -ß mRNA. Scale bar = 10 µM. 
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Figure 3.14. Bright -field photomicrograph showing silver grains over Purkinje cells 
in the cerebellum hybridised with an antisense probe for ER -ß mRNA. Scale bar = 
10 µM. 
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3.5. Discussion 
The current ISH study indicates distinct distribution patterns for both ER -a 
and -ß mRNAs, although they exhibit a considerable degree of overlap within certain 
CNS structures. By comparing the distribution of both ER mRNAs in adjacent 
sections both transcripts were present in the piriform cortex, the bed nucleus of the 
stria terminalis, the periventricular zone of the anterior hypothalamus, the 
amygdaloid nuclei, and the hippocampal formation. Exclusive expression of ER -a 
mRNA was found within the ventromedial hypothalamus, the subfornical organ and 
the locus coeruleus. The arcuate nucleus also expressed predominantly ER -a mRNA, 
with a barely detectable level of ER -(3 mRNA within this structure. In contrast ER -(3 
mRNA, but not ER -a, was detected in the paraventricular and supraoptic nuclei, 
choroid plexus and the Purkinje cell layers in the cerebellum. 
This pattern of expression corresponds to other recently published 
descriptions (Hrabovszky et al., 1998; Laflamme et al., 1998; Shughrue, Komm, & 
Merchenthaler, 1996; Shughrue, Lane, & Merchenthaler, 1997a). The possible 
functional significance of these patterns of ER-a/-Ps expression in these regions is 
discussed. 
Our understanding of the roles of sex steroids in reproductive behaviour and 
the regulation of GnRH neurones arises from the study of gonadal steroid actions in 
the anterior and ventral hypothalamus. The anterior hypothalamus is a well - 
established target structure for oestrogens, and showed a characteristic distribution of 
ER -a mRNA, similar to a previous ISH study carried out by Simerly et al. 1990 
(Simerly et al., 1990). The medial preoptic area (mPOA) and the ventromedial 
hypothalamus (VMH) are known to mediate several sexual behaviours including 
maternal behaviour and lordosis in female rats (Madeira & Lieberman, 1995) and the 
control of copulatory behaviour in males (McGinnis, Williams, & Lumia, 1996; 
Pfaus & Heeb, 1997). These areas expressed a strong hybridisation signal for ER -a 
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mRNA but a low level, or none, for ER -ß mRNA, suggesting that it is primarily the 
ER -a subtype that mediates these effects. Similarly cells containing strong ER -a 
mRNA were seen in regions of the periventricular hypothalamus such as the 
anteroventral periventricular (AVPV) and the arcuate nuclei, regions thought to be 
involved in the control of gonadotrophin (GnRH) secretion (Lehman et al., 1997), 
although the GnRH neurones themselves are not thought to possess either ER -a or -ß 
(Herbison & Theodosis, 1992; Li, Schwartz, & Rissman, 1997; Shivers et al., 1983; 
Shughrue et al., 1997a) (although see Butler, Sjöberg, & Coen, 1999). Especially, the 
oestrogen- receptive neurones in the AVPV are proposed to be the critical site where 
oestrogens exerts its stimulatory effects upon GnRH release and synthesis (Herbison, 
1998). In contrast the arcuate nuclei were only lightly labelled for ER -ß mRNA and 
the signal was restricted to a defined area of the AVPA. This suggests that the 
feedback of ovarian hormones in controlling the release of GnRH might involve ER- 
a rather than ER -13 subtype. 
The limbic areas that share bidirectional connections with the anterior 
hypothalamus, such as the medial amygdala (MeA) and the bed nucleus of the stria 
terminalis (BNST) expressed both ER -a and -13 mRNAs. The amygdaloid nuclei 
participate in a wide range of emotional behaviours related to anxiety, fear, sexual 
behaviour as well as learning and memory (Byrum, Ahearn, & Krishnan, 1999; 
Gallagher & Schoenbaum, 1999; Van Hoesen, Augustinack, & Redman, 1999). The 
patterns of distributions of both receptor mRNAs in the amygdala differed in the 
different subnuclei, suggesting that oestrogens could mediate these diverse 
physiological responses by means of both receptor subtypes via discrete populations 
of neurones. The BNST, serving as a relay site to various forebrain nuclei, also 
possesses both receptor mRNAs. Again the pattern of distribution shows subtle 
differences in terms of the localisation and the intensity of ER -a and -13 mRNA 
expressed here. The BNST is a target of gonadal steroids known to be involved in the 
endocrine and behavioural control of reproduction (Emery & Sachs, 1976). 
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The subfornical organ (SFO), a circumventricular organ, involved in aspects 
of cardiovascular and body fluid regulation (Ferguson & Bains, 1996; McKinley, 
Hards, & Oldfield, 1994; Phillips, 1987) contained neurones expressing ER -a 
mRNA. This finding is supported by an earlier study that had shown the 
accumulation of oestradiol by SFO neurones (Pfaff & Keiner, 1973). Angiotensin II 
(ANGH) is the predominant circulating hormone regulating function of the SFO via 
ANG II AT1- receptors (AT1R) (Gutman, Ciriello, & Mogenson, 1988). A recent 
study has identified the colocalisation of both AT1R and ER protein within the SFO 
(Rosas- Arellano, Solano- Flores, & Ciriello, 1999) suggesting that oestrogens could 
exert their effects, presumably via the ER -a receptor subtype, on SFO neurones thus 
modulating the cardiovascular response to ANG II. 
The finding that both ER mRNAs, particularly ER -(3, are distributed beyond 
hypothalamic neurones suggests that oestrogens might be involved in various other 
neural processes apart from the well -established reproductive functions. One of the 
interesting extrahypothalamic roles of oestrogens is the beneficial effects on the 
cognitive decline associated with ageing and various neurodegenerative diseases, 
particularly dementia of Alzheimer's type (AD) (see Henderson, 1997b). Although 
remaining inconclusive, several epidemiological studies in humans have suggested a 
potential role of oestrogen in improving cognitive function. For instance, Tang et al. 
1996, have shown a significant delay in the onset and decrease in the relative risk of 
developing AD in postmenopausal women with E2 replacement therapy (Tang et al., 
1996). Greater cognitive impairment is associated with increased hypothalamic - 
pituitary- adrenal axis activity (HPA) (Heuser, Litvan, & Juncos, 1988) which results 
in a marked release of cortisol level, a phenomenon seen in the elderly and AD 
patients (Greenwald et al., 1986). Oestrogen replacement therapy in postmenopausal 
women has been shown to blunt stress -induced cortisol elevations (Lindheim et al., 
1992) perhaps enhancing memory by diminishing deleterious effects of stress. 
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Although the underlying mechanism of how oestrogens are implicated in the 
process of cognitive function remains unclear, it could be speculated that oestrogens 
might mediate their actions, in part, via the forebrain hippocampus. Given that both 
receptor mRNAs are expressed in all subfields of the hippocampus, they may confer 
oestrogen's action in a synergistic manner upon this limbic structure. The 
hippocampus plays a key role in certain aspects of learning and memory, particularly 
in the process of long -term potentiation (LTP) and depression (LTD), unique forms 
of synaptic plasticity that provide a possible biological basis for learning and 
memory (Malenka, 1994). The hippocampus is also one of the most vulnerable brain 
areas consistently affected by Alzheimer's disease. In animal studies oestrogens have 
been shown to increase dendritic spine density (Gould et al., 1990a; McEwen, 
Tanapat, & Weiland, 1999) and synapses (Woolley & McEwen, 1992; Woolley et 
al., 1997), particularly in the CA1 subfield of the hippocampus which might enhance 
learning and memory function (McEwen & Alves, 1999). A number of studies have 
shown the correlation between the process of LTP and synaptic plasticity in this area 
(Chang & Greenough, 1984; Lee et al., 1980; Tsien, Huerta, & Tonegawa, 1996). 
LTP is also reported to vary across the oestrous cycle with the highest degree of 
potentiation during the afternoon of pro -oestrus when oestrogen levels reach their 
peak (Warren et al., 1995). Cultured hippocampal neurones in vitro have been shown 
to be protected in the presence of oestradiol against a number of toxic agents 
including glutamate, FeSO4 and amyloid 13-peptide (Goodman et al., 1996). The 
regulation of ER mRNA within the hippocampus especially in the context of 1 -IPA 
activity was of particular interest in this study and the subject of experimental 
investigation (see Chapter 4). 
Exclusive expression of ER -13 mRNA, without ER -a, was found within the 
hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei. While the PVN is 
comprised of a heterogeneous population of both magno- and parvo- cellular 
neurones, the SON consists of only the magnocellular type. A retrograde 
fluorescence tracing study conducted two decades ago by Swanson and Kuypers 
(Swanson & Kuypers, 1980) provided a detailed description of the organisation of 
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the subdivisions of the PVN and their projections. Based on this description we 
found a striking expression of ER -ß mRNA within the medial parvocellular ventral 
zone (mpvPVN) and, to a lesser extent, the dorsal zone (mpdPVN). Neurones in the 
mpvPVN project to the autonomic brainstem and spinal cord while those in the 
dorsomedial PVN project to the median eminence. Thus the present findings suggest 
the potential role of oestrogens in mediating certain autonomic functions (see more 
in Chapter 5) via ER -ß containing cells. Although the majority of cells intensely 
labelled for ER-(3 were localised within the parvocellular neurones, the hybridisation 
signal was nonetheless present in the magnocellular subdivision throughout the 
extent of the nuclei. Oestrogens have long been recognised as a modulator of the 
magnocellular vasopressin (VP) and oxytocin (OXT) neurones. The expression of 
OXT mRNA in the SON varies across the oestrous cycle (Van Tol et al., 1988) and 
decreases following castration (Miller et al., 1989). Replacement with oestradiol has 
been shown to increase the level of OXT mRNA in the SON and the anterior 
commissural nucleus in ovariectomised rats (Chung, McCabe, & Pfaff, 1991). The 
discovery of ER -ß mRNA in the PVN and SON may provide an explanation of how 
oestrogens can regulate the VP and OXT genes where numerous previous studies 
have failed to identify the ER -a mRNA and protein in these sites (see more in 
Chapter 5). 
Various laboratories have previously carried out histochemical studies to 
determine the distribution of the ER -(3 transcript and protein in the hypothalamus of 
the rat brain (Alves et al., 1998; Hrabovszky et al., 1998; Li et al., 1997; Shughrue et 
al., 1997a; Simonian & Herbison, 1997). Although our study on ER -ß mRNA 
expression is largely in agreement with other findings subtle differences exist 
between studies. While our results revealed an intense ER -(3 mRNA signal within the 
parvocellular neurones, in particular in the medial ventral zone, Shughrue et al., 
instead, reported a strong hybridisation signal in the magnocellular subdivision of the 
PVN (Hrabovszky et al., 1998; Shughrue et al., 1996). This difference might have 
originated from the difference in the riboprobes employed in this present and their 
studies. Our ER -(3 mRNA riboprobe was generated from the entire 5'- untranslated 
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region (5'UTR) of the rat ER -ß cDNA, which is a long single stretch of nucleotide 
sequence of -400 bp in length, whereas the riboprobe from Shughrue et al. was a 
mixture of two probes (Shughrue et al., 1996), one of which corresponds to 
nucleotide bases 52 -610, also encoded most part of the 5'UTR, and the other 
corresponds to bases 1809 -2094 extending the 3'end of the rat ER -(3 cDNA. So the 
combination of their probe might have detected the expression of some other splicing 
transcripts in addition to the original ER-I3 mRNA. This perhaps explains the 
intensification of the hybridisation signal obtained in their study. Alternatively the 
difference in the degree of expression between their and our studies might have 
resulted from the difference in animal strain, hormonal status or from some other 
external factors such as housing condition, animal treatment or tissue handling, for 
instance. 
Nonetheless, a recent immunocytochemical study by Alves et al. 1998 has 
demonstrated a distribution of ER -(3 protein in the paraventricular nucleus similar to 
our present ISH study (Alves et al., 1998). 
Apart from the PVN and SON, the cerebellar Purkinje cells, the only output 
element of the cerebellar cortex, is another example where ER -f3 is exclusively 
expressed. This provides a suggestion that oestrogens might be able to influence 
certain motor functions via this receptor subtype, although a functional study in the 
future is obviously required to ascertain this. 
Lastly, finding ER -13 mRNA within the choroid plexus is certainly intriguing 
although the function of oestrogens in this locus is currently unknown. It perhaps 
helps in the production of the cerebro- spinal fluid (CSF) or maybe is involved with 
regulating transport of peptides, such as prolactin or leptin (Bennett et al., 1999; Pi & 
Grattan, 1998; Zlokovic et al., 2000). 
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Conclusion 
Although ISH studies have advanced understanding of where oestrogens 
could exert their diverse effects upon target organs this technique actually determines 
the receptor mRNA. Ultimately the crucial determining step in whether and where E2 
could mediate their biological effects requires the translation of their receptor 
mRNAs into the functional protein. Prior to the cloning of ER -ß, numerous studies 
utilised various in vivo (Bettini & Maggi, 1991; Pfaff & Keiner, 1973; Stumpf, 1970) 
as well as in vitro techniques to determine oestrogen receptor binding sites (not 
protein as such). Shortly after the discovery of ER -ß, specific antibodies were 
successfully generated against this new receptor. As a result, several laboratories 
have carried out immunocytochemical studies to detect ER -3 protein especially in 
the nervous system (Alves et al., 1998; Li et al., 1997; Simonian & Herbison, 1997). 
Most of the literature available to date has yielded, more or less, a consistent result 
regarding the localisation of the protein. These are also in good agreement with our 
present ISH study. 
Certainly the actions of oestrogens would not only depend on where their 
respective receptors are expressed but also on whether they would homo- and /or 
heterodimerise in a region- specific manner (Cowley et al., 1997; Pace et al., 1997). 
The differential ligand specificity for each ER subtype is also a factor contributing to 
the final action of oestrogens in target organs (Kuiper et al., 1997; Pacch et al., 
1997). The generation of recent ERKO mice, both ER -a and -ß, has provided the 
opportunity to begin to partially dissect the functional significance of each receptor 
subtype and advance our knowledge of the oestrogen -signalling pathway (Couse et 
al., 1995; Krege et al., 1998; Lubahn et al., 1993; Rissman et al., 1999; Rissman et 
al., 1997; Shughrue, 1998). 
The overlapping but non -identical tissue distribution of both ER -a and -13 
transcripts indicates that discrete oestrogen- responsive neuronal populations are 
differentially regulated. This combination of different types of oestrogen receptor 
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and differing tissue distribution may be crucial in determining how the brain is likely 
to be affected by oestrogens. This is, however, not to discard the potential rapid non - 
genomic actions of this steroid all together. 
The future development of selective agonists and antagonists of each receptor 
isoform may allow further dissection of E2 function at each site throughout the CNS. 
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Regulation of oestrogen receptor mRNA in the hippocampus 
4.1. Introduction 
98 
The role of the ovarian steroid oestrogen was traditionally thought to be only 
involved in events related to reproduction and, in the brain, through actions 
predominantly mediated via certain neurones in the hypothalamus. However the past 
decade has witnessed revelation of other `extra- hypothalamic' actions of oestrogen. 
One such interesting finding suggests that oestrogen could exert beneficial effects 
upon the cognitive decline associated with ageing and various neurodegenerative 
disorders, especially dementia of Alzheimer's type (AD). 
The prevalence of dementia and AD doubles every 5 years after the 
population reaches the age of 65, so that nearly 50% of the elderly over the age of 85 
may suffer from the condition (Evans et al., 1989). AD is the most common 
neurodegenerative disease associated with ageing and affects as many as 4 million 
people in the United States (Evans, 1996). The total estimated cost for all AD 
patients in the United States alone was a staggering $67.3 billion in 1994 (Ernst & 
Hay, 1994) and has been increasing since. 
Several findings suggest that oestrogen deficiency in postmenopausal women 
increases the vulnerability of selected regions of the central nervous system to the 
multiple factors contributing to the neurodegenerative changes associated with 
ageing and AD. Postmenopausal oestrogen replacement therapy reduces the risk of 
myocardial infarction (Ross et al., 1989) and women with a history of myocardial 
infarction are more likely than other women to develop dementia (Aronson et al., 
1990). Several lines of evidence suggest that lower levels of circulating oestrogen are 
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associated with lower body weights in postmenopausal women (Meldrum et al., 
1981) and AD patients are thinner than control subjects (Berlinger & Potter, 1991). 
In ageing postmenopausal women, treatment with E, has been shown to promote 
memory function (Sherwin, 1997). Paganini -Hill and Henderson 1994 first 
demonstrated that E2 might have a protective effect in reducing the risk of 
developing AD (Paganini -Hill & Henderson, 1994). In a more recent study, Tang et 
al. 1996 also show that E2, given in the form of hormone replacement therapy 
following the menopause, is associated with a reduced subsequent risk of the 
individual developing AD (Tang et al., 1996) suggesting that oestrogen could 
potentially serve as a neuroprotective molecule (for recent reviews see Fillit & Luine, 
1997; Tierney & Luine, 1997). 
There are many hypotheses attempting to explain actions of oestrogens in the 
brains of AD patients. AD is a progressive neurodegenerative disease which can he 
characterised by neuronal loss and accumulation of intracellular neurofibrillary 
tangles and extracellular senile plaques, particularly in the hippocampus and 
associated neocortex. Oestrogen has been shown to affect the metabolism of the 
amyloid precursor protein (APP). Deposition of insoluble 3- amyloid in brain 
parenchyma is a distinctive feature in AD patients. In an oestrogen receptor - 
containing cell culture system, 1713- oestradiol at physiological concentrations 
increases the secretory metabolism of the soluble fragment of APP without 
increasing intracellular levels of APP, thereby reducing the deposition of 13-amyloid 
and the formation of senile plaques (Jaffe et al., 1994). 
Neurochemical deficits involving cholinergic, serotoninergic, and 
monoaminergic neurones are present in AD patients. The cholinergic deficit is most 
pronounced in AD (in the basal nucleus of Meynert, which contains oestrogen 
receptors and from which the major afferent projections to the frontal cortex 
originate), and oestrogen stimulates cholinergic markers e.g. choline acetyl 
transferase, the enzyme responsible for the synthesis of acetyl choline, perhaps the 
most important neurotransmitter in cognitive function and memory (Gibbs, 1994). 
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Further evidence for the neuroprotective effects of oestrogens has been 
provided in cell culture work. Steroid hormones, including oestrogens, progesterone, 
and glucocorticoids, can directly affect neuronal vulnerability to excitotoxic, 
metabolic, and oxidative insults, suggesting roles for these steroids in several 
different neurodegenerative disorders. In particular, oestrogen protects while 
glucocorticoids endanger these cultured hippocampal neurones (Goodman et al., 
1996). 
One of the interesting aspects of oestrogen action in the brain is its ability to 
reverse the hippocampal neuronal ageing and cell death caused by either inadequate 
or excessive levels of glucocorticoids. Glucocorticoids play a vital role in 
maintaining homeostasis under adverse conditions, i.e. `stress'. Corticosteroids act 
by binding to and activating intracellular receptors (GR and MR) which are highly 
expressed in the hippocampus (McEwen, Brinton, & Sapolsky, 1988), indicating that 
this area is a major target for glucocorticoid action. Chronic stress or elevated 
glucocorticoid levels result in decreased dendritic branch points and decreased total 
dendritic length of apical dendrites in the CA3 region (Woolley, Gould, & McEwen, 
1990b). Thus excessive corticosterone appears to be deleterious to the neurones in 
the hippocampus. On the other hand, inadequate levels of adrenal steroids also lead 
to degenerative changes within the hippocampus. An immunocytochemical study has 
shown shrinkage and cell death in the dentate gyrus (DG) following chronic 
adrenalectomy (Sloviter et al., 1989). Massive loss of granular cells in the 
hippocampus within 3 days after adrenalectomy has also been reported by Gould et 
al. 1990 (Gould, Woolley, & McEwen, 1990b). All of these changes probably 
underlie the impairment of spatial memory performance. On the contrary, with 
oestradiol treatment, spatial memory performance is enhanced which might he due to 
the increased spine density, particularly on CA1 apical dendrites, induced by 
oestrogens (Gould, Woolley, & McEwen, 1991b; Woolley & McEwen, 1992; 
Woolley et al., 1997). Thus the hippocampus shows structural changes after 
alterations in circulating levels of both oestradiol and corticosterone. 
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Moreover, the hippocampus is a key area of the brain responsible for 
integrating memory, mood and neural regulation of the hypothalamic- pituit :u - 
adrenal, neuroendocrine stress, axis. This area is also a key site of neural 
degeneration in AD and in ageing. Many studies have investigated the effects of 
oestrogens in the brain, but most were done outside the region of the hippocampus. 
Evidence regarding effects of oestrogen in the ventromedial hypothalamus and 
medial preoptic area which are involved in copulatory and reproductive behaviour 
are well documented, as well as the neural control of gonadotrophin secretion which 
is mediated via the periventricular and arcuate nuclei (see Chapter 3). Relatively few 
studies have been carried out to determine oestrogen function in the hippocampus. 
Yet why do people with AD have neurone loss in this particular area and manifest 
memory impairment? Why are neurones in the hippocampus so sensitive to 
glucocorticoids and gonadal steroid hormones? Are there any interactions between 
the two types of hormones and what are they? And if there are any interactions, do 
they occur only in the hippocampus, or are any other areas in the brain involved as 
well? All of these questions have led to our interest in pursuing the effect of 
oestrogen in the brain, particularly in the area of the hippocampus. 
From our ISH study we have shown that both ER -a and -ß mRNAs are 
evidently expressed in all subfields of the hippocampus, including the pyramidal 
neurones in CA1 and CA3 as well as the granule cells in DG, suggesting that there 
might be an interaction between ER -a and -ß in conferring the effects of oestrogens 
in these sites. 
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4.2. Aims 
Because the response of the target organ to a hormone is largely dictated by 
the expression of its receptor, knowledge of how the expression of the receptor is 
regulated is important. This is particularly appropriate in the hippocampus. the 
structure of which plays roles in learning and memory processes. Such study perhaps 
may give an insight into how some of the benefits of hormone replacement therapy 
upon cognitive function might be brought about. In this study we proposed to 
investigate whether and how ER -a and -ß mRNAs are regulated in the hippocampus 
by various steroid hormone manipulations. 
4.3. Methods 
We used a combination of hormone manipulations to study how ER mRNAs 
might be regulated in neurones in the hippocampus using quantitative ISH. 
4.3.1. Regulation of ER -a and -ß mRNAs in the hippocampus by sex steroid 
manipulation 
The regulation of steroid hormone receptors including ER -a and -3 has been 
shown to be regulated by an autologous mechanism, in which the prime regulator is 
the ligand itself. However, the magnitude of response is also influenced by many 
other factors including cell -/tissue -type specificity. The regulation of ER -a and -(3 
mRNA has not been extensively explored in the context of the hippocampus before. 
Thus we proposed to investigate whether such regulation occurs in this site. 
4.3.1.1. Effect of acute vs chronic gonadectomy 
To assess whether ER mRNAs can be regulated by sex steroids the 
endogenous source of sex hormones from both male and female rats was removed by 
bilateral gonadectomy. Adult male and random cycling female Hooded -Lister rats 
Regulation of ER -a and -ß mRNAs in the hippocampus 103 
were obtained from a local supplier (Harlan-Olac UK limited) and allowed to 
acclimatise to a 12 h light:dark cycle for at least 2 weeks prior to use. Rat chow and 
water were available ad libitum. Groups of male and female Hooded -Lister rats 
(n =5 /group) were bilaterally gonadectomised (castration (CX) in males and 
ovariectomy (OVX) in females) under halothane anaesthesia and left to recover for 
72 h or 2 weeks, prior to decapitation. Another set of rats was sham- operated as 
controls (sham -male (SM) vs sham -female (SF)) and killed at the same time as the 
experimental groups (animals were subjected to the same surgical procedures as the 
experimental group, except that the gonads were not removed). Surgical procedures 
are described in detail in Chapter 2, section 2.3.2.1. 
The effectiveness of the surgery was assessed by quantifying the expression 
of ER -a mRNA in the medial preoptic area which was expected to increase 72 h 
after castration as previously shown (Lisciotto & Morrell, 1993). 
4.3.1.2. Effect of exogenous 170- oestradiol (E2) in ovariectomised rats 
A follow -up study was conducted, to determine whether the effect which 
long -term ovariectomy had on the expression of ER mRNAs could be reversed by 
replacement of sex steroid to the hormonally- deprived animals. Specifically to 
establish if the increase in ER mRNA expression in OVX animals could be 
accounted for by the loss of the major endogenous sex steroid, E2. Two groups of 
adult random cycling female rats (n =6 /group) underwent bilateral ovariectomy under 
halothane anaesthesia. While still anaesthetised, one group of rats was given a 
subcutaneous implant of a silastic capsule containing 15 mg /ml of E2 in vehicle. The 
other group had a vehicle- containing implant as a control. (Details of steroid implant 
and surgical procedures are described in Chapter 2, section 2.3.2.1.) Rats were killed 
2 weeks later by decapitation. The effectiveness of the steroid implant was assessed 
by bioassay, by determining the uterine wet weight per body weight ratio. 
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4.3.2. Regulation of ER -a and -13 mRNAs in the hippocampus by adrenal 
steroid manipulation 
In addition to the role of the hippocampus in cognitive function, it is also 
known to have a role in controlling the hypothalamo- pituitary- adrenal (HPA) axis, 
particularly on the negative feedback mechanism (Jacobson & Sapolsky, 1991). 
Considerable evidence suggests a modulatory role of sex steroid hormone upon the 
HPA axis and that oestrogen exerts an excitatory effect upon the activity of this axis. 
For example, both the basal and stress levels of ACTH and CORT are significantly 
higher in female rats in pro -oestrus when their production of oestrogen is at its peak 
(Bohler et al., 1990; Carey et al., 1995; Hiroshige & Wada- Okada, 1973; Raps, 
Barthe, & Desaulles, 1971). We sought to determine whether manipulating adrenal 
steroid hormone would affect the expression of ER mRNAs in the hippocampus, 
perhaps contributing to the effects oestrogen has upon the HPA axis. We elected to 
use male rats because we found no differences between males and females in patterns 
of ER -a or -13 mRNA distribution in the hippocampus (see Chapter 3), while 
variations in E2 exposure through the oestrous cycle are avoided (also testosterone is 
a precursor for E2 and 5a- androstane -313, 17f3 -diol, which has agonist activity at ER- 
13, in the male brain (Kuiper et al., 1996). 
4.3.2.1. Effect of bilateral adrenalectomy and corticosterone replacement 
Three groups of adult male Hooded -Lister rats (n =5 /group) were treated as 
follows; 
1) Sham- operated plus subcutaneous vehicle (corn oil) injection 
2) Bilaterally adrenalectomised (ADX) plus subcutaneous vehicle 
injection, given 0.9% NaCI to drink 
3) ADX plus replacement of corticosterone (CORT) at a dose of 10 
mg/kg in oil via subcutaneous injection daily (at 1600 h), given 0.9% 
NaCI to drink 
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All surgery was performed under halothane anaesthesia. Surgical procedures 
are described in detail in Chapter 2, section 2.3.2.2.a. 
4.3.2.2. Effect of stress exposure 
One group of adult male Hooded -Lister rats (n =5 /group) was exposed to a 
cycle of stressors over 72 h (exposure to 5% halothane for 1 min; forced swim in 
cold water at 4 °C for 15 min; restraint in a Perspex cylinder for 60 min: each once 
daily, in random order at 1000, 1200 and 1600 h). The other group of male rats was 
left undisturbed and served as controls. Details of the experimental procedures are 
described in Chapter 2, section 2.3.2.2.b. 
Rats were killed by decapitation 72 h following surgery or after the beginning 
of stress exposure. The effectiveness of the treatments was confirmed by 
measurements of HPA axis parameters, including determining the expression of CRF 
mRNA in the dorsomedial parvocellular neurones of the PVN, plasma CORT 
concentration and thymus gland weight. Trunk blood was collected in tubes 
containing 5% EDTA and plasma separated by centrifugation and stored at -20 °C for 
subsequent radioimmunoassay of plasma CORT concentration, described in Chapter 
2, section 2.4.1. The thymus gland was excised and surrounding fat was removed, 
and the gland then weighed to assess tissue effects of integrated corticosterone 
secretion. 
At the end of each experiment quantitative ISH (described in (fct,aiI in 
Chapter 2, section 2.2.2.- 2.2.4.) was employed to determine the expression of ER -a 
and -13 mRNAs in the hippocampus. Autoradiographs were evaluated by counting 
silver grains over the profiles of individual neurones (x 40 objective), using a 
computer -aided image analysis system (MCID-4 Imaging Research, Canada). The 
relative amounts of ER -a and -ß mRNA expression was determined in pyramidal 
neurones in CAI, CA3 and granule cells of the DG in the hippocampus. Silver grain 
counts were made over 8 neurones per section, and in 3 -4 sections per region per rat. 
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Background measurements were made over adjacent tissue with no evident 
expressing neurones (adjacent to the hippocampal subfields) and subtracted to obtain 
the net value of silver grain counts. The slides were coded so that the experimenter 
was unaware of the treatment of the rats at the time of evaluation. Animal means 
were calculated for each variable, and these values were used to calculate group 
means. In addition some sections through the medial preoptic area in the acute 
gonadectomy (72 h) experiment were also hybridised with ER -a and -ß mRNA and 
some through the dorsomedial parvocellular division of the PVN, from rats in the 
adrenal steroid manipulation study, were hybridised with an antisense riboprobe for 
CRF mRNA (described in Chapter 2, section 2.2.5.). 
In each experiment Student's t -test or one -way Analysis of Variance 
(ANOVA) and post -hoc tests (Student- Newman -Keuls) (unless otherwise stated) 
were used (SigmaStat software) as appropriate to determine the statistical 
significance of differences between groups. The alpha value was set at P < 0.05. 
Results are expressed as the group means±sem. 
4.4. Results 
In this study we employed quantitative ISH to determine changes in the 
expression of ER mRNAs in the hippocampus under the influence of gonadal and 
adrenal steroid hormone modulation. Analysis of the ISH autoradiographs revealed 
specific hybridisation signal from both ER -a and ER -ß antisense riboprobes in all 
subfields of the hippocampus including pyramidal neurones in CA 1 and CA3 and 
granule cells in the DG (Figure 4.1A. &B.). Control experiments were conducted as 
described in Chapter 3, section 3.4.1. which included the use of sense probe controls. 
The ER -a sense labelling was undetectable while there was a degree of hybridisation 
signal for ER -13 sense probe in the hippocampus. 
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Figure 4.1A. Representative autoradiograph from in situ hybridisation histochemistry 
of tissue section hybridised with 35S- labelled antisense riboprobe for ER -a mRNA to 




Figure 4.1B. Representative autoradiograph from in situ hybridisation histochemistry 
of tissue section hybridised with 35S- labelled antisense riboprobe for ER-I3 mRNA to 
show the hippocampus 
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4.4.1. Regulation of ER -a and -ß mRNAs in the hippocampus by sex steroid 
manipulation 
4.4.1.1. Effect of acute vs chronic gonadectomy 
At 72 h after gonadectomy (GDX) the expression of neither ER -a nor -13 
mRNA in the gonadectomised (CX/OVX) rats was significantly different from that 
in the sham -operated groups (SM/SF) in any region of the hippocampus (Figure 
4.2.). In contrast, there was a significant increase in the expression of ER -a mRNA 
in the DG (P < 0.05, ANOVA, P < 0.05 Student -Newman -Keuls) and a significant 
increase in ER-13 mRNA expression in the CAI (P < 0.0005, ANOVA, P < 0.05 
Student -Newman -Keuls) and DG (P < 0.05, ANOVA, P < 0.05 Student- Newman- 
Keuls) in OVX rats compared to these regions in the SF group (Figure 4.3.). 
However, this increase in expression after GDX was not observed in males, 
as the expression of both ER -a or -ß mRNA remained relatively unchanged after 2 
weeks of CX. 
Interestingly there was also a significant sex difference in the basal 
expression of ER -a mRNA which was found only in the 2 week gonadectomy 
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4.4.1.2. Effect of acute gonadectomy on ER mRNAs in the medial preoptic area 
(mPOA) 
Seventy two hours after CX in male rats the expression of ER -a mRNA in 
the mPOA was significantly increased (P = 0.014, ANOVA, P < 0.05 Student - 
Newman- Keuls) while this effect was not observed in OVX rats compared to their 
sham -operated cohorts (SM /SF). On the other hand the expression of ER -13 mRNA 
here was not altered following GDX in either sex compared to the sham -operated 
controls (SF /SM) (Figure 4.4.). 
4.4.1.3. Effect of exogenous 17f3- oestradiol (E,) in ovariectomised rats 
Following 2 weeks of E2 replacement in the OVX rats, there was no 
significant change in the expression of either ER -a or 43 mRNA in any subfield of 
the hippocampus compared to the vehicle -treated OVX controls (Figure 4.5.). The 
effectiveness of steroid replacement was validated by the increase in uterine weight. 
There was a significant difference in the uterine weight relative to body weight 
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4.4.2. Regulation of ER -a and -13 mRNAs in the hippocampus by adrenal 
steroid manipulation 
4.4.2.1. Plasma corticosterone concentration and thymus gland weight 
The dose of CORT used increased plasma CORT concentration from 
26.6 ±16.3 nmol/1 after adrenalectomy to 2082 ±434 nmol /1; in sham -operated 
controls, plasma CORT concentration was 440 ±67 nmo1/1(P < 0.005, Kruskal- Wallis 
one -way ANOVA, P < 0.05, Dunn's Method). Following stress exposure plasma 
CORT concentration was significantly increased from 143.7 ±27.5 nmol /1 in controls 
to 452.2 ±118.1 nmol /1 in the stressed group (P < 0.05, Student's t- test). 
The weight of the thymus gland was significantly increased by ADX, and this 
increase was prevented by CORT replacement; mean thymus weight ±s.e.m. in 
controls, after ADX and after ADX with CORT replacement was 0.325 ±0.023, 
0.398±0.017 and 0.298 ±0.023 g, respectively (P < 0.05, ANOVA, P < 0.05, Student - 
Newman- Keuls). Following repeated stress thymus weight significantly decreased 
from 0.364 ±0.026 to 0.289±0.019 g (one -tailed t -test [t = 2.19, 9 dfl, P < 0.05). 
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4.4.2.2. Effect of adrenalectomy and corticosterone replacement 
Seventy two h after bilateral adrenalectomy (ADX) there was no significant 
change in the expression of either ER -a or -ß mRNA in any subfield of the 
hippocampus compared to those from sham- operated and ADX with CORT 
replacement groups. The exception was in the CA1 region where ER -ß mRNA was 
significantly decreased following ADX (by 34.5%) and in which the basal expression 
was also restored by CORT replacement (P = 0.022, ANOVA, P < 0.05 Student - 
Newman- Keuls) (Figure 4.7.). 
The expression of CRF mRNA in the dorsomedial parvocellular PVN 
neurones showed a substantial increase 72 h following ADX, while the expression 
significantly returned to the basal level upon CORT replacement (P = 0.0148, 
Kruskal- Wallis one -way ANOVA, P < 0.05 Dunn's Method) (Figure 4.8A.). The 
data were not normally distributed so non -parametric statistics were used. 
4.4.2.3. Effect of stress exposure 
There was no change in the expression of either ER -a or -(3 mRNA following 
72 h of stress exposure in any subfield of the hippocampus (Figure 4.9.) and the 
expression of CRF mRNA in the medial parvocellular PVN was not evidently 
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4.5. Discussion 
The distribution of ER -a and -(3 mRNA in the hippocampus has been 
previously described by others (Laflamme et al., 1998; Osterlund et al., 1998; 
Register, Shively, & Lewis, 1998; Shughrue, Lane, & Merchenthaler, 1997a; Simerly 
et al., 1990). In the present study, specific expression of both ER -a and -ß mRNAs 
was found throughout the hippocampus, evidently overlying the pyramidal neurones 
and overlying granule cell layers in the DG. Whether these mRNAs are present 
within the same neurones is unknown, but is likely given their near ubiquitous 
distribution throughout the hippocampal structure. 
Since there was a detectable degree of hybridisation from the sense probe for 
ER -(3 mRNA in the hippocampus, results must be viewed with caution. It might be 
appropriate to investigate further whether this residual hybridisation signal derives 
from the hybridisation of the probe to specific mRNA species or whether this reflects 
the non -specific binding of the ER -13 mRNA in the hippocampus. Nonetheless, 
numerous immunocytochemical studies have indicated the presence of ER -a and -r3 
proteins in the hippocampus (Bettini & Maggi, 1991; Bettini et al., 1992; Maggi et 
al., 1989) although this is controversial, because ER -a has been described to be 
confined to interneurones (Weiland et al., 1997), and ER-f3 as either non -detectable 
(McEwen & Alves, 1999) or present in the cytoplasm, rather than in neuronal nuclei 
as elsewhere (Li, Schwartz, & Rissman, 1997). Nonetheless, it is clear that pyramidal 
cells in CA1, 2 and 3 can accumulate 125I- labelled oestrogens (Shughrue & 
Merchenthaler, 2000). 
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4.5.1. Regulation of ER mRNAs in the hippocampus by sex steroid manipulation 
Changes in the expression of both ER -a and -ß mRNAs that we observed 
within the hippocampus as a result of gonadectomy suggest that these transcripts can 
be regulated by gonadal hormones. The increase in the level of both ER mRNAs that 
occurred 2 weeks after the surgery and not at 72 h reveals the prolonged time course 
of the regulation of ER mRNA in the hippocampus, suggesting that the direction of 
hormonal regulation of such transcripts is according to a time -dependent manner. It 
is unlikely that a lack of response of ER mRNAs at 72 h after GDX was due to 
insensitivity of the method, as changes were found in ER -a mRNA expression in the 
medial preoptic area (mPOA). Castration for 72 h has been previously shown to 
induce a 2 -fold increase in ER -a mRNA expression in the mPOA (Lisciotto & 
Morrell, 1993). In this study we were able to measure a comparable (1.5 -fold) 
induction of ER -a mRNA expression in this region after CX (see Figure 4.4.) 
indicating the effectiveness of the surgery. 
Secondly the increase in ER -a mRNA expression that was found in the DG 
and that of ER -(3 mRNA in CAl and the DG indicates a region- specificity of the 
regulation of ER mRNAs. Moreover, the increased expression in the present study 
after gonadectomy was observed in females (OVX) but not in (castrated) males 
(CX), suggesting that the regulation of ER mRNA is sexually dimorphic. 
Additionally there was also a sex difference in the basal expression of ER -a mRNA 
in the hippocampus, although this was found only in the 2 week gonadectomy 
experiment but not in the 72h experiment. This apparent discrepancy might have 
stemmed from the difference in the endogenous level of sex steroid hormone in the 
female rats which fluctuates cyclically thus contributing to the difference in the basal 
expression of the ER -a mRNA from one experiment to the other. 
Tight regulation of the expression of steroid hormone receptors will ensure 
that the appropriate amount of the receptor is available at the appropriate time in the 
correct cells to achieve the maximal responses of the target tissue. 
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Numerous previous studies have shown that region- specific, dose -dependent 
and, to a lesser extent, sex -specific regulation is a common feature of steroid 
receptors, including ER. For instance, Shughrue et al. 1992 have shown that the 
expression of ER -a mRNA within the hypothalamus is quantitatively different 
among many nuclei and varies across the 4 -day oestrous cycle according to the 
fluctuating level of E2. Furthermore, they demonstrated that the expression of ER -a 
transcript was significantly elevated following OVX ( Shughrue, Bushnell, & Dorsa, 
1992). Perhaps analogous to the present ISH study, Lauber et al. 1991 showed that 
the expression of ER -a mRNA in the ventromedial and arcuate nuclei in OVX rats 
was decreased by E2 treatment in a dose -dependent manner. Moreover, they also 
showed that there was a sex difference in the basal level of ER -a mRNA between 
OVX and CX rats in the two nuclei and that the level of ER -a transcript in CX rats 
was maintained throughout the treatment suggesting that E2 did not down -regulate 
the ER -a transcript in CX rats (Lauber et al., 1991). As well as ER -a mRNA, ER -ß 
mRNA has been shown to be modulated in a region specific and dose -dependent 
manner. In a recent ISH study by Osterlund et al. 1998 both transcripts have been 
shown to respond to E2 treatment when OVX rats were given high dose of E2 (170 
µg) but a low dose of E2 (17 µg) was largely ineffective. With a high dose of E2 the 
expression of ER -ß mRNA was reduced in the medial amygdala, the anterodorsal 
(MeAD) and posterodorsal (MePD) nuclei while the increase was observed in the 
arcuate nucleus. With a low dose of E2, however, the expression of the ER -ß 
transcript was only reduced in the MeAD but not anywhere else (Osterlund et al., 
1998). 
The molecular mechanism underlying the complex regulation of ER mRNA 
expression is not fully understood. Several previous studies indicate a tissue -specific 
alternative promoter usage as a mechanism in the regulation of ER gene expression 
which might partly explain the differential responses observed in a variety of tissues 
(see Chapter 1). The region- specific pattern of changes in ER mRNA in response to 
GDX within various subfields of the hippocampus in our study suggests that the 
regulation of these transcripts might also be under the influence of different 
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promoter- usage. Such a mechanism has recently been demonstrated for the GR in the 
hippocampus (McCormick et al., 2000). 
Although this present study does not show that the increase in the receptor 
mRNA following gonadectomy would necessarily result in an increase in the 
receptor protein, previous reports have demonstrated that oestrogen receptor protein 
in certain areas of the brain, including the hippocampus, is regulated by circulating 
sex steroids. For instance, a previous study has shown that oestradiol benzoate 
administered to OVX rats led to a decrease in the concentration of ER protein by up 
to 50% in the hippocampus (Maggi et al., 1989). This indicates that ER protein is 
physiologically functional and can be regulated in the hippocampus. It also indirectly 
implies that the increase in ER mRNA observed in our study might precede an 
increase in the actual receptor protein. These findings reinforce our present study and 
suggest that oestrogen has the potential to regulate the sensitivity of the hippocampal 
neurones to hormonal modulation, presumably, via regulation at the receptor level. 
It seems an obvious possibility that the up- regulation of ER mRNA observed 
in this present study was primarily due to the absence of 17 -13 oestradiol (E2) as a 
result of gonadectomy. Autoregulation of receptor mRNAs and/or protein by their 
cognate ligands, a process known as homologous regulation, has been established for 
many steroid hormone receptors, including ER. Such a mechanism involves partly a 
regulation of rate of gene transcription or an altered receptor mRNA stability, as well 
as some other possibilities as previously discussed (see Chapter 1 for more detail). 
The presence of an ERE in the promoter region of ER -a such as in the rainbow trout 
suggests a possibility of direct autoregulation of ER by its own ligand (Le Dréan et 
al., 1995). 
However in the study to test this, whereby E2 was replaced in the OVX rats 
for 2 weeks, the level of the ER mRNAs did not significantly differ from that in 
OVX females treated with vehicle. The effectiveness of E2 replacement was 
validated by determining the effects on uterine weight (Figure 4.6.). Thus the lack of 
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response of ER mRNA upon E2 replacement was likely to be due to factors other 
than inadequate E2 treatment. This indicates that E2 removal was not the only factor 
responsible for the increase in ER mRNA expression after OVX. This present finding 
suggests that ovariectomy may have removed additional ovarian factors that 
modulate ER expression and biosynthesis. One such candidate might be progesterone 
(P4). In a breast cancer cell line down -regulation of ER -a expression could be 
induced by P4 in vitro (Read, Greene, & Katzenellenbogen, 1989). In vivo, P4 has 
been shown to attenuate ER -a synthesis in rodent brain (Blaustein & Brown, 1984; 
Kato & Onouchi, 1984). Thus removing the ovaries would inevitably result in the 
loss of the endogenous source of P4. However, P4 is only transiently secreted in the 
normal rat oestrous cycle, and initial comparisons in the present study were made 
between OVX and intact rats at random stages of the cycle. For this reason, it was 
not considered appropriate to test P4 replacement. Whether P4 modulates the ER 
expression in the hippocampus is presently unknown. 
It is perhaps possible that a sustained high circulating concentration of E2, as 
indicated by the oestrus -state of the uteri post mortem in the present study, has 
different actions on ER mRNA expression from the intermittent secretion during the 
oestrous cycle. For ER -a, opposite effects of E2 on expression are seen between the 
uterus and liver (Koritnik, Koshy, & Hoversland, 1995; Shupnik, Gordon, & Chin, 
1989), reflecting the complex regulation of ER expression. On the other hand, it may 
be possible that a lower dose of E2 might have been effective; perhaps the dose - 
response relationship is U- shaped? This was, however, not explored in the present 
study. Nonetheless, previous studies have shown that, at the behavioural level, 
hormone replacement with relatively high E2 (mimicking pro -oestrus level) were 
ineffective (Luine & Rodriguez, 1994) while comparatively low E2 (producing di- 
oestrus /early pro -oestrus concentration) did enhance cognitive performance in OVX 
rats (Luine et al., 1998). 
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Although the notion of sex difference in the CNS has been mainly directed 
towards structures involved in reproduction, accumulating evidence over the past 
several years suggests that perhaps the hippocampus is also one of the structures in 
the brain which shows (subtle) sex differences. Synaptogenesis on excitatory spines 
in the hippocampal CA1 pyramidal neurones fluctuates cyclically in parallel with the 
natural ovarian cycle. This effect was only observed in female but not in male rats 
(Gould et al., 1990a; Lewis, McEwen, & Frankfurt, 1995; Woolley & McEwen, 
1992). The sex difference in the regulation of ER -a and -ß mRNA in the DG may 
underlie the sex difference in the reactive outgrowth of the commissural afferent 
fibers in the DG. Morse et al. 1986 have shown that removal of the entorhinal cortex 
results in less fiber outgrowth in the DG which was observed only in female rats. 
Upon hormone replacement therapy the outgrowth was brought back to the control 
levels again only in females, whereas fiber outgrowth in males was unaffected 
(Morse, Scheff, & DeKosky, 1986). Additionally, male rats have also been shown to 
have a larger and less lateral (more asymmetric) DG than females, and neonatal 
testosterone treatment induced the genetically female DG to appear like that of male 
(Roof & Havens, 1992). 
Sexual dimorphism can also be demonstrated at the behavioural level, 
particularly with regard to spatial ability as well as the strategies used in spatial 
learning between sexes (Beatty, 1984; Einon, 1980; Williams, Barnett, & Meck, 
1990; Williams & Meck, 1991). For instance, Roof and Havens 1992 showed that the 
performance of adult male and female rats in a Morris water maze task shows a sex 
difference with male rats learning the task more rapidly than females (Roof & 
Havens, 1992). In humans it has been repeatedly demonstrated that males score 
better on certain types of spatial abilities while females excel on others (Caplan, 
MacPherson, & Tobin, 1985; Postma, Izendoorn, & De Haan, 1998; Postma et al., 
1999). All this evidence supports the notion that there is a sexual dimorphism 
between the sexes regarding learning and memory and that the underlying neural 
mechanism might perhaps stem from the sex difference in the hippocampal 
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morphology and physiology which is brought about partly by effects of gonadal 
hormones. 
The underlying mechanism by which sex steroids mediate their effects in the 
hippocampus is perhaps via morphological alterations in the hippocampal neurones. 
Numerous studies suggest that E2 regulates hippocampal dendritic spines and 
synapses, an action which appears to involve NMDA receptor activation. Removal of 
endogenous sources of ovarian hormones results in a reduction in the number and 
density of dendritic spines as well as synapses in the apical dendrites of hippocampal 
CA1 pyramidal neurones (Gould et al., 1990a; Woolley & McEwen, 1992; Woolley 
& McEwen, 1993; Woolley et al., 1997). This decrease can be prevented or reversed 
by treatment with E2 (Gould et al., 1990a). Moreover, cyclic synaptic turnover in the 
hippocampus displays a remarkable plasticity as well as a high degree of specificity. 
Oestrogen- induced synaptogenesis occurs on dendritic spines and not on dendritic 
shafts and such synaptogenesis fluctuates significantly within a short period of the 
natural ovarian cycle. Surprisingly, such synaptic plasticity is specific only to CAl 
and does not occur on CA3 pyramidal neurones or dentate granule neurones 
(Woolley et al., 1990a). Perhaps these synapses may be involved in learning and 
memory processes as reflected by long -term potentiation (LTP), the sensitivity of 
which correlates with excitatory synapse density and E2 level (Warren et al., 1995). 
Non -conventionally, E2 has been shown to regulate hippocampal neuronal 
excitability through a non -genomic mechanism in which it rapidly potentiates 
glutamate receptor- mediated excitatory post- synaptic potentials (EPSPs) (Wong & 
Moss, 1992) and excitatory post- synaptic currents (Gu & Moss, 1996) on 
hippocampal CA1 pyramidal neurones. These rapid effects (occurring within 
minutes) have been proposed to involve activation of intracellular second -messenger 
coupling systems (Gu & Moss, 1996; Moss, Gu, & Wong, 1997). These actions, 
however, may involve ER expressed in the cell membrane. 
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4.5.2. Regulation of ER mRNAs in the hippocampus by adrenal steroid 
manipulation 
In the study involving adrenal steroid hormone manipulation, the expression 
of ER -a mRNA remained stable through the different treatments. The only change in 
ER -(3 mRNA expression that was found was a decrease in the CAI subfield after 
ADX, which was prevented by glucocorticoid replacement. Repeated stress did not 
affect expression of either transcript in intact rats. Thus basal glucocorticoid 
secretion maintains ER -13 mRNA expression in the CA 1 subfield. 
Replacement of CORT in the present study was sufficient to fully reverse 
both the increases in CRF mRNA expression in the dorsomedial parvocellular PVN 
neurones (Figure 4.9.) and the increase in thymus weight following ADX. Although 
there was no significant increase in the expression of CRF mRNA following stress 
exposure, CORT secretion was nonetheless significantly increased in the stressed 
groups. Several studies have demonstrated that exposure of rats to either repeated 
(daily but intermittently) or chronic (continuous) stress causes elevations in plasma 
CORT and changes in CORT- sensitive tissues, such as decreased thymus gland 
weight (Hauger et al., 1988; Kiss & Aguilera, 1993). All these parameters are 
indicative of chronic activation of the HPA axis. Numerous studies have 
demonstrated that chronic stress increases CRF mRNA expression in the 
parvocellular PVN (Kiss & Aguilera, 1993; Makino, Smith, & Gold, 1995; 
Mamalaki et al., 1992). However, other studies have failed to find any up- regulation 
(Harbuz et al., 1992). Thus the sensitivity of CRF expression towards stress exposure 
appears to be dependent upon the type of stress used in the study. 
The hippocampus, including CA1 neurones in particular, express a high level 
of GR (and MR), so it is possible that CORT positively regulates ER -(3 expression 
directly through GR and/or MR in the same neurones. Previously, glucocorticoids 
with growth hormone, or thyroid hormone have been shown to stimulate ER -a 
expression in hepatocytes (Stavreus- Evers, Freyschuss, & Eriksson, 1997). There are 
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other examples of regulation of expression of members of the steroid/thyroid 
superfamily by one another as previously discussed. Oestrogen has been shown to 
decrease GR and MR expression in hippocampal neurones (Burgess & Handa, 1993). 
The role of ER -(3 in mediating these effects of sex steroids on GR and MR 
expression is unknown but subtle regulation might be possible. The sensitivity to 
glucocorticoids of ER-I3 expression in the CA1 subfield is particularly interesting 
since this subfield is where oestradiol induces increased dendritic spine density, 
synapses, and NMDA binding sites on pyramidal neurones, and enhances LTP 
(Warren et al., 1995; Weiland et al., 1997; Woolley et al., 1997). In rats, E2 
treatment enhances retention in a spatial discrimination task, whether given 
systemically or into the hippocampus, with effects in both males and females, and 
evidently involving cholinergic mechanisms (Packard, 1998; Simpkins et al., 1997). 
It is not yet known whether adrenalectomy affects these actions of E2. 
The present study indicates that effectiveness of ER- 3 l i gands on CA 1 
neurones may be reduced in the absence of glucocorticoids. However, the results also 
indicate that in the presence of stress levels of glucocorticoids there may be no 
change in effectiveness of oestrogens as a result of changes in ER expression. The 
lack of changes in ER -a or -P mRNA expression in the CA3 subfield indicates that 
actions of oestrogen here are unaffected by changes in corticosterone exposure, 
perhaps because GR expression is low; notably, this subfield is where stress and 
corticosteroids cause atrophy of dendrites (McEwen, 1999). Similarly, in the DG, 
where E2 stimulates neurogenesis (Tanapat et al., 1999), the present study indicates 
that E2 action will not be affected by glucocorticoid effects on ER -a or 43 mRNA 
expression, as these were not found. 
From the present finding it is inferred that actions of E2 are likely to be 
enhanced by stimulation of ER -ß mRNA expression by basal, non -stress, secretion of 
glucocorticoids. Such an action of basal secretion of glucocorticoids may be 
expected to be through MR since they have a higher affinity for corticosterone, and 
are thus the predominant mediator of glucocorticoid action at basal levels (Reul, van 
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den Bosch, & de Kloet, 1987). This facilitation of oestrogen action through 
maintenance of ER -13 expression could contribute to the known positive effects of 
low levels of glucocorticoids on cognitive aspects of hippocampal function 
(Landfield, Baskin, & Pitler, 1981). 
Our present finding further suggests that any modulatory effects of oestrogen 
upon the HPA axis during stress exposure is unlikely to be mediated via ER in the 
hippocampus. Recent studies have shown that many of the components involved in 
the regulation of the HPA activity are modulated by sex steroid hormones. The 
synthesis of the ACTH secretagogues, CRF and VP, in the PVN is influenced by 
gonadal steroids (Almeida et al., 1992; Bohler et al., 1990; Greer et al., 1986; Haas 
& George, 1988; Vamvakopoulos & Chrousos, 1993). Likewise the synthesis and 
binding properties of corticosteroid hormone receptors in brain regions regulating the 
HPA axis have been shown to be modulated by sex steroids (Carey et al., 1995; 
Patchev & Almeida, 1996; Viau & Meaney, 1991). Indeed, the gene encoding CRF 
has been identified to contain the ERE (Vamvakopoulos & Chrousos, 1993), 
providing the evidence for direct genomic regulation of CRF by E2. Our current 
finding that there is no change in ER -a or -13 mRNA expression following stress 
exposure in the hippocampus perhaps is not surprising but reinstates the notion that 
E2 exerts a variety of actions in different ways at distinct loci. 
Reculation of ER -a and 
Conclusion 
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The expression of ER -a mRNA in the DG, and ER -ß mRNA in the CA 1 and 
the DG increase over a prolonged period after OVX, but do not change in castrated 
males; chronic E2 replacement did not reduce ER expression after OVX. The 
expression of ER -ß mRNA in the CA1 subfield of the hippocampus is positively 
regulated by basal glucocorticoid secretion, but does not respond to the increased 
corticosterone secretion of chronic stress. ER -a mRNA expression in the 
hippocampus was not affected by adrenal corticosteroid manipulation. 
The present finding in this chapter shows that ER mRNAs are present in loci 
not traditionally involved in aspects of reproduction and are regulated in a region -, 
time- and sexually dimorphic pattern; how these steroid hormone transcripts are 
regulated is not fully understood, however. Recent studies indicate that E2 enhances 
performances of learning and memory tasks both in animal models and in humans 
(for review see Luine, 1997). These sex steroid hormones appear to exert a 
physiological influence upon learning and memory since differences in aspects of 
cognition have been demonstrated over the course of the natural menstrual cycle as 
well as during the peri- and post -menopausal periods (Hampson, 1990; Phillips & 
Sherwin, 1992b). However it is not clear which ovarian hormone(s) - E2 or P4 or, 
indeed, both are responsible, although replacement studies in women suggest that E2 
may be perhaps most important in maintaining and restoring cognitive functions 
(Phillips & Sherwin, 1992a; Sherwin, 1994). The influence of gonadal hormones on 
memory processes appears to involve actions on brain structures such as the 
hippocampus and basal forebrain. The hippocampus is known to play an essential 
role in memory (Morris et al., 1982; O'Keefe & Nadel, 1978; Squire, 1992) and in 
particular spatial memory (Olton & Papas, 1979; Olton, Walker, & Gage, 1978). 
Ovarian steroid deprivation resulted in a learning impairment which was reversed 
upon steroid replacement (Singh et al., 1994). This present study suggests a 
possibility of direct action of sex steroids upon the hippocampus. 
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It is not known whether actions of E2 on the hippocampus are mediated by 
ER -a or -ß or indeed by both (Pettersson et al., 1997). The detection of both ER -a 
and -ß mRNA and of changes with both transcripts in the hippocampus, however, 
suggests that oestrogens might predominantly confer their activity via both receptor 
subtypes in a synergistic manner. A consequence of the pattern and dynamics of ER 
mRNA expression seen in the hippocampus following chronic withdrawal of ovarian 
hormones, is that, if translated into function receptor protein, the sensitivity of 
neurones in CAl or the dentate gyrus to E2 action will be increased in the absence of 
the ligand. 
The implications for the effects on hippocampal function of continuous 
oestrogen treatment therapy in post -menopausal women are that ER -a and -ß 
expression will not be reduced, and thus the sensitivity to E2 will be retained. Indeed, 
prolonged withdrawal of E2 may increase expression of both ER -a and -ß, increasing 
sensitivity to E2 with the replacement therapy. This perhaps explains the mechanism 
of how benefits of HRT is brought about in post -menopausal women. Indeed, in a 
recent study by Luine et al. 1998 chronic E2 treatment for 12 d, but not 3 d, 
facilitated spatial memory, as assessed by choice accuracy on a radial arm maze, in 
OVX rats, suggesting enhancing effects of E2 on learning and memory over a 
relatively prolonged period (Luine et al., 1998). 
The presence of both gonadal and adrenal steroid receptors in the 
hippocampus as well as the susceptibility of this structure to actions of both types of 
steroid (see Luine, 1997), despite being in rather opposing directions, suggests a 
possibility of mutual regulation of both molecules. The results imply that 
maintenance of ER -ß mRNA expression in CA1 by basal glucocorticoid secretion 
may ensure E2 action here alongside glucocorticoid action, while E2 replacement 
after ovarian failure is expected to be able to act on a still E2- sensitive hippocampus. 
By studying the expression of ER in a variety of tissues including the 
hippocampus it is hoped that one could perhaps devise an oestrogenic molecule that 
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specifically targets one organ while leaving the others unaffected. The benefits 
would be paramount if such moiety is available, particularly those counteracting the 
cognitive decline; the process, inevitably, accompanies human ageing. 
Regulation of ER -13 mRNA in the SON and PVN 
Chapter 5 
Regulation of oestrogen receptor -13 mRNA in the hypothalamic 
paraventricular and supraoptic nuclei 
5.1. Introduction 
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The hypothalamus is considered important in organising the neural and 
neuroendocrine defence of homeostasis. The paired SON and PVN nuclei are 
particularly important in the control of endocrine and autonomic responses. Most of 
the OXT and VP magnocellular neurones project their axons through the pituitary 
stalk and terminate on capillaries in the neurohypophysis where the two peptides are 
released from their nerve terminals into the systemic circulation (for reviews see 
Leng, Brown, & Russell, 1999; Swanson & Sawchenko, 1983). In the periphery, VP 
is involved in maintaining osmotic balance by promoting reabsorption of water in the 
collecting ducts of the renal tubules and in maintaining blood pressure through 
vasoconstriction (Hatton & Li, 1998). Its synthesis and secretion is, in turn, 
controlled by plasma osmolarity as well as by osmotic blood pressure and volume 
(Hatton & Li, 1998). On the other hand, the principal functions of OXT secreted by 
the neurohypophysis are related to reproduction: it is essential for milk ejection, and 
important in promoting established parturition (Russell & Leng, 1998). In rats, OXT 
is also natriuretic, involving a stimulatory action on atrial natriuretic peptide 
secretion (Jankowski et al., 1998) and thus co- ordinates with VP in maintaining body 
fluid osmolarity. Its synthesis has also been shown to respond to changes in plasma 
osmolarity (Hatton, 1990). 
The ovarian steroid oestrogen has long been recognised as a modulator of the 
neurosecretory system influencing the OXT and VP neurones. Oestradiol, 17 -(3 (E2) 
has been shown to stimulate the release of both OXT and VP secretion from the 
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magnocellular neurones (Skowsky, Swan, & Smith, 1979; Yamaguchi, Akaishi, & 
Negoro, 1979). Systemically administered radiolabelled- oestrogen can be detected in 
OXT (Rhodes, Morrell, & Pfaff, 1982) as well as VP neurones (Sar & Stumpf, 
1980). Administration of E2 stimulates the peripheral release of OT 
immunoreactivity (Amico, Seif, & Robinson, 1981). Changes in OXT mRNA in the 
SON vary across the oestrous cycle with a marked increase in expression during 
oestrus (Van Tol et al., 1988). At the end of pregnancy, the decline in progesterone 
secretion, and relative increase in E2 secretion has been reported to result in 
increased OXT gene expression in the magnocellular neurones (Van Tol et al., 1988; 
Zingg & Lefebvre, 1988; Zingg & Lefebvre, 1989). In vitro E2 has been shown to 
induce OXT gene transcription (Burbach et al., 1990). Conversely, many previous 
reports have failed to find changes in OXT or VP gene expression in response to sex 
steroid hormones manipulation. For instance it has been previously reported that 
gonadectomy (both ovariectomy (OVX) in females and castration (CX) in males) 
alters neither the expression of VP /OXT mRNA (Carter, Pardy, & Murphy, 1993; 
Crowley & Amico, 1993) nor OXT pituitary contents (Crowley & Amico, 1993). 
Roy et al. 1999 also reported that treatment with E2 in OVX rhesus monkeys failed 
to modulate the expression of VP mRNA in the magnocellular neurones (Roy, Reid, 
& Van Vugt, 1999). 
How oestrogen exerts its effects upon neurones in the SON and PVN remains 
unclear since these neurones lack the classical oestrogen receptor (ER -a, (Corodimas 
& Morrell, 1990), although these neurones have been shown to concentrate [3H] -E2 
in in vivo binding studies (Corodimas & Morrell, 1990; Rhodes et al., 1982). 
Recently, Kuiper et al. 1996 cloned a novel oestrogen receptor, designated ER -ß, 
from the rat prostate cDNA library (Kuiper et al., 1996). This receptor shares a 
considerable degree of homology and shows an overlapping but non -identical tissue 
distribution with ER -a, particularly within the central nervous system (see Chapter 
3). A striking difference is that while the SON and PVN show a complete absence of 
ER -a, the PVN in particular expresses a high level of ER -ß (both mRNA and 
protein), and a lesser degree of expression is found in the SON. A substantial number 
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of studies have shown co- localisation of ER -ß- like -immunoreactivity ( -ir) or mRNA 
within the OXT- and VP- immunopositive neurones in the SON and PVN (Alves et 
al., 1998; Hrabovszky et al., 1998; Li, Schwartz, & Rissman, 1997; Shughrue, 
Komm, & Merchenthaler, 1996). Moreover, the up- stream regulatory elements of the 
OXT and VP genes contain sequences similar to an oestrogen- response element 
(ERE) (Adan et al., 1993; Mohr & Schmitz, 1991; Richard & Zingg, 1990 for OXT 
and Wafters, Poulin, & Dorsa, 1998 for VP), suggesting a possible direct genomic 
action of E2 upon the OXT and VP genes, perhaps via the ER -ß subtype. Collectively 
these findings indicate a possibility that neurones in the SON and PVN can be 
regulated by E2. 
5.2. Aims 
Much information on the influence of sex steroid hormones upon the 
hypothalamic SON and PVN is available but the mechanism mediating these effects 
remains largely unknown. Since the effects of the hormones are in large part 
mediated by the receptors, any changes in their expression would alter the 
responsiveness of the cells in target organs, and might help indicate the 
circumstances in which this factor is important. Because of the prominent expression 
of ER -ß mRNA in the SON and PVN neurones we proposed to investigate in vivo 
regulation of the transcript by sex steroid hormones and its expression under 
conditions known to alter the activity of the magnocellular neurones. In particular, 
we also determined the expression of ER -ß mRNA in the ventral group of 
parvocellular, predominantly oxytocin, neurones in the PVN that project to the 
brainstem and spinal cord, and are involved in autonomic regulation (Sawchenko & 
Swanson, 1982). These neurones express ER -ß mRNA more strongly than other 
neurones observed in the study. 
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5.3. Methods 
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We employed both steroid hormone manipulations as well as physiological 
conditions known to stimulate neurones in the SON and PVN to determine whether 
and how ER -ß mRNA might be regulated in these neurones, using quantitative ISH 
as a measure of expression. 
5.3.1. Regulation of ER -ß mRNA in the hypothalamic SON and PVN by sex 
steroid manipulation 
As previously reported, steroid hormone receptors, including ER -ß, can be 
regulated by their own ligands. However the relatively recent discovery of ER -13 has 
not as yet led to many detailed studies on the regulation of its mRNA transcript in the 
magnocellular neurones, especially in in vivo models. A recent study by Patisaul et 
al. 1999 has shown that ER -ß mRNA expression in the PVN in ovariectomised rats 
is decreased by E2 treatment, but increased by phyto- oestrogen ingestion, 
demonstrating the plasticity of ER-13 expression in these neurones (Patisaul, Whitten, 
& Young, 1999). 
5.3.1.1. Effect of gonadectomy 
To assess whether ER -ß mRNA can be regulated by sex steroids, in the first 
experiment, the endogenous source of sex hormones from both male and female rats 
was removed by bilateral gonadectomy and left to recover for 72 h prior to 
decapitation. These were the same rats as those used in Chapter 4, section 4.3.1.1. 
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5.3.1.2. Effects of exogenous 17f3-oestradiol (E,) 
5.3.1.2.a. Effect of acute E, treatment in intact male rats 
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One group of adult male Hooded -Lister rats (n =5 /group) was injected with 
E2, 100 p.g /kg subcutaneously daily for 72 h. Another group of male and another 
group of random cycling female rats were injected with vehicle as controls over the 
same period of time. Rats were left for 72 h prior to decapitation. 
5.3.1.2.b. Effect of chronic E, treatment in ovariectomised rats 
Two groups of adult random cycling female Hooded -Lister rats (n =6 /group) 
underwent bilateral ovariectomy (OVX) under halothane anaesthesia. While still 
anaesthetised, one group of rats had a subcutaneous implant of a silastic capsule 
containing 15 mg /ml of E2 in oil. The other group had a vehicle- containing implant 
as a control. These were the same rats as those used in Chapter 4, section 4.3.1.2. 
5.3.1.3. Expression of ER-I3 mRNA in the hypothalamic PVN and SON during 
pregnancy and parturition 
The role of OXT in parturition is well established. In rats, the store of OXT 
peptide in the posterior pituitary is substantially increased so that by the end of 
pregnancy ca. 30% excess of OXT is accumulated, most of which would be depleted 
during the ensuing parturition (Leng et al., 1988). Thus the oxytocinergic 
magnocellular neurones are prepared during pregnancy to switch from basal activity 
to the maximal activation during the 60 -90 min of parturition. Although not all, a 
number of previous studies indicate that magnocellular OXT mRNA is increased in 
pregnancy, particularly immediately prepartum (12 -24 h) (Crowley et al., 1993; 
Horwitz et al., 1994; Van Tol et al., 1988; Zingg & Lefebvre, 1988; Zingg & 
Lefebvre, 1989) suggesting that the OXT gene has been turned on. This increased 
expression of the OXT gene occurs in association with pronounced changes in the 
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secretion of E2 which rises throughout pregnancy and reaches a peak at term while 
progesterone (P4) secretion declines precipitously 24 -48 h prior to delivery (Bridges, 
1984). Exposure of ovariectomised virgin rats to a hormone regime simulating the 
profile of E2 /P4 secretion in pregnancy (Crowley et al., 1995) also results in an 
increase in OXT mRNA expression in the magnocellular neurones. Given the 
importance of E2 priming (with P4 withdrawal) in regulating the magnocellular OXT 
gene in late pregnancy, it is possible that E2 might mediate the induction of the OXT 
gene, perhaps involving altered expression of the ER -ß present in the hypothalamic 
magnocellular neurones. 
Adult female Sprague -Dawley rats were obtained from the supplier (Bantin 
and Kingman) and allowed to acclimatise to a 12 h light:dark cycle for at least 2 
weeks prior to use. They were mated overnight with sexually experienced male rats. 
The day on which the vaginal plug was present in the morning was designated as day 
1 of pregnancy. Pro -oestrus virgins (determined by daily vaginal smears), day 15 and 
day 22 (parturient, 90 min after birth of the second pup) pregnant rats (n =6 /group) 
were killed by decapitation. 
5.3.2. Expression of ER -f3 mRNA in the hypothalamic SON and PVN during 
physiological stimulation 
5.3.2.1. Effect of adrenal steroid manipulation 
Disturbance in hydromineral balance following manipulation of adreno- 
corticosteroid hormones is known to alter the activity of neural inputs to the 
magnocellular neurones, and hence their activity. Secondary adrenocortical 
insufficiency mimics the syndrome of inappropriate secretion of antidiuretic 
hormone whereby plasma VP is elevated in the presence of hyponatraemia (Oelkers, 
1989; Share & Travis, 1970). Thus, in these situations it appears that VP secretion is 
not down -regulated appropriately to plasma sodium. Replacement of glucocorticoids 
restores the basal plasma VP concentration (Ahmed et al., 1967; Seif et al., 1978). 
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On the other hand, elevated glucocorticoid levels inhibit VP release in 
response to hypoxia (Raff et al., 1984), hypotension (Raff, Skelton, & Cowley, 
1990), and osmotic stimulation (Papanek & Raff, 1994b). These findings suggest that 
glucocorticoids might also control the basal and stimulated VP release from the 
magnocellular neurones. As far as we are aware, there has been no study to date 
investigating the effects of gonadal steroids in controlling the VP gene under these 
conditions. The presence of ER-13 within the magnocellular neurones and the known 
involvement of sex steroid hormones in the hypothalamo -neurohypophysial system 
has prompted us to look at the expression of ER -ß mRNA in magnocellular neurones 
in states with altered adrenocortical activity. 
In this study bilateral ADX was performed which will reduce basal plasma 
glucocorticoid thus mimicking the condition of adrenal insufficiency. In parallel we 
also subjected the rats to stress exposure, a condition which is expected to increase 
plasma glucocorticoid concentration. We elected to use male rats because there are 
no differences between males and females in patterns of ER -ß mRNA distribution in 
the PVN and SON (see Chapter 3), while variations in E2 exposure through the 
oestrous cycle are avoided, and testosterone is a precursor for E2 in the male brain; 
the SON contains abundant aromatase enzyme (Sanghera et al., 1991). 
5.3.2.1.a. Effect of bilateral adrenalectomy and corticosterone replacement 
These were the same rats as those in Chapter 4, section 4.3.2.1. and were 
treated as follows; 
1) Sham -operated plus subcutaneous vehicle (corn oil) injection 
2) Bilaterally adrenalectomised (ADX) plus subcutaneous vehicle 
injection, given 0.9% NaC1 to drink 
3) ADX plus replacement of corticosterone (CORT) at a dose of 10 
mg /kg in oil via subcutaneous injection daily (at 1600 h), given 0.9% 
NaCl to drink 
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5.3.2.1.b. Effect of stress exposure 
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One group of adult male Hooded -Lister rats (n =5 /group) was exposed to a 
cycle of stressors over 72h while the other group of male rats was left undisturbed 
and served as controls. These were the identical rats as previously used in Chapter 4, 
section 4.3.2.2. 
Rats were killed by decapitation 72 h following surgery or after the beginning 
of stress exposure. The effectiveness of the treatments was confirmed by 
measurements of HPA axis parameters as described in Chapter 4. 
5.3.2.2. Effect of 3 -day chronic salt loading 
In rats both VP and OXT neurones are activated by increased extracellular 
fluid osmolarity, especially as a consequence of increased sodium concentration. The 
consequence of increased osmolarity is that 3 days of maintaining 2% NaC1 solution 
as a sole source of fluid intake results in a large increase in both VP and OXT mRNA 
content in the magnocellular SON and PVN, and a depletion of the peptide contents 
in the neurohypophysis (see below). Thus induction of hyperosmolarity using stimuli 
such as chronic salt loading provides a useful model to study the regulation of gene 
expression in the magnocellular neurosecretory system. An in vivo study by Crowley 
et al. 1993 showed that an increase in osmolarity failed to induce OXT /VP mRNA 
accumulation in gonadectomiscd animals, and that the response can be restored upon 
sex steroid replacement (Crowley & Amico, 1993). This indicates that circulating 
gonadal steroid is required to drive these responses to osmotic stimulus. The 
underlying mechanism in mediating these sex steroid responses seems unclear but 
might act via the nuclear ER-13 present in the magnocellular neurones. 
One group of adult Hooded -Lister male rats (n =6 /group) was given 2% NaCI 
solution to drink while the other group continued to receive tap water ad libitum to 
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drink. 72 h later the rats were decapitated. Trunk blood was collected for determining 
concentrations of plasma Na+ and K. 
At the end of each experiment quantitative ISH (described in detail in 
Chapter 2, section 2.2.2.- 2.2.4.) was employed to determine the expression of ER -ß 
mRNA in the SON and PVN. Specifically two neuronal subpopulations within the 
PVN were quantified; one was the posterior magnocellular neurones, in the lateral 
zone, projecting to the neurohypophysis and the other the medial parvocellular 
neurones, in the ventral zone, projecting to the brainstem and spinal cord (referred to, 
herein, as magnocellular division and ventral parvocellular division of the PVN, 
respectively). The sub -divisions of the paraventricular nucleus were defined after 
Swanson and Kuypers (Swanson & Kuypers, 1980). In addition some sections 
through the dorsomedial parvocellular division of the PVN, from rats in the adrenal 
steroid manipulation study, were hybridised with a 35S- labelled antisense riboprobe 
for CRF mRNA. Background measurements were made over adjacent tissue with no 
evident expressing neurones (dorsal to the SON) and subtracted to obtain the net 
value of silver grain counts. The slides were coded so that the experimenter was 
unaware of the treatment of the rats at the time of evaluation. Animal means were 
calculated for each variable, and these values were used to calculate group means. 
In each experiment Student's t -test or one -way Analysis of Variance 
( ANOVA) followed by Student -Newman -Keuls post -hoc comparison (except for the 
measurement of CRF mRNA and plasma CORT concentration following ADX 
where Kruskal- Wallis one -way ANOVA on ranks was applied) were used as 
appropriate to determine the statistical significance of differences between groups. 
The alpha value was set at P < 0.05. Results are expressed as the group means ±sem. 
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5.4. Results 
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Specific hybridisation signal from the ER -13 antisense riboprobe in the 
hypothalamic SON and PVN was clearly evident both at the cellular level (see Figure 
3.11 & 3.12.) seen in dipped emulsion autoradiographs as well as at the macroscopic 
level in film autoradiograms (Figure 5.1A.). Sections that were hybridised with a 
sense probe for ER -I3 mRNA revealed no hybridisation signal in the SON or PVN 
indicating the specificity of the probe and methodology used in the present study (see 
Chapter 3). 
Although the experiments conducted in the present study did not differentiate 
the expression of ER -13 mRNA between the OXT- containing and VP- containing 
neurones, the expression was nonetheless present throughout the rostro- caudal extent 
and in both the dorsal (predominantly oxytocin -containing) and ventral 
(predominantly vasopressin- containing) portions of the SON. The most prominent 
expression was found in the ventral parvocellular group of neurones in the PVN that 
express OXT and project to central autonomic sites, as also seen in other studies 
(Alves et al., 1998; Hrabovszky et al., 1998). There was sparse labelling for ER -(3 
mRNA in the parvocellular dorsomedial zone, containing CRF neurones (some of 
which also contain VP- producing neurones) projecting to the median eminence. The 
differential cellular distribution between ER -ß and CRF mRNA in the PVN is 
evident in Figure 5.1A. & 5.1B. (Note that sections were taken from the same brain 
ca. 10 tM apart). 
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Figure 5.1A. Representative autoradiograph from in situ hybridisation iòrER -ß 
mRNA antisense riboprobe in the supraoptic (SON) and paraventricular (PVN) 
nucleus. The strongest hybridisation signal for ER-I3 mRNA was found in the ventral 
parvocellular group of neurones in the PVN, projecting to central autonomic sites. 
Figure 5.1B. Representative autoradiograph from in situ hybridisation for CRF 
mRNA antisense riboprobe in the paraventricular nucleus (PVN). The expression of 
the CRF mRNA was confined to the parvocellular dorsomedial portion of the PVN, 
projecting to the median eminence. (This section is 10 µM caudal to the section in 
Figure 5.1A.) 
Regulation of ER-13 mRNA in the SON and PVN 144 
Changes in the expression of ER -ß mRNA in the SON and PVN occurred 
following specific hormonal manipulations and physiological stimulation suggesting 
that oestrogens could potentially influence the activity (and perhaps function ?) of 
neurones within these hypothalamic nuclei, and that this influence may be modified 
by changes in ER-13 expression. 
5.4.1. Regulation of ER-13 mRNA in the hypothalamic SON and PVN by sex 
steroid manipulation 
In the first experiment the silver grain signal from ER-f3 mRNA ISH in the 
magnocellular SON from sham- operated female (SF) rats was found to be 
significantly greater (ca. 1.4 -fold) than that from the sham- operated male (SM) rats 
(P < 0.05, ANOVA, P < 0.05 Student -Newman- Keuls, SF vs SM) (Figure 5.2A.). 
This sex difference in expression was abolished at 72 h after gonadectomy (GDX), 
although GDX itself did not significantly alter the expression of ER-I3 mRNA in 
either sex. 
Within the magnocellular division of the PVN there was a similar trend in the 
expression of ER -ß mRNA transcript, although the difference in the expression 
between SF and SM was not statistically significant. (Figure 5.2B.) Similarly in the 
ventral parvocellular division of the PVN there was no sex -difference in the 
expression of ER -ß mRNA. However, 72 h after GDX, the grain density for ER -ß 
mRNA here from OVX rats was significantly increased (ca. 25 %) (P < 0.05, 
ANOVA, P < 0.05 Student -Newman- Keuls) while the expression from CX rats 
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In the experiments involving treatment with exogenous E2, the expression of 
ER -ß mRNA in the magnocellular neurones remained largely unaffected while the 
expression in the parvocellular neurones was substantially modulated by the same 
hormone treatment. In intact male rats treated with an acute dose of E2 (100 .tg/kg 
s.c. injection for 72 h), the ER -13 mRNA level was not significantly altered in either 
the SON or in the magnocellular division of the PVN compared to the vehicle -treated 
controls (Figure 5.3A./B.). On the other hand, the hybridisation signal for ER-(3 
mRNA in the ventral parvocellular PVN was significantly decreased (ca. 30 %) in 
male rats following E2 treatment compared to the vehicle control groups (P < 0.05, 
ANOVA, P < 0.05 Student -Newman- Keuls) (Figure 5.3C.). 
However, the expression of ER-I3 mRNA at the level of film optical density 
in the same experiment was somewhat different from that obtained at the level of 
grain density per neurone. In the SON there was a significant increase (ca. 15 %) in 
the optical density value indicating ER -ß mRNA from male rats treated with E2 
compared to that from vehicle controls (P < 0.05, ANOVA, P < 0.05 Student - 
Newman- Keuls) (Figure 5.4A.). In the magnocellular division of the PVN there was 
a greater optical density from female control than male control rats while the value 
from males treated with E2 was not significantly different from either control group 
(P < 0.05, ANOVA, P < 0.05 Student -Newman- Keuls) (Figure 5.4B.). Lastly, there 
was no significant difference in the expression of ER -ß mRNA as indicated by film 
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In another experiment, treatment with chronic E2 over 2 weeks in 
ovariectomised (OVX) rats was found to exert no significant effect upon the 
expression of ER -ß mRNA in either the SON or the magnocellular division of the 
PVN (Figure 5.5A./B.). On the contrary ER -ß mRNA level in the ventral 
parvocellular PVN in OVX rats following E2 treatment was evidently lower than 
those in the vehicle control group, although this cannot be demonstrated statistically 
due to the insufficient number in the control group (n =2; due to sections lost during 
processing for ISH) (Figure 5.5C.). 
Lastly, in the pregnancy experiment, the ER -ß mRNA hybridisation signal in 
the SON, the magnocellular division and the ventral parvocellular division of the 
PVN from day 15 or day 22 (parturient) pregnant rats were not significantly different 
from those found in the pro -oestrus virgin controls (Figure 5.6A. & 5.7.). However, 
at the level of film optical density, the expression of ER -ß mRNA in the SON from 
day 15 pregnant rats was significantly greater compared to parturient or pro- oestrus 
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5.4.2. Regulation of ER-13 mRNA in the hypothalamic SON and PVN under 
specific physiological stimulation 
Contrary to prior experiments where modulation of sex steroids was shown to 
exert minimal effects upon the expression of ER-(3 mRNA, specific physiological 
stimulation involving adrenal steroid hormones and salt- loading dramatically altered 
the expression of the transcript in the SON and PVN. 
5.4.2.1. Plasma corticosterone and thymus gland weight 
Plasma CORT and thymus gland weight following adrenal steroid 
manipulation were identical as and previously shown in Chapter 4, p 116. 
5.4.2.2. Effect of adrenalectomy and corticosterone replacement 
At 72 h after bilateral adrenalectomy (ADX) the ER -ß mRNA level was 
significantly increased in the magnocellular SON and PVN. Silver grain density per 
neurone in the SON was significantly increased by ca. 2.5 -fold (P = 0.0001, 
ANOVA, P < 0.05 Student -Newman- Keuls) (Figure 5.8A.), and in the magnocellular 
division of the PVN ca. 2.2 -fold (P < 0.005, ANOVA, P < 0.05 Student- Newman- 
Keuls) (Figure 5.8B.). The pattern of ER -ß mRNA expression in the ventral 
parvocellular division of the PVN showed the same trend following ADX although 
this was not statistically significant (Figure 5.8C.). The increases in ER -ß mRNA 
expression following ADX were partially reversed by CORT replacement 
(significantly decreased in the SON by 36 %, P = 0.0001, ANOVA, P < 0.05 Student - 
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5.4.2.3. Effect of stress exposure 
There was no change in the expression of ER -ß mRNA either in the SON or 
the magnocellular subdivision of the PVN 72 h after stress exposure (Figure 
5.9A.ß.); however, ER -ß mRNA expression was significantly increased in the 
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5.4.2.4. Effect of 3 -day chronic salt loading 
Salt loading for 72 h resulted in a dramatic decrease in the expression of ER- 
S mRNA in the SON and PVN, measured as either silver grain density per neurone 
or optical density on film. In the SON and magnocellular PVN, silver grain density 
per neurone was reduced to 39% in SON (P = 0.003, Student's t -test) and 38% in 
magnocellular PVN (P < 0.0001, Student's t- test), respectively, of the control value 
(Figure 5.10A.ß. for grain density per neurone measurement and Figure 5.11A./B. 
for optical density measurement). There was also a significant decrease with salt - 
loading in the ventral parvocellular PVN in the number of silver grains per neurone, 
but only to 87% of the control value (P = 0.02, Student's t -test) (Figure 5.10C.), with 
no change in optical density measurement in this region (Figure 5.11C.). Salt loading 
significantly increased plasma [Na +] by ca. 13.0 mmol /L (one -tailed t -test [t = 1.93, 
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Figure 5.12. ER -ß mRNA expression in the supraoptic nucleus (SON) during salt - 
loading. Autoradiographs of coronal sections of hypothalamus, hybridised with 
antisense riboprobe for ER -ß mRNA. A) Control vs B) 2% NaC1 to drink for 72 h. 
OX denotes optic chiasm. Scale bar = 100 µM. 
Figure 5.13. Bright -field photomicrograph showing silver grains over neurones in the 
supraoptic nucleus (SON) hybridised with ER -ß mRNA antisense riboprobe. A) 
Control vs B) 2% NaC1 to drink for 72 h. Scale bar = 20 µM. 
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The expression of ER -p in the hypothalamic SON and PVN neurones has 
been reported in several previous studies (Alves et al., 1998; Shughrue, Scrimo, 
Merchenthaler, 1998), with a stronger ER -p mRNA signal in the magnocellular OXT 
neurones than in VP neurones in the PVN (Alves et al., 1998), and vice versa in the 
SON, where ER -p protein is more evident in VP neurones (Hrabovszky et al., 1998). 
The experiments described in this chapter have shown that modulation of 
gonadal steroids produced modest changes in the expression of ER -p mRNA in the 
magnocellular neurones in male and female rats, and in the PVN only in the ventral 
group of parvocellular neurones projecting centrally to sites involved in autonomic 
regulation. On the other hand dramatic changes in the expression of ER -p mRNA in 
the hypothalamic SON and PVN neurones were observed following changes in 
adrenal steroid availability and specific stimuli, suggesting that the sensitivity of 
these neurones to E2 is altered during physiological perturbations where the system is 
driven to decreased or increased activity. This highlights potential significant effects 
of sex steroid hormones in responses of the neurones in different functional states. 
5.5.1. Influences of sex steroid hormones on ER-f3 mRNA expression 
a) Magnocellular neurones 
In the first gonadectomy (GDX) experiment there was a sex difference in the 
basal expression of ER -p mRNA in the magnocellular SON, with sham -operated 
female rats exhibiting a greater expression than sham -operated males. This difference 
was abolished by GDX. The expression of ER -p mRNA in the magnocellular PVN 
showed a similar trend to that seen in the SON, although this was not statistically 
significant. The result indicates that female gonadal hormone positively, while male 
gonadal hormone negatively, regulates the expression of ER -p mRNA in the 
magnocellular neurones. 
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In the subsequent studies, however, this small sex difference in the expression 
of ER-f3 mRNA was not found consistently. For instance, in the experiment where 
intact male rats were treated with exogenous E2 there was no significant sex 
difference in the expression of ER -13 mRNA in the SON, either at the level of silver 
grain density per neurone or film optical density. Similarly, the difference in grain 
density per neurone for ER-I3 mRNA between male and female rats was not seen in 
the magnocellular PVN neurones and although such a difference became apparent at 
the level of film optical density, this was rather small (ca. 16 %). 
Merkelbach et al.1975 reported that the 24 h urine excretion of VP was 
higher in men than in women (Merkelbach et al., 1975). In rats a number of reports 
also indicated a sex difference in basal plasma VP concentration (Crofton et al., 
1985; Crofton, Share, & Brooks, 1988; Stone, Crofton, & Share, 1989) as well as VP 
release in response to intravenous hypertonic saline injection (Crofton & Share, 
1989). A recent report by Dai and Yao 1995 also showed a sex difference in 
hypothalamic VP mRNA and plasma osmolarity in the rats (Dai & Yao, 1995). There 
is also a sexual dimorphism in the diurnal stress response of OXT secretion in rats 
(Carter & Lightman, 1986). Conversely, similar amounts of OXT and VP mRNA 
have been reported in the SON and PVN of male and female rats (Swaab, Pool, & 
Nijveldt, 1975b). Thus the finding of a sex difference in ER-13 mRNA in the 
magnocellular neurones in this present study might contribute to the sex difference in 
basal functional activity in the magnocellular neurones indicated by previous studies, 
although such a difference in itself is not reliably detected. 
Although the sex difference in ER-I3 mRNA expression in the SON in this 
study was abolished by GDX, the change in expression of ER -13 mRNA was not 
significantly altered by GDX in either sex. This lack of change was also seen in the 
magnocellular PVN neurones. This finding, again, reflects the small differences in 
this effect between the sexes. Following acute E2 treatment for 72 h there was no 
significant change in the expression of ER -ß mRNA in the magnocellular SON and 
PVN, measured as silver grains per neurone, in intact male rats compared to that in 
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vehicle- treated male and female controls. Although there was a significant increase 
in ER -ß mRNA expression, measured as film optical density, this was found only in 
the SON, and was of the order of about 15 %. Similarly chronic treatment of OVX 
rats with E2 over 2 weeks did not induce any significant change in the expression of 
ER -ß mRNA either in the SON or the magnocellular PVN. 
Collectively these findings suggest that the regulation of ER -13 mRNA 
expression in the magnocellular neurones by sex steroid hormones is rather weak, as 
revealed by small changes in the expression of the transcript following either 
exposure to or deprivation of E2 in male or female rats. 
The role of ER -ß (in the magnocellular neurones) is not known although we 
assume it is a ligand- regulated transcription factor that mediates effects of E2. The 
oxytocinergic and vasopressinergic magnocellular neurones are known to be 
influenced by gonadal steroids. As previously mentioned, given that the OXT and 
VP genes have been identified to possess nucleotide sequences similar to an ERE, it 
is conceivable that oestrogens, presumably via binding to ER -ß in these neurones, 
could directly modulate the transcription and other downstream consequences of 
these peptide genes. Nonetheless several previous attempts to characterise oestrogen 
modulation of OXT and VP genes in the magnocellular neurones have resulted in a 
rather conflicting literature, with different researchers reporting different results. For 
instance, it has been previously reported that gonadectomy (both ovariectomy (OVX) 
in females and castration (CX) in males) alters neither the expression of VP /OXT 
mRNA (Carter et al., 1993; Crowley & Amico, 1993) nor OXT pituitary contents 
(Crowley & Amico, 1993) yet in some other studies OVX has been shown to result 
in a reduction in circulating plasma VP concentrations (Peysner & Forsling, 1990; 
Skowsky et al., 1979). In another study administration of E2 failed to modulate the 
expression of VP mRNA in magnocellular neurones in OVX rhesus monkeys (Roy et 
al., 1999). Additionally, treatment of OVX rats with E2 has been shown to either 
influence or leave unchanged the expression of OXT mRNA in the SON and PVN 
neurones (Caldwell et al., 1989; Chung, McCabe, & Pfaff, 1991; Miller el al., 1989). 
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The promoter of the rat OXT gene has been shown to contain a direct repeat 
of the half -site motif (AGGTCA) as well as an imperfect palindromic sequence 
similar to the ERE (Richard & Zingg, 1990) supporting the notion that E2 could 
directly influence the regulation of the OXT gene. The effects of gonadal steroids on 
the OXT gene have also been previously demonstrated in many in vitro studies 
(Adan et al., 1993; Adan et al., 1991; Richard & Zingg, 1990). However, Stedronsky 
et al. 1999 have recently looked at the interaction between many nuclear receptors, 
including ER, and the human OXT gene promoter and suggest that, at least in an in 
vitro model, the human OXT gene is not a natural target for ER (both -a and -ß 
forms) (Stedronsky, Walther, & Ivell, 1999). Instead they have shown that orphan - 
like receptors, such as SF -1 and COUP -TF1, interacted with a much higher affinity 
to the natural human OXT ERE, compared to ER -a or -ß, suggesting that the orphan - 
like nuclear receptors, and not the ERs, are the likely candidates to mediate the 
regulation of the OXT gene. However, since these experiments were performed in 
vitro, where many other factors which might interact with the OXT gene in vivo were 
not included, the possibility that the interaction observed in their study might be 
different under in vivo physiological conditions cannot be ruled out. 
These conflicting findings are perhaps reflected by this present study where 
changes in ER -ß mRNA expression in the magnocellular neurones by sex steroid 
modulation were small and hence the responsiveness of these neurones to sex steroid 
hormones will also be little affected. So the references that have described effects of 
E2 on OXT and VP genes in the literature might not be necessarily directly related to 
actions of gonadal hormones on these genes in the magnocellular neurones 
themselves but, rather, secondary to other mechanisms, perhaps as an indirect result 
of altered hydromineral balance found in some cases, but not in others. 
b) Ventral parvocellular neurones 
It is interesting that where modest change in ER -ß mRNA expression was 
observed in the magnocellular neurones following gonadal steroid manipulation, the 
expression of the transcript in the ventral parvocellular neurones was also evidently 
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modulated following the same steroid treatment. After OVX, the expression of ER -ß 
mRNA was significantly increased by 25 %, while treatment of OVX rats with 
exogenous E2 over 2 weeks evidently decreased the expression of ER-I3 mRNA 
(although this could not be demonstrated statistically due to an insufficient number 
of OVX control animals). Similarly treatment with E2 for 72 h induced a 30% 
decrease in the expression of ER -ß mRNA here in intact male rats compared to their 
control cohorts. This present finding is also supported by a recent report by Patisaul 
et al. 1999 in which a substantial decrease (44.5 %) in the expression of ER -p mRNA 
in the PVN was observed in OVX rats following E2 exposure. However, the change 
that was observed in their study was seen at the level of film autoradiographs 
whereby the entire PVN which comprises both magno- and parvo- cellular neurones 
was visualised and quantified. This present study was directed to examine the 
expression at higher resolution by quantifying the ER -ß mRNA hybridisation signal 
in two specific neuronal sub -populations, each of which sends axons to different sites 
and mediates distinct physiological functions (Swanson and Kuipers 1980). Thus it is 
possible that the change in the expression of ER -ß mRNA observed in the study by 
Patisaul et al. was perhaps due to changes that occurred in the ventral parvocellular 
neurones rather than a uniform response of the ER- 3 mRNA signal from the entire 
nucleus as they implied (Patisaul et al., 1999). The functional significance of this 
finding is discussed below. 
The regulation of steroid hormone receptor expression is complex. Changes 
in the expression of ER -13 mRNA observed in this study may have been a 
consequence of altered mRNA stability or altered transcription (see Chapter 1). In 
the magnocellular neurones, loss of ovarian steroids decreased ER -(3 mRNA 
expression while castration in males increased it suggesting that E2 maintains ER -¡3 
at a higher level in females than in males. In contrast, in the ventral parvocellular 
neurones, the findings indicate that E2 decreases ER -ß mRNA expression in both 
sexes; the effect being in the opposite direction to the magnocellular neurones. This 
reinforces the neuronally specific direction of ER-3 mRNA regulation by E2 and 
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further indicates the plasticity of ER-I3 mRNA expression in these neurones. The 
mechanism underlying the differential responses of ER -p mRNA in the two neuronal 
cell groups is not known but might result from the regulation of gene expression by 
an alternative promoter usage, as previously discussed (see Chapter 1 &4). 
5.5.2. ER-13 mRNA expression in pregnancy and parturition 
a) Pregnancy 
The results in this experiment also showed that even in pregnancy, when rats 
are exposed to pronounced changes in sex steroid hormone levels, the expression of 
ER-p mRNA at the level of grain density in the magnocellular neurones was little 
altered, both at mid -pregnancy (day 15) or during parturition (day 22) compared to 
that of virgin controls. However, in the SON, there was a significantly greater 
expression of the transcript at the level of film optical density from day 15 pregnant 
rats which was ca. 14% higher than that of the virgin controls. A small increase in 
ER -ß mRNA expression in the SON magnocellular neurones that was found in day 
15 pregnant rats which was apparent at the level of film optical density but not at the 
level of grain density per neurone suggests that there was an increase in the number 
of neurones expressing ER-I3 mRNA without a corresponding increase in the degree 
of expression by each neurone. This increase in expression might be related to an 
altered hydromineral balance during pregnancy (see below). 
Garland et al. 1987 have shown that the level of E2 rises throughout 
pregnancy and is significantly higher than in virgin controls from around mid - 
pregnancy (day 16) reaching a peak at term. Similarly, the level of P4 is higher than 
in virgin controls at all stages of pregnancy except towards the end when the level 
declines precipitously 24 -48 h prior to delivery (Garland et al., 1987). During 
pregnancy and parturition changes in the levels of ER expression have been observed 
in many brain regions. An increase in the levels of ER -a immunoreactivity (ir) was 
observed in the medial preoptic nucleus (MPN) on day 16 and day 22 of pregnancy 
compared to day 8 of pregnancy or day 1 postpartum, and such an increase is 
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implicated in the induction of maternal behaviour around the time of parturition. 
Equally the mean ER -a it per cell in the ventromedial nucleus (VMN) was 
significantly greater on day 22 compared to day 16 of pregnancy or postpartum day 
1; this region is known to be involved in the oestrogen induction of postpartum 
female sexual receptivity (Wagner & Morrell, 1996). 
Gonadal steroids have also been implicated in the regulation of the 
magnocellular neurosecretory neurones in pregnancy, especially towards the end of 
gestation. Parturition is a time of high demand for OXT and so in preparation the 
pituitary stores of OXT increase substantially during pregnancy (Douglas et al., 
1993; Leng et al., 1988). The accumulation of OXT peptide in the neural lobe is a 
result of both a restraint of peptide release from the nerve terminal as well as a 
possible increase in its synthesis in the magnocellular neurones. Although not 
conclusively (Brooks, 1992; Douglas et al., 1998), a number of previous studies have 
shown an up- regulation in the expression of OXT mRNA in the magnocellular 
neurones during pregnancy, especially immediately prepartum (12 -24 h) (Horwitz el 
al., 1994; Luckman & Larsen, 1997; Van Tol et al., 1988; Zingg & Lefebvre, 1988; 
Zingg & Lefebvre, 1989) indicating a stimulation of the OXT gene. This increase in 
OXT mRNA expression occurs in association with the marked changes in the sex 
steroid hormone profile, when rats are exposed to a rise in E2 (from ca. 30 pg /ml 
during the early stages of gestation to about 60 pg /ml mid -pregnancy to 80 pg /ml 
before term) and P4 during pregnancy (from 70 ng /ml on day 4 -10 to an average of 
100 -152 ng /ml from day 12 -20 of gestation) and a subsequent steep decline in P4 
prior to term (to ca. 10 ng /ml on day 22) (Bridges, 1984). A correlation of increased 
OXT mRNA levels in the magnocellular neurones with increased circulating E2 in 
rats before term suggests the possibility that E2 might be an important regulator of 
OXT gene expression. However, the up- regulation of OXT expression observed in 
those studies occurred specifically immediately prepartum (i.e. ca. 12 -24 h prior to 
term) and not during gestation (not on day 12, 15 or 18, (Van Tol et al., 1988) and 
not on day 7 (Luckman & Larsen, 1997), it is perhaps not surprising that the 
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expression of ER -3 mRNA at day 15 of pregnancy was barely increased, as seen in 
this study. 
The similar sequential hormone regime (i.e. E2 and P4 priming with 
subsequent P4 withdrawal) is also seen during other physiological conditions such as 
during days 10 -12 of lactation (Crowley et al., 1993; Thomas, Crowley, & Amico, 
1995) and interruption of nursing for 48 h during the first week of lactation (Crowley 
et al., 1993; Thomas et al., 1995), all of which lead to an increase in hypothalamic 
OXT mRNA. In fact, exposure of ovariectomised virgin rats to the same hormone 
regime (Crowley et al., 1995), as well as castrated male rats (Thomas & Amico, 
1996), also induced an up- regulation of magnocellular neurone OXT mRNA. Failing 
to imitate this hormone regime (i.e. either omitting E2 or P4 priming or sustaining P4 
exposure) resulted in a blunted response of the OXT gene (Crowley et al., 1995). 
Intriguingly, the increase in hypothalamic OXT mRNA following this sequential 
hormone regime, mimicking the sex steroid milieu of pregnancy, was not 
accompanied by a corresponding increase in the peptide content in the pituitary 
(Amico, Thomas, & Hollingshead, 1997a; Amico et al., 1997b; Crowley et al., 1995; 
Thomas & Amico, -1996; Thomas et al., 1995). This raises a question as to whether 
an influence of sex steroid hormones upon the hypothalamic magnocellular neurones 
significantly contributes to the increase in neural lobe peptide content. It was 
suggested that perhaps an increase in OXT mRNA might be related to a central role 
of OXT, since the increase was not only seen in the magnocellular but also in the 
parvocellular division of the PVN which is known to send some axons to sites within 
the CNS (Swanson & Sawchenko, 1983). Perhaps the influence of sex steroid 
hormones upon the OXT gene may relate to the role of OXT in maternal behaviour, 
since the aforementioned sex steroid hormone regime has been shown to induce 
maternal behaviour in OVX virgin rats (Bridges, 1984). Sadly, no evidence so far has 
been produced about whether such an increase in OXT mRNA would precede an 
increase in central OXT peptide release in the CNS. 
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The accumulation in the pituitary OXT store during pregnancy might be 
mediated via a mechanism of restraint of OXT release, rather than an increase in 
peptide synthesis, perhaps by endogenous opioid acting on both the OXT neurones as 
well as the neural lobe over the last few days of pregnancy (Douglas et al., 1994; 
Douglas et al., 1995). Additionally other mechanisms such as post -transcriptional 
processing and efficiency of splicing of OXT mRNA and cleavage of preprohormone 
may also contribute to the availability of the OXT pool. Whether the increase in 
OXT peptide storage during pregnancy arises from an increase in synthesis remains 
obscure. Whether E2 has any stimulatory effect upon the production of the peptide is 
unknown, although it is clear that changes in sex steroid profile do increase OXT 
mRNA expression. It might be worth looking at the regulation of ER -p mRNA over 
a different time frame i.e. 24 -48 h prepartum for this is the period where OXT gene 
stimulation was observed. 
b) Parturition 
The results from the present study further demonstrated that parturition itself 
did not change the expression of ER -ß mRNA, relative to day 15 pregnant or virgin 
rats. Thus the activation of OXT neurones at parturition was evidently not associated 
with any change in ER -ß mRNA expression in the magnocellular neurones. This 
indicates that E2 probably does not have any significance influence upon the 
magnocellular neurones during parturition, at least not through changes in the 
expression of ER -ß mRNA as these was not found. 
5.5.3. ER -13 mRNA expression during neuronal activation 
a) Magnocellular neurones 
As far as we are aware the present study was the first to be undertaken to 
investigate the regulation of ER -ß mRNA in the magnocellular neurones in activated 
states. This is the first report on changes in ER -ß mRNA in these neurones by 
manipulation of adrenal corticosteroid hormones, or in relation to activation of the 
neurones by hyperosmotic stimulation. There was a striking increase in expression in 
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both the SON and magnocellular PVN after ADX, and a striking decrease after salt - 
loading. In both regions there are both OXT and VP neurones, which have 
characteristic distributions within the nuclei (Swaab, Nijveldt, & Pool, 1975a; 
Vandesande & Dierickx, 1975). Although we did not distinguish formally between 
the two neuronal populations, the large changes in expression that we quantified 
appeared not to be restricted to any particular subset of magnocellular neurones. 
Similar changes were seen for both measurements of film optical density overlying 
these regions as well as silver grain density overlying individual neurones. Together, 
these measurements indicate altered ER -ß mRNA expression within individual as 
well as across the populations of neurones. Notably there was no effect of repeated 
stress on ER-I3 mRNA expression in the magnocellular neurones. This is despite the 
known stimulation of OXT secretion by stress (see Chapter 1), and the enhancement 
of this secretion by E2 (Douglas et al., 2000). 
A key question in interpreting these findings is whether the changes seen in 
ER -ß mRNA expression are a direct result of changes in corticosteroid secretion or 
availability, or are a consequence of stimuli to the neurones arising from changes in 
hydromineral balance. First, following ADX, lack of CORT and aldosterone leads to 
increased sodium excretion, tending to hyponatraemia, but accompanied by water 
loss, with consequent reduced blood volume and pressure, leading to hypovolaemia 
and hypotension. In general, hyponatraemia inhibits synthesis (Iványi, Dohanics, & 
Verbalis, 1995; Robinson et al., 1990) and secretion of VP and OXT ( Verbalis, 
1993) while hypovolaemia and hypotension stimulate VP secretion (and /or 
synthesis ?), in particular (see Robertson, 1995). The net outcome of adrenocortical 
insufficiency is the stimulation of both VP mRNA synthesis in the magnocellular 
neurones (Carter et al., 1993) and VP secretion (Ahmed et al., 1967; Share & Travis, 
1970) leading to more water retention and hyponatraemia; although PVN and not 
SON VP neurones are evidently stimulated (Suemaru et al., 1990). Thus the increase 
in ER-I3 mRNA expression in the magnocellular neurones after ADX is associated 
with hyponatraemia. 
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Alternatively, removing adrenal steroids by ADX increased ER -ß mRNA 
expression, and this was only partially prevented by CORT replacement that was 
nonetheless sufficient to fully reverse both the increase in CRF mRNA expression in 
parvocellular PVN neurones and the increase in thymus gland weight following 
ADX. So it seems that perhaps the expression of ER -ß mRNA is under the regulation 
of CORT. However, the identification of glucocorticoid receptor (GR), which CORT 
could act through, in the magnocellular neurones is controversial. Previous 
immunocytochemical studies have either failed to detect GR in magnocellular 
neurones (Fuxe et al., 1985; Uht et al., 1988) or identified GR- immunoreactivity in 
uncharacterised neurones in the SON and scattered neurones in the PVN (Kiss el al., 
1988). Additionally, most previous in situ hybridisation studies have not been able to 
identify GR mRNA in the magnocellular neurones (Aronsson el al., 1988; Herman, 
1993). However, up- regulation of GR expression has been demonstrated in the 
magnocellular neurones in induced hyponatraemia (Berghorn et al., 1995; Iványi el 
al., 1995). These results suggest that perhaps CORT could be acting in the 
magnocellular neurones via GR under hyponatraemic conditions to regulate the 
expression of ER -ß mRNA. However, although there was a significant increase in 
ER -p mRNA following ADX, CORT replacement in ADX animals did not fully 
normalise the expression of ER -ß mRNA raising the question whether another factor 
from the adrenals (e.g. perhaps aldosterone ?) regulates the expression of ER -¡3 
mRNA in these neurones. Moreover, in the experiment involving stress exposure, a 
significant rise in the plasma CORT concentration following repeated stress did not 
affect the expression of ER -ß mRNA in the magnocellular neurones, comparing the 
control and the stressed groups. Collectively the findings point in the direction that 
suggests an association between the expression of ER -ß mRNA in the magnocellular 
neurosecretory neurones with changes in hydromineral balance (and hence the 
activity of these neurones, although see below too), rather than direct regulation by 
gluco- or mineralo- corticoids. 
Regulation of ER-I3 mRNA in the SON and PVN 172 
Indeed, in the subsequent studies a dramatic reduction in the expression of 
ER-f3 mRNA in the magnocellular neurones was observed following increased 
osmolarity induced by 2% NaC1 ingestion. Increased hyperosmolarity following 
chronic salt -loading initially causes intracellular dehydration, and is a strong stimulus 
to sustained activation of magnocellular OXT and VP neurones in rats (see Leng et 
al., 1999) leading to an increase in the production of mRNA for these peptides 
(Carter et al., 1993; Lightman & Young, 1987; Majzoub et al., 1983; Rehbein et al., 
1986; Van Tol, Voorhuis, & Burbach, 1987), depletion in neural lobe peptide content 
(Crowley & Amico, 1993; Jones & Pickering, 1969; O'Keefe et al., 1995) as well as 
increase in plasma concentration of OXT and VP (Brimble, Dyball, & Forsling, 
1978; Burbach et al., 1984; Wade et al., 1982). The present finding that ER -ß mRNA 
expression in the magnocellular neurones is reduced following salt -loading suggests 
that the sensitivity of these neurones to E2 would also be decreased under this 
condition. 
The roles of sex steroid hormone in the regulation of OXT and VP genes 
during perturbation of osmotic balance, particularly by salt loading, has been 
extensively explored both in vivo and in vitro. An initial in vivo study by Crowley el 
al. 1993 has shown that the response of the OXT and VP genes (i.e. their mRNA 
accumulation) to increased osmolarity induced by salt loading in the SON and PVN 
is absent in gonadectomised (GDX) rats (both male and female), and that the 
response can be restored, at least in male rats, upon testosterone (T) replacement 
(Crowley & Amico, 1993). This suggests that the gonadal hormones and /or their 
receptors are required to permit the effects of osmotic stimulation upon OXT and VP 
gene expression. Absence of the response in the VP and OXT genes to 
hyperosmolarity was observed following GDX in both male and female rats, while T 
can be further aromatised into E2 (Lieberburg & McEwen, 1977), and there is ER -U, 
but not AR (although see below too), in the magnocellular neurones. This suggests 
that the permissive (or stimulatory) effect of E2 and T upon osmotic stimulation on 
OXT and VP gene expression could conceivably be mediated through ER -(3. Yet in 
the present study, osmotic stimulation induced a dramatic decrease in ER -(3 mRNA 
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expression in the magnocellular neurones indicating a possible reduction in the 
sensitivity of these neurones to E2 under this condition. In other words, the response 
of the OXT and VP genes to increased osmolarity evidently only occurs in the 
presence of E2, but the expression of the receptor (ER -ß) mediating such a task is 
decreased. This raises the question of whether any stimulatory effect of E, is 
mediated by ER -ß. 
Intriguingly it has been further demonstrated in a subsequent study that T and 
its more potent metabolite 5a- dihydrotestosterone (DHT), but not E2, restored the 
osmotic response of VP mRNA in male rat SON neurones (O'Keefe et al., 1995). 
The DHT binds to androgen receptor (AR) with a higher affinity than testosterone 
and is androgen- specific as it cannot be further aromatised to E2 (Kovacs et al., 
1984). Thus it is conceivable that effects of DHT upon VP gene expression is 
mediated via the AR. Despite such speculation, there has been no report to date 
describing the localisation of AR within either the SON or PVN (Zhou, Blaustein, & 
De Vries, 1994), except in one study in which AR mRNA has been identified in 
neurones in the SON, albeit with low degree of expression (Simerly et al., 1990). So 
DHT (and T) might be acting upon other AR- expressing neurones which in turn 
project to and influence the VP neurones in the SON. Alternatively, androgens may 
be modulating the VP neurones through other non -genomic pathways. It is 
interesting though that the follow -up study of O'Keefe et al., 1995 was carried out 
only in male rats, yet absence of a response of VP mRNA accumulation to increased 
osmolarity following GDX was evident in both sexes. 
The effects of sex steroids upon the regulation of VP during increased 
osmolarity have also been studied in vitro using the perifused hypothalamo- 
neurohypophyseal system (HNS) explants. This approach is particularly useful since 
these neural explant models contain only the magnocellular neurones in the SON 
together with their axons terminating in the neural lobe and neurones in the organum 
vasculosum of the lamina terminalis (OVLT) region. This enables the determination 
of the direct effects of sex steroid hormones upon the magnocellular neurones, as 
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opposed to their actions on other loci that might secondarily influence the 
neurosecretory system. These perifused explants show a characteristic response of 
VP and OXT with both an increase in their peptide release and mRNA content in 
response to increased osmolarity (Sladek & Knigge, 1977; Yagil & Sladek, 1990). 
By using these neural explants, Swenson and Sladek 1997 demonstrated that there 
was no significant difference in VP release stimulated by increased osmolarity 
between the explants obtained from sham- operated intact vs. gonadectomised male 
rats (Swenson & Sladek, 1997). Furthermore they have shown that exogenous T and 
its metabolites, DHT, and E2 at dose which mimics the physiological plasma 
concentration, inhibited osmotically stimulated VP (and OXT) release from these 
explants while only T and E2, but not DHT, also inhibited an increase in VP mRNA 
content following induced osmolarity. Moreover this inhibition in VP mRNA content 
was still present using BSA -conjugated E2 suggesting that non -genomic action of 
steroids are involved. Thus it seems that the effects of steroids E2, T, and DHT upon 
magnocellular VP mRNA accumulation in response to osmotic stimul i observed in in 
vivo and in vitro studies are in opposite directions. 
Since the in vitro model lacks many of the afferent inputs that are present in 
vivo, it remains possible that effects of sex steroid hormones in vivo might be acting 
at sites other than or in addition to the SON, which in turn influence the activity of 
these magnocellular neurones. These loci include the SFO, MnPO, OVLT, NTS and 
VML, some of which have also been shown to contain ER and are known to be 
influenced by sex steroids (Akaishi & Homma, 1996a; Akaishi & Homma, 1996b; 
Blache, Batailler, & Fabre-Nys, 1994; Pfaff & Keiner, 1973; Rosas- Arellano, 
Solano- Flores, & Ciriello, 1999; Simerly, 1990). It would be interesting to look at the 
regulation of gonadal hormones as well as the receptors in these structures using 
various hormone and endocrine manipulations. This perhaps might enhance 
understanding of how sex steroids could affect the neurohypophysial system 
observed in this study. 
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Despite the rather conflicting results of previous reports both in vivo and in 
vitro, it is clear that sex steroid hormones do influence the function of the 
magnocellular neurosecretory system. Collectively these findings suggest a 
modulatory role for sex steroid hormones in hypothalamic OXT and VP gene 
expression. Whether E2 and/or ER-f3 has a stimulatory or inhibitory effect, and 
whether such an action is direct or indirect it is not at all clear at present. Perhaps the 
role of E2 and/or ER-f3 in the magnocellular neurones, on the other hand, might not 
be involved in the regulation of the OXT or VP genes, but in the regulation of some 
other genes. Notably, CRF mRNA in the magnocellular neurones is massively up- 
regulated following salt -loading (see Chapter 1). Moreover, the gene encoding CRF 
has been identified to contain the ERE (Vamvakopoulos & Chrousos, 1993), 
providing the evidence for direct genomic regulation of CRF by E2, perhaps via ER- 
(3 present in these neurones. The exact role of ER -13 remains to be determined. 
b) Ventral parvocellular neurones 
The paraventricular nucleus, in addition to its magnocellular peptidergic 
projections to the posterior pituitary, contains parvocellular oxytocin- or vasopressin- 
containing neurones projecting to the locus coeruleus, nucleus tractus solitarii (NTS), 
dorsal vagal complex, and the intermediolateral cell column in thoracic levels of the 
spinal cord (Saper et al., 1976). Some of these neurones project directly to 
sympathetic preganglionic neurones, and are involved in autonomic regulation by the 
PVN, particularly in defence against plasma volume expansion (Coote et al., 1998; 
Gilbey et al., 1982). This current study has shown that ER -13 mRNA expression in 
these neurones markedly responded to changes in circulating E2 as well as during 
physiological perturbations. OXT evokes hypertensive responses via the dorsal vagal 
complex, while the responses of dorsal vagal complex neurones to OXT are altered 
by E2 exposure (Tian & Ingram, 1997; Tolchard & Ingram, 1993). These neurones 
showed a significant increase of ER -13 mRNA expression after repeated stress, but 
not following ADX and CORT replacement (although this followed the same 
direction as the magnocellular neurones, it was not statistically significant). It is 
likely that these neurones are activated during repeated stress to co- ordinate the 
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autonomic responses. They showed a modest decrease in ER -ß mRNA expression 
after salt -loading (ca. 12% reduction, but nonetheless significant), a condition in 
which autonomic drive to the cardiovascular system and input from baroreceptors 
will change. Thus, it seems that for these neurones, the expression of ER -ß mRNA 
may be related to their activity, and sex steroid influences. 
Interestingly a report by Estacio et al. 1996 showed that following 
immobilisation for 1 h in the rats, ER- immunoreactivity (ir) was increased within the 
PVN (Estacio et al., 1996). Although the study did not indicate specifically which 
subdivision within the PVN the increase in ER -ir occurred and while the antibody 
employed in their study was a polyclonal antibody generated against the rat ER -a, 
this also may have detected the immunoreactivity for ER -13, given that the two rat ER 
peptides share a considerable degree of homology (see Chapter 1). So the increase in 
ER -ir observed in their studies conceivably was due to an increase in the ER -ß 
protein within the ventral parvocellular neurones following an immobilisation 
parallel (similar) to the increase in ER -ß mRNA observed in the present study. 
5.5.4. Mechanisms regulating ER-f3 mRNA expression: Relationship with 
hydromineral balance, states of activation or hormone signal? 
Since ER -ß is capable of binding to oestrogenic compounds and can stimulate 
the transcription of oestrogen- responsive genes via an ERE this suggests that it 
functions as a ligand- regulated transcription factor. The presence of both ER -ß 
mRNA as well as protein has been previously characterised in the magnocellular 
neurones. The present finding which demonstrated that the ER -ß mRNA transcript is 
indeed regulated in these neurones suggests that ER -ß is a functional transcription 
factor mediating the effects of E2 via genomic mechanism. Nonetheless, the effect of 
BSA conjugated- steroid hormone, including that of E2, in regulating the VP gene in 
the magnocellular neurones described by Swenson and Sladek 1997 also indicates 
the potential involvement of a non -genomic mechanism (also see Sladek et al., 
2000). It is not at all obvious how ER -ß mRNA is regulated in the magnocellular 
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neurones under these circumstances. Whether one or more mechanism is involved is 
not clear. 
a) Genomic mechanism 
At first glance, the dramatic decrease in the expression of ER -p mRNA in the 
magnocellular neurones that occurred following salt loading offers two obvious 
possibilities; 
1) The expression of ER -p mRNA is related to hydromineral status (or 
Na + ?) 
2) The expression of the transcript is related to magnocellular neuronal 
activity, a consequence of altered plasma osmolarity 
An increase in plasma osmolarity (or hypernatraemia) following salt loading 
is associated with a down -regulation in the expression of ER -p mRNA in the 
magnocellular neurones. Conversely, there is a slight increase in the expression of 
the transcript (observed at the level of film optical density but not by grain density 
per neurone) during mid -pregnancy when there is an alteration in plasma osmolarity 
(and volume) with a tendency towards hyponatraemia (see Chapter 1). Similarly, 
adrenocortical insufficiency, such as following bilateral ADX, is associated with 
hyponatraemia and results in an increase in ER -p mRNA expression. So the 
expression of ER -p mRNA seems to vary in relation to alteration in plasma Na" 
(mineral) concentration. The problem is how the actual solute Na+ could influence 
the expression of ER- p mRNA? Does it somehow directly influence the 
transcription of the gene encoding ER -p or perhaps alter the stability of the 
transcript? This seems unlikely. So the effect of changes in Na+ content upon the 
expression of ER-f3 mRNA would probably be related to an alteration of the activity 
of neurones consequent on changes in plasma osmolarity instead. Moreover, it is not 
clear if the reduction in the ER -p mRNA expression is a consequence of increased 
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osmolarity (suggested by the present study), or whether this reduction in the 
expression of the transcript allows the effect of increased osmolarity upon the 
accumulation of the VP and OXT mRNA to occur (suggested indirectly by Crowley 
& Amico, 1993). What is the causal relationship between the two? 
Looking from the neuronal activity perspective, the expression of ER -13 
mRNA seems to be associated with an alteration in the activity of the magnocellular 
neurones. An increase in plasma osmolarity following salt loading excites 
magnocellular neurones leading to an increase in the firing rates and hence the 
increased activity of both OXT and VP neurones. This is associated with a decrease 
in ER -3 mRNA expression in the magnocellular neurosecretory cells. Similarly, 
adrenal insufficiency is associated with elevated plasma VP release and its mRNA 
synthesis, despite the presence of hyponatraemia, indicating the activation of the 
magnocellular neurones. Thus, the finding that bilateral ADX led to an increase in 
the expression of ER -ß mRNA, opposite to that observed during salt loading, 
suggests that either lack of corticosteroids or the expected hyponatraemia (as a result 
of lack of aldosterone), rather than increased neuronal activity, was the dominant 
factor. Moreover, in spite of intense excitation of, in particular, the OXT neurones 
during parturition, albeit over a short time span, there was no change in the 
expression of ER-(3 mRNA in the magnocellular neurones. 
Some possible explanations to reconcile the discrepancy might be that; 
1) It is not known whether ADX for 72 h led to an activation of V P /OXT 
neurone secretory activity; this was not explored. Apparently the expression of the 
mRNA for OXT and VP genes in the magnocellular neurones was found to increase 
following ADX in some studies (Carter et al., 1993) (and Suemaru et al., 1990, but 
only in the PVN neurones) but not in others (Davis et al., 1986b; Swanson & 
Simmons, 1989; Young, Mezey, & Siegel, 1986b). Moreover, an increase in the VP 
mRNA content in the magnocellular neurones following ADX, indicated in some 
studies, is not necessarily a result of an increase in the mRNA synthesis. Rather this 
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could also be due to a decreased degradation of the transcript. Thus an increase in 
ER -13 mRNA expression following ADX might not be related to the activation of 
neurones. 
2) In response to osmotic challenge, there is a continuous release of 
OXT and VP with an increase in `non- burst' background firing activity of the 
magnocellular neurones. On the other hand, parturition evokes an intermittent intense 
`burst -like' activity of OXT neurones. Moreover, a decrease in ER-f3 mRNA 
expression following salt loading was observed over a relatively prolonged period 
(72 h) while parturition in rats normally only lasts for 60 -90 min. Thus the 
expression of ER -ß mRNA might be dependent on a specific state of neuronal 
activation and /or perhaps require a longer period of activation. Sadly, the experiment 
to test this hypothesis seems without the bounds of possibility since normal 
parturition cannot be prolonged to 72 h, but it would be interesting to look at the 
expression of ER -ß mRNA following shorter periods of osmotic stimulation (e.g. 
perhaps via acute intraperitoneal administration of NaC1). Another option would be 
to explore the regulation of ER -ß mRNA during lactation since suckling induces a 
pulsatile `burst -like' increase in the OXT neurone activity similar to that occurred 
during parturition but which continues over a period of 12 -14 days before pups are 
weaned. This would be particularly interesting since changes in the sex steroid 
hormone profile during the first week of lactation arc similar to those occurring 
around the end of pregnancy when OXT mRNA up- regulation in the magnocellular 
neurones has been observed (see above). 
3) Various inputs are involved in regulating magnocellular neurone 
activity in each of the conditions examined in the present study. For example, salt 
loading influences the activity of neurones in the circumventricular organs (e.g. 
SFO /OVLT /AP) which are indispensable for activation of the VP and OXT neurones 
(Hamamura et al., 1992; Leng et al., 1989). Thus changes in hydromineral balance 
following salt -loading will involve these structures, as well as inputs from the 
brainstem mediating information from baroreceptors (Hochstenbach & Ciriello, 
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1995). During pregnancy, relaxin acts to sustain an increase in electrical activity of 
the VP and OXT neurones by activating inputs from these rostral circumventricular 
structures (McKinley et al., 1997). Thus it is possible that the changes in expression 
of ER -3 mRNA that were observed under the different physiological conditions was 
a result of the pattern of changes in activity in these inputs to the magnocellular 
neurones contributing to the overall expression of the ER -ß transcript. The 
underlying mechanism(s) remains to be further investigated. 
b) Non -genomic pathway 
Although ER-I3 mRNA was detected and present in the perikarya, this does 
not necessarily mean that the protein would only be confined to the cytoplasmic 
compartment. Instead, this protein might be transported to the cell membrane and act 
as a membrane -bound receptor to mediate a non -genomic action of E2. However, this 
perhaps requires further investigation since 
1) No such membrane -bound ER in the SON or PVN has been reported 
to date. Moreover, most of the previous immunocytochemical studies detected the 
presence of ER -ß it in the nuclear compartment and not in the perikarya (except in 
the hippocampus and lateral septum (Li et al., 1997). 
2) If ER -ß protein was to be transported to the cell membrane, this 
perhaps requires assistance from a transporting molecule. No such molecule is 
known for ER -ß thus far. 
However, the apparent non -genomically mediated action of E2 (and T) upon 
inhibiting the accumulation of OXT and VP mRNA in the neurohypophysial explain 
substantiates the existence of a non -transcriptional pathway. Moreover, E2 has also 
been shown to act rapidly to increase release of OXT and VP from the dendrites of 
SON neurones (Wang, Ward, & Morris, 1995). There are also rapid effects of E2 on 
the electrical activity of the magnocellular neurones (Israel & Poulain, 1999). 
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It is not known whether ER-I3 when expressed alone, in sites such as 
magnocellular SON and PVN neurones, is functional in vivo, although in vitro ER -ß 
homodimers bind to DNA, and ER -ß appears to contain the AF1 and AF2 elements 
to regulate transcription (Labrie et al., 1999; Tremblay et al., 1999). If ER -ß is active 
alone in situ, then it could explain actions of E2 on OXT and VP neurones that are 
indicated by other previous studies. 
It seems that the effects of sex steroid hormone on the neurohypophysial 
system and the expression of the ER-I3 mRNA are not particularly robust. However, 
under conditions such as pregnancy, ADX or those related to alterations in plasma 
osmolarity there may be altered effects of E2 as a consequence of changes in the 
expression of ER -ß mRNA observed in this study. The study leaves open the 
question of the physiological significance of the influence of sex steroids and/or ER- 
ß in regulating the neurohypophysial system and whether such an effect is 
stimulatory or inhibitory to the magnocellular neurosecretory system is not at present 
known. It is clear, however, that the ER -ß, at least at the level of mRNA, can and is 
indeed regulated in these neurones, and this is expected to contribute to the 
sensitivity of the magnocellular neurosecretory system to E2. Thus, the influence of 
sex steroids may decrease in conditions where the roles of OXT and VP in regulating 
hydromineral homeostasis are paramount, and conversely may increase when 
corticosteriod secretion (and/or action ?), is minimal, then evoking expression of 
characteristics in these neurones appropriate for their adaptive roles. In the medial 
ventral parvocellular PVN neurones, the increased expression of ER -ß mRNA 
following repeated stress, but evidently not as a consequence of regulation by 
glucocorticoids, may enhance regulation of these neurones by E2 to modulate the 
autonomic responses. 
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Undoubtedly the significance of the recent discovery of ER -ß and its 
expression in various structures of the brain including the hypothalamic PVN and 
SON gives rise to other possible mechanisms of how sex steroids could influence the 






Although E2 is generally regarded as a sex steroid hormone, a growing body 
of evidence in recent years suggests roles of E2 beyond those associated directly with 
reproduction. This is also reflected by the extensive expression of both ERs in 
structures that are not typically involved in reproductive physiology including brain 
areas that are important for learning and memory such as the hippocampus, as well as 
autonomic function and homeostasis in a number of the hypothalamic nuclei . 
6.1. Distribution of ER -a and -ß mRNA in rat brain 
The present study revealed a distinct pattern of expression for both ER -a and 
-ß mRNAs within the rat brain. This suggests the significance of each receptor 
subtype in mediating specific biological effects in a cell type -specific manner. The 
degree of expression of each transcript varies considerably from one region to 
another. Moreover, each transcript is also differentially expressed in a number of 
individual brain nuclei, as clearly seen in the PVN in the case of ER -(3 mRNA and in 
the amygdala for both ER transcripts. Such heterogeneity in the degree and pattern of 
expression of both ER mRNAs, if translated into receptor protein, could allow E2 to 
elicit a pattern of actions in the correct cell types at the right level appropriate for its 
biological roles. As further demonstrated in Chapter 4 and 5, the expression of both 
ER transcripts changes with the diverse functional states examined. Such findings 
indicate the dynamic nature of ER mRNA expression, and suggest shifts in the 
influence of E2, and/or other endogenous ER -ß ligands, upon specific physiological 
processes under different conditions. 
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Ultimately, the impact of the ER-a/-13 receptor genes will only be exerted 
when the transcript is translated into the receptor protein. Nevertheless, the 
distribution in the brain of both ER mRNAs observed in this study is generally in 
good agreement with a number of previous reports, both at the level of the mRNA 
and protein, suggesting that the pattern of expression of ER mRNAs seen here is 
likely to reflect the subsequent expression of the receptor protein. 
6.2. ER -a and -13 mRNAs and the hippocampus 
Both ER -a and -p mRNAs are evidently expressed in the pyramidal neurones 
of the hippocampus and in the granule cell layer of the dentate gyrus. We have 
shown that the expression of the two ER mRNAs is differentially regulated by sex 
steroid manipulation in a region- and sex -specific and time -dependent manner. On 
the other hand, regulation by another hormone signal, specifically from 
glucocorticoid, was only evident for ER -p and occurred in the hippocampus only in 
the CA1 subfield where adrenalectomy resulted in a decrease in ER -p mRNA 
expression, an effect which was reversed upon corticosterone replacement. In 
contrast stress, which increased corticosterone secretion, did not induce any 
significant change in the expression of either transcript in any of the subfields 
examined. 
Changes in the expression of ER mRNAs in the hippocampus observed in the 
present study suggest functional importance of ER. The ER expressed here might 
orchestrate the morphological changes in the hippocampal neurones that follow 
changes in sex steroid hormone exposure. Experimentally, exogenous E2 treatment as 
well as an increase in E2 secretion during the pro- oestrus period of the natural 
oestrous cycle results in increased spine density and de novo synapse formation on 
the pyramidal neurones. Such increases promote synaptic connectivity of the 
hippocampal neurones contributing perhaps to an enhancement of long -term 
potentiation, the long -lasting change in excitatory synaptic transmission that seems to 
be involved in the process of learning and memory. 
General discussion 
6.2.1. Physiological implications 
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With an increasing life span women are more likely to spend a large part of 
their lives in an oestrogen -deficiency state. Many physiological changes including a 
decline in cognitive performance as well as an increased susceptibility to 
neurodegenerative disorders such as dementia accompany the loss of ovarian 
hormones in postmenopausal women. Oestrogen replacement therapy in ageing 
women has been shown to improve cognitive function and delay the onset of 
Alzheimer's disease (Fillit et al., 1986; Tang et al., 1996) as well as to benefit 
cognition in non -demented women (Jacobs et al., 1998; Resnick, Metter, & 
Zonderman, 1997). 
Thus the role of ER in the hippocampus is perhaps to mediate actions of E2 in 
maintaining aspects of cognition that is dependent on the hippocampal formation. It 
might also be involved in modulating activity of the HPA axis, though paradoxically 
E2 enhances responsiveness of the HPA axis, and the increased glucocorticoid 
potentially damages hippocampal neurones; however, the parallel protective action 
of E2 may offset this. 
6.3. ER-0 mRNA in the hypothalamic SON and PVN 
The magnocellular neurosecretory system is modulated by sex steroid 
hormones. Previous studies have failed to demonstrate expression of ER -a in the 
magnocellular neurones, so the discovery of ER-I3 here may explain the enigma of 
how E2 could act on them. In this study we have shown that there is a weak 
regulation of ER -ß mRNA expression in the magnocellular neurones by sex steroid 
hormones. On the other hand, there was a striking increase in the expression of ER -13 
mRNA here following ADX while a large decrease in expression was observed 
following activation of these neurones by a chronic hyperosmotic stimulus. Thus ER- 
ß mRNA expression may be negatively regulated by basal secretion of adrenal 
corticosteroid, and negatively regulated by hyperosmotic cue. The more than 6 -fold 
variation in ER -ß mRNA expression in the magnocellular neurones from salt- loading 
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to adrenalectomy could profoundly alter the sensitivity of these neurones to E2 under 
these conditions. In contrast, the expression of the ER -13 transcript in the ventral 
parvocellular PVN neurones involved in autonomic regulation was evidently 
modulated by the sex steroid hormone treatment while salt loading and ADX 
produced only modest changes in expression of such transcript. Repeated stress 
enhanced ER -ß mRNA expression only in the ventral parvocellular PVN neurones 
while leaving the expression of this transcript unchanged in the magnocellular 
neurones. The expression of ER -ß mRNA in both groups of neurones hardly changed 
during pregnancy and parturition, despite the large sustained increase in E2 secretion 
in pregnancy. 
It is not clear at present what the physiological role of ER -p hi the 
hypothalamic SON and PVN neurones is. The genes encoding peptides synthesised 
by magnocellular neurones, OXT and VP, are the obvious candidates to be regulated 
by E2 (or other endogenous ligand). However, there are also many others expressed 
in these two nuclei that could be regulated via ER -ß (see Levin & Sawchenko, 1993). 
Such regulation could be direct, via an ERE in the target gene, or indirect, via an 
ERE in another gene whose product could then regulated the OXT /VP genes. The 
upstream regulatory sequences of the OXT gene constitute a composite hormone 
response element, similar to an ERE which allows binding of many nuclear 
transcription factors including thyroid hormone, retinoic acid and numerous orphan 
nuclear receptors (see Burbach et al., 1998). This suggests that these transcription 
factors, in addition to ER -ß, could perhaps interact and potentially control the 
expression of the OXT gene. For instance, both thyroid hormones and E2 can activate 
the rat and human OXT gene promoter in vitro (Adan & Burbach, 1992). Treatment 
with tri- iodothyronine (T3) in vivo increased hypothalamic OXT mRNA content, 
pituitary OXT peptide and plasma OXT concentration (Adan et al., 1992). Indeed, as 
pointed out in a recent study, thyroid hormone interferes with E2 in regulating 
expression of the rat OXT gene. Dellovade et al. 1999 have shown that treatment of 
ovariectomised (OVX) rats with oestradiol- benzoate (EB) alone did not affect OXT 
mRNA expression, but in OVX plus thyroidectomised (TX) rats the same hormone 
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treatment significantly increased OXT gene expression. Moreover exogenous 
administration of T3 inhibited an EB- induced increase in OXT mRNA in OVX /TX 
rats (Dellovade, Zhu, & Pfaff, 1999). 
Thus thyroid hormone normally inhibits, and conceals, a stimulatory action of 
E2 on OXT gene expression. The present and many previous studies were conducted 
on rats in a, presumably, euthyroid- state. It thus remains possible that the different 
responses of the genes in the magnocellular system, at least for OXT, to E2, whether 
being stimulatory, inhibitory, gradual or even a complete absence of response, could 
be due to the lack of control over thyroid hormone status. That said, it does not 
follow that actions of E2 upon OXT gene expression are entirely secondary to (or 
dependent on) the effects of thyroid hormone, but rather this consideration 
demonstrates the complex interaction of a given set of genes capable of modulating 
one another to influence the expression of a target gene. 
6.3.1. Physiological implications 
The ER -ß expressed in the magnocellular neurones might be involved in 
modulating the physiological activity of these neurones. Since VP plays a pivotal 
role in the control of fluid and electrolyte balance it is likely that E2, or other ligands, 
could potentially modulate such a physiological process by changes in the 
responsiveness of the neurones. It is possible that E2 might perhaps be involved in 
altering the sensitivity of the osmotic response of VP in the face of changes in blood 
volume or pressure as found, for example, during pregnancy. 
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6.4.1. Behavioural studies: a knock -out model? 
One of the approaches that has been commonly used in assessing the function 
of any particular gene is via interpretation of the consequences of disruption of the 
gene in studies on knockout mice. However, this is not as straightforward in the case 
of the ER -ß since the wild -type mice themselves do not normally express ER -13, at 
least not at the level of mRNA, in the magnocellular SON neurones (although 
expression is present in the PVN) (Shughrue et al., 1997). This suggests that perhaps 
in mice ER -ß may not play any major role in magnocellular neurone physiology. 
Indeed, although no direct study has been reported on the progression of parturition 
itself, a study of PERKO mice has shown that these homozygous knockout mice 
have successful pregnancy, albeit with fewer and smaller litter sizes. Moreover, they 
have normal breast development and can lactate normally (Krege et al., 1998) 
suggesting that, at least during lactation, OXT production is not compromised by the 
lack of ER -ß. Whether these findings indicate that ER-13 does not mediate any 
physiological function upon the magnocellular neurones in preparation for 
parturition, as also indirectly suggested by the lack of changes in the expression of 
ER -ß mRNA during pregnancy and parturition observed in the rats in the present 
study, or simply reflects a species difference in the expression and function of this 
receptor between rats and mice is not clear. 
Incidentally, shortly following the production of aERKO mice in 1994, 
transgenic mice over -expressing the wild -type mouse oestrogen receptor -a were also 
generated. Intriguingly, these transgenic mice demonstrated several aberrant 
reproductive phenotypes including, in particular, delayed parturition (prolonged up to 
4 days beyond normal gestation of 19 days), prolonged labour (up to 3 days to 
deliver all pups) as well as an increased incidence of still born litters (Davis et al., 
1994). Moreover, administration of OXT was not able to rescue females with 
difficult labour. The finding suggests that the progress of parturition is disrupted in 
the presence of ER -a over -expression although this might reflect ER functions in the 
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reproductive tract rather than in the magnocellular neurones since OXT cannot 
rescue difficult labour while ER -a is not found to be expressed in the magnocellular 
neurones. 
6.4.2. Differential ER -ß expression in magnocellular neurones 
Although both OXT and VP neurones share the same anatomical location, the 
SON and the PVN, both peptides are rarely expressed in the same neurones (Kiyama 
& Emson, 1990; Vandesande & Dierickx, 1979). Moreover, the two peptides 
generally mediate distinct biological effects. Despite the ubiquitous distribution of 
ER-f3 mRNA in the SON which does not appear to be restricted to any particular 
portion of the nucleus, the basal expression as well as the expression during 
physiological perturbations of the ER -ß mRNA in the OXT- containing vs VP- 
containing neurones might be different. The use of double -labelling histochemistry 
would allow the detection of OXT or VP peptide and of ER -ß mRNA simultaneously 
thus enabling the determination of any differences in the expression of the transcript 
between the two populations of neurone. 
As discussed in Chapter 5, the expression of ER -ß mRNA following salt 
loading appears to be inversely related to the activity of the neurones. However, the 
discrepancy in the response of ER -ß mRNA expression between salt loading and the 
lack of changes of the transcript during parturition suggests that the expression may 
also be governed by other factor(s). The difference might lie in the large time lag 
discrepancy (72 h salt- loading vs 2 h parturition) or the pattern of neuronal activity 
between the two physiological processes. The advantage of the prolonged time scale 
during lactation (several days) plus the similar pattern of neuronal activity to that in 
parturition (intermittent bursting discharge) is thus of key importance to pursue. 
Moreover, lactation is probably the only known physiological process where 
there is a selective release of OXT without VP from the neurohypophysis, at least in 
a pulsatile pattern during suckling (hence the OXT- knockout mouse cannot transfer 
milk to its young). Nonetheless VP neurones are also evidently activated in lactation, 
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probably consequent on the loss of water accompanying milk transfer. Thus by 
studying ER-I3 mRNA expression in lactation, one could perhaps begin to partially 
dissect the response of ER -3 mRNA between the two different groups of neurones in 
a physiological setting. 
Another approach in evaluating roles mediated by ER-f3 (as well as ER -a) is 
perhaps by using an antagonist, sub -type selective, to specifically inhibit the actions 
of E2, or other ligand, upon the target tissues (Sun et al., 1999) including the 
SON /PVN and the hippocampus. 
6.5. Criticism of the experiments 
The experiments conducted in the present study used the ISH approach to 
determine ER mRNA expression. However, the crucial step from the point of view of 
function is when these transcripts are translated into the receptor protein to mediate 
the biological effects. In some instances, it has been shown that the mRNA levels do 
not correlate with receptor protein levels (Uhl, Zingg, & Habener, 1985). The use of 
immunocytochemistry (ICC), particularly when combined with ISH on the same 
tissue section, allows the detection of the receptor protein and mRNA simultaneously 
thus providing the crucial information about translation. However, although ICC 
does detect the receptor protein, these molecules can exist in inactive forms that 
either cannot bind to hormones (cryptic receptors), fail to trigger a transduction 
system (desensitised receptors), or cannot bind to DNA (untransformed receptor). 
Mono- and poly -clonal antibodies employed in ICC may not be able to distinguish 
among these different forms (Bolander, 1994b). Moreover ICC, in theory, does not 
allow an accurate determination of the receptor protein level, except when coupled 
with fluorescence. On the other hand ISH, when employed within a linear range, 
gives a hybridisation signal which is quantitatively related to the level of the receptor 
mRNA. Another approach would be perhaps by western blot analysis which detects 
the receptor protein, although this technique does not permit the precise anatomical 
localisation of the protein. This could be particularly problematic especially when 
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dealing with tissue of high heterogeneity like the brain. Nonetheless this technique is 
quantifiable. 
The OXT and VP genes are the most obvious targets for ER -ß in the 
magnocellular neurones. However, the present study did not study whether there was 
any change in the activity of the OXT and VP genes in the neurosecretory neurones 
following stimuli such as salt loading, ADX or parturition. Nonetheless previous 
studies have shown that activation of OXT and VP gene expression (as indicated by 
an increase in their hypothalamic mRNA content as well as a depletion of the neural 
lobe peptide) in the magnocellular neurones via 2% NaCI ingestion occurs within 24 
h of initiation of the treatment (Jones & Pickering, 1969; Lightman & Young, 1987) 
with the effect persisting by for at least 12 days ( Lightman & Young, 1987). 
Similarly, parturition has been repeatedly shown to induce activation of the 
magnocellular, in particular the OXT neurones (Douglas et al., 1998; Lin et crl., 
1995; Summerlee, 1981). Despite all that, it is clear that the expression of ER -13 
mRNA is indeed regulated in the magnocellular neurones under the conditions 
examined. Whether these changes in the expression of ER -13 mRNA is associated 
with, regulates or is regulated by, the expression of OXT and /or VP genes is subject 
to further investigation. 
Conclusion 
In the brain, the gonadal steroid E2, and hence its precursor T, (and maybe 
other products ?), profoundly affects the activity and the connectivity of certain 
neuronal populations. Its actions are principally mediated by genomic mechanisms 
that rely on the expression of intracellular ER. The recent discovery of ER -(3, in 
addition to ER -a, expands ways by which E2 could modulate the responsive genes, 
thereby increasing the plethora of functions E2 could influence in the CNS. 
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Although the molecular mechanism underlying the changes in ER mRNA 
expression are far from being understood, the preliminary data obtained from the 
present study provide an initial step in elucidating the influence of E2 upon two 
specific neuronal structures. It is clearly demonstrated, however, that the expression 
of both ER transcripts is subject to multiple mechanisms of regulation as indicated by 
the temporal -, regional -, as well as sex -dependency in the pattern of expression of 
both ER mRNAs. Moreover, the regulation of the ER -ß transcript is also influenced 
by physiological cues such as by osmotic stimulation in functionally relevant 
neurones. 
The functional significance of these findings is the implication for changing 
the effectiveness of E2 on neurones in the hippocampus and the SON and PVN as 
their expression of ER -ß mRNA increases or decreases. Future studies on the genes 
that regulate as well as those that are regulated by ER in these and other relevant loci 
should yield valuable data contributing to a better understanding of the roles of E2 
and their receptors in neurobiology. 
References 
193 
Acher, R. (1980). Molecular evolution of biologically active polypeptides. Proceedings of the Royal 
Society of London (Biology), 210, 21 -43. 
Adan, R. A., & Burbach, J. P. (1992). Regulation of vasopressin and oxytocin gene expression by 
estrogen and thyroid hormone. Progress In Brain Research, 92, 127 -36. 
Adan, R. A., Cox, J. J., Beischlag, T. V., & Burbach, J. P. (1993). A composite hormone response 
element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone 
receptors. Molecular Endocrinology, 7(1), 47 -57. 
Adan, R. A., Cox, J. J., van Kats, J. P., & Burbach, J. P. (1992). Thyroid hormone regulates the 
oxytocin gene. Journal Of Biological Chemistry, 267(6), 3771 -7. 
Adan, R. A., Walther, N., Cox, J. J., Ivell, R., & Burbach, J. P. (1991). Comparison of the estrogen 
responsiveness of the rat and bovine oxytocin gene promoters. Biochemical And Biophysical 
Research Communications, 175(1), 117 -22. 
Ahmed, A. B., George, B. C., Gonzalez -Auvert, C., & Dingman, J. F. (1967). Increased plasma 
arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids. 
Journal Of Clinical Investigation, 46(1), 111 -23. 
Akaishi, T., & Homma, S. (1996a). Estrogen modifies the baroreceptor- induced responses of 
supraoptic vasopressin neurons in the ovariectomized rat. Neuroscience Letters, 219(1), 33 -6. 
Akaishi, T., & Homma, S. (1996b). Osmolality- and angiotensin- induced responses in the AV3V 
neurons are affected by estrogen in the ovariectomized rat. Neuroscience Letters, 202(3), 153 -6. 
Akana, S.F., Cascio C.S., Shinsako, J., & Dallman, M.F. (1985). Corticosterone: narrow range 
required for normal body and thymus weight and ACTH. American Journal Of Physiology, 249(5 Pt 
2), R527 -32. 
Alarid, E. T., Bakopoulos, N., & Solodin, N. (1999). Proteasome- mediated proteolysis of estrogen 
receptor: a novel component in autologous down -regulation. Molecular Endocrinology. 13(9), 1522- 
34. 
Almeida, O. F., Hassan, A. H., Harbuz, M. S., Linton, E. A., & Lightman, S. L. (1992). Hypothalamic 
corticotropin- releasing hormone and opioid peptide neurons: functional changes after adrenalectomy 
and/or castration. Brain Research, 571(2), 189 -98. 
References 194 
Alves, S. E., Lopez, V., McEwen, B. S., & Weiland, N. G. (1998). Differential colocalization of 
estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic 
nuclei of the female rat brain: an immunocytochemical study. Proceedings Of The National Academy 
Of Sciences Of The United States Of America, 95(6), 3281 -6. 
Alzein, M., Jeandel, L., Lutz- Bucher, B., & Koch, B. (1984). Evidence that CRF stimulates 
vasopressin secretion from isolated neurointermediate pituitary. Neuroendocrinology Letter, 6, 151- 
154. 
Amico, J. A., Seif, S. M., & Robinson, A. G. (1981). Oxytocin in human plasma: correlation with 
neurophysin and stimulation with estrogen. Journal Of Clinical Endocrinology And Metabolism, 
52(5), 988 -93. 
Amico, J. A., Thomas, A., & Hollingshead, D. J. (1997a). The duration of estradiol and progesterone 
exposure prior to progesterone withdrawal regulates oxytocin mRNA levels in the paraventricu lar 
nucleus of the rat. Endocrine Research, 23(3), 141 -56. 
Amico, J. A., Thomas, A., Hollingshead, D. J., & Kim, N. B. (1997b). Administration of long -term 
estradiol and progesterone followed by progesterone withdrawal does not alter the plasma oxytocin 
secretory response to cholecystokinin or the pituitary oxytocin content in ovariectomized rats. 
Endocrine Research, 23(1 -2), 69 -80. 
Angulo, J. A., Ledoux, M., & McEwen, B. S. (1991). Genomic effects of cold and isolation stress on 
magnocellular vasopressin mRNA- containing cells in the hypothalamus of the rat. Journal Of 
Neurochemistry, 56(6), 2033 -8. 
Antoni, F. A. (1984). Novel ligand specificity of pituitary vasopressin receptors in the rat. 
Neuroendocrinology, 39(2), 186 -8. 
Antoni, F. A. (1986a). Hypothalamic control of adrenocorticotropin secretion: advances since 
the 
discovery of 41- residue corticotropin- releasing factor. Endocrine Reviews, 7(4), 351 -78. 
Antoni, F. A. (1986b). Oxytocin receptors in rat adenohypophysis: evidence from 
radioligand binding 
studies. Endocrinology, 119(5), 2393 -5. 
Antoni, F. A., Fink, G., & Sheward, W. J. (1990). Corticotrophin- releasing 
peptides in rat hypophysial 
portal blood after paraventricular lesions: a marked reduction in the concentration 
of corticotrophin - 
releasing factor -41, but no change in vasopressin. Journal Of Endocrinology, 
125(2), 175 -83. 
References 195 
Antoni, F. A., Holmes, M. C., & Jones, M. T. (1983). Oxytocin as well as vasopressin potentiate ovine 
CRF in vitro. Peptides, 4(4), 411 -5. 
Argiolas, A., & Gessa, G. L. (1991). Central functions of oxytocin. Neuroscience And Biobehavioral 
Reviews, 15(2), 217 -31. 
Armstrong, W. E. (1995). Morphological and electrophysiological classification of hypothalamic 
supraoptic neurons. Progress In Neurobiology, 47(4 -5), 291 -339. 
Armstrong, W. E., Warach, S., Hatton, G. I., & McNeill, T. H. (1980). Subnuclei in the rat 
hypothalamic paraventricular nucleus: a cytoarchitectural, horseradish peroxidase and 
immunocytochemical analysis. Neuroscience, 5(11), 1931 -58. 
Arnold, A. P., & Breedlove, S. M. (1985). Organizational and activational effects of sex steroids on 
brain and behavior: a reanalysis. Hormones And Behavior, 19(4), 469 -98. 
Aronsson, M., Fuxe, K., Dong, Y., Agnati, L. F., Okret, S., & Gustafsson, J. A. (1988). Localization 
of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proceedings Of The 
National Academy Of Sciences Of The United States Of America, 85(23), 9331 -5. 
Aronson, M. K., Ooi, W. L., Morgenstern, H., Hafner, A., Masur, D., Crystal, H., Frishman, W. H., 
Fisher, D., & Katzman, R. (1990). Women, myocardial infarction, and dementia in the very old [see 
comments]. Neurology, 40(7), 1102 -6. 
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. 
M. (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and 
functional kinship with the glucocorticoid receptor. Science, 237(4812), 268 -75. 
Baertschi, A. J., & Friedli, M. (1985). A novel type of vasopressin receptor on anterior pituitary 
corticotrophs? Endocrinology, 116(2), 499 -502. 
Barberis, C., Mouillac, B., & Durroux, T. (1998). Structural bases of vasopressin /oxytocin receptor 
function. Journal Of Endocrinology, 156(2), 223 -9. 
Barberis, C., & Tribollet, E. (1996). Vasopressin and oxytocin receptors in the central 
nervous system. 
Critical Reviews In Neurobiology, 10(1), 119 -54. 
References 
196 
Bartanusz, V., Aubry, J. M., Steimer, T., Baffi, J., & Kiss, J. Z. (1994). Stressor -specific increase of 
vasopressin mRNA in paraventricular hypophysiotrophic neurons. Neuroscience Letters, 170(1), 35 -8. 
Bathgate, R. A., & Sernia, C. (1994). Characterization and localization of oxytocin receptors in the rat 
testis. Journal Of Endocrinology, 141(2), 343 -52. 
Baulieu, E. E., & Robel, P. (1996). Dehydroepiandrosterone and dehydroepiandrosterone sulfate as 
neuroactive neurosteroids. Journal Of Endocrinology, 150 Sunul, S221 -39. 
Beato, M. (1989). Gene regulation by steroid hormones. Cell, 56(3), 335 -44. 
Beatty, W. W. (1984). Hormonal organization of sex differences in play fighting and spatial behavior. 
Progress In Brain Research, 61, 315 -30. 
Bennett, P. A., Lindell, K., Wilson, C., Carlsson, L. M., Carlsson, B., & Robinson, I. C. (1999). 
Cyclical variations in the abundance of leptin receptors, but not in circulating leptin, correlate with 
NPY expression during the oestrous cycle. Neuroendocrinology, 69(6), 417 -23. 
Berghorn, K. A., Knapp, L. T., Hoffman, G. E., & Sherman, T. G. (1995). Induction of glucocorticoid 
receptor expression in hypothalamic magnocellular vasopressin neurons during chronic 
hypoosmolality. Endocrinology, 136(2), 804 -7. 
Berlinger, W. G., & Potter, J. F. (1991). Low Body Mass Index in demented outpatients. Journal Of 
The American Geriatrics Society, 39(10), 973 -8. 
Beroukas, D., Willoughby, J. O., & Blessing, W. W. (1989). Neuropeptide Y -like immunoreactivity is 
present in boutons synapsing on vasopressin- containing neurons in rabbit supraoptic nucleus. 
Neuroendocrinology, 50(2), 222 -8. 
Bettini, E., & Maggi, A. (1991). A rapid method for the quantitation of estrogen receptors in small 
amounts of tissue. Journal Of Immunological Methods, 144(1), 87 -91. 
Bettini, E., Pollio, G., Santagati, S., & Maggi, A. (1992). Estrogen receptor in rat brain: presence in 
the hippocampal formation. Neuroendocrinology, 56(4), 502 -8. 
Biegon, A., & McEwen, B. S. (1982). Modulation by estradiol of serotonin receptors in brain. Journal 
Of Neuroscience, 2(2), 199 -205. 
References 
197 
Blache, D., Batailler, M., & Fabre -Nys, C. (1994). Oestrogen receptors in the preoptico -hypothalamic 
continuum: immunohistochemical study of the distribution and cell density during induced oestrous 
cycle in ovariectomized ewe. Journal Of Neuroendocrinology, 6(3), 329 -39. 
Blackburn, R. E., Demko, A. D., Hoffman, G. E., Stricker, E. M., & Verbalis, J. G. (1992). Central 
oxytocin inhibition of angiotensin- induced salt appetite in rats. American Journal Of Physiology, 
263(6 Pt 2), R1347 -53. 
Blaustein, J. D., & Brown, T. J. (1984). Progesterone decreases the concentration of hypothalamic and 
anterior pituitary estrogen receptors in ovariectomized rats. Brain Research, 304(2), 225 -36. 
Bodian, D., & Maren, T. H. (1951). The effect of neuro- and adenohypophysectomy on retrograde 
degeneration in hypothalamic nuclei of the rat. Journal of Comparative Neurology, 94, 485 -511. 
Bohler, H. C. J., Zoeller, R. T., King, J. C., Rubin, B. S., Weber, R., & Merriam,G.R. (1990). 
Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular 
paraventricular nuclei of the female rat. Brain Research. Molecular Brain Research, 8(3), 259 -62. 
Bolander, F. F. (1994a). Chapter 2: Classical endocrinology, Molecular Endocrinology (2nd ed., pp. 
33). London: Academic Press, Inc. 
Bolander, F. F. (1994b). Chapter 4: Kinetics, Molecular Endocrinology (2nd ed., pp. 105). London: 
Academic Press, Inc. 
Brandenberger, A. W., Tee, M. K., & Jaffe, R. B. (1998). Estrogen receptor alpha (ER- alpha) and beta 
(ER -beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: 
down- regulation of ER -beta in neoplastic tissues. Journal Of Clinical Endocrinology And Metabolism, 
83(3), 1025 -8. 
Breton, C., Pechoux, C., Morel, G., & Zingg, H. H. (1995). Oxytocin receptor messenger ribonucleic 
acid: characterization, regulation, and cellular localization in the rat pituitary gland. Endocrinology, 
136(7), 2928 -36. 
Bridges, R. S. (1984). A quantitative analysis of the roles of dosage, sequence, and duration of 
estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology, 
114(3), 930 -40. 
References 198 
Brimble, M. J., Dyball, R. E., & Forsling, M. L. (1978). Oxytocin release following osmotic activation 
of oxytocin neurones in the paraventricular and supraoptic nuclei. Journal Of Physiology, 278, 69 -78. 
Brooks, P. J. (1992). The regulation of oxytocin mRNA levels in the medial preoptic area. 
Relationship to maternal behavior in the rat. Annals Of The New York Academy Of Sciences, 652, 
271 -85. 
Brown, R.E. (1994). Chapter 3: The pituitary gland and its hormones, An Introduction to 
Neuroendocrinology (pp. 33). Cambridge: Cambridge University Press. 
Brown, T. H., & Zador, A. M. (1990). Chapter 11: Hippocampus. In G. M. Shephard (Ed.), The 
synaptic organisation of the brain (3rd ed., pp. 346 -388). New York: Oxford University Press. 
Burbach, J. P., De Hoop, M. J., Schmale, H., Richter, D., De Kloet, E. R., Ten Haaf, J. A., & De 
Wied, D. (1984). Differential responses to osmotic stress of vasopressin -neurophysin mRNA in 
hypothalamic nuclei. Neuroendocrinology, 39(6), 582 -4. 
Burbach, J. P., van Schaick, H., Lopes da Silva, S., Asbreuk, C. H., & Smidt, M. P. (1998). 
Hypothalamic transcription factors and the regulation of the hypothalamo -neurohypophysial system. 
Advances In Experimental Medicine And Biology, 449, 29 -37. 
Burbach, J. P. H., Adan, R. A. H., van Tol, H. H. M., Verbeeck, M. A. E., Axelson, J. F., van 
Leeuwen, F. W., Beekman, J. M., & Ab, G. (1990). Regulation of the rat oxytocin gene by estradiol; 
Examination of promoter activity in transfected cells and of messenger ribonucleic acid and peptide 
levels in the hypothalamo -neurohypophyseal system. Journal of Neuroendocrinology, 2(5), 633 -639. 
Burgess, L. H., & Handa, R. J. (1993). Estrogen -induced alterations in the regulation of 
mineralocorticoid and glucocorticoid receptor messenger RNA expression in the female rat anterior 
pituitary gland and brain. Molecular and Cellular Neuroscience, 4, 191 -198. 
Burnatowska- Hledin, M. A., & Spielman, W. S. (1989). Vasopressin VI receptors on the principal 
cells of the rabbit cortical collecting tubule. Stimulation of cytosolic free calcium and inositol 
phosphate production via coupling to a pertussis toxin substrate. Journal Of Clinical Investigation, 
83(1), 84 -9. 
Butler, J. A., Sjoberg, M., & Coen, C. W. (1999). Evidence for oestrogen 
receptor alpha - 
immunoreactivity in gonadotrophin- releasing hormone- expressing neurones [see 
comments]. Journal 
Of Neuroendocrinology, 11(5), 331 -5. 
References 199 
Byers, M., Kuiper, G. G., Gustafsson, J. A., & Park- Sarge, O. K. (1997). Estrogen receptor -beta 
mRNA expression in rat ovary: down -regulation by gonadotropins. Molecular Endocrinology, 11(2), 
172 -82. 
Byrum, C. E., Ahearn, E. P., & Krishnan, K. R. (1999). A neuroanatomic model for depression. 
Progress In Neuro- Psychopharmacology And Biological Psychiatry, 23(2), 175 -93. 
Caldwell, J. D., Brooks, P. J., Jirikowski, G. F., Barakat, A. S., Lund, P. K., & Pedersen, C. A. (1989). 
Estrogen alters oxytocin mRNA levels in the preoptic area. Journal of neuroendocrino logy, 1(4), 273- 
278. 
Callahan, M. F., Kirby, R. F., Cunningham, J. T., Eskridge- Sloop, S. L., Johnson, A. K., McCarty, R., 
& Gruber, K. A. (1989). Central oxytocin systems may mediate a cardiovascular response to acute 
stress in rats. American Journal Of Physiology, 256(5 Pt 2), H1369 -77. 
Callahan, M. F., Thore, C. R., Sundberg, D. K., Gruber, K. A., O'Steen, K., & Morris, M. (1992). 
Excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA 
levels. Brain Research, 597(1), 8 -15. 
Caplan, P. J., MacPherson, G. M., & Tobin, P. (1985). Do sex -related differences in spatial abilities 
exist? A multilevel critique with new data. American Psychologist, 40(7), 786 -99. 
Carey, M. P., Deterd, C. H., de Koning, J., Helmerhorst, F., & de Kloet, E. R. (1995). The influence of 
ovarian steroids on hypothalamic -pituitary- adrenal regulation in the female rat. Journal Of 
Endocrinology, 144(2), 311 -21. 
Carter, D. A., & Lightman, S. L. (1986). Diurnal pattern of stress- evoked neurohypophyseal hormone 
secretion: sexual dimorphism in rats. Neurosci Lett, 71(2), 252 -5. 
Carter, D. A., Pardy, K., & Murphy, D. (1993). Regulation of vasopressin gene expression: 
changes in 
the level, but not the size, of vasopressin mRNA following endocrine manipulations. 
Cellular And 
Molecular Neurobiology, 13(1), 87 -95. 
Casada, J. H., & Dafny, N. (1991). Restraint and stimulation of bed nucleus 
of the stria terminales 
produce similar stress -like behaviors. Brain Research Bulletin, 27(2), 
207 -12. 
References 200 
Chadio, S. E., & Antoni, F. A. (1993). Specific oxytocin agonist stimulates prolactin release but has 
no effect on inositol phosphate accumulation in isolated rat anterior pituitary cells. Journal Of 
Molecular Endocrinology, 10(2), 107 -14. 
Chang, F. L., & Greenough, W. T. (1984). Transient and enduring morphological correlates of 
synaptic activity and efficacy change in the rat hippocampal slice. Brain Research, 309(1), 35 -46. 
Chowdrey, H. S., & Lightman, S. L. (1993). Role of central amino acids and peptide -mediated 
pathways in neurohypophysial hormone release. Annals Of The New York Academy Of Sciences, 
689,183 -93. 
Chung, S. K., McCabe, J. T., & Pfaff, D. W. (1991). Estrogen influences on oxytocin mRNA 
expression in preoptic and anterior hypothalamic regions studied by in situ hybridization. Journal Of 
Comparative Neurology, 307(2), 281 -95. 
Ciriello, J., Kline, R. L., Zhang, T. X., & Caverson, M. M. (1984). Lesions of the paraventricular 
nucleus alter the development of spontaneous hypertension in the rat. Brain Research, 310(2), 355 -9. 
Clarke, C. H., Norfleet, A. M., Clarke, M. S. F., Watson, C. S., Cunningham, K. A., & Thomas, M. L. 
(2000). Perimembrane localization of the estrogen receptor alpha protein in neuronal processes of 
cultured hippocampal neurons. Neuroendocrinology, 71, 34 -42. 
Compagnone, N. A., & Mellon, S. H. (2000). Neurosteroids: Biosynthesis and function of these novel 
neuromodulators. Frontiers in Neuroendocrinology, 21, 1 -56. 
Conrad, L. C., & Pfaff, D. W. (1976). Efferents from medial basal forebrain and hypothalamus in the 
rat. II. An autoradiographic study of the anterior hypothalamus. Journal Of Comparative Neurology, 
169(2), 221 -61. 
Coote, J. H., Yang, Z., Pyner, S., & Deering, J. (1998). Control of sympathetic outflows by the 
hypothalamic paraventricular nucleus. Clinical And Experimental Pharmacology And Physiology, 
25(6), 461 -3. 
Corodimas, K. P., & Morrell, J. 1. (1990). Estradiol- concentrating forebrain and midbrain neurons 
project directly to the medulla. Journal Of Comparative Neurology, 291(4), 609 -20. 
References 
201 
Couse, J. F., Curtis, S. W., Washburn, T. F., Lindzey, J., Golding, T. S., Lubahn, D. B., Smithies, O., 
& Korach, K. S. (1995). Analysis of transcription and estrogen insensitivity in the female mouse after 
targeted disruption of the estrogen receptor gene. Molecular Endocrinology, 9(11), 1441 -54. 
Couse, J. F., & Korach, K. S. (1999). Estrogen receptor null mice: what have we learned and where 
will they lead us? Endocrine Reviews, 20(3), 358 -417. 
Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J. A., & Korach, K. S. (1997). Tissue distribution 
and quantitative analysis of estrogen receptor -alpha (ERalpha) and estrogen receptor -beta (ERbeta) 
messenger ribonucleic acid in the wild -type and ERalpha -knockout mouse. Endocrinology, 138(11), 
4613 -21. 
Cowley, S. M., Hoare, S., Mosselman, S., & Parker, M. G. (1997). Estrogen receptors alpha and beta 
form heterodimers on DNA. Journal Of Biological Chemistry, 272(32), 19858 -62. 
Cox, K. H., DeLeon, D. V., Angerer, L. M., & Angerer, R. C. (1984). Detection of mRNAs in sea 
urchin embryos by in situ hybridization using asymmetric RNA probes. Developmental Biology, 
101(2), 485 -502. 
Crofton, J. T., Baer, P. G., Share, L., & Brooks, D. P. (1985). Vasopressin release in male and female 
rats: effects of gonadectomy and treatment with gonadal steroid hormones. Endocrinology, 117(3), 
1195 -200. 
Crofton, J. T., & Share, L. (1989). Osmotic control of vasopressin in male and female rats. American 
Journal Of Physiology, 257(4 Pt 2), R738 -43. 
Crofton, J. T., Share, L., & Brooks, D. P. (1988). Pressor responsiveness to and secretion of 
vasopressin during the estrous cycle. American Journal Of Physiology, 255(6 Pt 2), R1041 -8. 
Crowley, R. S., & Amico, J. A. (1993). Gonadal steroid modulation of oxytocin and vasopressin gene 
expression in the hypothalamus of the osmotically stimulated rat. Endocrinology, 133(6), 2711-8. 
Crowley, R. S., Insel, T. R., O'Keefe, J. A., & Amico, J. A. (1993). Cytoplasmic oxytocin and 
vasopressin gene transcripts decline postpartum in the hypothalamus of the lactating rat. 
Endocrinology, 133(6), 2704 -10. 
References 202 
Crowley, R. S., Insel, T. R., O'Keefe, J. A., Kim, N. B., & Amico, J. A. (1995). Increased 
accumulation of oxytocin messenger ribonucleic acid in the hypothalamus of the female rat: induction 
by long term estradiol and progesterone administration and subsequent progesterone withdrawal. 
Endocrinology, 136(1), 224 -31. 
Cuhna, G. R., Cooke, P. S., Bigsby, R., & Brody, J. R. (1991). Ontogeny of sex steroid receptors in 
mammals. In M. G. Parker (Ed.), Nuclear Hormone Receptors: Molecular Mechanisms, Cellular 
Functions, Clinical Abnormalities (pp. 235 -268). London: Academic Press. 
Cullinan, W. E., Herman, J. P., Battaglia, D. F., Akil, H., & Watson, S. J. (1995). Pattern and time 
course of immediate early gene expression in rat brain following acute stress. Neuroscience, 64(2), 
477 -505. 
Cullinan, W. E., Herman, J. P., & Watson, S. J. (1993). Ventral subicular interaction with the 
hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. 
Journal Of Comparative Neurology, 332(1), 1 -20. 
Cunningham, E. T. J., Bohn, M. C., & Sawchenko, P. E. (1990). Organization of adrenergic inputs to 
the paraventricular and supraoptic nuclei of the hypothalamus in the rat. Journal Of Comparative 
Neurology, 292(4), 651 -67. 
Cunningham, E. T. J., & Sawchenko, P. E. (1988). Anatomical specificity of noradrenergic inputs to 
the paraventricular and supraoptic nuclei of the rat hypothalamus. Journal Of Comparative Neurology, 
274(1), 60 -76. 
Dai, W. J., & Yao, T. (1995). Effects of dehydration and salt -loading on hypothalamic vasopressin 
mRNA level in male and female rats. Brain Research, 676(1), 178 -82. 
Dallman, M. F., Akana, S. F., Cascio, C. S., Darlington, D. N., Jacobson, L., & Levin, N. (1987). 
Regulation of ACTH secretion: variations on a theme of B. Recent Progress In Hormone Research, 
43,113 -73. 
Darlington, D. N., Barraclough, C. A., & Gann, D. S. (1992). Hypotensive hemorrhage 
elevates 
corticotropin- releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin 
mRNA in 
the rat hypothalamus. Endocrinology, 130(3), 1281 -8. 
References 203 
Davis, K. L., Davis, B. M., Greenwald, B. S., Mohs, R. C., Mathé, A. A., Johns, C. A., & Horvath, T. 
B. (1986a). Cortisol and Alzheimer's disease, I: Basal studies. American Journal Of Psychiatry, 
143(3), 300 -5. 
Davis, L. G., Arentzen, R., Reid, J. M., Manning, R. W., Wolfson, B., Lawrence, K. L., & Baldino, F. 
J. (1986b). Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of 
the rat. Proceedings Of The National Academy Of Sciences Of The United States Of America, 83(4), 
1145 -9. 
Davis, V. L., Couse, J. F., Goulding, E. H., Power, S. G., Eddy, E. M., & Korach, K. S. (1994). 
Aberrant reproductive phenotypes evident in transgenic mice expressing the wild -type mouse estrogen 
receptor. Endocrinology, 135(1), 379 -86. 
Day, T. A., Ferguson, A. V., & Renaud, L. P. (1984). Facilitatory influence of noradrenergic afferents 
on the excitability of rat paraventricular nucleus neurosecretory cells. Journal Of Physiology, 355, 
237 -49. 
de Leon, M. J., McRae, T., Tsai, J. R., George, A. E., Marcus, D. L., Freedman, M., Wolf, A. P., & 
McEwen, B. (1988). Abnormal cortisol response in Alzheimer's disease linked to hippocampal 
atrophy [letter]. Lancet, 2(8607), 391 -2. 
de Wied, D., Diamant, M., & Fodor, M. (1993). Central nervous system effects of the 
neurohypophyseal hormones and related peptides. Frontiers In Neuroendocrinology, 14(4), 251 -302. 
Dellovade, T. L., Zhu, Y. S., & Pfaff, D. W. (1999). Thyroid hormones and estrogen affect oxytocin 
gene expression in hypothalamic neurons. Journal Of Neuroendocrinology, 11(1), 1 -10. 
Di Paolo, T. (1994). Modulation of brain dopamine transmission by sex steroids. Reviews In The 
Neurosciences, 5(1), 27 -41. 
Diamond, D. M., Bennett, M. C., Fleshner, M., & Rose, G. M. (1992). Inverted -U relationship 
between the level of peripheral corticosterone and the magnitude of hippocampal primed burst 
potentiation. Hippocampus, 2(4), 421 -30. 
Diamond, D. M., Fleshner, M., & Rose, G. M. (1994). Psychological stress repeatedly 
blocks 
hippocampal primed burst potentiation in behaving rats. Behavioural Brain Research, 
62(1), 1 -9. 
References 204 
Dicker, S. E., & Heller, H. (1946). The renal action of posterior pituitary extract and its fraction as 
analysed by clearance experiments in rats. Journal of Physiology, 101, 236 -251. 
Dinan, T. (1994). Glucocorticoids and the genesis of depressive illness: a psychobiological model. 
British Journal of Psychiatry, 164, 365 -371. 
Diorio, D., Viau, V., & Meaney, M. J. (1993). The role of the medial prefrontal cortex (cingulate 
gyrus) in the regulation of hypothalamic -pituitary- adrenal responses to stress. Journal Of 
Neuroscience, 13(9), 3839 -47. 
Dobrakovová, M., Kvetnbreveanskÿ, R., Torda, T., & Murgas, K. (1982). Changes of plasma and 
adrenal catecholamines and corticosterone in stressed rats with septal lesions. Physiology And 
Behavior, 29(1), 41 -5. 
Dohanics, J., Kovacs, K. J., & Makara, G. B. (1990). Oxytocinergic neurons in rat hypothalamus. 
Dexamethasone -reversible increase in their corticotropin- releasing factor -41 -like immunoreactivity in 
response to osmotic stimulation. Neuroendocrinology, 51(5), 515 -22. 
Dotzlaw, H., Alkhalaf, M., & Murphy, L. C. (1992). Characterization of estrogen receptor variant 
mRNAs from human breast cancers. Molecular Endocrinology, 6(5), 773 -85. 
Douglas, A. J., Antonijevic, I. A., Johnstone, L. E., Leng, G., & Russell, J. A. (1994). Parturition and 
oxytocin neurone activity in anaesthetised rats. Neuroendocrinology, 60(S 1), 64. 
Douglas, A. J., Dye, S., Leng, G., Russell, J. A., & Bicknell, R. J. (1993). Endogenous opioid 
regulation of oxytocin secretion through pregnancy in the rat. Journal Of Neuroendocrinology, 5(3), 
307 -14. 
Douglas, A. J., Johnstone, H., Brunton, P., & Russell, J. A. (2000). Sex -steroid induction of 
endogenous opioid inhibition on oxytocin secretory responses to stress. Journal of 
neuroendocrinology, 12, 343 -350. 
Douglas, A. J., Meeren, H. K., Johnstone, L. E., Pfaff, D. W., Russell, J. A., & Brooks, P. J. (1998). 
Stimulation of expression of the oxytocin gene in rat supraoptic neurons at parturition. Brain 
Research, 782(1 -2), 167 -74. 
References 
205 
Douglas, A. J., Neumann, I., Meeren, H. K., Leng, G., Johnstone, L. E., Munro, G., & Russell, J. A. 
(1995). Central endogenous opioid inhibition of supraoptic oxytocin neurons in pregnant rats. Journal 
Of Neuroscience, 15(7 Pt 1), 5049 -57. 
Du Pasquier, D., Dreifuss, J. J., Dubois -Dauphin, M., & Tribollet, E. (1991). An autoradiographical 
study of binding sites for vasopressin located on corticotrophs in rat and sheep pituitary glands. 
Journal Of Endocrinology, 129(2), 197 -203. 
Du Vigneaud, V. (1956). Hormones of the posterior pituitary gland: Oxytocin and vasopressin. 
Harvey Lectures, 50, 1 -26. 
Eichenbaum, H., Otto, T., & Cohen, N. J. (1992). The hippocampus- -what does it do? Behavioral And 
Neural Biology, 57(1), 2 -36. 
Einon, D. (1980). Spatial memory and response strategies in rats: age, sex and rearing differences in 
performance. Quarterly Journal Of Experimental Psychology, 32(3), 473 -89. 
Elands, J., Resink, A., & De Kloet, E. R. (1990). Neurohypophyseal hormone receptors in the rat 
thymus, spleen, and lymphocytes. Endocrinology, 126(5), 2703 -10. 
Emery, D. E., & Sachs, B. D. (1976). Copulatory behavior in male rats with lesions in the bed nucleus 
of the stria terminalis. Physiology And Behavior, 17(5), 803 -6. 
Enmark, E., Pelto- Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjöld, 
M., & Gustafsson, J. A. (1997). Human estrogen receptor beta -gene structure, chromosomal 
localization, and expression pattern. Journal Of Clinical Endocrinology And Metabolism, 82(12), 
4258 -65. 
Ernst, R. L., & Hay, J. W. (1994). The US economic and social costs of Alzheimer's disease revisited. 
American Journal Of Public Health, 84(8), 1261 -4. 
Estacio, M. A., Yamada, S., Tsukamura, H., Hirunagi, K., & Maeda, K. (1996). Effect of fasting and 
immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female 
rats. Brain Research, 717(1 -2), 55 -61. 
Evans, D. A., Funkenstein, H. H., Albert, M. S., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. 
E., Hennekens, C. H., & Taylor, J. O. (1989). Prevalence of Alzheimer's disease in a community 
population of older persons. Higher than previously reported [see comments]. Jama, 262(18), 2551 -6. 
References 
206 
Evans, D. A. (1996). Descriptive epidemiology of Alzheimer's disease. In Z. S. Khachaturian & T. S. 
Radebaugh (Eds.), Alzheimer's disease . Boca Raton, Florida: CRC Press. 
Feldman, S., & Conforti, N. (1976). Feedback effects of dexamethasone on adrenocortical responses 
in rats with fornix section. Hormone Research, 7(1), 56 -60. 
Feldman, S., Conforti, N., & Melamed, E. (1987). Paraventricular nucleus serotonin mediates neurally 
stimulated adrenocortical secretion. Brain Research Bulletin, 18(2), 165 -8. 
Ferguson, A. V., & Bains, J. S. (1996). Electrophysiology of the circumventricular organs. Frontiers 
In Neuroendocrinology, 17(4), 440 -75. 
Fillit, H., & Luine, V. (1997). The neurobiology of gonadal hormones and cognitive decline in late 
life [editorial]. Maturitas, 26(3), 159 -64. 
Fillit, H., Weinreb, H., Cholst, I., Luine, V., McEwen, B., Amador, R., & Zabriskie, J. (1986). 
Observations in a preliminary open trial of estradiol therapy for senile dementia -Alzheimer's type. 
Psychoneuroendocrinology, 11(3), 337 -45. 
Fink, G., Sumner, B. E., Rosie, R., Grace, O., & Quinn, J. P. (1996). Estrogen control of central 
neurotransmission: effect on mood, mental state, and memory. Cellular And Molecular Neurobiology, 
16(3), 325 -44. 
Fisher, A. W., Price, P. G., Burford, G. D., & Lederis, K. (1979). A 3- dimensional reconstruction of 
the hypothalamo- neurohypophysial system of the rat. The neurons projecting to the 
neuro /intermediate lobe and those containing vasopressin and somatostatin. Cell And Tissue 
Research, 204(3), 343 -54. 
Flouriot, G., Griffin, C., Kenealy, M., Sonntag -Buck, V., & Gannon, F. (1998). Differentially 
expressed messenger RNA isoforms of the human estrogen receptor -alpha gene are generated by 
alternative splicing and promoter usage. Molecular Endocrinology, 12(12), 1939 -54. 
Flouriot, G., Pakdel, F., & Valotaire, Y. (1996). Transcriptional and post -transcriptional regulation of 
rainbow trout estrogen receptor and vitellogenin gene expression. Molecular And Cellular 
Endocrinology, 124(1 -2), 173 -83. 
Frankfurt, M. (1994). Gonadal steroids and neuronal plasticity. Studies in the adult rat hypothalamus. 
Annals Of The New York Academy Of Sciences, 743, 45 -59; discussion 59 -60. 
References 207 
Fuchs, A. R., Behrens, O., Helmer, H., Vangsted, A., Ivanisevic, M., Grifo, J., Barros, C., & Fields, 
M. (1990). Oxytocin and vasopressin binding sites in human and bovine ovaries. American Journal Of 
Obstetrics And Gynecology, 163(6 Pt 1), 1961 -7. 
Fuchs, A. R., & Dawood, M. Y. (1980). Oxytocin release and uterine activation during parturition iin 
rabbits. Endocrinology, 107(4), 1117 -26. 
Fuxe, K., Wikström, A. C., Okret, S., Agnati, L. F., Härfstrand, A., Yu, Z. Y., Granholm, L., Zoli, M., 
Vale, W., & Gustafsson, J. A. (1985). Mapping of glucocorticoid receptor immunoreactive neurons in 
the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. 
Endocrinology, 117(5), 1803 -12. 
Gainer, H., & Wray, S. (1994). Cellular and molecular biology of oxytocin and vasopressin. In E. 
Knobil & J. D. Neill (Eds.), The Physiology of Reproduction (pp. 1099 -1129). New York: Raven 
Press Ltd. 
Gallagher, M., & Schoenbaum, G. (1999). Functions of the amygdala and related forebrain areas in 
attention and cognition. Annals Of The New York Academy Of Sciences, 877, 397 -411. 
Garland, H. O., Atherton, J. C., Baylis, C., Morgan, M. R., & Milne, C. M. (1987). Hormone profiles 
for progesterone, oestradiol, prolactin, plasma renin activity, aldosterone and corticosterone during 
pregnancy and pseudopregnancy in two strains of rat: correlation with renal studies. Journal Of 
Endocrinology, 113(3), 435 -44. 
Gaub, M. P., Bellard, M., Scheuer, I., Chambon, P., & Sassone- Corsi, P. (1990). Activation of the 
ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell, 63(6), 1267 -76. 
Gibbs, D. M. (1984). High concentrations of oxytocin in hypophysial portal plasma. Endocrinology, 
114(4), 1216 -8. 
Gibbs, D. M., Vale, W., Rivier, J., & Yen, S. S. (1984). Oxytocin potentiates the ACTH -releasing 
activity of CRF(41) but not vasopressin. Life Sciences, 34(23), 2245 -9. 
Gibbs, R. B. (1994). Estrogen and nerve growth factor -related systems in 
brain. Effects on basal 
forebrain cholinergic neurons and implications for learning and memory processes 
and aging. Annals 
Of The New York Academy Of Sciences, 743, 165 -96; discussion 197 -9. 
References 
208 
Giguère, V., Tremblay, A., & Tremblay, G. B. (1998). Estrogen receptor beta: re- evaluation of 
estrogen and antiestrogen signaling. Steroids, 63(5 -6), 335 -9. 
Gilbey, M. P., Coote, J. H., Fleetwood- Walker, S., & Peterson, D. F. (1982). The influence of the 
paraventriculo- spinal pathway, and oxytocin and vasopressin on sympathetic preganglionic neurones. 
Brain Research, 251(2), 283 -90. 
Gillies, G., & Lowry, P. (1979). Corticotrophin releasing factor may be modulated vasopressin. 
Nature, 278(5703), 463 -4. 
Goodman, Y., Bruce, A. J., Cheng, B., & Mattson, M. P. (1996). Estrogens attenuate and 
corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta -peptide toxicity in 
hippocampal neurons. Journal Of Neurochemistry, 66(5), 1836 -44. 
Goto, A., Ikeda, T., Tobian, L., Iwai, J., & Johnson, M. A. (1981). Brain lesions in the paraventricular 
nuclei and catecholaminergic neurons minimize salt hypertension in Dahl salt -sensitive rats. Clinical 
Science, 61 Suppl 7, 53s -55s. 
Gould, E., Woolley, C. S., Frankfurt, M., & McEwen, B. S. (1990a). Gonadal steroids regulate 
dendritic spine density in hippocampal pyramidal cells in adulthood. Journal Of Neuroscience, 10(4), 
1286 -91. 
Gould, E., Woolley, C. S., & McEwen, B. S. (1990b). Short-term glucocorticoid manipulations affect 
neuronal morphology and survival in the adult dentate gyrus. Neuroscience, 37(2), 367 -75. 
Gould, E., Woolley, C. S., & McEwen, B. S. (1991a). Adrenal steroids regulate postnatal development 
of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. Journal Of Comparative 
Neurology, 313(3), 479 -85. 
Gould, E., Woolley, C. S., & McEwen, B. S. (1991b). The hippocampal formation: morphological 
changes induced by thyroid, gonadal and adrenal hormones. Psychoneuroendocrinology, 16(1 -3), 67- 
84. 
Gray, T. S., Piechowski, R. A., Yracheta, J. M., Rittenhouse, P. A., Bethea, C. L., & Van de Kar, L. 
D. (1993). Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress - 
induced increases in prolactin, ACTH and corticosterone. Neuroendocrinologv, 57(3), 517 -24. 
References 
209 
Greco, T. L., Duello, T. M., & Gorski, J. (1993). Estrogen receptors, estradiol, and diethylstilbestrol in 
early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity 
in embryonic development of male and female reproductive tracts. Endocrine Reviews, 14(1), 59 -71. 
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., & Chambon, P. (1986). Human 
oestrogen receptor cDNA: sequence, expression and homology to v- erb -A. Nature, 320(6058), 134 -9. 
Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., & Shine, J. (1986). Sequence and 
expression of human estrogen receptor complementary DNA. Science. 231(4742), 1150 -4. 
Greenwald, B. S., Mathé, A. A., Mohs, R. C., Levy, M. I., Johns, C. A., & Davis, K. L. (1986). 
Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective 
symptoms. American Journal Of Psychiatry, 143(4), 442 -6. 
Greer, E. R., Caldwell, J. D., Johnson, M. F., Prange, A. J. J., & Pedersen, C. A. (1986). Variations in 
concentration of oxytocin and vasopressin in the paraventricular nucleus of the hypothalamus during 
the estrous cycle in rats. Life Sciences, 38(25), 2311 -8. 
Gu, Q., & Moss, R. L. (1996). 17 beta -Estradiol potentiates kainate- induced currents via activation of 
the cAMP cascade. Journal Of Neuroscience, 16(11), 3620 -9. 
Gutman, M. B., Ciriello, J., & Mogenson, G. J. (1988). Effects of plasma angiotensin II and 
hypernatremia on subfornical organ neurons. American Journal of Physiology, 254, R746 -54. 
Haas, D. A., & George, S. R. (1988). Gonadal regulation of corticotropin -releasing factor 
immunoreactivity in hypothalamus. Brain Research Bulletin, 20(3), 361 -7. 
Hahn, W. E., Van Ness, J., & Chaudhari, N. (1982). Overview of the molecular genetics of mouse 
brain. In F. O. Schmitt, S. J. Bird, & F. E. Bloom (Eds.), Molecular Genetic Neuroscience (pp. 323- 
334). New York: Raven Press. 
Hamamura, M., Nunez, D. J., Leng, G., Emson, P. C., & Kiyama, H. (1992). c -fos may code for a 
common transcription factor within the hypothalamic neural circuits involved in osmoregulation. 
Brain Research, 572(1 -2), 42 -51. 
Hampson, E. (1990). Estrogen- related variations in human spatial and articulatory -motor skills. 
Psychoneuroendocrinology, 15(2), 97 -111. 
References 210 
Hanstein, B., Liu, H., Yancisin, M. C., & Brown, M. (1999). Functional analysis of a novel estrogen 
receptor -beta isoform. Molecular Endocrinology, 13(1), 129 -37. 
Harbuz, M. S., Jessop, D. S., Lightman, S. L., & Chowdrey, H. S. (1994). The effects of restraint or 
hypertonic saline stress on corticotrophin- releasing factor, arginine vasopressin, and proenkephalin A 
mRNAs in the CFY, Sprague -Dawley and Wistar strains of rat. Brain Research, 667(1), 6 -12. 
Harbuz, M. S., Rees, R. G., Eckland, D., Jessop, D. S., Brewerton, D., & Lightman, S. L. (1992). 
Paradoxical responses of hypothalamic corticotropin- releasing factor (CRF) messenger ribonucleic 
acid (mRNA) and CRF -41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic 
inflammatory stress. Endocrinology, 130(3), 1394 -400. 
Hashimoto, K., Suemaru, S., Takao, T., Sugawara, M., Makino, S., & Ota, Z. (1988). Corticotropin- 
releasing hormone and pituitary- adrenocortical responses in chronically stressed rats. Regulatory 
Peptides, 23(2), 117 -26. 
Hatton, G. I. (1990). Emerging concepts of structure -function dynamics in adult brain: the 
hypothalamo -neurohypophysial system. Progress In Neurobiology, 34(6), 437 -504. 
Hatton, G. I. (1997). Function- related plasticity in hypothalamus. Annual Review Of Neuroscience, 
20, 375 -97. 
Hatton, G. I., & Li, Z. H. (1998). Neurophysiology of magnocellular neuroendocrine cells: recent 
advances. Progress In Brain Research, 119, 77 -99. 
Hauger, R. L., Milian, M. A., Lorang, M., Harwood, J. P., & Aguilera, G. (1988). Corticotropin- 
releasing factor receptors and pituitary adrenal responses during immobilization stress. 
Endocrinology, 123(1), 396 -405. 
Hawthorn, J., Ang, V. T., & Jenkins, J. S. (1985). Effects of lesions in the hypothalamic 
paraventricular, supraoptic and suprachiasmatic nuclei on vasopressin and oxytocin in rat brain and 
spinal cord. Brain Research, 346(1), 51 -7. 
Healy, D. L., Chrousos, G. P., Schulte, H. M., Gold, P. W., & Hodgen, G. D. (1985). 
Increased 
adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after 
the 
antiglucocorticoid steroid RU 486: dose response relationships. Journal Of Clinical 
Endocrinology 
And Metabolism, 60(1), 1 -4. 
References 211 
Henderson, V. W. (1997a). The epidemiology of estrogen replacement therapy and Alzheimer's 
disease. Neurology, 48(5 Suppl 7), S27 -35. 
Henderson, V. W. (1997b). Estrogen, cognition, and a woman's risk of Alzheimer's disease. The 
American Journal of Medicine: The role of estrogen in the treatment and prevention of dementia, 
103(3A), 11 S. 
Herbison, A. E. (1998). Multimodal influence of estrogen upon gonadotropin -releasing hormone 
neurons. Endocrine Reviews, 19(3), 302 -30. 
Herbison, A. E., & Theodosis, D. T. (1992). Localization of oestrogen receptors in preoptic neurons 
containing neurotensin but not tyrosine hydroxylase, cholecystokinin or luteinizing hormone -releasing 
hormone in the male and female rat. Neuroscience, 50(2), 283 -98. 
Herman, J. P. (1993). Regulation of adrenocorticosteroid receptor mRNA expression in the central 
nervous system. Cellular And Molecular Neurobiology, 13(4), 349 -72. 
Herman, J. P. (1995). In situ hybridization analysis of vasopressin gene transcription in the 
paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. Journal Of 
Comparative Neurology, 363(1), 15 -27. 
Herman, J. P., Prewitt, C. M., & Cullinan, W. E. (1996). Neuronal circuit regulation of the 
hypothalamo- pituitary- adrenocortical stress axis. Critical Reviews In Neurobiology, 10(3 -4), 371 -94. 
Herman, J. P., Schäfer, K. H., Sladek, C. D., Day, R., Young, E. A., Akil, H., & Watson, S. J. (1989a). 
Chronic electroconvulsive shock treatment elicits up- regulation of CRF and AVP mRNA in select 
populations of neuroendocrine neurons. Brain Research, 501(2), 235 -46. 
Herman, J. P., Schäfer, M. K., Young, E. A., Thompson, R., Douglass, J., Akil, H., & Watson, S. J. 
(1989b). Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo- 
pituitary-adrenocortical axis. Journal Of Neuroscience, 9(9), 3072 -82. 
Heuser, I. J., Litvan, I., & Juncos, J. L. (1988). Cortisol baseline secretion and memory performance 
in patients with dementia of the Alzheimer type. In A. Agnoli, J. Cahn, N. Lassen, & R. 
Mayeux 
(Eds.), Senile Dementias: Il International Symposium (pp. 351 -353). Paris: John Libbey Eurotext. 
Higuchi, T., Honda, K., Fukuoka, T., Negoro, H., & Wakabayashi, 
K. (1985). Release of oxytocin 
during suckling and parturition in the rat. Journal Of Endocrinology, 
105(3), 339 -46. 
References 
212 
Higuchi, T., Uchide, K., Honda, K., & Negoro, H. (1986). Oxytocin release during parturition in the 
pelvic -neurectomized rat. Journal Of Endocrinology, 109(2), 149 -54. 
Hilf, R., & Wittliff, J. L. (1975). Mechanisms of action of oestrogens. In A. C. Sartorelli & D. G. 
Johns (Eds.), Handbook of Experimental Pharmacology (pp. 104 -138). New York: Springer Verlag. 
Hiroshige, T., & Wada- Okada, S. (1973). Diurnal changes of hypothalamic content of corticotropin- 
releasing activity in female rats at various stages of the estrous cycle. Neuroendocrinology, 12(4), 
316 -9. 
Hochstenbach, S. L., & Ciriello, J. (1995). Plasma hypernatremia induces c -fos activity in medullary 
catecholaminergic neurons. Brain Research, 674(1), 46 -54. 
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., 
Rosenfeld, M. G., & Evans, R. M. (1985). Primary structure and expression of a functional human 
glucocorticoid receptor cDNA. Nature, 318(6047), 635 -41. 
Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., & Tung, L. (1996). 
Nuclear receptor coactivators and corepressors. Molecular Endocrinology, 10(10), 1167 -77. 
Horwitz, M. J., Bloch, K. D., Kim, N. B., & Amico, J. A. (1994). Expression of the endothelin - I and 
oxytocin genes in the hypothalamus of the pregnant rat. Brain Research, 648(1), 59 -64. 
Hrabovszky, E., Kalló, I., Hajszán, T., Shughrue, P. J., Merchenthaler, 1., & Liposits, Z. (1998). 
Expression of estrogen receptor -beta messenger ribonucleic acid in oxytocin and vasopressin neurons 
of the rat supraoptic and paraventricular nuclei. Endocrinology, 139(5), 2600 -4. 
Hsu, M., & Buzsáki, G. (1993). Vulnerability of mossy fiber targets in the rat hippocampus to 
forebrain ischemia. Journal Of Neuroscience, 13(9), 3964 -79. 
Imaki, T., Nahan, J. L., Rivier, C., Sawchenko, P. E., & Vale, W. (1991). Differential regulation of 
corticotropin- releasing factor mRNA in rat brain regions by glucocorticoids and stress. Journal Of 
Neuroscience, 11(3), 585 -99. 
Imaki, T., Vale, W., & Sawchenko, P. E. (1992). Regulation of corticotropin -releasing factor mRNA 
in neuroendocrine and autonomic neurons by osmotic stimulation and volume loading. 
Neuroendocrinology, 56(5), 633 -40. 
References 
213 
Insel, T. R. (1992). Oxytocin --a neuropeptide for affiliation: evidence from behavioral, receptor 
autoradiographic, and comparative studies. Psychoneuroendocrinology, 17(1), 3 -35. 
Israel, J., & Poulain, D. (1999). 17beta- estradiol modulates electrical properties and kainate -induced 
responses of oxytocin neurones in lactating rats. Journal of Physiology (submission). 
Iványi, T., Dohanics, J., & Verbalis, J. G. (1995). Effect of chronic hyponatremia on central and 
peripheral oxytocin and vasopressin secretion in rats. Neuroendocrinology, 61(4), 412 -20. 
Iványi, T., Wiegant, V. M., & de Wied, D. (1991). Differential effects of emotional and physical stress 
on the central and peripheral secretion of neurohypophysial hormones in male rats. Life Sciences, 
48(13), 1309 -16. 
Ivell, R., & Richter, D. (1984). Structure and comparison of the oxytocin and vasopressin genes from 
rat. Proceedings Of The National Academy Of Sciences Of The United States Of America, 81(7), 
2006 -10. 
Iwai, C., Ochiai, H., & Nakai, Y. (1989). Electron- microscopic immunocytochemistry of neuropeptide 
Y immunoreactive innervation of vasopressin neurons in the paraventricular nucleus of the rat 
hypothalamus. Acta Anatomica, 136(4), 279 -84. 
Jacobs, D. M., Tang,- M. X., Stern, Y., Sano, M., Marder, K., Bell, K. L., Schofield, P., Dooneief, G., 
Gurland, B., & Mayeux, R. (1998). Cognitive function in nondemented older women who took 
estrogen after menopause. Neurology, 50(2), 368 -73. 
Jacobson, L., & Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the 
hypothalamic- pituitary- adrenal axis. Endocrine Reviews, 12, 118-134. 
Jaffe, A. B., Toran- Allerand, C. D., Greengard, P., & Gandy, S. E. (1994). Estrogen regulates 
metabolism of Alzheimer amyloid beta precursor protein. Journal Of Biological Chemistry, 269(18), 
13065 -8. 
Jankowski, M., Hajjar, F., Kawas, S. A., Mukaddam- Daher, S., Hoffman, G., McCann, S. M., & 
Gutkowska, J. (1998). Rat heart: a site of oxytocin production and action. Proceedings Of The 
National Academy Of Sciences Of The United States Of America, 95(24), 14558 -63. 
References 
214 
Jard, S., Elands, J., Schmidt, A., & Barberis, C. (1988). Vasopressin and oxytocin receptors: an 
overview. In H. Imura & K. Shizume (Eds.), Progress in endocrinology (pp. 1183). Amsterdam: 
Elsevier. 
Jenkins, J. S., & Nussey, S. S. (1991). The role of oxytocin: present concepts. Clinical Endocrinology, 
34(6), 515 -25. 
Jessop, D. S., Eckland, D. J., Todd, K., & Lightman, S. L. (1989). Osmotic regulation of 
hypothalamo -neurointermediate lobe corticotrophin- releasing factor -41 in the rat. Journal Of 
Endocrinology, 120(1), 119 -24. 
Jezová, D., Michajlovskij, N., Kvet &nbreve;ansky, R., & Makara, G. B. (1993). Paraventricular and 
supraoptic nuclei of the hypothalamus are not equally important for oxytocin release during stress. 
Neuroendocrinology, 57(5), 776 -81. 
Joëls, M., & de Kloet, E. R. (1992). Control of neuronal excitability by corticosteroid hormones. 
Trends In Neurosciences, 15(1), 25 -30. 
John, H. A., Birnstiel, M. L., & Jones, K. W. (1969). RNA -DNA hybrids at the cytological level. 
Nature. 223(206), 582 -7. 
Jones, C. W., & Pickering, B. T. (1969). Comparison of the effects of water deprivation and sodium 
chloride imbibition on the hormone content of the neurohypophysis of the rat. Journal Of Physiology, 
203(2), 449 -58. 
Kalra, S. P., & Kalra, P. S. (1983). Neural regulation of luteinizing hormone secretion in the rat. 
Endocrine Reviews, 4(4), 311 -51. 
Kannan, H., & Koizumi, K. (1981). Pathways between the nucleus tractus solitarius and 
neurosecretory neurons of the supraoptic nucleus: electrophysiological studies. Brain Research, 
213(1), 17 -28. 
Kato, J., Hirata, S., Koh, T., Yamada -Mouri, N., Hoshi, K., & Okinaga, S. (1998). The multiple 
untranslated first exons and promoters system of the oestrogen receptor gene in the brain and 
peripheral tissues of the rat and monkey and the developing rat cerebral cortex. Journal Of Steroid 
Biochemistry And Molecular Biology, 65(1 -6), 281 -93. 
References 
215 
Kato, J., & Onouchi, T. (1984). Ovarian steroid hormone receptors in developing rat brain and 
progesterone modulation of estrogen receptors in the hypothalamus. In B. B. Saxena, K. J. Catt, L. 
Birnbaumer, & L. Martini (Eds.), Hormone Receptors in Growth and Reproduction (Vol. 9, pp. 279- 
289). New York: Raven Press. 
Keightley, M. C. (1998). Steroid receptor isoforms: exception or rule? Molecular And Cellular 
Endocrinology, 137(1), 1 -5. 
Keller -Wood, M. E., & Dallman, M. F. (1984). Corticosteroid inhibition of ACTH secretion. 
Endocrine Reviews, 5(1), 1 -24. 
Kendall, E. C. (1941). The function of the adrenal cortex. Journal of the American Medical 
Association, 116, 2394 -2398. 
Kerr, D. S., Huggett, A. M., & Abraham, W. C. C. (1994). Modulation of hippocampal long -term 
potentiation and long -term depression by corticosteroid receptor activation. Psychobiology, 22, 123- 
133. 
Kiss, A., & Aguilera, G. (1993). Regulation of the hypothalamic pituitary adrenal axis during chronic 
stress: responses to repeated intraperitoneal hypertonic saline injection. Brain Research, 630(1 -2), 
262 -70. 
Kiss, J. Z., Mezey, E., & Skirboll, L. (1984). Corticotropin- releasing factor -immunoreactive neurons 
of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proceedings Of The 
National Academy Of Sciences Of The United States Of America, 81(6), 1854 -8. 
Kiss, J. Z., Van Eekelen, J. A., Reul, J. M., Westphal, H. M., & De Kloet, E. R. (1988). 
Glucocorticoid receptor in magnocellular neurosecretory cells. Endocrinology, 122(2), 444 -9. 
Kiyama, H., & Emson, P. C. (1990). Evidence for the coexpression of oxytocin and vasopressin 
messenger ribonucleic acids in magnocellular neurosecretory cells: simultaneous demonstration of 
two neurophysin messenger ribonucleic acids by hybridisation histochemistry. Journal of 
Neuroendocrinology, 2, 257 -260. 
Kjaer, A., Knigge, U., Rouleau, A., Garbarg, M., & Warberg, J. (1994a). Dehydration- induced release 




Kjaer, A., Larsen, P. J., Knigge, U., Moller, M., & Warberg, J. (1994b). Histamine stimulates c -fos 
expression in hypothalamic vasopressin -, oxytocin -, and corticotropin -releasing hormone- containing 
neurons. Endocrinology, 134(1), 482 -91. 
Klein -Hitpass, L., Ryffel, G. U., Heitlinger, E., & Cato, A. C. (1988). A 13 bp palindrome is a 
functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic 
Acids Research, 16(2), 647 -63. 
Klein -Hitpass, L., Schorpp, M., Wagner, U., & Ryffel, G. U. (1986). An estrogen- responsive element 
derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected 
human cells. Cell, 46(7), 1053 -61. 
Koenig, J. I., Meltzer, H. Y., Devane, G. D., & Gudelsky, G. A. (1986). The concentration of arginine 
vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine. Endocrinology, 
118(6), 2534 -9. 
Koike, S., Sakai, M., & Muramatsu, M. (1987). Molecular cloning and characterization of rat estrogen 
receptor cDNA. Nucleic Acids Research, 15(6), 2499 -513. 
Koritnik, D. R., Koshy, A., & Hoversland, R. C. (1995). 17 beta -estradiol treatment increases the 
levels of estrogen receptor and its mRNA in male rat liver. Steroids, 60(8), 519 -29. 
Kovacs, W. J., Griffin, J. E., Weaver, D. D., Carlson, B. R., & Wilson, J. D. (1984). A mutation that 
causes lability of the androgen receptor under conditions that normally promote transformation to the 
DNA -binding state. Journal Of Clinical Investigation, 73(4), 1095 -104. 
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F., Sar, M., Korach, K. 
S., Gustafsson, J. A., & Smithies, O. (1998). Generation and reproductive phenotypes of mice lacking 
estrogen receptor beta. Proceedings Of The National Academy Of Sciences Of The United States Of 
America, 95(26), 15677 -82. 
Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J. A. 
(1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen 
receptors alpha and beta. Endocrinology, 138(3), 863 -70. 
Kuiper, G. G., Enmark, E., Pelto- Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996). Cloning of a 
novel receptor expressed in rat prostate and ovary. Proceedings Of The National Academy Of 
Sciences Of The United States Of America, 93(12), 5925 -30. 
References 217 
Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der 
Burg, B., & Gustafsson, J. A. (1998a). Interaction of estrogenic chemicals and phytoestrogens with 
estrogen receptor beta. Endocrinology, 139(10), 4252 -63. 
Kuiper, G. G., Shughrue, P. J., Merchenthaler, I., & Gustafsson, J. A. (1998b). The estrogen receptor 
beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Frontiers In 
Neuroendocrinology, 19(4), 253 -86. 
Kumar, V., & Chambon, P. (1988). The estrogen receptor binds tightly to its responsive element as a 
ligand- induced homodimer. Cell, 55(1), 145 -56. 
Labrie, F., Labrie, C., Bélanger, A., Simard, J., Gauthier, S., Luu -The, V., Mérand, Y., Giguere, V., 
Candas, B., Luo, S., Martel, C., Singh, S. M., Fournier, M., Coquet, A., Richard, V., Charbonneau, R., 
Charpenet, G., Tremblay, A., Tremblay, G., Cusan, L., & Veilleux, R. (1999). EM -652 (SCH 57068), 
a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. Journal 
Of Steroid Biochemistry And Molecular Biology, 69(1 -6), 51 -84. 
Laflamme, N., Nappi, R. E., Drolet, G., Labrie, C., & Rivest, S. (1998). Expression and 
neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat 
brain: anatomical evidence of distinct roles of each subtype. Journal Of Neurobiology, 36(3), 357 -78. 
Landfield, P. W., Baskin, R. K., & Pitler, T. A. (1981). Brain aging correlates: retardation by 
hormonal -pharmacological treatments. Science, 214(4520), 581 -4. 
Landfield, P. W., Waymire, J. C., & Lynch, G. (1978). Hippocampal aging and adrenocorticoids: 
quantitative correlations. Science, 202(4372), 1098 -102. 
Lang, R. E., Heil, J., Ganten, D., Hermann, K., Rascher, W., & Unger, T. (1983a). Effects of lesions 
in the paraventricular nucleus of the hypothalamus on vasopressin and oxytocin contents in brainstem 
and spinal cord of rat. Brain Research, 260(2), 326 -9. 
Lang, R. E., Heil, J. W., Ganten, D., Hermann, K., Unger, T., & Rascher, W. (1983b). Oxytocin 
unlike vasopressin is a stress hormone in the rat. Neuroendocrinologv, 37(4), 314 -6. 
Lauber, A. H., Mobbs, C. V., Muramatsu, M., & Pfaff, D. W. (1 991). Estrogen 
receptor messenger 
RNA expression in rat hypothalamus as a function of genetic sex and estrogen 
dose. Endocrinology, 
129(6), 3180 -6. 
References 
218 
Laycock, J. F., & Wise, P. H. (1996). Chapter 8: Female reproductive endocrinology, Essential 
Endocrinology (3rd ed., pp. 163 -202). New York: Oxford University Press. 
Le Dréan, Y., Lazennec, G., Kern, L., Saligaut, D., Pakdel, F., & Valotaire, Y. (1995). 
Characterization of an estrogen- responsive element implicated in regulation of the rainbow trout 
estrogen receptor gene. Journal Of Molecular Endocrinology, 15(1), 37 -47. 
Lee, K. S., Schottler, F., Oliver, M., & Lynch, G. (1980). Brief bursts of high- frequency stimulation 
produce two types of structural change in rat hippocampus. Journal Of Neurophysiology, 44(2), 247- 
58. 
Lee, Y. J., & Gorski, J. (1996). Estrogen -induced transcription of the progesterone receptor gene does 
not parallel estrogen receptor occupancy. Proceedings Of The National Academy Of Sciences Of The 
United States Of America, 93(26), 15180 -4. 
Lehman, M. N., Goodman, R. L., Karsch, F. J., Jackson, G. L., Berriman, S. J., & Jansen, H. T. 
(1997). The GnRH system of seasonal breeders: anatomy and plasticity. Brain Research Bulletin, 
44(4), 445 -57. 
Lehrer, S., Sanchez, M., Song, H. K., Dalton, J., Levine, E., Savoretti, P., Thung, S. N., & Schachter, 
B. (1990). Oestrogen receptor B- region polymorphism and spontaneous abortion in women with 
breast cancer. Lancet, 335(8690), 622 -4. 
Leng, G., Blackburn, R. E., Dyball, R. E. J., & Russell, J. A. (1989). Role of anterior peri -third 
ventricular structures in the regulation of supraoptic neuronal activity and neurohypophysial hormone 
secretion in the rat. Journal of Neuroendocrinology, 1, 35 -46. 
Leng, G., Brown, C. H., & Russell, J. A. (1999). Physiological pathways regulating the activity of 
magnocellular neurosecretory cells. Progress In Neurobiology, 57(6), 625 -55. 
Leng, G., & Brown, D. (1997). The origins and significance of pulsatility in hormone secretion from 
the pituitary. Journal of Neuroendocrinology, 9, 493 -513. 
Leng, G., Mansfield, S., Bicknell, R. J., Blackburn, R. E., Brown, D., Chapman, C., Dyer, R. G., 
Hollingsworth, S., Shibuki, K., Yates, J. O., & et al. (1988). Endogenous opioid actions and effects of 
environmental disturbance on parturition and oxytocin secretion in rats. Journal Of Reproduction And 
Fertility, 84(1), 345 -56. 
References 
219 
Lephart, E. D., & Ojeda, S. R. (1990). Hypothalamic aromatase activity in male and female rats 
during juvenile peripubertal development. Neuroendocrinology, 51(4), 385 -93. 
Léránth, C., Záborszky, L., Marton, J., & Palkovits, M. (1975). Quantitative studies on the supraoptic 
nucleus in the rat. I. Synaptic organization. Experimental Brain Research, 22(5), 509 -23. 
Levin, M. C., & Sawchenko, P. E. (1993). Neuropeptide co- expression in the magnocellular 
neurosecretory system of the female rat: evidence for differential modulation by estrogen. 
Neuroscience, 54(4), 1001 -18. 
Lewis, C., McEwen, B. S., & Frankfurt, M. (1995). Estrogen -induction of dendritic spines in 
ventromedial hypothalamus and hippocampus: effects of neonatal aromatase blockade and adult GDX. 
Brain Research. Developmental Brain Research, 87(1), 91 -5. 
Li, X., Schwartz, P. E., & Rissman, E. F. (1997). Distribution of estrogen receptor- beta -like 
immunoreactivity in rat forebrain. Neuroendocrinology, 66(2), 63 -7. 
Lieberburg, I., & McEwen, B. S. (1977). Brain cell nuclear retention of testosterone metabolites, 
5alpha- dihydrotestosterone and estradiol- 17beta, in adult rats. Endocrinology, 100(2), 588 -97. 
Lightman, S. L., & Young, W. S. d. (1987). Vasopressin, oxytocin, dynorphin, enkephalin and 
corticotrophin- releasing factor mRNA stimulation in the rat. Journal Of Physiology, 394, 23 -39. 
Lightman, S. L., & Young, W. S. d. (1988). Corticotrophin -releasing factor, vasopressin and pro - 
opiomelanocortin mRNA responses to stress and opiates in the rat. Journal Of Physiology, 403, 5 I I - 
23. 
Lin, S. H., Miyata, S., Itoh, T., Kawarabayashi, T., Nakashima, T., & Kiyohara, T. (1995). Fos 
expression in the hypothalamic magnocellular neurons of rats during pregnancy, parturition and 
lactation. Neuroscience Research, 23(1), 29 -34. 
Lindheim, S. R., Legro, R. S., Bernstein, L., Stanczyk, F. Z., Vijod, M. A., Presser, S. C., & Lobo, R. 
A. (1992). Behavioral stress responses in premenopausal and postmenopausal women and the effects 
of estrogen. American Journal Of Obstetrics And Gynecology, 167(6), 1831 -6. 
Lisciotto, C. A., & Morrell, J. I. (1993). Circulating gonadal steroid hormones regulate estrogen 
receptor mRNA in the male rat forebrain. Brain Research. Molecular Brain Research, 20(1 -2), 79 -90. 
References 220 
Lovick, T. A., Malpas, S., & Mahony, M. T. (1993). Renal vasodilatation in response to acute volume 
load is attenuated following lesions of parvocellular neurones in the paraventricular nucleus in rats. 
Journal Of The Autonomic Nervous System, 43(3), 247 -55. 
Lowenstein, D. H., Thomas, M. J., Smith, D. H., & McIntosh, T. K. (1992). Selective vulnerability of 
dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head 
trauma and disorders of the hippocampus. Journal Of Neuroscience, 12(12), 4846 -53. 
Lu, B., Leygue, E., Dotzlaw, H., Murphy, L. J., Murphy, L. C., & Watson, P. H. (1998). Estrogen 
receptor -beta mRNA variants in human and murine tissues. Molecular And Cellular Endocrinology, 
138(1 -2), 199 -203. 
Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993). 
Alteration of reproductive function but not prenatal sexual development after insertional disruption of 
the mouse estrogen receptor gene. Proceedings Of The National Academy Of Sciences Of The United 
States Of America, 90(23), 11162 -6. 
Luckman, S. M., & Larsen, P. J. (1997). Evidence for the involvement of histaminergic neurones in 
the regulation of the rat oxytocinergic system during pregnancy and parturition. Journal Of 
Physiology, 501 (Pt 3), 649 -55. 
Luine, V., & Rodriguez, M. (1994). Effects of estradiol on radial arm maze performance of young and 
aged rats. Behavioral And Neural Biology, 62(3), 230 -6. 
Luine, V. N. (1997). Steroid hormone modulation of hippocampal dependent spatial memory. Stress 
2, 21 -36. 
Luine, V. N., Richards, S. T., Wu, V. Y., & Beck, K. D. (1998). Estradiol enhances learning and 
memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Hormones 
And Behavior, 34(2), 149 -62. 
Lupien, S. J., Nair, N. P. V., Briere, S., Maheu, F., Tu, M. T., Lemay, M., McEwen, B. 
S., & Meaney, 
M. J. (1999). Increased cortisol levels and impaired cognition in human 
aging: Implication for 
depression and dementia in later life. Reviews in the Neurosciences, 10(2), 
117 -139. 
MacLusky, N. .1., & Naftolin, F. (1981). Sexual differentiation of 




Madeira, M. D., & Lieberman, A. R. (1995). Sexual dimorphism in the mammalian limbic system. 
Progress In Neurobiology, 45(4), 275 -333. 
Maggi, A., Susanna, L., Bettini, E., Mantero, G., & Zucchi, I. (1989). Hippocampus: a target for 
estrogen action in mammalian brain. Molecular Endocrinology, 3(7), 1165 -70. 
Majewska, M. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. 
Mechanism of action and physiological significance. Progress In Neurobiology, 38(4), 379 -95. 
Majzoub, J. A., Rich, A., van Boom, J., & Habener, J. F. (1983). Vasopressin and oxytocin mRNA 
regulation in the rat assessed by hybridization with synthetic oligonucleotides. Journal Of Biological 
Chemistry, 258(23), 14061 -4. 
Makino, S., Smith, M. A., & Gold, P. W. (1995). Increased expression of corticotropin -releasing 
hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular 
nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. 
Endocrinology, 136(8), 3299 -309. 
Malenka, R. C. (1994). Synaptic plasticity in the hippocampus: LTP and LTD. Ccll, 78(4), 535 -8. 
Mamalaki, E., Kvetnansky, R., Brady, L. S., Gold, P. W., & Herkenham, M. (1992). Repeated 
immobilization stress alters tyrosine hydroxylase, corticotropin- releasing hormone and corticosteroid 
receptor messenger ribonucleic acid levels in rat brain. Journal of Neuroendocrinology, 4(6), 689 -699. 
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., 
Kastner, P., Mark, M., Chambon, P., & et al. (1995). The nuclear receptor superfamily: the second 
decade. Cell, 83(6), 835 -9. 
Martin, M. B., Garcia- Morales, P., Stoica, A., Solomon, H. B., Pierce, M., Katz, D., Zhang, S., 
Danielsen, M., & Saceda, M. (1995). Effects of 12- O- tetradecanoylphorbol -13- acetate on estrogen 
receptor activity in MCF -7 cells. Journal Of Biological Chemistry, 270(42), 25244 -51. 
Maruyama, K., Endoh, H., Sasaki -Iwaoka, H., Kanou, H., Shimaya, E., Hashimoto, S., Kato, S., 
& 
Kawashima, H. (1998). A novel isoform of rat estrogen receptor beta with 18 amino acid 
insertion in 
the ligand binding domain as a putative dominant negative regular of estrogen 
action. Biochemical 
And Biophysical Research Communications, 246(1), 142 -7. 
References 222 
Mason, H. L. (1950). Isolation of adrenal cortical hormones from urine: 17- hydroxycorticosterone and 
17- hydroxy -1 l- dehydrocorticosterone. Journal of Biological Chemistry, 182, 131 -149. 
Mason, W. T. (1980). Supraoptic neurones of rat hypothalamus are osmosensitive. Nature. 287(5778), 
154 -7. 
Maxwell, B. L., McDonnell, D. P., Conneely, O. M., Schulz, T. Z., Greene, G. L., & O'Malley, B. W. 
(1987). Structural organization and regulation of the chicken estrogen receptor. Molecular 
Endocrinology, 1(1), 25 -35. 
McCormick, J. A., Lyon, V., Jacobson, M. D., Noble, J., Diorio, J., Nyirenda, M., Weaver, S., Ester, 
W., Yao, J. L. W., Meaney, M. J., Seckl, J. R., & Chapman, K. E. (2000). 5'- heterogeneity of 
glucocorticoid receptor messenger RNA is tissue specific: differential regulation of variant transcript 
by early -life events. Molecular Endocrinology, 14(4), 506 -517. 
McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review Of Neuroscience, 22, 105- 
22. 
McEwen, B. S., & Alves, S. E. (1999). Estrogen actions in the central nervous system. Endocrine 
Reviews, 20(3), 279 -307. 
McEwen, B. S., Angulo, J., Cameron, H., Chao, H. M., Daniels, D., Gannon, M. N., Gould, E., 
Mendelson, S., Sakai, R., Spencer, R., & al, e. (1992). Paradoxical effects of adrenal steroids on the 
brain: protection versus degeneration. Biological Psychiatry, 31(2), 177 -99. 
McEwen, B. S., Brinton, R. E., & Sapolsky, R. M. (1988). Glucocorticoid receptors and behavior: 
implications for the stress response. Adv Exp Med Biol, 245, 35 -45. 
McEwen, B. S., De Kloet, E. R., & Rostene, W. (1986). Adrenal steroid receptors and actions in the 
nervous system. Physiological Reviews, 66(4), 1121 -88. 
McEwen, B. S., Tanapat, P., & Weiland, N. G. (1999). Inhibition of dendritic spine induction 
on 
hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist 
in female rats. 
Endocrinology, 140(3), 1044 -7. 
McGinnis, M. Y., Williams, G. W., & Lumia, A. R. (1996). 
Inhibition of male sex behavior by 
androgen receptor blockade in preoptic area or hypothalamus, 
but not amygdala or septum. 
Physiology And Behavior, 60(3), 783 -9. 
References 
223 
McKinley, M. J., Burns, P., Colvill, L. M., Oldfield, B. J., Wade, J. D., Weisinger, R. S., & Tregear, 
G. W. (1997). Distribution of Fos immunoreactivity in the lamina terminalis and hypothalamus 
induced by centrally administered relaxin in conscious rats. Journal Of Neuroendocrinology, 9(6), 
431 -7. 
McKinley, M. J., Hards, D. K., & Oldfield, B. J. (1994). Identification of neural pathways activated in 
dehydrated rats by means of Fos -immunohistochemistry and neural tracing. Brain Research, 653(1 -2), 
305 -14. 
McKinley, M. J., Pennington, G. L., & Oldfield, B. J. (1996). Anteroventral wall of the third ventricle 
and dorsal lamina terminalis: headquarters for control of body fluid homeostasis? Clinical And 
Experimental Pharmacology And Physiology, 23(4), 271 -81. 
Meister, B., Villar, M. J., Ceccatelli, S., & Hökfelt, T. (1990). Localization of chemical messengers in 
magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an 
immunohistochemical study using experimental manipulations. Neuroscience, 37(3), 603 -33. 
Meldrum, D. R., Davidson, B. J., Tataryn, I. V., & Judd, H. L. (1981). Changes in circulating steroids 
with aging in postmenopausal women. Obstetrics And Gynecology, 57(5), 624 -8. 
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984). 
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids 
containing a bacteriophage SP6 promoter. Nucleic Acids Research, 12(18), 7035 -56. 
Merkelbach, U., Czernichow, P., Gaillard, R. C., & Vallotton, M. B. (1975). Radioimmunoassay of 
(8- arginine) -vasopressin. II. Application to determination of antidiuretic hormone in urine. Acta 
Endocrinologica, 80(3), 453 -64. 
Meyer, J. S., Micco, D. J., Stephenson, B. S., Krey, L. C., & McEwen, B. S. (1979). Subcutaneous 
implantation method for chronic glucocorticoid replacement therapy. Physiology And Behavior, 
22(5), 867 -70. 
Miesfeld, R., Okret, S., Wikström, A. C., Wrange, O., Gustafsson, J. A., & Yamamoto, K. R. (1984). 
Characterization of a steroid hormone receptor gene and mRNA in wild -type and mutant cells. Nature, 
312(5996), 779 -81. 
References 
224 
Miller, F. D., Ozimek, G., Milner, R. J., & Bloom, F. E. (1989). Regulation of neuronal oxytocin 
mRNA by ovarian steroids in the mature and developing hypothalamus. Proceedings Of The National 
Academy Of Sciences Of The United States Of America, 86(7), 2468 -72. 
Miller, W. L. (1988). Molecular biology of steroid hormone synthesis. Endocrine Reviews, 9(3), 295- 
318. 
Miselis, R. R., Shapiro, R. E., & Hand, P. J. (1979). Subfornical organ efferents to neural systems for 
control of body water. Science, 205(4410), 1022 -5. 
Moats, R. K. n., & Ramirez, V. D. (1998). Rapid uptake and binding of estradiol-17beta-6-(O- 
carboxymethyl)oxime: 1251- labeled BSA by female rat liver. Biology Of Reproduction, 58(2), 531 -8. 
Mohr, E., & Schmitz, E. (1991). Functional characterization of estrogen and glucocorticoid responsive 
elements in the rat oxytocin gene. Brain Research. Molecular Brain Research, 9(4), 293 -8. 
Moltz, H., Lubin, M., Leon, M., & Numan, M. (1970). Hormonal induction of maternal behavior in 
the ovariectomized nulliparous rat. Physiology And Behavior, 5(12), 1373 -7. 
Monje, P., & Boland, R. (1999). Characterization of membrane estrogen binding proteins from rabbit 
uterus. Molecular And Cellular Endocrinology, 147(1 -2), 75 -84. 
Moore, J. T., McKee, D. D., Slentz- Kesler, K., Moore, L. B., Jones, S. A., Home, E. L., Su, J. L., 
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1998). Cloning and characterization of human 
estrogen receptor beta isoforms. Biochemical And Biophysical Research Communications, 247(1), 
75 -8. 
Morris, M., Callahan, M. F., Li, P., & Lucion, A. B. (1995). Central oxytocin mediates stress- induced 
tachycardia. Journal Of Neuroendocrinology, 7(6), 455 -9. 
Morris, R. G., Garrud, P., Rawlins, J. N., & O'Keefe, J. (1982). Place navigation impaired in rats with 
hippocampal lesions. Nature, 297(5868), 681 -3. 
Morse, J. K., Scheff, S. W., & DeKosky, S. T. (1986). Gonadal steroids influence axon sprouting in 




Moss, R. L., & Gu, Q. (1999). Estrogen: mechanisms for a rapid action in CA1 hippocampal neurons. 
Steroids, 64(1 -2), 14 -21. 
Moss, R. L., Gu, Q., & Wong, M. (1997). Estrogen: nontranscriptional signaling pathway. Recent 
Progress In Hormone Research, 52, 33 -68; discussion 68 -9. 
Mosselman, S., Polman, J., & Dijkema, R. (1996). ER beta: identification and characterization of a 
novel human estrogen receptor. Febs Letters, 392(1), 49 -53. 
Murphy, L. C., & Dotzlaw, H. (1989). Variant estrogen receptor mRNA species detected in human 
breast cancer biopsy samples. Molecular Endocrinology, 3(4), 687 -93. 
Naftolin, F., Ryan, K. J., Davies, I. J., Reddy, V. V., Flores, F., Petro, Z., Kuhn, M., White, R. J., 
Takaoka, Y., & Wolin, L. (1975). The formation of estrogens by central neuroendocrine tissues. 
Recent Progress In Hormone Research, 31, 295 -319. 
Nelson, D. H., Samuels, L. T., Willardson, D. G., & Tyler, F. H. (1951). The levels of 17- 
hydroxycorticosteroids in peripheral blood of human subjects. Journal of Clinical Endocrinology, 11, 
1021 -1029. 
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996). Oxytocin is 
required for nursing but is not essential for parturition or reproductive behavior. Proceedings Of The 
National Academy Of Sciences Of The United States Of America, 93(21), 11699 -704. 
Nishioka, T., Anselmo- Franci, J. A., Li, P., Callahan, M. F., & Morris, M. (1998). Stress increases 
oxytocin release within the hypothalamic paraventricular nucleus. Brain Research, 781(1 -2), 56 -60. 
Normington, K., & Russell, D. W. (1992). Tissue distribution and kinetic characteristics of rat steroid 
5 alpha- reductase isozymes. Evidence for distinct physiological functions. Journal Of Biological 
Chemistry, 267(27), 19548 -54. 
Oelkers, W. (1989). Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) 
in patients with hypopituitarism [see comments]. New England Journal Of Medicine, 321(8), 492 -6. 
Ogawa, S., Eng, V., Taylor, J., Lubahn, D. B., Korach, K. S., & Pfaff, D. W. (1998a). Roles of 
estrogen receptor -alpha gene expression in reproduction- related behaviors in female mice. 
Endocrinology, 139(12), 5070 -81. 
References 226 
Ogawa, S., Inoue, S., Watanabe, T., Orimo, A., Hosoi, T., Ouchi, Y., & Muramatsu, M. (1998b). 
Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor 
ofestrogen action in human. Nucleic Acids Research, 26(15), 3505 -12. 
Ogawa, S., Lubahn, D. B., Korach, K. S., & Pfaff, D. W. (1997). Behavioral effects of estrogen 
receptor gene disruption in male mice. Proceedings Of The National Academy Of Sciences Of The 
United States Of America, 94(4), 1476 -81. 
Ogawa, S., Washburn, T. F., Taylor, J., Lubahn, D. B., Korach, K. S., & Pfaff, D. W. (1998c). 
Modifications of testosterone -dependent behaviors by estrogen receptor -alpha gene disruption in male 
mice. Endocrinology, 139(12), 5058 -69. 
O'Keefe, J. A., Crowley, R. S., Hrivnak, P., Kim, N. B., & Amico, J. A. (1995). Effect of testosterone 
and its metabolites upon the level of vasopressin messenger ribonucleic acid in the hypothalamus of 
the hyperosmotically stimulated male rat. Neuroendocrinologyy61(4), 405 -11. 
O'Keefe, J., & Nadel, L. (1978). The hippocampus as a cognitive map. London: Oxford University 
Press. 
Oldfield, B. J., Badoer, E., Hards, D. K., & McKinley, M. J. (1994). Fos production in retrogradely 
labelled neurons of the lamina terminalis following intravenous infusion of either hypertonie saline or 
angiotensin II. Neuroscience, 60(1), 255 -62. 
Oliet, S. H., & Bourque, C. W. (1993). Mechanosensitive channels transduce osmosensitivity in 
supraoptic neurons. Nature, 364(6435), 341 -3. 
Olson, R. E., Thayer, S. A., & Kopp, L. J. (1944). The glycogenic activity of certain crystalline 
steroids of the adrenal cortex when administered singly and with cortical extract to fasted, normal, and 
adrenalectomized rats. Endocrinology, 35, 464 -472. 
Olton, D. S., & Papas, B. C. (1979). Spatial memory and hippocampal function. Neuropsychologia, 
17(6), 669 -82. 
Olton, D. S., Walker, J. A., & Gage, F. H. (1978). Hippocampal 
connections and spatial 
discrimination. Brain Research, 139(2), 295 -308. 
Onaka, T., & Yagi, K. (1993). Effects of novelty stress on vasopressin 
and oxytocin secretion by the 
pituitary in the rat. Journal Of Neuroendocrinology, 5(4), 365 -9. 
References 
227 
Osterlund, M., Kuiper, G. G., Gustafsson, J. A., & Hurd, Y. L. (1998). Differential distribution and 
regulation of estrogen receptor -alpha and -beta mRNA within the female rat brain. Brain Research. 
Molecular Brain Research, 54(1), 175 -80. 
Ostrowski, N. L., Young, W. S. d., Knepper, M. A., & Lolait, S. J. (1993). Expression of vasopressin 
Vla and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, 
and adult rats. Endocrinology, 133(4), 1849 -59. 
Pace, P., Taylor, J., Suntharalingam, S., Coombes, R. C., & Ali, S. (1997). Human estrogen receptor 
beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. Journal Of 
Biological Chemistry, 272(41), 25832 -8. 
Packard, M. G. (1998). Posttraining estrogen and memory modulation. Hormones And Behavior, 
34(2), 126 -39. 
Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., & Scanlan, T. S. 
(1997). Differential ligand activation of estrogen receptors ERalpha and ERbeta at API sites [see 
comments]. Science, 277(5331), 1508 -10. 
Paganini -Hill, A., & Henderson, V. W. (1994). Estrogen deficiency and risk of Alzheimer's disease in 
women. American Journal Of Epidemiology, 140(3), 256 -61. 
Papanek, P. E., & Raff, H. (1994a). Physiological increases in cortisol inhibit basal vasopressin 
release in conscious dogs. American Journal Of Physiology, 266(6 Pt 2), R1744-51. 
Papanek, P. E., & Raff, H. (1994b). Chronic physiological increases in cortisol inhibit the vasopressin 
response to hypertonicity in conscious dogs. American Journal Of Physiology, 267(5 Pt 2), R1342 -9. 
Pappas, T. C., Gametchu, B., Yannariello- Brown, J., Collins, T. J., & Watson, C. S. (1994). 
Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen- induced release of 
prolactin. Endocrine, 2, 813 -822. 
Parker, M. G. (1995). Structure and function of estrogen receptors. Vitamins And Hormones, 51, 
267- 
87. 
Pasqualini, J. R., & Sumida, C. (1986). Ontogeny of steroid receptors in the 
reproductive system. 
International Review Of Cytology, 101, 275 -324. 
References 
228 
Pasquier, F., Bail, L., Lebert, F., Pruvo, J. P., & Petit, H. (1994). Determination of medial temporal 
lobe atrophy in early Alzheimer's disease with computed tomography [letter; comment]. Lancet, 
343(8901), 861 -2. 
Patchev, V. K., & Almeida, O. F. (1996). Gonadal steroids exert facilitating and buffering effects on 
glucocorticoid- mediated transcriptional regulation of corticotropin -releasing hormone and 
corticosteroid receptor genes in rat brain. Journal Of Neuroscience, 16(21), 7077 -84. 
Patel, P. D., Sherman, T. G., Goldman, D. J., & Watson, S. J. (1989). Molecular cloning of a 
mineralocorticoid (type I) receptor complementary DNA from rat hippocampus. Molecular 
Endocrinology, 3(11), 1877 -85. 
Patisaul, H. B., Whitten, P. L., & Young, L. J. (1999). Regulation of estrogen receptor beta mRNA in 
the brain: opposite effects of 17beta- estradiol and the phytoestrogen, coumestrol. Brain Research. 
Molecular Brain Research, 67(1), 165 -71. 
Paxinos, G., & Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates. (2nd ed.). London: 
Academic Press. 
Paxinos, G., & Watson, C. (1996). The Rat Brain in Stereotaxic Coordinates. (3rd ed.). London: 
Academic Press. 
Pedersen, C. A., & Prange, A. J. J. (1979). Induction of maternal behavior in virgin rats after 
intracerebroventricular administration of oxytocin. Proceedings Of The National Academy Of 
Sciences Of The United States Of America, 76(12), 6661 -5. 
Petersen, D. N., Tkalcevic, G. T., Koza -Taylor, P. H., Turi, T. G., & Brown, T. A. (1998). 
Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in 
normal rat tissues. Endocrinology, 139(3), 1082 -92. 
Pettersson, K., Grandien, K., Kuiper, G. G., & Gustafsson, J. A. (1997). Mouse estrogen receptor beta 
forms estrogen response element -binding heterodimers with estrogen receptor alpha. Molecular 
Endocrinology, 11(10), 1486 -96. 
Peysner, K., & Forsling, M. L. (1990). Effect of ovariectomy and treatment with ovarian steroids on 




Pfaff, D., & Keiner, M. (1973). Atlas of estradiol- concentrating cells in the central nervous system of 
the female rat. Journal Of Comparative Neurology, 151(2), 121 -58. 
Pfaus, J. G., & Heeb, M. M. (1997). Implications of immediate -early gene induction in the brain 
following sexual stimulation of female and male rodents. Brain Research Bulletin, 44(4), 397 -407. 
Phillips, M. I. (1987). Functions of angiotensin in the central nervous system. Annual Review Of 
Physiology, 49, 413 -35. 
Phillips, S. M., & Sherwin, B. B. (1992a). Effects of estrogen on memory function in surgically 
menopausal women. Psychoneuroendocrinology, 17(5), 485 -95. 
Phillips, S. M., & Sherwin, B. B. (1992b). Variations in memory function and sex steroid hormones 
across the menstrual cycle. Psychoneuroendocrinology, 17(5), 497 -506. 
Phoenix, C. H., Goy, R. W., Gerrall, A. A., & Yound, W. C. (1959). Organizing action of prenatally 
administered testosterone proprionate on the tissues mediating mating behavior in the female guinea 
pig. Endocrinology, 65, 369 -382. 
Pi, X. J., & Grattan, D. R. (1998). Distribution of prolactin receptor immunoreactivity in the brain of 
estrogen- treated, ovariectomized rats. Journal Of Comparative Neurology, 394(4), 462 -74. 
Pietras, R. J., & Szego, C. M. (1979a). Estrogen receptors in uterine plasma membrane. Journal Of 
Steroid Biochemistry, 11(4), 1471 -83. 
Pietras, R. J., & Szego, C. M. (1979b). Metabolic and proliferative responses to estrogen by 
hepatocytes selected for plasma membrane binding -sites specific for estradiol-17beta. Journal Of 
Cellular Physiology, 98(1), 145 -59. 
Pietras, R. J., & Szego, C. M. (1980). Partial purification and characterization of oestrogen receptors 
in subfractions of hepatocyte plasma membranes. Biochemical Journal, 191(3), 743 -60. 
Plotsky, P. M. (1987). Regulation of hypophysiotropic factors mediating ACTH secretion. Annals Of 
The New York Academy Of Sciences, 512, 205 -17. 
Plotsky, P. M., Cunningham, E. T. J., & Widmaier, E. P. (1989). Catecholaminergic 
modulation of 
corticotropin -releasing factor and adrenocorticotropin secretion. Endocrine Reviews, 
10(4), 437 -58. 
References 230 
Poletti, A., Coscarella, A., Negri -Cesi, P., Colciago, A., Celotti, F., & Martini, L. (1998). 5 alpha - 
reductase isozymes in the central nervous system. Steroids, 63(5 -6), 246 -51. 
Postma, A., Izendoorn, R., & De Haan, E. H. (1998). Sex differences in object location memory. 
Brain And Cognition, 36(3), 334 -45. 
Postma, A., Winkel, J., Tuiten, A., & van Honk, J. (1999). Sex differences and menstrual cycle effects 
in human spatial memory. Psychoneuroendocrinology, 24(2), 175 -92. 
Raff, H. (1987). Glucocorticoid inhibition of neurohypophysial vasopressin secretion. American 
Journal Of Physiology, 252(4 Pt 2), R635 -44. 
Raff, H., Shinsako, J., Keil, L. C., & Dallman, M. F. (1984). Feedback inhibition of 
adrenocorticotropin and vasopressin responses to hypoxia by physiological increases in endogenous 
plasma corticosteroids in dogs. Endocrinology, 114(4), 1245 -9. 
Raff, H., Skelton, M. M., & Cowley, A. W. J. (1990). Cortisol inhibition of vasopressin and ACTH 
responses to arterial hypotension in conscious dogs. American Journal Of Physiology, 258(1 Pt 2), 
R64 -9. 
Ramirez, V. D., Zheng, J., & Siddique, K. M. (1996). Membrane receptors for estrogen, progesterone, 
and testosterone in the rat brain: fantasy or reality. Cellular And Molecular Neurobiology, 16(2), 175- 
98. 
Raps, D., Barthe, P. L., & Desaulles, P. A. (1971). Plasma and adrenal corticosterone levels during the 
different phases of the sexual cycle in normal female rats. Experientia, 27(3), 339 -40. 
Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999). Cell membrane and nuclear estrogen 
receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in 
Chinese hamster ovary cells. Molecular Endocrinology, 13(2), 307 -19. 
Read, L. D., Greene, G. L., & Katzenellenbogen, B. S. (1989). Regulation of estrogen 
receptor 
messenger ribonucleic acid and protein levels in human breast cancer cell 
lines by sex steroid 
hormones, their antagonists, and growth factors. Molecular Endocrinology, 3(2), 
295 -304. 
Register, T. C., Shively, C. A., & Lewis, C. E. (1998). Expression 
of estrogen receptor alpha and beta 
transcripts in female monkey hippocampus and hypothalamus. Brain 
Research, 788(1 -2), 320 -2. 
References 231 
Rehbein, M., Hillers, M., Mohr, E., Ivell, R., Morley, S., Schmale, H., & Richter, D. (1986). The 
neurohypophyseal hormones vasopressin and oxytocin. Precursor structure, synthesis and regulation. 
Biological Chemistry Hoppe -Seyler, 367(8), 695 -704. 
Reich, H., Nelson, D. H., & Zaffaroni, A. (1950). Isolation of 17- hydroxycorticosterone from blood 
obtained from adrenal veins of dogs. Journal of Biological Chemistry, 187, 411 -417. 
Resnick, S. M., Metter, E. J., & Zonderman, A. B. (1997). Estrogen replacement therapy and 
longitudinal decline in visual memory. A possible protective effect? Neurology, 49(6), 1491 -7. 
Reul, J. M., & de Kloet, E. R. (1985). Two receptor systems for corticosterone in rat brain: 
microdistribution and differential occupation. Endocrinology, 117(6), 2505 -11. 
Reul, J. M., van den Bosch, F. R., & de Kloet, E. R. (1987). Relative occupation of type -1 and type -Il 
corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional 
implications. Journal Of Endocrinology, 115(3), 459 -67. 
Rhodes, C. H., Morrell, J. I., & Pfaff, D. W. (1982). Estrogen -concentrating neurophysin -containing 
hypothalamic magnocellular neurons in the vasopressin -deficient (Brattleboro) rat: a study combining 
steroid autoradiography and immunocytochemistry. Journal Of Neuroscience, 2(12), 1718 -24. 
Richard, P., Moos, F., & Freund -Mercier, M. J. (1991). Central effects of oxytocin. Physiological 
Reviews, 71(2), 331 -70. 
Richard, S., & Zingg, H. H. (1990). The human oxytocin gene promoter is regulated by estrogens. 
Journal Of Biological Chemistry, 265(11), 6098 -103. 
Rissman, E. F., Wersinger, S. R., Fugger, H. N., & Foster, T. C. (1999). Sex with knockout models: 
behavioral studies of estrogen receptor alpha. Brain Research, 835(1), 80 -90. 
Rissman, E. F., Wersinger, S. R., Taylor, J. A., & Lubahn, D. B. (1997). Estrogen receptor function as 
revealed by knockout studies: neuroendocrine and behavioral aspects. Hormones And Behavior, 
31(3), 232 -43. 
Rivier, C., & Vale, W. (1985a). Effects of corticotropin- releasing factor, neurohypophyseal 
peptides, 
and catecholamines on pituitary function. Federation Proceedings, 44(1 
Pt 2), 189 -95. 
l.l l.l l.11l.liJ 
232 
Rivier, C., & Vale, W. (1985b). Neuroendocrine interactions between corticotrophin releasing factor 
and vasopressin on adrenocorticotrophic secretion in the rat. In R. W. Schrier (Ed.), Vasopressin . 
New York: Raven Press. 
Robel, P., & Baulieu, E. E. (1994). Neurosteroids: Biosynthesis and function. Trends in 
Endocrinology and Metabolism, 5, 1 -8. 
Robertson, G. L. (1995). Chapter 9: Posterior Pituitary. In P. Felig, J. D. Baxter, & L. A. Frohman 
(Eds.), Endocrinology and Metabolism (3rd ed., pp. 385 -432): McGraw -Hill, Inc. 
Robinson, A. G., Roberts, M. M., Evron, W. A., Verbalis, J. G., & Sherman, T. G. (1990). 
Hyponatremia in rats induces downregulation of vasopressin synthesis. Journal Of Clinical 
Investigation, 86(4), 1023 -9. 
Roof, R. L., & Havens, M. D. (1992). Testosterone improves maze performance and induces 
development of a male hippocampus in females. Brain Research, 572(1 -2), 310 -3. 
Rosas- Arellano, M. P., Solano- Flores, L. P., & Ciriello, J. (1999). Co- localization of estrogen and 
angiotensin receptors within subfornical organ neurons. Brain Research, 837, 254 -262. 
Roselli, C. E., Horton, L. E., & Resko, J. A. (1987). Time -course and steroid specificity of aromatase 
induction in rat hypothalamus -preoptic area. Biology Of Reproduction, 37(3), 628 -33. 
Roselli, C. E., & Klosterman, S. A. (1998). Sexual differentiation of aromatase activity in the rat 
brain: effects of perinatal steroid exposure. Endocrinology, 139(7), 3193 -201. 
Rosenfeld, C. S., Yuan, X., Manikkam, M., Calder, M. D., Garverick, H. A., & Lubahn, D. B. (1999). 
Cloning, sequencing, and localization of bovine estrogen receptor -beta within the ovarian follicle. 
Biology Of Reproduction, 60(3), 691 -7. 
Ross, R. K., Paganini -Hill, A., Mack, T. M., & Henderson, B. E. (1989). Cardiovascular benefits of 
estrogen replacement therapy. American Journal Of Obstetrics And Gynecology, 160(5 Pt 2), 1301 -6. 
Roy, B. N., Reid, R. L., & Van Vugt, D. A. (1999). The effects of estrogen and progesterone on 
corticotropin- releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the 
paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinology, 140(5), 2191 -8. 
1\G1G1G11GG3 
233 
Rusin, K. I., Giovannucci, D. R., Stuenkel, E. L., & Moises, H. C. (1997). Kappa- opioid receptor 
activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals. Journal 
Of Neuroscience, 17(17), 6565 -74. 
Russell, D. W., & Wilson, J. D. (1994). Steroid 5 alpha -reductase: two genes /two enzymes. Annual 
Review Of Biochemistry, 63, 25 -61. 
Russell, J. A., & Leng, G. (1998). Sex, parturition and motherhood without oxytocin? Journal Of 
Endocrinology, 157(3), 343 -59. 
Sanghera, M. K., Simpson, E. R., McPhaul, M. J., Kozlowski, G., Conley, A. J., & Lephart, E. D. 
(1991). Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using 
peptide -generated polyclonal antibodies. Endocrinology, 129(6), 2834 -44. 
Saper, C. B., & Levisohn, D. (1983). Afferent connections of the median preoptic nucleus in the rat: 
anatomical evidence for a cardiovascular integrative mechanism in the anteroventral third ventricular 
(AV3V) region. Brain Research, 288(1 -2), 21 -31. 
Saper, C. B., Loewy, A. D., Swanson, L. W., & Cowan, W. M. (1976). Direct hypothalamo- 
autonomic connections. Brain Research, 117(2), 305 -12. 
Saphier, D., & Feldman, S. (1989). Paraventricular nucleus neuronal responses following electrical 
stimulation of the midbrain dorsal raphe: evidence for cotransmission. Experimental Brain Research, 
78(2), 407 -14. 
Sapolsky, R. M. (1985). A mechanism for glucocorticoid toxicity in the hippocampus: increased 
neuronal vulnerability to metabolic insults. Journal Of Neuroscience, 5(5), 1228 -32. 
Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1984). Glucocorticoid- sensitive hippocampal 
neurons are involved in terminating the adrenocortical stress response. Proceedings Of The National 
Academy Of Sciences Of The United States Of America, 81(19), 6174 -7. 
Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1985). Prolonged glucocorticoid exposure reduces 
hippocampal neuron number: implications for aging. Journal Of Neuroscience, 5(5), 1222 -7. 
Sar, M., & Stumpf, W. E. (1980). Simultaneous localization of [3H]estradiol and neurophysin I or 
arginine vasopressin in hypothalamic neurons demonstrated by a combined technique of dry-mount 
autoradiography and immunohistochemistry. Neuroscience Letters, 17(1 -2), 179 -84. 
11G1G1 G11liGJ 
234 
Sawchenko, P. E. (1987a). Adrenalectomy- induced enhancement of CRF and vasopressin 
immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity. 
Journal Of Neuroscience, 7(4), 1093 -106. 
Sawchenko, P. E. (1987b). Evidence for differential regulation of corticotropin -releasing factor and 
vasopressin immunoreactivities in parvocellular neurosecretory and autonomic -related projections of 
the paraventricular nucleus. Brain Research, 437(2), 253 -63. 
Sawchenko, P. E., Arias, C., & Bittencourt, J. C. (1990). Inhibin beta, somatostatin, and enkephalin 
immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of 
the hypothalamus. Journal Of Comparative Neurology, 291(2), 269 -80. 
Sawchenko, P. E., Plotsky, P. M., Pfeiffer, S. W., Cunningham, E. T. J., Vaughan, J., Rivier, J., & 
Vale, W. (1988). Inhibin beta in central neural pathways involved in the control of oxytocin secretion. 
Nature, 334(6183), 615 -7. 
Sawchenko, P. E., & Swanson, L. W. (1982). Immunohistochemical identification of neurons in the 
paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. 
Journal Of Comparative Neurology, 205(3), 260 -72. 
Sawchenko, P. E., & Swanson, L. W. (1983). The organization of to the 
paraventricular and supraoptic nuclei of the rat. Journal Of Comparative Neurology, 218(2), 121 -44. 
Sawchenko, P. E., & Swanson, L. W. (1985). Localization, colocalization, and plasticity of 
corticotropin -releasing factor immunoreactivity in rat brain. Federation Proceedings, 44(1 Pt 2), 221- 
7. 
Sawchenko, P. E., Swanson, L. W., Steinbusch, H. W., & Verhofstad, A. A. (1983). The distribution 
and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain 
Research, 277(2), 355 -60. 
Sawchenko, P. E., Swanson, L. W., & Vale, W. W. (1984). Co- expression of corticotropin -releasing 
factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the 
adrenalectomized rat. Proceedings Of The National Academy Of Sciences Of The United States Of 
America, 81(6), 1883 -7. 
ttelerellceS 
235 
Scaccianoce, S., Muscolo, L. A., Cigliana, G., Navarra, D., Nicolai, R., & Angelucci, L. (1991). 
Evidence for a specific role of vasopressin in sustaining pituitary- adrenocortical stress response in the 
rat. Endocrinology, 128(6), 3138 -43. 
Scharrer, E., & Scharrer, B. (1954). Hormones produced by neurosecretory cells. Recent Progress in 
Hormone Research, 10, 183 -240. 
Schlosser, S. F., Almeida, O. F., Patchev, V. K., Yassouridis, A., & Elands, J. (1994). Oxytocin- 
stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin 
receptors of the V lb type. Endocrinology, 135(5), 2058 -63. 
Schmale, H., Heinsohn, S., & Richter, D. (1983). Structural organization of the rat gene for the 
arginine vasopressin -neurophysin precursor. Embo Journal, 2(5), 763 -7. 
Schmidt, A., Jard, S., Dreifuss, J. J., & Tribollet, E. (1990). Oxytocin receptors in rat kidney during 
development. American Journal Of Physiology, 259(6 Pt 2), F872 -81. 
Schmidt, B. M. W., Gerdes, D., Feuring, M., Falkenstein, E., Christ, M., & Welding, M. (2000). 
Rapid, nongenomic steroid actions: A new age? Frontiers in Neuroendocrinology, 21(1), 57 -94. 
Schumacher, M., Coirini, H., Frankfurt, M., & McEwen, B. S. (1989). Localized actions of 
progesterone in hypothalamus involve oxytocin. Proceedings Of The National Academy Of Sciences 
Of The United States Of America, 86(17), 6798 -801. 
Seggie, J., Uhlir, I., & Brown, G. M. (1974). Adrenal stress responses following septal lesions in the 
rat. Neuroendocrinology, 16(3 -4), 225 -36. 
Seif, S. M., Robinson, A. G., Zimmerman, E. A., & Wilkins, J. (1978). Plasma neurophysin and 
vasopressin in the rat: response to adrenalectomy and steroid replacement. Endocrinology, 103(4), 
1009 -15. 
Seiler -Tuyns, A., Walker, P., Martinez, E., Mérillat, A. M., Givel, F., & Wahli, W. (1986). 
Identification of estrogen- responsive DNA sequences by transient expression experiments in a human 
breast cancer cell line. Nucleic Acids Research, 14(22), 8755 -70. 
Selmanoff, M. K., Brodkin, L. D., Weiner, R. I., & Siiteri, P. K. (1977). 
Aromatization and 5alpha- 
reduction of androgens in discrete hypothalamic and limbic regions of the 
male and female rat. 
Endocrinology, 101(3), 841 -8. 
icererences 
236 
Share, L., & Travis, R. H. (1970). Plasma vasopressin concentration in the adrenally insufficient dog. 
Endocrinology, 86(2), 196 -201. 
Sherlock, D. A., Field, P. M., & Raisman, G. (1975). Retrograde transport of horseradish peroxidase 
in the magnocellular neurosecretory system of the rat. Brain Research, 88(3), 403 -14. 
Sherwin, B. B. (1994). Estrogenic effects on memory in women. Annals Of The New York Academy 
Of Sciences, 743, 213 -30; discussion 230 -1. 
Sherwin, B. B. (1997). Estrogen effects on cognition in menopausal women. Neurology, 48(5 Suppl 
7), S21 -6. 
Sherwood, O. D., Crnekovic, V. E., Gordon, W. L., & Rutherford, J. E. (1980). Radioimmunoassay of 
relaxin throughout pregnancy and during parturition in the rat. Endocrinology, 107(3), 691 -8. 
Shivers, B. D., Harlan, R. E., Morrell, J. I., & Pfaff, D. W. (1983). Absence of oestradiol 
concentration in cell nuclei of LHRH -immunoreactive neurones. Nature, 304(5924), 345 -7. 
Shughrue, P. J. (1998). Estrogen action in the estrogen receptor alpha -knockout mouse: is this due to 
ER -beta? Molecular Psychiatry, 3(4), 299 -302. 
Shughrue, P. J., Bushnell, C. D., & Dorsa, D. M. (1992). Estrogen receptor messenger ribonucleic 
acid in female rat brain during the estrous cycle: a comparison with ovariectomized females and intact 
males. Endocrinology, 131(1), 381 -8. 
Shughnie, P. J., Komm, B., & Merchenthaler, I. (1996). The distribution of estrogen receptor -beta 
mRNA in the rat hypothalamus. Steroids. 61(12), 678 -81. 
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997a). Comparative distribution of estrogen 
receptor -alpha and -beta mRNA in the rat central nervous system. Journal Of Comparative Neurology, 
388(4), 507 -25. 
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1999). Biologically active estrogen receptor -beta: 
evidence from in vivo autoradiographic studies with estrogen receptor alpha- knockout mice. 
Endocrinology, 140(6), 2613 -20. 
References 237 
Shughrue, P. J., Lane, M. V., Scrimo, P. J., & Merchenthaler, I. (1998). Comparative distribution of 
estrogen receptor -alpha (ER- alpha) and beta (ER -beta) mRNA in the rat pituitary, gonad, and 
reproductive tract. Steroids, 63(10), 498 -504. 
Shughrue, P. J., Lubahn, D. B., Negro- Vilar, A., Korach, K. S., & Merchenthaler, I. (1997b). 
Responses in the brain of estrogen receptor alpha -disrupted mice. Proceedings Of The National 
Academy Of Sciences Of The United States Of America, 94(20), 11008 -12. 
Shughrue, P. J., & Merchenthaler, I. (2000). Estrogen is more than just a 'Sex Hormone': Novel sites 
for estrogen action in the hippocampus and cerebral cortex. Frontiers in Neuroendocrinology, 21(1), 
95 -101. 
Shughrue, P., Scrimo, P., Lane, M., Askew, R., & Merchenthaler, I. (1997). The distribution of 
estrogen receptor -beta mRNA in forebrain regions of the estrogen receptor -alpha knockout mouse. 
Endocrinology, 138(12), 5649 -52. 
Shughrue, P. J., Scrimo, P. J., & Merchenthaler, I. (1998). Evidence for the colocalization of estrogen 
receptor -beta mRNA and estrogen receptor -alpha immunoreactivity in neurons of the rat forebrain. 
Endocrinology, 139(12), 5267 -70. 
Shupnik, M. A., Gordon, M. S., & Chin, W. W. (1989). Tissue -specific regulation of rat estrogen 
receptor mRNAs. Molecular Endocrinology, 3(4), 660 -5. 
Siegel, H. I., & Rosenblatt, J. S. (1975). Estrogen- induced maternal behavior in hysterectomized- 
overiectomized virgin rats. Physiology And Behavior, 14(04), 465 -71. 
Simerly, R. B. (1990). Hormonal control of neuropeptide gene expression in sexually dimorphic 
olfactory pathways. Trends In Neurosciences, 13(3), 104 -10. 
Simerly, R. B., Chang, C., Muramatsu, M., & Swanson, L. W. (1990). Distribution 
of androgen and 
estrogen receptor mRNA- containing cells in the rat brain: an in situ hybridization 
study. Journal Of 
Comparative Neurology, 294(1), 76 -95. 
Simonian, S. X., & Herbison, A. E. (1997). Differential expression 
of estrogen receptor alpha and beta 
immunoreactivity by oxytocin neurons of rat paraventricular nucleus. 
Journal Of Neuroendocrinology, 
9(11), 803 -6. 
Llelelelllies 238 
Simpkins, J. W., Green, P. S., Gridley, K. E., Singh, M., de Fiebre, N. C., & Rajakumar, G. (1997). 
Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss 
associated with Alzheimer's disease. American Journal Of Medicine, 103(3A), 19S -25S. 
Singh, M., Meyer, E. M., Millard, W. J., & Simpkins, J. W. (1994). Ovarian steroid deprivation results 
in a reversible learning impairment and compromised cholinergic function in female Sprague -Dawley 
rats. Brain Research, 644(2), 305 -12. 
Skipper, J. K., Young, L. J., Bergeron, J. M., Tetzlaff, M. T., Osborn, C. T., & Crews, D. (1993). 
Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in 
the brain. Proceedings Of The National Academy Of Sciences Of The United States Of America, 
90(15), 7172 -5. 
Skowsky, W. R., Swan, L., & Smith, P. (1979). Effects of sex steroid hormones on arginine 
vasopressin in intact and castrated male and female rats. Endocrinology, 104(1), 105 -8. 
Skrede, K. K., & Westgaard, R. H. (1971). The transverse hippocampal slice: a well -defined cortical 
structure maintained in vitro. Brain Research, 35(2), 589 -93. 
Sladek, C. D., & Knigge, K. M. (1977). Osmotic control of vasopressin release by rat hypothalamo- 
neurohypophyseal explants in organ culture. 101(6), 1834 -8. 
Sladek, C. D., Swenson, K. L., Kapoor, R., & Sidorowicz, H. E. (2000). The role of steroid hormones 
in the regulation of vasopressin and oxytocin release and mRNA expression in hypothalamo- 
neurohypophysial explants from the rat. Experimental Physiology, 85S (special edition), 171S-177S. 
Sloviter, R. S. (1983). Epileptic brain damage in rats induced by sustained electrical stimulation of the 
perforant path. I. Acute electrophysiological and light microscopic studies. Brain Research Bulletin, 
10(5), 675 -97. 
Sloviter, R. S., Valiquette, G., Abrams, G. M., Ronk, E. C., Sollas, A. L., Paul, L. A., & Neubort, S. 
(1989). Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. 
Science, 243(4890), 535 -8. 
Smith, D. F. (1993). Dynamics of heat shock protein 90- progesterone receptor 
binding and the 
disactivation loop model for steroid receptor complexes. Molecular 
Endocrinology, 7(11), 1418 -29. 
iS. l.i1...11llll.l.J 
239 
Smith, D. F., & Toft, D. 0. (1993). Steroid receptors and their associated proteins. Molecular 
Endocrinology, 7(1), 4 -11. 
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., 
Lubahn, D. B., & Korach, K. S. (1994). Estrogen resistance caused by a mutation in the estrogen - 
receptor gene in a man [see comments] [published erratum appears in N Engl J Med 1995 Jan 
12;332(2):131]. New England Journal Of Medicine, 331(16), 1056 -61. 
Soloff, M. S., Fernström, M. A., & Fernström, M. J. (1989). Vasopressin and oxytocin receptors on 
plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation 
of inositol phosphate formation, and oxytocin receptors by binding of a specific 1251- labeled oxytocin 
antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr- NH2(9)]OVT. Biochemistry And Cell Biology, 67(2 -3), 
152 -62. 
Spencer, R. L., Young, E. A., Choo, P. H., & McEwen, B. S. (1990). Adrenal steroid type I and type 
II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying 
level of steroid. Brain Research, 514(1), 37 -48. 
Squire, L. R. (1992). Memory and the hippocampus: a synthesis from findings with rats, monkeys, 
and humans [published erratum appears in Psychol Rev 1992 Jul;99(3):582]. Psychological Review, 
99(2), 
Squire, L. R., Shimamura, A. P., & Amaral, D. G. (1989). Memory and the hippocampus. In J. H. 
Byrne & W. O. Berry (Eds.), Neural Models of Plasticity: Experimental and Theoretical Approaches 
(pp. 208 -239). San Diego: Academic Press. 
Stavreus- Evers, A. C., Freyschuss, B., & Eriksson, H. A. (1997). Hormonal regulation of the estrogen 
receptor in primary cultures of hepatocytes from female rats. Steroids, 62(10), 647 -54. 
Stedronsky, K., Walther, N., & Ivell, R. (1999, ). The -160 hormone response element of the human 
oxytocin gene is not a natural target for estrogen receptors. Paper presented at the 1999 World 
Congress on Neurohypophysial Hormones, Edinburgh, Scotland. 
Stone, J. D., Crofton, J. T., & Share, L. (1989). Sex differences in central 
adrenergic control of 
vasopressin release. American Journal Of Physiology, 257(5 Pt 2), R1040 
-5. 
Stricker, E. M., & Verbalis, J. G. (1987). Central inhibitory 
control of sodium appetite in rats: 
correlation with pituitary oxytocin secretion. Behavioral Neuroscience, 
101(4), 560 -7. 
IAG1G1GI14GJ 240 
Stricker, E. M., & Verbalis, J. G. (1996). Central inhibition of salt appetite by oxytocin in rats. 
Regulatory Peptides, 66(1 -2), 83 -5. 
Stumpf, W. E. (1970). Estrogen- neurons and estrogen- neuron systems in the periventricular brain. 
American Journal Of Anatomy, 129(2), 207 -17. 
Suemaru, S., Hashimoto, K., Ogasa, T., Takao, T., Ota, Z., Hirakawa, M., & Kawata, M. (1990). 
Effects of hyperosmotic stimulation and adrenalectomy on vasopressin mRNA levels in the 
paraventricular and supraoptic nuclei of the hypothalamus: in situ hybridization histochemical 
analysis using a synthetic oligonucleotide probe. Acta Medica Okayama, 44(5), 233 -41. 
Summerlee, A. J. (1981). Extracellular recordings from oxytocin neurones during the expulsive phase 
of birth in unanaesthetized rats. Journal Of Physiology, 321, 1 -9. 
Sun, J., Meyers, M. J., Fink, B. E., Rajendran, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. 
(1999). Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor -alpha 
or estrogen receptor -beta. Endocrinology, 140(2), 800 -4. 
Swaab, D. F., Nijveldt, F., & Pool, C. W. (1975a). Distribution of oxytocin and vasopressin in the rat 
supraoptic and paraventricular nucleus. Journal Of Endocrinology, 67(3), 461 -2. 
Swaab, D. F., Pool, C. W., & Nijveldt, F. (1975b). Immunofluorescence of vasopressin and oxytocin 
in the rat hypothalamo -neurohypophypopseal system. Journal Of Neural Transmission, 36(3 -4), 195- 
215. 
Swanson, L. W. (1987). The hypothalamus. In B. Bjorklund & T. Hokfelt (Eds.), Handbook of 
Chemical Neuroanatomy (pp. 1 -124). Amsterdam: Elsevier. 
Swanson, L. W., Kohler, C., & Bjorklund, A. (1987). The limbic region. I: the septohippocampal 
system. In A. Bjorklund, T. Hokfelt, & L. W. Swanson (Eds.), Handbook of Chemical Neuroanatomy 
(Vol. 5, pp. 125 -277). Amsterdam: Elsevier. 
Swanson, L. W., & Kuypers, H. G. (1980). The paraventricular 
nucleus of the hypothalamus: 
cytoarchitectonic subdivisions and organization of projections to the 
pituitary, dorsal vagal complex, 
and spinal cord as demonstrated by retrograde fluorescence 
double -labeling methods. Journal Of 
Comparative Neurology, 194(3), 555 -70. 
241 
Swanson, L. W., & Sawchenko, P. E. (1983). Hypothalamic integration: organization of the 
paraventricular and supraoptic nuclei. Annual Review Of Neuroscience, 6, 269 -324. 
Swanson, L. W., Sawchenko, P. E., Wiegand, S. J., & Price, J. L. (1980). Separate neurons in the 
paraventricular nucleus project to the median eminence and to the medulla or spinal cord. Brain 
Research, 198(1), 190 -5. 
Swanson, L. W., & Simmons, D. M. (1989). Differential steroid hormone and neural influences on 
peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study 
in the rat. Journal Of Comparative Neurology, 285(4), 413 -35. 
Swenson, K. L., & Sladek, C. D. (1997). Gonadal steroid modulation of vasopressin secretion in 
response to osmotic stimulation. Endocrinology, 138(5), 2089 -97. 
Tanapat, P., Hastings, N. B., Reeves, A. J., & Gould, E. (1999). Estrogen stimulates a transient 
increase in the number of new neurons in the dentate gyrus of the adult female rat. Journal Of 
Neuroscience, 19(14), 5792 -801. 
Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, 
R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease [see 
comments]. Lancet, 348(9025), 429 -32. 
Tannahill, L. A., Sheward, W. J., Robinson, I. C., & Fink, G. (1991). Corticotrophin -releasing factor - 
41, vasopressin and oxytocin release into hypophysial portal blood in the rat: effects of electrical 
stimulation of the hypothalamus, amygdala and hippocampus. Journal Of Endocrinology, 129(1), 99- 
107. 
Tchoudakova, A., Pathak, S., & Callard, G. V. (1999). Molecular cloning of an estrogen receptor beta 
subtype from the goldfish, Carassius auratus. General And Comparative Endocrinology, 113(3), 388- 
400. 
Thomas, A., & Amico, J. A. (1996). Sequential estrogen and progesterone 
(P) followed by P 
withdrawal increases the level of oxytocin messenger ribonucleic acid 
in the hypothalamic 
paraventricular nucleus of the male rat. Life Sciences, 58(19), 1615 -20. 
Thomas, A., Crowley, R. S., & Amico, J. A. (1995). Effect of progesterone 
on hypothalamic oxytocin 
messenger ribonucleic acid levels in the lactating rat. Endocrinology, 
136(10), 4188 -94. 
References 242 
Thompson, R. C., Seasholtz, A. F., & Herbert, E. (1987). Rat corticotropin- releasing hormone gene: 
sequence and tissue -specific expression. Molecular Endocrinology, 1(5), 363 -70. 
Tian, P. S., & Ingram, C. D. (1997). Evidence for independent hypertensive effects of oxytocin and 
vasopressin in the rat dorsal vagal complex. Neuroscience Research, 27(3), 285 -8. 
Tierney, M. C., & Luire, V. N. (1997). New concepts in hormone replacement: Selective estrogen 
receptor modulators (SERMS). IV. Effects of estrogens and antiestrogens on the CNS. Journal of 
Canadian Society of Obstetrics and Gynecology, 19 (Supplement), 46 -56. 
Tolchard, S., & Ingram, C. D. (1993). Electrophysiological actions of oxytocin in the dorsal vagal 
complex of the female rat in vitro: changing responsiveness during the oestrous cycle and after steroid 
treatment. Brain Research, 609(1 -2), 21 -8. 
Tremblay, G. B., Tremblay, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Labrie, F., & Giguère, 
V. (1997). Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor 
beta. Molecular Endocrinology, 11(3), 353 -65. 
Tremblay, G. B., Tremblay, A., Labrie, F., & Giguère, V. (1999). Dominant activity of activation 
function 1 (AF -1) and differential stoichiometric requirements for AF -1 and -2 in the estrogen 
receptor alpha -beta heterodimeric complex. Molecular And Cellular Biology, 19(3), 1919 -27. 
Tribollet, E., Barberis, C., Dreifuss, J. J., & Jard, S. (1988a). Autoradiographic localization of 
vasopressin and oxytocin binding sites in rat kidney. Kidney International, 33(5), 959 -65. 
Tribollet, E., Barberis, C., Jard, S., Dubois -Dauphin, M., & Dreifuss, J. J. (1988b). Localization and 
pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat 
brain by light microscopic autoradiography. Brain Research, 442(1), 105 -18. 
Tsai, M. J., & O'Malley, B. W. (1994). Molecular mechanisms of action of steroid /thyroid receptor 
superfamily members. Annual Review Of Biochemistry, 63, 451 -86. 
Tsien, J. Z., Huerta, P. T., & Tonegawa, S. (1996). The essential role of hippocampal 
CA I NMDA 
receptor- dependent synaptic plasticity in spatial memory [see comments]. 
Cell, 87(7), 1327 -38. 
References 243 
Uhl, G. R., Zingg, H. H., & Habener, J. F. (1985). Vasopressin mRNA in situ hybridization: 
localization and regulation studied with oligonucleotide cDNA probes in normal and Brattleboro rat 
hypothalamus. Proceedings Of The National Academy Of Sciences Of The United States Of America, 
82(16), 5555 -9. 
Uht, R. M., McKelvy, J. F., Harrison, R. W., & Bohn, M. C. (1988). Demonstration of glucocorticoid 
receptor -like immunoreactivity in glucocorticoid- sensitive vasopressin and corticotropin- releasing 
factor neurons in the hypothalamic paraventricular nucleus. Journal Of Neuroscience Research, 19(4), 
405 -11, 468 -9. 
Vamvakopoulos, N. C., & Chrousos, G. P. (1993). Evidence of direct estrogenic regulation of human 
corticotropin- releasing hormone gene expression. Potential implications for the sexual dimophism of 
the stress response and immune /inflammatory reaction. Journal Of Clinical Investigation, 92(4), 1896- 
902. 
Van Hoesen, G. W., Augustinack, J. C., & Redman, S. J. (1999). Ventromedial temporal lobe 
pathology in dementia, brain trauma, and schizophrenia. Annals Of The New York Academy Of 
Sciences, 877, 575 -94. 
Van Tol, H. H., Bolwerk, E. L., Liu, B., & Burbach, J. P. (1988). Oxytocin and vasopressin gene 
expression in the hypothalamo -neurohypophyseal system of the rat during the estrous cycle, 
pregnancy, and lactation. Endocrinology, 122(3), 945 -51. 
Van Tol, H. H., Voorhuis, D. T., & Burbach, J. P. (1987). Oxytocin gene expression in discrete 
hypothalamic magnocellular cell groups is stimulated by prolonged salt loading. Endocrinology, 
120(1), 71 -6. 
Vandesande, F., & Dierickx, K. (1975). Identification of the vasopressin producing 
and of the 
oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy 
system of the rat. Cell 
And Tissue Research, 164(2), 153 -62. 
Vandesande, F., & Dierickx, K. (1979). The activated hypothalamic 
magnocellular neurosecretory 
system and the one neuron --one neurohypophysial hormone 
concept. Cell And Tissue Research, 
200(1), 29 -33. 
Verbalis, J. G. (1993). Osmotic inhibition of neurohypophysial 
secretion. Annals Of The New York 
Academy Of Sciences, 689, 146 -60. 
References 244 
Verbalis, J. G., Blackburn, R. E., Hoffman, G. E., & Stricker, E. M. (1995). Section C: Oxytocin and 
Behaviour Establishing behavioural and Physiological Functions of Central Oxytocin: Insights from 
Studies of Oxytocin and Ingestive Behaviours. In R. Ivell & J. A. Russell (Eds.), Oxytocin; Cellular 
and Molecular Approaches in Medicine and Research (Vol. 395, pp. 209 -225). new York: Plenum 
Press. 
Verbalis, J. G., Mangione, M. P., & Stricker, E. M. (1991). Oxytocin produces natriuresis in rats at 
physiological plasma concentrations. Endocrinology, 128(3), 1317 -22. 
Viau, V., & Meaney, M. J. (1991). Variations in the hypothalamic -pituitary- adrenal response to stress 
during the estrous cycle in the rat. Endocrinology, 129(5), 2503 -11. 
Waddell, B. J., & Atkinson, H. C. (1994). Production rate, metabolic clearance rate and uterine 
extraction of corticosterone during rat pregnancy. Journal Of Endocrinology, 143(1), 183 -90. 
Wade, C. E., Bie, P., Keil, L. C., & Ramsay, D. J. (1982). Effect of hypertonic intracarotid infusions 
on plasma vasopressin concentration. American Journal Of Physiology, 243(6), E522- 6.Wakerley, J. 
B., & Lincoln, D. W. (1973). The milk- ejection reflex of the rat: a 20- to 40 -fold acceleration in the 
firing of paraventricular neurones during oxytocin release. Journal Of Endocrinology, 57(3), 477 -93. 
Wagner, C. K., & Morrell, J. I. (1996). Levels of estrogen receptor immunoreactivity are altered in 
behaviorally -relevant brain regions in female rats during pregnancy. Brain Research. Molecular Brain 
Research, 42(2), 328 -36. 
Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., 
Scrace, G., Waterfield, M., & al, e. (1985). Cloning of the human estrogen receptor cDNA. 
Proceedings Of The National Academy Of Sciences Of The United States Of America, 82(23), 7889- 
93. 
Wang, H., Zeng, X., & Khan, S. A. (1999). Estrogen receptor varients ERdelta5 and ER delta7 down - 
regulate wild -type estrogen receptor activity. Molecular and Cellular Endocrinology, 156, 159 -168. 
Wang, H., Ward, A. R., & Morris, J. F. (1995). Oestradiol acutely stimulates 
exocytosis of oxytocin 
and vasopressin from dendrites and somata of hypothalamic magnocellular neurons. 
Neuroscience, 
68(4), 1179 -88. 
Warner, M., Nilsson, S., & Gustafsson, J. A. (1999). The estrogen 
receptor family. Current Opinion In 
Obstetrics And Gynecology, 11(3), 249 -54. 
References 245 
Warren, S. G., Humphreys, A. G., Juraska, J. M., & Greenough, W. T. (1995). LTP varies across the 
estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Research, 703(1 -2), 26 -30. 
Watanabe, T., Inoue, S., Ogawa, S., Ishii, Y., Hiroi, H., Ikeda, K., Orimo, A., & Muramatsu, M. 
(1997). Agonistic effect of tamoxifen is dependent on cell type, ERE- promoter context, and estrogen 
receptor subtype: functional difference between estrogen receptors alpha and beta. Biochemical And 
Biophysical Research Communications, 236(1), 140 -5. 
Watanabe, Y., Gould, E., Cameron, H. A., Daniels, D. C., & McEwen, B. S. (1992a). Phenytoin 
prevents stress- and corticosterone- induced atrophy of CA3 pyramidal neurons. Hippocampus, 2(4), 
431 -5. 
Watanabe, Y., Gould, E., & McEwen, B. S. (1992b). Stress induces atrophy of apical dendrites of 
hippocampal CA3 pyramidal neurons. Brain Research, 588(2), 341 -5. 
Wafters, J. J., Poulin, P., & Dorsa, D. M. (1998). Steroid hormone regulation of vasopressinergic 
neurotransmission in the central nervous system. Progress In Brain Research, 119, 247 -61. 
Way, S. A., & Leng, G. (1992). Relaxin increases the firing rate of supraoptic neurones and increases 
oxytocin secretion in the rat. Journal Of Endocrinology, 132(1), 149 -58. 
Wehling, M. (1997). Specific, nongenomic actions of steroid hormones. Annual Review Of 
Physiology, 59, 365 -93. 
Weiland, N. G., Orikasa, C., Hayashi, S., & McEwen, B. S. (1997). Distribution and hormone 
regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. 
Journal Of Comparative Neurology, 388(4), 603 -12. 
Weiss, M. L., Yang, Q. Z., & Hatton, G. I. (1989). Magnocellular tuberomammillary nucleus input to 
the supraoptic nucleus in the rat: anatomical and in vitro electrophysiological investigations. 
Neuroscience, 31(2), 299 -311. 
White, R., Lees, J. A., Needham, M., Ham, J., & Parker, M. (1987). 
Structural organization and 
expression of the mouse estrogen receptor. Molecular Endocrinology, 1(10), 735 -44. 
Whitnall, M. H. (1993). Regulation of the hypothalamic 
corticotropin- releasing hormone 
neurosecretory system. Progress In Neurobiology, 40(5), 573 -629. 
References 246 
Whitnall, M. H., Smyth, D., & Gainer, H. (1987). Vasopressin coexists in half of the corticotropin- 
releasing factor axons present in the external zone of the median eminence in normal rats. 
Neuroendocrinology, 45(5), 420 -4. 
Wiegand, S. J., & Price, J. L. (1980). Cells of origin of the afferent fibers to the median eminence in 
the rat. Journal Of Comparative Neurology, 192(1), 1 -19. 
Wilkinson, D.G. (1992). The theory and practice of in situ hybridisation. In D.G. Wilkinson (Ed.), In 
Situ Hybridisation: A practical approach (pp. 1 -13). New York: 
Oxford University Press. 
Williams, C. L., Barnett, A. M., & Meck, W. H. (1990). Organizational effects of early gonadal 
secretions on sexual differentiation in spatial memory. Behavioral Neuroscience, 104(1), 84 -97. 
Williams, C. L., & Meck, W. H. (1991). The organizational effects of gonadal steroids on sexually 
dimorphic spatial ability. Psychoneuroendocrinology, 16(1 -3), 155 -76. 
Wilson, M. M., Greer, S. E., Greer, M. A., & Roberts, L. (1980). Hippocampal inhibition of pituitary- 
adrenocortical function in female rats. Brain Research, 197(2), 433 -41. 
Wolfson, B., Manning, R. W., Davis, L. G., Arentzen, R., & Baldino, F. J. (1985). Co- localization of 
corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature, 
315(6014), 59 -61. 
Wong, M., & Moss, R. L. (1992). Long -term and short-term electrophysiological effects of estrogen 
on the synaptic properties of hippocampal CAI neurons. Journal Of Neuroscience, 12(8), 3217 -25. 
Woolley, C. S., Gould, E., Frankfurt, M., & McEwen, B. S. (1990a). Naturally occurring fluctuation 
in dendritic spine density on adult hippocampal pyramidal neurons. Journal Of Neuroscience, 10(12), 
4035-9. 
Woolley, C. S., Gould, E., & McEwen, B. S. (1990b). Exposure to excess glucocorticoids 
alters 
dendritic morphology of adult hippocampal pyramidal neurons. Brain Research, 531(1 -2), 225 -31. 
Woolley, C. S., & McEwen, B. S. (1992). Estradiol mediates fluctuation 
in hippocampal synapse 
density during the estrous cycle in the adult rat [published erratum 
appears in J Neurosci 1992 
Oct;12(10):following table of contents]. Journal Of Neuroscience, 12(7), 
2549 -54. 
References 247 
Woolley, C. S., & McEwen, B. S. (1993). Roles of estradiol and progesterone in regulation of 
hippocampal dendritic spine density during the estrous cycle in the rat. Journal Of Comparative 
Neurology, 336(2), 293 -306. 
Woolley, C. S., Weiland, N. G., McEwen, B. S., & Schwartzkroin, P. A. (1997). Estradiol increases 
the sensitivity of hippocampal CAI pyramidal cells to NMDA receptor- mediated synaptic input: 
correlation with dendritic spine density. Journal Of Neuroscience, 17(5), 1848 -59. 
Xia, Z., Patiño, R., Gale, W. L., Maule, A. G., & Densmore, L. D. (1999). Cloning, in vitro 
expression, and novel phylogenetic classification of a channel catfish estrogen receptor. General And 
Comparative Endocrinology, 113(3), 360 -8. 
Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, 
J. N., Seeger, M., Relkin, N. R., Liao, F., Checler, F., Buxbaum, J. D., Chit, B. T., Thinakaran, G., 
Sisodia, S. S., Wang, R., Greengard, P., & Gandy, S. (1998). Estrogen reduces neuronal generation of 
Alzheimer beta -amyloid peptides. Nature Medicine, 4(4), 447 -51 
Yagil, C., & Sladek, C. D. (1990). Effect of extended exposure to hypertonicity on vasopressin 
messenger ribonucleic acid content in hypothalamo -neurohypophyseal explants. Endocrinology, 
127(3), 1428 -35. 
Yamaguchi, K., Akaishi, T., & Negoro, H. (1979). Effect of estrogen treatment on plasma oxytocin 
and vasopressin in ovariectomized rats. Endocrinologia Japonica, 26(2), 197 -205. 
Yamamoto, C., & Mcllwain, H. (1966). Electrical activities in thin sections from the mammalian 
brain maintained in chemically -defined media in vitro. Journal Of Neurochemistry, 13(12), 1333 -43. 
Yang, Q. Z., & Hatton, G. I. (1994). Histamine mediates fast synaptic inhibition of rat supraoptic 
oxytocin neurons via chloride conductance activation. Neuroscience, 61(4), 955 -64. 
Yates, F. E., Russell, S. M., Dallman, M. F., Hodge, G. A., McCann, S. M., & Dhariwal, A. 
P. (1971). 
Potentiation by vasopressin of corticotropin release induced by corticotropin- releasing 
factor. 
Endocrinology, 88(1), 3 -15. 
Young, T. K., & Van Dyke, H. B. (1968). Repletion of vasopressin 
and oxytocin in the posterior lobe 
of the pituitary gland of the rat. Journal Of Endocrinology, 40(3), 337 -42. 
References 
248 
Young, W. S. 3rd. (1986). Corticotropin- releasing factor mRNA in the hypothalamus is affected 
differently by drinking saline and by dehydration. Febs Letters, 208(1), 158 -62. 
Young, W. S. 3rd., Mezey, E., & Siegel, R. E. (1986a). Quantitative in situ hybridization 
histochemistry reveals increased levels of corticotropin- releasing factor mRNA after adrenalectomy in 
rats. Neuroscience Letters, 70(2), 198 -203. 
Young, W. S. 3rd., Mezey, E., & Siegel, R. E. (1986b). Vasopressin and oxytocin mRNAs in 
adrenalectomized and Brattleboro rats: analysis by quantitative in situ hybridization histochemistry. 
Brain Research, 387(3), 231 -41. 
Young, W. S. 3rd., Shepard, E., Amico, J., Hennighausen, L., Wagner, K. U., LaMarca, M. E., 
McKinney, C., & Ginns, E. I. (1996). Deficiency in mouse oxytocin prevents milk ejection, but not 
fertility or parturition. Journal Of Neuroendocrinology, 8(11), 847 -53. 
Zhou, L., Blaustein, J. D., & De Vries, G. J. (1994). Distribution of androgen receptor 
immunoreactivity in vasopressin- and oxytocin -immunoreactive neurons in the male rat brain. 
Endocrinology, 134(6), 2622 -7. 
Zhou, Y., Shughrue, P. J., & Dorsa, D. M. (1995). Estrogen receptor protein is differentially regulated 
in the preoptic area of the brain and in the uterus during the rat estrous cycle. Neuroendocrinology, 
61(3), 276 -83. 
Zingg, H. H. (1996). Vasopressin and oxytocin receptors. Baillieres Clinical Endocrinology And 
Metabolism, 10(1), 75 -96. 
Zingg, H. H., & Lefebvre, D. L. (1988). Oxytocin and vasopressin gene expression during gestation 
and lactation. Brain Research, 464(1), 1 -6. 
Zingg, H. H., & Lefebvre, D. L. (1989). Oxytocin mRNA: increase of polyadenylate tail size during 
pregnancy and lactation. Molecular And Cellular Endocrinology, 65(1 -2), 59 -62. 
Zlokovic, B. V., Jovanovic, S., Miao, W., Samara, S., Verma, S., & Farrell, C. L. (2000). Differential 
regulation of leptin transport by the choroid plexus and blood -brain barrier and high affinity transport 
systems for entry into hypothalamus and across the blood- cerebrospinal fluid barrier. Endocrinology, 
141(4), 1434 -41. 
